0001829126-23-002253.txt : 20230324 0001829126-23-002253.hdr.sgml : 20230324 20230324170113 ACCESSION NUMBER: 0001829126-23-002253 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 60 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230324 DATE AS OF CHANGE: 20230324 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Innovative Eyewear Inc CENTRAL INDEX KEY: 0001808377 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 842794274 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41392 FILM NUMBER: 23760646 BUSINESS ADDRESS: STREET 1: 11900 BISCAYNE BLVD STREET 2: STE 630 CITY: MIAMI STATE: FL ZIP: 33181 BUSINESS PHONE: 786-910-1898 MAIL ADDRESS: STREET 1: 66 W FLAGLER ST. SUITE 900 STREET 2: STE 216 CITY: MIAMI STATE: FL ZIP: 33130 10-K 1 innovativeeye_10k.htm 10-K
0001808377 false 2022 FY 0001808377 2022-01-01 2022-12-31 0001808377 LUCY:CommonStock0.00001ParValueMember 2022-01-01 2022-12-31 0001808377 LUCY:WarrantsToPurchaseCommonStockMember 2022-01-01 2022-12-31 0001808377 2022-06-30 0001808377 2023-03-17 0001808377 2022-12-31 0001808377 2021-12-31 0001808377 2021-01-01 2021-12-31 0001808377 us-gaap:CommonStockMember 2021-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2021-12-31 0001808377 us-gaap:RetainedEarningsMember 2021-12-31 0001808377 us-gaap:CommonStockMember 2020-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2020-12-31 0001808377 us-gaap:RetainedEarningsMember 2020-12-31 0001808377 2020-12-31 0001808377 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2022-01-01 2022-12-31 0001808377 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001808377 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2021-01-01 2021-12-31 0001808377 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001808377 us-gaap:CommonStockMember 2022-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2022-12-31 0001808377 us-gaap:RetainedEarningsMember 2022-12-31 0001808377 LUCY:MobileKioskDisplayMember 2022-12-31 0001808377 LUCY:MobileKioskDisplayMember 2021-12-31 0001808377 LUCY:MobileKioskDisplayMember 2022-01-01 2022-12-31 0001808377 us-gaap:ComputerEquipmentMember 2022-12-31 0001808377 us-gaap:ComputerEquipmentMember 2021-12-31 0001808377 us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0001808377 us-gaap:OfficeEquipmentMember 2022-12-31 0001808377 us-gaap:OfficeEquipmentMember 2021-12-31 0001808377 us-gaap:OfficeEquipmentMember 2022-01-01 2022-12-31 0001808377 LUCY:InternalUseSoftwareMember 2022-12-31 0001808377 LUCY:InternalUseSoftwareMember 2021-12-31 0001808377 LUCY:InternalUseSoftwareMember srt:MinimumMember 2022-01-01 2022-12-31 0001808377 LUCY:InternalUseSoftwareMember srt:MaximumMember 2022-01-01 2022-12-31 0001808377 us-gaap:PatentsMember 2022-12-31 0001808377 us-gaap:PatentsMember 2021-12-31 0001808377 LUCY:ParentAndAffiliatesMember 2020-11-29 2020-12-01 0001808377 2022-05-30 2022-06-01 0001808377 2022-06-01 0001808377 2022-09-01 2022-09-05 0001808377 2022-09-05 0001808377 LUCY:ParentAndAffiliatesMember 2021-10-29 2021-11-01 0001808377 2022-11-01 2022-11-16 0001808377 2022-11-16 0001808377 us-gaap:IPOMember LUCY:LucydMember 2022-08-01 2022-08-15 0001808377 us-gaap:IPOMember LUCY:LucydMember 2022-08-15 0001808377 LUCY:TekcapitalEuropeLtdMember 2022-01-01 2022-12-31 0001808377 LUCY:TekcapitalEuropeLtdMember 2021-01-01 2021-12-31 0001808377 us-gaap:IPOMember 2022-08-01 2022-08-17 0001808377 us-gaap:CommonStockMember 2022-08-01 2022-08-17 0001808377 us-gaap:IPOMember 2022-08-17 0001808377 us-gaap:IPOMember LUCY:MaximMember 2022-08-01 2022-08-15 0001808377 us-gaap:IPOMember LUCY:MaximMember 2022-08-15 0001808377 us-gaap:IPOMember 2022-08-01 2022-08-15 0001808377 srt:MinimumMember 2022-12-31 0001808377 srt:MaximumMember 2022-12-31 0001808377 srt:MinimumMember 2022-01-01 2022-12-31 0001808377 srt:MaximumMember 2022-01-01 2022-12-31 0001808377 us-gaap:SubsequentEventMember 2023-02-01 2023-02-28 0001808377 us-gaap:SubsequentEventMember 2023-02-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-K

 

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2022

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission file number: 001-41392

 

INNOVATIVE EYEWEAR, INC.

 

 

(Exact Name of Registrant as Specified in its Charter)

 

Florida   84-2794274

(State or Other Jurisdiction of
Incorporation or Organization)

  

(I.R.S. Employer

Identification No.)

 

11900 Biscayne Blvd., Suite 630

North Miami, Florida 33181

(954) 826-0329

 

(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class:   Trading Symbol   Name of Each Exchange on Which Registered:
Common Stock, $0.00001 par value   LUCY   The NASDAQ Stock Market LLC
Warrants to purchase Common Stock   LUCYW   The NASDAQ Stock Market LLC

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐   No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐   No ☒

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒   No ☐

 

 

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer ☐ Accelerated filer ☐
  Non-accelerated filer ☒ Smaller reporting company ☒
  Emerging growth company ☒  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the fi ling reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐   No ☒

 

The registrant’s shares were not listed on any exchange and had no value as of the last business day of the second fiscal quarter of 2022. The registrant’s shares of common stock began trading on The NASDAQ Capital Market on August 15, 2022.

 

As of March 17, 2023, the registrant had outstanding 7,715,757 shares of common stock, par value $0.00001 per share, which is the registrant’s only class of common stock.

 

DOCUMENTS INCORPORATED BY REFERENCE:

 

NONE

 

 

 

 

 

 

TABLE OF CONTENTS

 

        Page
PART I
         
Item 1.   Business   1
Item 1A.   Risk Factors   20
Item 1B.   Unresolved Staff Comments   42
Item 2.   Properties   42
Item 3.   Legal Proceedings   42
Item 4.   Mine Safety Disclosures   42
         
PART II
         
Item 5.   Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities   43
Item 6.   Reserved   43
Item 7.   Management’s Discussion and Analysis of Financial Condition and Results of Operations   44
Item 7A.   Quantitative and Qualitative Disclosures about Market Risk   56
Item 8.   Financial Statements and Supplementary Data   56
Item 9.   Changes in and Disagreements With Accountants on Accounting and Financial Disclosure   56
Item 9A.   Controls and Procedures   56
Item 9B.   Other Information   57
         
PART III
         
Item 10.   Directors, Executive Officers and Corporate Governance   58
Item 11.   Executive Compensation   62
Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters   68
Item 13.   Certain Relationships and Related Transactions, and Director Independence   69
Item 14.   Principal Accounting Fees and Services   71
         
PART IV
         
Item 15.   Exhibits, Financial Statement Schedules   72
Item 16.   Form 10-K Summary   73

 

i

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

Information included in this Annual Report on Form 10-K (this “Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results. We generally use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “will” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in this Report under “Item 1A. – Risk Factors” below. Except as required by applicable law, including the securities laws of the United States, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this Report.

 

CERTAIN TERMS USED IN THIS REPORT

 

References in this Report to “we,” “us,” “our,” the “Company” or “Innovative Eyewear” means Innovative Eyewear, Inc. unless otherwise indicated.

 

ii

 

 

PART I

 

Item 1. Business.

 

Our History

 

We develop and sell smart eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Founded and headquartered in Miami, Florida, we were initially organized as a Florida limited liability company effective August 15, 2019. We were founded by Lucyd Ltd., the inventor and licensor of the technology that our products are based upon which is a portfolio company of Tekcapital Europe Ltd. (“Tekcapital”). Tekcapital is a U.K. based university intellectual property accelerator. Tekcapital builds portfolio companies around new technologies. On March 26, 2020, we converted from a Florida limited liability company into a Florida corporation.

 

Our Product

 

In January 2020, we introduced our first beta product and began market testing.

 

In January 2021, we officially launched our first commercial product, Lucyd Lyte® (“Lucyd Lyte”). This initial product offering embodied our goal of creating smart eyewear for all day wear that looks like and is priced similarly to designer eyewear, but is also light weight and comfortable, and enables the wearer to remain connected to their digital lives. The product was initially launched with six styles, and in September 2021, an additional six styles were added.

 

We recently launched version 2.0 of our Lucyd Lyte eyewear, and our current product offering consists of 16 version 1.0 models and 15 version 2.0 models, which offers a similar amount of style variety as many traditional eyewear collections. All styles are each available with 70 different lens types, resulting in hundreds of variations of products currently available.

 

Additionally, Lucyd Lyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands-free. Some of the many things that can be done with Lucyd Lyte glasses include:

 

  1. “Send a voice message to (contact)”: this command begins the recording of an audio message to be sent to named contact.
     
  2. “Send a text to (contact)”: begins recording of a speech-to-text message to be sent by SMS to named contact.
     
  3. “Call (contact)”: speed-dials the named contact.
     
  4. “Send $___ to (contact)”: this command allows our user to send money to a contact via Venmo or Apple Pay. Follow the digital assistant’s prompts to confirm.
     
  5. “Check my messages”: this command reads out our user’s latest incoming text messages and offers a prompt to reply to each. Close out the digital assistant to end the readout.
     
  6. “Check my mailbox”: this command announces the number of unread emails, and reads them out with a prompt to continue after each one. In the prompt after each one, our customers can tell their digital assistant “Reply” and dictate an email response to the previous email.
     
  7.  “Find (cuisine type) food nearby”: this command reads through a list of nearby restaurants and their ratings, and prompts our user for directions or to call after each one.

 

1

 

 

  8. “Call me an Uber”: this command prompts our user on which type of Uber ride they want, then asks to confirm to send a car to our user’s location.
     
  9. “What time is it?”: announces the current time.
     
  10. “Play (song/album/artist)”: this command begins playing the requested song, album or artist via Apple Music.
     
  11. “Get me directions to (location)”: this command begins navigating on phone, with audible directions on glasses.
     
  12. “Take a memo”: this command begins recording a speech-to-text memo in Notes. Say “Read my Notes” to play back.

 

Since the launch of Lucyd Lyte, we witnessed interest and demand from customers throughout the United States and have sold thousands of our smart glasses. Within six months of the launch of Lucyd Lyte, several optical stores in the United States and Canada have on- boarded the product and we have had discussions with several other large eyewear chains (by number of locations) regarding onboarding our product. We believe smart eyewear is a product category whose time has come, and we believe we are well positioned to capitalize on and help develop this exciting new sector–where eyewear meets electronics in a user-friendly, mass market format, priced similarly to designer eyewear.

 

In first quarter of 2022 we introduced a virtual try-on kiosk for select retail stores. This device introduces our products to prospective retail customers and enables them to digitally try-on our line of smart glasses in a touch free manner.

 

We anticipate introducing six styles of Nautica smart eyewear, six to twelve additional styles of Lucyd Lyte glasses, and our first Bluetooth safety glasses in 2023. In addition, we anticipate the following upgrades to accessory products in 2023:

 

●The patent-pending Lucyd charging dock will be upgraded to feature a charging status LED and USB data capability, enabling it to be used as a USB hub for computers in addition to a charging hub.

 

●The Lucyd virtual try-on kiosk will be upgraded with a store control panel enabling the kiosk owner to change the display into Spanish language mode and control which frames and lens options are shown in the digital experience.

 

In the fourth quarter of 2022, we introduced key features in the Vyrb app, including live broadcasts for up to 100 users in one digital “room”, and the ability to upload external audio content into Vyrb, enabling longstanding content creators to import their existing libraries swiftly into the platform. Also in the fourth quarter of 2022, we completed development of core audio eyewear product improvements, such as upgrading all frames to quadraphonic sound, which have been rolled out across all new eyewear models as of January 2023.

 

Our Mission

 

Our mission is to Upgrade Your Eyewear®. Our smart eyewear is a fusion of headphones with glasses, bringing vision correction and protection together with digital connectivity and clear audio, while also offering a safer solution for listening to music outdoors (as compared to in-ear headphones). The convenience of having a Bluetooth headset and comfortable glasses in one, especially for those who are already accustomed to all-day eyewear use, offers a lifestyle upgrade at a price most consumers can afford.

 

In a sense, we view this integration of technology and vison correction/protection as the next evolutionary step in the development of eyewear. Over the entire course of eyewear development and history, many of the innovations have dealt with improving the lenses of the glasses. Notably, eyewear frames have not improved much in the past 400 years, with the exception, in our view, of the utilization of plastic to reduce weight and provide a wider range of designs and finishes, and the introduction of new hinge types. We view the integration of Bluetooth technology into the arms of the glasses as one of the key next steps to Upgrade Your Eyewear®.

 

Our focus is to enhance one of the world’s most important wearables: eyewear.

 

2

 

 

Additionally, as part of our commitment to a great customer experience, we listen to feedback from our customers, and continuously strive to improve customer satisfaction and experience with our products. Our customers’ extensive feedback pointed to a need and desire for better interaction with social media while on-the-go. We are addressing this need by developing an exciting software application called Vyrb™, which enables Lucyd Lyte users to hear and reply to social media posts, with their voice, hands-free, through their glasses (“Vyrb”). Other Vyrb users will be able hear these posts. Additionally, Vyrb offers Lucyd Lyte users external social media sharing features, which allow posts made on Vyrb to be exported to other platforms such as Facebook, Twitter and Instagram. We launched Vyrb in December 2021 for both iOS and Android, and we believe that Vyrb is one of the first social applications designed specifically with a focus on smart glasses and other voice enabled wearables. We subsequently expanded Vyrb’s capabilities through software upgrades released in the fourth quarter of 2022, and anticipate the commercial launch of Vyrb in the fourth quarter of 2023.

 

We have made strong strides towards our goal of making smart eyewear accessible to the mass market. Several developments towards this end include developing our smart frames in two temple lengths, with a third length planned for 2023; the introduction of smart eyewear specifically for women and youth, which are typically missing from similar offerings; and the introduction of smart eyewear for adults with petite or narrow faces. In addition, we have launched an expansive offering consisting of 16 version 1.0 models and 15 version 2.0 models so far, which offer a similar amount of style variety as many traditional eyewear collections. When paired with the Vyrb application, Lucyd Lyte glasses will provide a new and safer wearable user experience suitable for everyone.

 

Our goal is to become a meaningful player in the smart eyewear market. Innovative Eyewear’s early successes have shown our ability to not only compete, but to lead in this rapidly changing and expanding technological eyewear market, and our goal is to continue spearheading innovation in the field.

 

Giving Back

 

We donate an optical frame for every Lucyd Lyte sold at retail locations.

 

We are also very active in supporting the various communities we serve through donations and support. From the beginning, Innovative Eyewear has supported those in need through its donation of glasses frames to New Eyes (https://new-eyes.org/about-us), a charity dedicated to helping children and adults in need of eyewear. We’ve partnered with New Eyes because they fit the Lucyd brand mission: enhancing the vision of people all over the world, and we believe that it simply is the right thing to do.

 

Additionally, university students, educators, healthcare workers, uniformed service members, and veterans are eligible for an ongoing 18% discount off all frames and lens upgrades on www.lucyd.co.

 

Our Competitive Strengths

 

A Unique Solution to a Common Problem. While immensely useful, smartphones can present a safety hazard to motorists, pedestrians and cyclists because smartphones can distract people from the task or activity at hand. In 2021, pedestrian deaths were at a 40-year high according to the Governors Highway Safety Association, and experts believe smartphones were partially to blame. Recent data from the Governors Highway Safety Association indicates that from 2010 to 2020, the number of pedestrian deaths rose by 54%, while all other traffic deaths increased by 13% (Pedestrian Traffic Fatalities by State: 2021 Preliminary Data – (https://www.ghsa.org/resources/Pedestrians22). We believe that the distraction created by smartphones originates in two forms: (1) via headphones or earbuds, where the user is deprived of full audible situational awareness; and, (2) via the visual interface of the phone, which distracts the user completely from their surroundings. Lucyd Lyte open ear audio helps address this problem by having the speakers mounted at the temples (in the arms) of the glasses. There is nothing in the ear canal and, as a result, individuals can better maintain situational awareness, such as hearing the traffic around them, as well as nearby sounds. Many of our competitors have relatively bulky speakers enclosed within the temples, while Lucyd Lyte’s speakers and temples are thin, which allows them to look similar to traditional designer glasses. Furthermore, through the quick and easy touch controls on the Lucyd Lyte, the wearer can perform many tasks that they would normally pull out their phone for, untethering the eyes of the user from their smartphones throughout the day and enabling them to remain more visually vigilant and aware of the traffic around them.

 

3

 

 

Affordable Price Point. Our Lucyd Lyte eyewear provides both optical-quality glasses and a Bluetooth headset together, at roughly the same price as a traditional pair of designer glasses, which is core to the disruptive potential of our product. Our Lucyd Lyte line of smart eyewear enables prescription and sunglass wearers to interact with digital assistants and social media without having to take their eyes off the road and are nearly handsfree, thereby improving the safety and convenience of taking calls, listening to music and audibly accessing digital information on the go. The Manufacturer’s Suggested Retail Price (“MSRP”) for Lucyd Lyte 2.0 eyewear starts at $199, with advanced options and customizations available at higher price points, which are at the discretion of the customer. A basic prescription lens upgrade is offered for $40. By comparison, most of our U.S.-based competitors offer products that are more expensive, starting at approximately $249 or higher, with higher costs to add prescriptions.

 

Quality. All of our frames can be outfitted in-house or by optical resellers with any combination of prescription, sunglass, readers and blue light formats. Our frame fronts are made with what we believe are high quality optical materials to ensure easy lens fitting by any optician.

 

Customizable Product Offering. There are 70 lens types available for Lucyd Lyte, making it the most customizable smart eyewear in the world. Innovative Eyewear has a partnership with a high-quality optical lab in Boston to produce prescription and custom lenses for our frames quickly and affordably. Our contract with a third-party optical lab also allows us to offer direct prescription fulfillment to our customers.

 

Comfort. At just 1.0-1.45 ounces, our eyewear has a feather-light fit, suitable for all day vision correction or sun protection (traditional glasses weigh about 1 ounce). This is especially important while on the go. Our 1.0 ounce titanium aviators are among the lightest smart eyewear ever made.

 

Long Battery Life. At 12 hours of playback per charge, Lucyd Lyte 2.0 glasses outpace most, if not all, of the competition on battery life.

 

Capital Light Business Model. All of our products are sold through multiple e-commerce channels, including on our website (Lucyd.co), BestBuy.com, DicksSportingGoods.com and Amazon.com, and are distributed through optical or other retailers (such as, but not limited to, Metro Optics Eyewear and Marca Eyewear Group, Inc.). We believe this capital light approach is highly scalable and efficient in the deployment of resources. We view “capital light” as being more efficient by obviating the need to build factories and retail stores, while partnering with existing companies in both of these groups.

 

Multiple-Channel Approach. We sell our products both through multiple online channels and multiple categories of brick-and-mortar retail stores. We believe this multi-channel approach provides us with an advantage against our competitors who sell in a narrower selection of channels.

 

Experienced Management Team. We have an experienced board of directors with more than 80 years of combined experience in the eyewear industry, and a management team with substantial experience in software and electronics engineering and operating eyewear and technology companies.

 

Our Business Strategy

 

When we organized Innovative Eyewear two years ago, there were, in our view, no attractive smart eyewear that addressed the basic consumer need for good looking designer glasses that were stylish, comfortable, lightweight and provided the functionality of hearables, and priced around the same as regular glasses.

 

All of our products are designed in Miami, manufactured in China, and sold through e-commerce, channels, including on our website (Lucyd.co), BestBuy.com, DicksSportingGoods.com and Amazon.com, or sold by over 200 optical and sporting goods retailers. Additionally, we are pursuing online and in-store big box retailers, and in-store and online specialty Based on the existing demand for our products, current distribution and recently consummated supply agreements, we anticipate that our products will be available in a significant number of new third-party retail locations in 2023.

 

4

 

 

We believe that people care about what they wear on their faces, and because we understand that customers have diverse preferences about the shape, size, and design of their eyewear, we aim to continuously introduce new models in an effort to offer a wide variety of designs. We continuously present new models of eyewear to our network of followers to vote on those styles they find most appealing. We view this as community approved design.

 

Sales

 

We have two major sales channels: (1) e-commerce via Lucyd.co and Amazon and, (2) our ongoing development of a network of eyewear, sporting goods and electronics resellers, including but not limited to, BestBuy.com, DicksSportingGoods.com and Brookstone, to offer our frames. Most of our resellers are experienced opticians who provide valuable feedback that informs the development of our product lines, which we would not receive if we were solely direct to consumer. Additionally, we have a robust presence on multiple e-commerce and social media platforms, which facilitates several customer on-ramps for the Lucyd brand, and numerous ad campaign strategies. Building on our early successes of driving traffic to Lucyd.co, the website run by a subsidiary of our majority stockholder, from Facebook and TikTok, we deploy high quality content on multiple platforms to continuously keep customers engaged and drive brand awareness.

 

We have two levels of margins, one for business to consumers (“B2C”), and one for business to business (“B2B”). The majority of our sales have been through e-commerce with current gross margins of approximately 75%; retail sales have gross margins of approximately 40%. Lens upgrades sold on Lucyd.co have a standardized profit margin of approximately 35%. As a company still in an early growth stage, we are investing heavily in our B2C and B2B efforts to capture as much market share as possible, which included in fiscal year 2022 several activities which impacted the gross deficit. Among these promotional activities were single-item B2C discounts, heavy B2B discounts on large bulk orders, a large number of free sample units provided to media, influencers and reviewers, and significant spending on upsells, promo items, and merchandising materials which were in many cases given to B2C and B2B customers for free. Additionally, the logistical costs of the high number of B2C returns in fiscal year 2022 contributed to the deficit. However, with the better establishment of the Lucyd brand expected in 2023, and with the current improvements to the product and increase in MSRP by $50, we expect to neutralize the gross deficit in fiscal year 2023 as our per-unit profitability is increasing. We expect that our retail sales will account for the majority of our sales by the end of 2023.

 

E-commerce Channels

 

  1. Company website: Lucyd.co

 

Lucyd.co is our primary e-commerce point of sale. The site offers the most customization options of any of our sales channels and a full prescription lens lab, offering a total of 70 different lens combinations (21 key lens tints offered in plano, single prescription and progressive bifocal; seven types of reading lenses). Additionally, the Lucyd website ships worldwide and is used to provide a quick and smooth buying experience.

 

  2. Amazon

 

Amazon.com/lucyd is our brand shop on Amazon. It drives approximately half of our online sales, but limits the number of variations we can offer on our frames (e.g., prescription lenses are not permitted on Amazon). However, through Amazon, we are still able to offer color lens sunglass variants and blue light blocker pairs, in addition to our charging dock accessory item. We are constantly testing traffic flow to Lucyd.co vs. Amazon to ensure our online ad spend is fully optimized.

 

  3. Walmart.com, BestBuy.com, DicksSportingGoods.com, Brookstone.com, eBay and Touch of Modern

 

In addition to our key online sales channel through Lucyd.co, our products are also sold on Walmart.com, BestBuy.com, DicksSportingGoods.com, Brookstone.com, and eBay.

 

5

 

 

  4. Social Selling

 

Not only do we use social media to drive traffic to our main sales channels, but we also take advantage of intra-social shops as well, and have deployed shopping experiences through Facebook, Instagram and TikTok to gain further brand awareness.

 

We also offer two affiliate platforms via shareasale.com and Shopify for peer-driven sales. The Shareasale program is for professional affiliate and deal promotion companies, and increases revenue on Lucyd.co by offering direct commissions in exchange for converting web traffic. The Shopify affiliate program enables Lucyd brand enthusiasts to get a financial reward for sharing the brand, and operates on similar terms as the Shareasale program where we provide a commission rate in exchange for converting web traffic.

 

Retail Channels

 

  1. Independent Eyewear Stores

 

The core of our B2B business is formed by our relationship with numerous eyewear store retailers across the United States and Canada, which provide Lucyd Lyte frames directly to their optical customers. Many of these retail stores have placed multiple stocking orders since launching our wholesale business in June 2021. To support our resellers, we offer a strong co-op marketing program that includes free store display materials. As part of this strategy, we have launched a digital try-on kiosk for our resellers to help educate their in-store customers about Lucyd eyewear, and increase our brand’s physical presence in the optical industry. We have launched our in-store digital try-on kiosk to key retailers in December 2021 and we have upgraded the kiosk’s capabilities to allow for the customer to try different lens tints, explore an FAQ, download the company’s Vyrb™ social app, and enable in-store reordering from the kiosk.

 

  2. National Eyewear Chains

 

Lucyd eyewear is currently being evaluated by multiple leading eyewear chains in the United States for potential inclusion in their brick-and-mortar stores. After the recent introduction of Ray Ban Stories smart eyewear, many retailers are keen to include one or more smart eyewear products in their stores and on their e-commerce platforms. Based on our current discussion with several major optical chains (by store size), we believe at least one major optical chain or national optical buying group will onboard our product line in 2023.

 

  3. Big Box Retail Stores (Electronics, sporting goods, general merchandise)

 

In addition to mainstream optical channels, we have begun placing our products and are pursuing additional product placements with leading big box stores, either in their eyewear or electronics departments. Specifically, we have begun selling our products on Bestbuy.com and Dickssportinggoods.com.

 

  4. License Agreements and Specialty Retail Stores

 

We are leaving no stone unturned in our mission to bring smart eyewear mainstream. We have licensed two leading fashion brands, Nautica and Eddie Bauer, to produce new powered by Lucyd cobranded frames, which will be launched in 2023 on Lucyd sales channels as well as in select Nautica and Eddie Bauer stores. Additionally, we are pursuing other potential sales outlets such as home shopping channels, cellular stores and boutique retailers.

 

6

 

 

Manufacturing and Supply Chain

 

Our products are designed and specified in the United States and subsequently manufactured in China. The products are designed in-house, 3-D CAD files are then produced with product renderings. We then subject these rendered images for focus group review, to determine which designs we should move to the prototype development stage. Pre-production prototypes are developed by our factories in China to our specifications. Our factories source components for the smart eyewear in China including plastic and titanium for the frames, electronic components, speakers, microphones and batteries. All packaging is designed in Miami and fabricated in China. Once completed, our products are tested in the United States, to assess functionality, fit and finish. Production orders are placed and fabricated in China based on anticipated demand, whereupon they undergo a rigorous thirteen-point third party product inspection process. The inspection is conducted on 100% of our manufactured products. Inspections include testing procedures to help ensure our customers receive only functional, high-quality products. For large bulk orders from clients, we are able to order this inventory on demand, due to the expected lead times in the traditional frame sourcing business.

 

All of our frames are manufactured with prefabricated, ready to wear sunglass or blue light lenses, and are directly shipped to the customer in this state if the customer declines purchasing custom lens upgrades. If a customer orders with prescription or specialty lenses, then the smart eyewear frames are sent to an optical contractor laboratory in Boston, Massachusetts, to have the lenses cut, ground and mounted in the frames, whereupon they are directly shipped to customers.

 

Our in-store kiosks are comprised of a fixture, a tablet, and proprietary software, which enable the prospective customer to virtually try on our smart glasses. The fixtures, which sport our Company name, are manufactured by a U.S.-based third-party company, and are designed to serve as a holding mechanism for the tablet. We purchase each tablet through Amazon.com, which is then fitted to the kiosk fixture. The Company currently utilizes Samsung’s tablets for its in-store kiosks. Once each tablet is fitted to its kiosk fixture, the tablet is loaded with software which ultimately presents the Company’s try-on application. This software-based chain of processes relies on the tablet’s built-in camera and enables the prospective buyer of our smart eyewear to virtually try-on the glasses, which are superimposed in different styles onto the customer’s face using the front-facing camera. The tablet is fitted to the kiosk and loaded with our software in our Miami facility, from where they are shipped to a third-party warehouse in Miami for distribution to retail stores.

 

Marketing

 

We employ a 360-degree marketing strategy that encompasses both brand and user generated content syndication across earned, owned and paid platforms (channels where the company pays a fee to have its product advertised). Long form and video content generation are a key focus points for the brand, they allow us to better leverage both emerging and critical smart eyewear narratives through persistent search engine optimization (SEO); increasing our organic brand awareness across the board, in addition to strategic loyalty, influencer and affiliate marketing campaigns.

 

Our online marketing strategy is primarily driven by pay-per-click advertisements on mainstream search engines, social media apps, and Amazon and other marketplaces. In addition, we support our primary efforts with influencer created and promoted “UGC” (user-generated content), email automations and newsletters, and website push notifications. We have also deployed nationwide broadcast cable TV campaigns and plan to use this channel in the future.

 

We believe we are trendsetters in creating relevant, omni-channel touchpoints that derive meaningful experiences and products designed for our customers.

 

Our wholesale marketing strategy is primarily focused on traditional sales email and call outreach, national and regional optical trade shows, and optical and athletic trade advertisements.

 

7

 

 

From a brand perspective, strategically offering value-added optical smart eyewear coupled with expansive end-user customization our social audio app initiatives can potentially rapidly expand brand awareness and revenue. At Innovative Eyewear, we strive to lead and own critical narratives within the Bluetooth and smart eyewear space.

 

We seek to create memorable experiences and products that resonate with our customers, coupled with premium content and campaigns designed to expand our brand presence and market share. We also attend major regional eyewear and sporting goods trade shows to build awareness among our potential retail partners.

 

Our influencers

 

To accelerate brand awareness and product sales, we are embarking on an influencer strategy to engage leading figures in sports and the arts, who like and enjoy wearing Lucyd Lyte®. To date we have onboarded Chris Clark, a pro golfer, Monique Billings, a WNBA basketball player, and Hadar Adora, an up-and-coming musical artist. We plan to add additional influencers to enhance awareness and sell-through for a number of key demographics.

 

Influencers are a key part of our marketing strategy, as they help our products relate to large, variable audiences. Lucyd Lyte is a perfect fit for the fitness tech and audio product spaces, so athletes and musicians are a natural fit for our brand and the active lifestyles that Lucyd products promote. We plan to add A-list musical talent to the brand in the near future, as well as a host of audio content creators to support the Vyrb experience.

 

Our Market Opportunity

 

According to Statista, the total addressable market for eyewear in the U.S. is projected to be $33.8 billion in 2023. The market for digital assistants like Siri, Google Voice, Bixby and Alexa has grown rapidly worldwide, and is projected at $4.5 billion in revenue in 2023. The worldwide hearables market was estimated at $69.0 billion in 2022. We view the popularity of hearables as an important catalyst for the smart eyewear market.

 

The common denominator among markets for the hearables and digital assistant is that they facilitate real-time access to digital data, whether it is through music, calls, navigational directions, or information, among other uses. The combination of hearables and digital assistants provides a transparent, ergonomic interface between the users and their digital lives. At Innovative Eyewear, we are dedicated to a touch-free interface and untethering our customers eyes from their smartphone screens, through our smart eyewear product.

 

The synergistic fusion of these three markets enables, in our view, an opportunity to create a completely new experience of connected eyewear, which smoothly delivers the functionality of both optical glasses and headphones, eliminating the need for either on its own. Nevertheless, several orthodoxies of the eyewear industry still hold, namely: if you want to sell a lot of eyewear, we believe it should be attractive, stylish, comfortable (e.g., lightweight, which we believe to be approximately 1oz) and cost roughly the same as traditional eyewear. This is what we have sought to achieve, and in our view have accomplished with the introduction of Lucyd Lyte eyewear.

 

Intellectual Property

 

We license from Lucyd Ltd., a subsidiary of our majority stockholder, an intellectual property portfolio designed to protect our unique eyewear designs and certain technological features in current and anticipated future products. More recently, the company has begun filing patents under its own name.

 

We have licensed and filed 48 patents to date, covering all of our current product designs and certain advanced features such as Vyrb, replaceable front frames, and multi-channel Bluetooth connectivity. The Company will seek to file new IP to protect new styles and features of its smart eyewear as they are introduced.

 

8

 

 

Our current U.S. and foreign patent portfolio is as listed below:

 

App/Patent Number Title Country Filing Date Status Grant Date
10,908,419 Smartglasses and Methods and Systems for Using Artificial Intelligence to Control Mobile Devices Used for Displaying and Presenting Tasks and Applications and Enhancing Presentation and Display of Augmented Reality Information US June 28, 2018 Issued February 2, 2021
D899,493 Smart Glasses US March 22, 2019 Issued October 20, 2020
D900,203 Smart Glasses US March 22, 2019 Issued October 27, 2020
D899,494 Smart Glasses US March 22, 2019 Issued October 20, 2020
D899,495 Smart Glasses US March 22, 2019 Issued October 20, 2020
D899,496 Smart Glasses US March 22, 2019 Issued October 20, 2020
D900,204 Smart Glasses US March 22, 2019 Issued October 27, 2020
D900,205 Smart Glasses US March 22, 2019 Issued October 27, 2020
D900,920 Smart Glasses US March 22, 2019 Issued November 3, 2020
D900,206 Smart Glasses US March 22, 2019 Issued October 27, 2020
D899,497 Smart Glasses US March 22, 2019 Issued October 20, 2020
D899,498 Smart Glasses US March 22, 2019 Issued October 20, 2020
D899,499 Smart Glasses US March 22, 2019 Issued October 20, 2020
D899,500 Smart Glasses US March 22, 2019 Issued October 20, 2020

 

9

 

 

D954,135 Round Smartglasses Having Flat Connector Hinges US December 12, 2019 Issued June 7, 2022
D958,234 Round Smartglasses Having Pivot Connector Hinges US December 12, 2019 Issued July 19, 2022
D955,467 Sport Smartglasses Having Flat Connector Hinges US December 12, 2019 Issued June 21, 2022
D954,136 Smartglasses Having Pivot Connector Hinges US December 12, 2019 Issued June 7, 2022
62/941,466 Wireless Smartglasses with Quick Connect Front Frames US November 27, 2019 Non-Provisional Application filed on November 25, 2020; U.S. App. No. 17/104,849 n/a
D954,137 Flat Connector Hinges for Smartglasses Temples US December 19, 2019 Issued June 7, 2022
D974,456 Pivot Hinges and Smartglasses Temples US December 19, 2019 Issued n/a
11,282,523 Voice Assistant Management US March 25, 2020 Issued March 22, 2022
29/743,256 Wayfarer Smartglasses US July 20, 2020 Pending n/a
D951,334 Round Smartglasses US July 20, 2020 Issued May 10, 2022
17/104,849 Wireless Smartglasses with Quick Connect Front Frames US November 25, 2020 Pending n/a
29/806,200 Smartglasses US September 1, 2021 Pending n/a
29/806,204 Smartglasses US September 1, 2021 Pending n/a
29/806,207 Smartglasses US September 1, 2021 Pending n/a
29/806,209 Smartglasses US September 1, 2021 Pending n/a
207516 Smartglasses Canada October 29, 2021 Pending n/a
207517 Smartglasses Canada October 29, 2021 Pending n/a
207518 Smartglasses Canada October 29, 2021 Pending n/a
207519 Smartglasses Canada October 29, 2021 Pending n/a
29/814,016 Safety Smartglasses US November 2, 2021 Pending n/a
29/814,017 Safety Shields US November 2, 2021 Pending n/a

 

10

 

 

63/274,920 Safety Glasses US November 2, 2021 Non-Provisional Application filed on October 21, 2022; U.S. App. No. 18/048,715 n/a
29/815,040 Charging Cradle US November 10, 2021 Pending n/a
207956 Safety Smartglasses Canada November 17, 2021 Pending n/a
207957 Safety Shields Canada November 17, 2021 Pending n/a
2021307950576 Safety Smartglasses China December 2, 2021 Pending n/a
ZL 2021307955902

Safety Shields

 China December 2, 2021 Issued May 3, 2022
63/297,056 Charging Cradle for Smartglasses US January 6, 2022 Non-Provisional Application filed on December 29, 2022; U.S. App. No. 18/147,002 n/a
212589 Charging Cradle Canada May 9, 2022 Pending n/a
ZL 2022302715131 Charging Cradle China May 10, 2022 Issued October 21, 2022
18/048,715 Safety Glasses US October 21, 2022

Pending

 n/a

3180624

 Safety Glasses Canada November 1, 2022 Pending n/a
202211367067X Safety Glasses China November 2, 2022 Pending n/a
18/147,002 Charging Cradle for Smartglasses US December 27, 2022 Pending n/a

 

11

 

 

Additionally, we have acquired the exclusive rights to 11 registered trademarks and applications as follows:

 

Trademark   Trademark Number   Status   Jurisdiction
LUCYD   UK00003258030   Registered   UK
Lucyd Lens   UK00003258093   Registered   UK
Lucyd Loud   UK00003400531   Registered   UK
Upgrade your eyewear   UK00003400579   Registered   UK
GaaS   UK00003451728   Registered   UK
Vyrb   UK00003477240   Registered   UK
Lyte   UK00003526151   Registered   UK
Upgrade your eyewear   Application No. 90/407,646   Application   US
LUCYD   Application No. 90/407,723   Application   US
Lyte   Application No. 90/381051   Application   US
Vyrb   Application No. 90/820713   Application   US

 

Material Agreements

 

License Agreement between Innovative Eyewear, Inc. and Lucyd Ltd.

 

On April 1, 2020, we entered into an exclusive, worldwide license agreement with Lucyd Ltd. for all fields of use of the Lucyd® brand, and the associated intellectual property and assets (the “License Agreement”). We were founded by Lucyd Ltd., the inventor and licensor of the technology that our products are based upon, which is a portfolio company of Tekcapital, our majority stockholder. The License Agreement is a royalty-free, fully paid up, perpetual license, for the exclusive use of the following assets:

 

  1. All Lucyd intellectual property, including, all patents, patent applications and any continuations of such.
     
  2. All Lucyd trademarks.
     
  3. All Lucyd collateral material, artwork, subscriber lists, eyeglass model and frame shots and renders, as well as 3D models.
     
  4. All Lucyd logos such as, but not limited to: Lucyd® word mark, Lucyd Hexagon, Upgrade Your Eyewear® slogan and the Vyrb® trademark.
     
  5. All Lucyd company developed software and any new software developed by Innovative Eyewear, utilizing the Lucyd software, will be owned by Innovative Eyewear.
     
  6. Lucyd Store portals through Shopify, Amazon and Walmart.
     
  7. Relevant websites domain names including Lucyd.co, Lucyd.net, Lucyd.eu.
     
  8. All supply and endorsement agreements.
     
  9.  All current inventory as of the execution date of license.

 

12

 

 

  10. All social media accounts under the Lucyd name, including, but not limited to: Twitter, Facebook and Instagram.
     
  11. All advertising material and trade show displays, brochures and related materials.

 

Under the terms of the License Agreement, we have the exclusive right to effectuate sublicenses, either exclusively or non-exclusively, to any or all of our licensed intellectual property, at its sole discretion. Upon execution of the License Agreement, we paid Lucyd Ltd. £1 for the life of the licensed assets, and the License Agreement shall continue in perpetuity, unless terminated according to the terms of the agreement. Additionally, we issued 3,750,000 shares of our common stock to Lucyd Ltd. as compensation for entering into the License Agreement and for the contribution of certain other assets. Lucyd Ltd. may terminate the license with immediate effect by providing written notice to us if, among other things: we commit a material breach, as such is defined by the terms of the agreement; or, if we suspend, or threaten to suspend, payment of our debts or are unable to pay our debts.

 

The License Agreement requires us to indemnify Lucyd against all liabilities, costs, expenses, damages, and losses (including but not limited to any direct, indirect or consequential losses, loss of profit, loss of reputation and all interest, penalties, and legal costs (calculated on a full indemnity basis) and all other reasonable professional costs and expenses) suffered or incurred by Lucyd Ltd. arising out of or in connection with actual or alleged infringement of third party intellectual property rights; our breach or non-performance of or the enforcement of License Agreement. We have the right to sublicense any of our rights under the License Agreement, provided that any sublicense also shall enter into a supplemental agreement satisfactory to Lucyd Ltd.

 

On October 5, 2021, the parties to the License Agreement executed an Addendum, to the exclusive license agreement, which clarified that Innovative Eyewear shall commercialize, continue with any on-going intellectual property prosecutions and pay all maintenance or other patent fees (the “Addendum”). For all new intellectual property, Innovative Eyewear will own and control it and be responsible for all prosecution and maintenance costs. The Addendum also confirms that Innovative Eyewear issued Lucyd Ltd. 3,750,000 shares of its common stock as consideration for the license.

 

Sales Representation Agreement

 

On March 4, 2021, we entered into a commission-only, sale representation agreement with D. Landstrom Associates, Inc. for prospecting a wholesale relationship with Walmart, Target and Best Buy stores in the United States (the “Representation Agreement”). The Representation Agreement provides for D. Landstrom to act as our commission based, manufacturer’s representative, with the exclusive right to solicit offers on behalf of us to purchase our products in the United States, for the named big box stores. The term of the Representation Agreement is five years. Contract may be terminated for “good cause” with 90 days’ notice by either party. Upon termination, commissions of orders procured will extend 180 days beyond termination date. Thus far, the representation has resulted in a successful launch of the Company’s products on BestBuy.com.

 

Distribution Agreement

 

On June 30, 2021, we entered into a distribution agreement with 8 Points Inc., a subsidiary of Marca Eyewear Group Inc., for exclusive distribution of Lucyd Lyte products in Canada (the “Distribution Agreement”). The Distribution Agreement provides that 8 Points Inc. will have exclusive purchase and distribution rights and obligations in Canada. The term of the Distribution Agreement is 3.5 years and either party may terminate by providing 180 days’ notice to the other party. The distributor will perform services, which shall include, but shall not be limited to the following):

 

  1. Sales of our products into retail distribution by servicing potential purchasers and by generating new business within the Territory (as defined in the Distribution Agreement).

 

13

 

 

  2. Handling of all account inquiries on sales made pursuant to this Distribution Agreement.
     
  3. Innovative Eyewear will receive all Canadian returns on a timely basis. Currently, distributor will organize customer returns such that all returns will be shipped in bulk to Company’s distribution center in Miami, Florida.
     
  4. Company will provide marketing activities to support the sales of all the collections sold by the Distributor in the territory.
     
  5. Distributor will provide logistic service to distribute the product in the territory covering all provinces and provide internal customer service and warehousing and shipping, as well as after purchase care to customer.
     
  6. Distributor will provide a minimum purchase of $4.6 million worth of Lucyd Lyte products over 30 months to maintain exclusivity for sales in Canada.
     
  7. Monthly minimum committed purchases increase incrementally over the term of the Distribution Agreement. In the event that 8 Points Inc. does not meet the minimum monthly purchase requirements then we may convert 8 Points Inc. exclusive contract to a non-exclusive contract or terminate the Distribution Agreement.

 

The distributor has not met the requirements to maintain exclusivity; as such, we have converted the Distribution Agreement to a non-exclusive contract in accordance with the terms of the agreement as outlined above.

 

Nautica® License Agreement

 

On September 28, 2022, we entered into a multi-year global licensing agreement with Nautica Apparel, Inc., which became effective July 1, 2022. Pursuant to this agreement, we received a license to utilize the global lifestyle brand Nautica® for our smart eyewear products. The company intends to launch their first line of Nautica Powered by Lucyd sport lifestyle audio glasses in 2023. This agreement requires us to pay royalties based on a percentage of net retail and wholesale sales, and also requires guaranteed minimum royalty payments. The agreement has a base term of 10 years but is cancellable at our option during the fifth year. The future minimum payments due during the noncancelable portion of the contract term (2022-2027) are approximately $1.1 million in aggregate; future minimum payments due during the remaining term of the contract (2028-2032) are approximately $3.6 million in aggregate.

 

The Next Step

 

Vyrb™ Social Audio App

 

We believe eyewear should enable customers to freely interact with social media. While digital assistants, once enabled, can provide the basis for this interaction, we believe that the ability to receive and send social media posts with an individual’s voice may greatly enhance ease of use of these platforms on the go. To facilitate this, we have been developing Vyrb, our full stack social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with an individual’s voice. The application launched out of beta in December 2021, and the further development of the Vyrb app is continuing on pace, with two major features launched in December 2022: the ability to host live audio streams with up to 100 visitors and six live speakers at a time; and the ability to import external audio files into Vyrb, which allows longstanding podcasters and other content creators to add their content libraries into Vyrb. After the introduction of several more features and key user experience improvements, we anticipate a commercial launch of Vyrb in the fourth quarter of 2023. At or soon after this time, advertising and monetization features will be introduced into the app to make it a new revenue stream for our business.

 

14

 

 

We believe that Vyrb will enhance the utility of current and future Lucyd Lyte glasses by enabling users to be untethered from their smartphones, yet still be able to hear and make social media posts. A goal of our products is to free our customers from other technologies. As such, we are designing Vyrb with a transparent, voice-centric interface in mind, so that as soon as our customers can say “Ok Google,” they are connected to a world of engaging audio content and have the ability to create audio posts and messages. We believe social interaction via smart eyewear will be instrumental in bringing new, youthful customers to our company.

 

A number of companies recently have started to launch voice mediated social media applications, such as Clubhouse, Discord, Audlist, Listen and Riffr. We are designing Vyrb to host audiobooks, podcasts and entire music albums on the platform. With Vyrb, Lucyd Lyte customers are able to hear their social media feeds, post messages, hold gatherings and musical performances (by inviting other Vyrb users to connect with each other at a specific date and time), and enjoy social media with the authenticity of their own voice, all through their eyewear and without taking their phone out of their pocket.

 

The Product and Market for Vyrb

 

Vyrb is being designed as a full social media experience to enhance voice-based communications on wearables and mobile devices. The sophistication of Vyrb’s interface enables a large array of in-app purchases and subscriptions, as well as easy connectivity with the Lucyd Lyte line of smart eyewear. In addition to an ad-driven revenue model that is typical of social media applications, the robust and highly variable selection of planned in-app purchases provide important improvements and fine-tuned customizations to help personalize the user experience. We plan to roll out these and other exciting features of Vyrb over the course of several software updates.

 

The Vyrb app is contemplated to feature an in-app item shop with a number of fun and useful upgrades, such as:

 

●Loot Boxes — Random packs of multiple upgrade items, a best-selling in-app purchase format frequently deployed in online video games.

 

●Skins — Items that alter the appearance of the app to help personalize it to the user’s preferences, such as Dark Mode.

 

●Accents — Items that change the accent used by the app’s text-to-speech engine, which is employed frequently to vocalize textual content.

 

●Metal Mics — Items that lengthen the maximum allowable verbal post length and image/video sizes per post for users.

 

●Post Embellishments — Items that can be used to animate posts in the feed to make them more prominent.

 

●Sound FX Packs — Items that increase the number of audio emojis (Sound FX) available to the user, livening up their posts.

 

●Ad Tokens — Items that can be spent to expand the reach of a feed post to a larger audience.

 

●Vyrb Gold — A premium, monthly subscription to the app that blocks all ads and brings additional benefits like a more prominent username.

 

●Vyrb Gems — In-app currency that can be spent to tip a user’s favorite content creators, to buy premium paywalled content and to buy certain other in-app purchases. Gems can also be traded to other users for their items on the Vyrb Marketplace module. Users will also be rewarded Gems for their engagement with ads on the platform, creating a positive feedback loop that rewards app engagement with premium content and experiences.

 

15

 

 

●Command Tokens — Items that can be spent to create new custom voice assistant commands (based on Vyrb’s Voice Command Creation Interface).

 

●Mega-Tag Tokens — Items that can expand the number of mega-tags available to the user (mega-tags are a unique Vyrb feature, they are automatically applied hashtags that make a user’s posts more discoverable to others).

 

Users spend approximately 145 minutes per day on social media applications and regularly click on advertisements they view through their applications. We believe Vyrb is strategically positioned to become a prime advertisement space, allowing both visual and audible advertisements to be purchased. Vyrb ads will be shown in a user’s regular newsfeed, which we believe will create an opportunity and need for a subscription in-app purchase (Vyrb Gold) for a premium, ad-free browsing experience. For ease of use, Vyrb ads can be created by any user through the application in just moments: users will be able to purchase “Ad Token” items from the in-app store, and then use these tokens to turn standard posts into wide-reaching ads. A rapid-response reporting system will be developed and monitored to remove objectionable or illegal content from the platform. With its focus on high quality audio, we are designing Vyrb to lift up professional and creative audio content developers by helping them reach new audiences. To ensure a positive user experience, we are developing a system in Vyrb which will automatically promote positively reviewed content, and automatically remove content that has been reported in a high ratio compared to the number of viewers, providing the basis for user product discovery as well as a failsafe against any mistake in our manual and algorithmic moderation of the application’s hosted content.

 

Vyrb users will be able to purchase and support content from indie and professional creators via an in-app currency (referred to as “gems” in this document, a virtual point the user typically accumulates by viewing ad content or by purchasing them). Creators will receive gems from typical users as tips during live broadcasts, and in exchange for access to premium posts. The creators will then be able to cash out these gems at an exchange rate that provides profit to Vyrb. For example, users purchase the gems, its in-app loyalty token at a rate of $1 each, but creators only receive $0.75 for each gem they cash out. A 25% effective platform fee would put the content transaction fees of Vyrb at a lower rate than most digital content marketplaces. In the case of typical livestreaming applications, a functionality Vyrb supports, they are often exorbitant, taking as much as 50% in effective fees on in-app currency transactions.

 

To acquire the gems, users must buy them in the Vyrb Shop or gain them by engaging with sufficient ad content (e.g., using the application for an hour, or an amount of time that effectively pays for the gem). While Vyrb allows users the flexibility of choice of either buying or earning these gems, we believe that there is a huge revenue stream potential for us through a strategic implementation of the Vyrb Shop and peer-to-peer content transactions.

 

Also, we plan for users to be able to charge a fixed price to be able to access particular audio posts. For example, this feature could be used by a podcaster to sell their premium episodes, or by a recording artist to sell their music albums. In tandem with this feature, audio posts will be divisible into tracks to support long form content such as albums and audiobooks. Vyrb will take a flat percentage fee on all sales of premium content within the application by allowing creators to cash out gems they receive for selling their content. We believe the major benefit of this system is that it will provide audio content creators a new platform for rapidly creating, listing and selling their content, and help create an environment full of rich, unique and interactive audio experiences such as live “radio shows,” indie content and virtual concerts for typical Vyrb users.

 

We believe that Vyrb will effectively leverage multiple successful gamification models from the world of social media to provide a flexible and highly interactive user experience that can potentially draw high-value content creators. A fundamental aspiration of Vyrb is to provide a new platform and source of revenue for high quality audio content creators in particular; to that end, we designed Vyrb with a goal of providing a rapid, user-friendly platform for creators and consumers to share, sell and enjoy the best audio the web has to offer. We believe that through Vyrb, we can make the interaction between our users and our product a fun and rewarding experience, which can also be monetized by the company and content creators alike. By putting audio front and center, we hope to provide a new meeting ground for audio content creators and those who enjoy lots of music, podcasts and talk shows. We hope to provide a mutually beneficial relationship, where Vyrb takes a reasonable fee on the transacting of these parties in exchange for bringing them together.

 

16

 

 

Competition

 

The smart eyewear industry in which we operate is competitive and subject to changes in practice. While we believe that our products are hybrid of eyeglasses and audio technology, which gives us a unique product that provides us with competitive advantages, we may face competition from many different entities now and in the future. As of now, we face competition from the following products:

 

●Bose Corporation’s Bose Frames. These are a Bluetooth eyewear product, but in a bulkier form factor and with what we believe to be comparable models at a higher list price ($249 MSRP) than Lucyd Lyte 2.0 ($199).

 

●Amazon’s Echo Glasses. Another entry in the Bluetooth eyewear space offered at a $249 list price. Not available directly from the manufacturer in prescription, and in only one frame shape. The cost of the Amazon Echo Glasses is higher than Lucyd Lyte. While lightweight like Lucyd Lyte glasses, Amazon Echo Glasses have, in our view, a less fashionable form factor, and the battery life is about half of that of Lucyd Lyte.

 

●Snapchat Spectacles. This is a camera-focused smart eyewear product and, in our view, not a direct competitor as to its style, weight, pricing and suitability for all-day wear, as compared with our products; however, Snapchat Spectacles may introduce further entries in the space that may directly compete with Lucyd Lyte. Snapchat Spectacles Version 3 have a list price of $380.

 

●Ray-Ban Stories Glasses. Developed in association with Facebook, are a camera-focused smart eyewear product, and despite the fact they are available in prescription, in our view not a direct competitor; Ray-Ban may, however, introduce further entries in the space that may directly compete with Lucyd Lyte. Ray-Ban Spectacles have a well-known and respected brand, and a list price starting at $299, which makes them 50% more expensive than Lucyd Lyte. They weigh considerably more (20-70% depending upon the Lyte model) than Lucyd Lyte glasses, have a shorter battery life, thicker temple profiles and are not water resistant.

 

All of the competitors discussed above have substantially greater manufacturing, financial, research and development, personnel and marketing resources than we do. As a result, although we believe our products are currently superior, our competitors may be able to develop superior products, and compete more aggressively and sustain their competitive advantage over a longer period of time than us. Our products may be rendered obsolete in the face of competition.

 

Employees

 

As of December 31, 2022, we had 9 full time employees with two in product development, two in sales, one in finance, one in customer service, one in marketing, one in graphic design and one in video production. Employees are supported by a number of consultants and part time employees, including a group of 8 independent sales representatives.

 

Other

 

Our principal executive offices are located at 11900 Biscayne Blvd., Suite 630, North Miami, Florida 33181, our telephone number is (954) 826-0329 and our Internet website address is www.lucyd.co. We make available free of charge on or through our Internet website our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements on Schedule 14A, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such materials with, or furnish them to, the Securities and Exchange Commission (the “SEC”). Alternatively, you may also access our reports at the SEC’s website at www.sec.gov.

 

17

 

 

Summary Risk Factors

 

The risk factors described below are a summary of the principal risk factors associated with an investment in us. These are not the only risks we face. You should carefully consider these risk factors, together with the risk factors set forth in Item 1A. of this Report and the other reports and documents filed by us with the SEC.

 

Risks Related to our Business, Strategy and Industry

 

●We have a history of losses, and we may be unable to achieve or sustain profitability.

 

●The optical industry is highly competitive, and if we do not compete successfully, our business may be adversely impacted.

 

●We have limited experience in scaling a smart eyewear business. If we are unable to manage our expected growth effectively, our brand, and financial performance may suffer, which may have a material adverse effect on our business, financial condition, and operating results.

 

●Increases in component costs, shipping costs, long lead times, supply shortages, and supply changes could disrupt our supply chain; factors such as wage rate increases and inflation can have a material adverse effect on our business, financial condition, and operating results.

 

●We currently derive all of our revenue from sales of our glasses. A decline in sales of our eyewear would negatively affect our business, financial condition, and results of operation.

 

●We face significant risks due to our dependency on foreign supply and manufacturing chains, geopolitical and economic changes, and changes in public perception about internationally sourced and manufactured products.

 

●We rely on a limited number of contract manufacturers and logistics partners for our products. A loss of any of these partners could negatively affect our business.

 

●If we fail to cost-effectively retain our existing customers or to acquire new customers, our business, financial condition, and results of operations would be harmed.

 

●Eyeglasses are regulated as medical devices by the FDA, and our failure, or the failure of any third-party manufacturer or optical laboratory, to obtain and maintain the necessary marketing authorizations for our products could have a material adverse effect on our business.

 

●Our profitability and cash flows may be negatively affected if we are not successful in managing our supply chain and customer demands for product deliveries.

 

●If we fail to maintain and enhance our brand, our ability to engage or expand our base of customers will be impaired, and our business, financial condition, and results of operations may suffer.

 

●We rely heavily on our information technology systems, as well as those of our third-party vendors, business partners, and service providers, for our business to effectively operate and to safeguard confidential information; any significant failure, inadequacy, interruption, or data security incident could adversely affect our business, financial condition, and operations.

 

●Our multichannel channel business faces distinct risks, and our failure to successfully manage it could have a negative impact on our profitability.

 

18

 

 

●If we fail to adapt and respond effectively to rapidly changing technology, evolving industry standards and changing customer needs or requirements, our solutions may become less competitive.

 

●We depend on highly skilled personnel to grow and operate our business, and if we are unable to hire, retain, and motivate our personnel, we may not be able to grow effectively.

 

●A decline in sales of our eyewear would negatively affect our business, financial condition, and results of operations.

 

●We could be adversely affected by product liability, product recall or personal injury issues.

 

Risks Related to our Intellectual Property

 

●We license some of our technology from Lucyd Ltd., the majority stockholder of the Company, and our inability to maintain this license could materially affect our business, financial condition, and operating results.

 

●Failure to adequately maintain and protect our intellectual property and proprietary rights could harm our brand, devalue our proprietary content, and adversely affect our ability to compete effectively.

 

●We may incur costs to defend against, face liability or for being vulnerable to intellectual property infringement claims brought against us by others.

 

Risks Related to Our Dependence on Third Parties

 

●We face risks associated with suppliers from whom our products are sourced and are dependent on a limited number of suppliers.

 

●Our projects could be hindered due to our dependence on third parties to complete many of our contracts.

 

●We depend on search engines, social media platforms, digital application stores, content-based online advertising, and other online sources to attract consumers to and promote our website and our mobile applications, which may be affected by third-party interference beyond our control; and, as we grow, the cost of acquiring new customers may continue to rise and become uneconomical.

 

Risks Related to Our Common Stock

 

●Our directors, executive officers and principal stockholders have substantial control over our company, which could limit your ability to influence the outcome of key transactions, including a change of control.

 

19

 

 

Item 1A. Risk Factors.

 

Our business involves a high degree of risk and uncertainty, including the following risks and uncertainties:

 

Risks Relating to Our Business, Strategy and Industry

 

The optical industry is highly competitive, and if we do not compete successfully, our business may be adversely impacted.

 

We compete directly with large, integrated optical players that sell both at the retail level and online such as Ray-Ban® that have multiple products, well regarded brands and retail banners, as well as established and well-regarded consumer electronics companies such as Bose®. This diversified and capable competition takes place both in physical retail locations as well as online, for smart glasses. To compete effectively, we must continue to create, invest in, or acquire, advanced technology, incorporate this technology into our products, obtain regulatory approvals in a timely manner where required, and process and successfully market our products.

 

Most if not all of our competitors have significantly greater financial and operational resources, longer operating histories, greater brand recognition, and broader geographic presence than we do. As a result, they may be able to outmaneuver us in the marketplace and offer capable products at more competitive prices, which may adversely affect our business. They also are able to spend far more than we do for advertising. We may be at a substantial disadvantage to larger competitors with greater economies of scale. If our costs are greater compared to those of our competitors, the pricing of our products may not be as attractive, thus depressing sales or the profitability of our products and services. Our competitors may expand into markets in which we currently operate, and we remain vulnerable to the marketing power and high level of customer recognition of these larger competitors and to the risk that these competitors or others could attract our customer base. Some of our competitors are vertically integrated and are also engaged in the manufacture and distribution of glasses and many of our competitors operate under a variety of brands and price points. These competitors can advantageously leverage this structure to better compete and access the market with significant market power could make it more difficult for us to compete. We purchase some of our product components from suppliers who may be affiliates of one or more competitors or may compete with ourselves in the future.

 

We may not continue to be able to successfully compete against existing or future competitors. Our inability to respond effectively to competitive pressures, improved performance by our competitors, and changes in the retail and e-commerce markets could result in lost market share and have a material adverse effect on our business, financial condition, and results of operations.

 

We have a history of losses, and we may be unable to achieve or sustain profitability.

 

We had a net loss of $5,681,833 for the year ended December 31, 2022, and a net loss of $3,244,506 for the year ended December 31, 2021. As of December 31, 2022, we had an accumulated deficit of $10,305,987. Because we have a short operating history it is difficult for us to predict our future operating results. We will need to generate and sustain increased revenue and manage our costs to achieve profitability. Even if we do, we may not be able become or increase our profitability.

 

Our ability to generate profit depends on our ability to strengthen and expand our brand, continue to provide exciting products customers love, expand sales and improve margins. We are aiming to achieve profitability in the next two years, and between now and then we plan to efficiently invest in the business to bring it to scale by:

 

●enhancing our products with new designs, functionality, and technology to widen our appeal and delight customers in a wide variety of demographic groups; and,

 

●investing in our product development, supply chain and sales and marketing capabilities to leverage external resources as efficiently as possible to ensure that smart glasses are affordable for the majority of the world’s population who need them.

 

However, we may not succeed in any of the foregoing, and the planned investments may not result in profitability.

 

20

 

 

We have limited experience in the smart eyewear space. If we are unable to manage our growth effectively, our brand “Lucyd”, and our financial performance may suffer, which may have a material adverse effect on our business, financial condition, and operating results.

 

The smart eyewear industry is newly emerging. Whilst our directors have more than 80 years of combined experience in the eyewear industry, the smart eyewear market presents numerous new challenges. To effectively manage these challenges and continue to grow, we must continue to invest in the design of new frames and technology, expand our product line and effectively integrate several new technologies into eyewear. Achieving this could strain our existing resources, and we could experience ongoing operating difficulties in managing our business and bringing it to scale. Failure to scale could harm our competitive position and future success, including our ability to retain and recruit personnel and to effectively execute our corporate objectives.

 

Our ability to generate net revenue will depend upon many factors, some of which we may have no control over.

 

The industry for stylish, affordable smart glasses, is rapidly evolving and may not develop as we expect. Even if our net revenue continues to increase, our net revenue growth rates may decline in the future as a result of a variety of factors, including macroeconomic factors, increased competition, and the maturation of our business. As a result, you should not rely on our net revenue growth rate for any prior period as an indication of our future performance. Overall growth of our net revenue will depend on a number of factors, including our ability to:

 

●Increase exogenous distribution of our products in optical stores, big box retailers, specialty retailers and through multiple e-commerce channels;

 

●Price our products so that we are able to attract new customers, and expand our relationships with existing customers;

 

●Accurately forecast our net revenue and plan our operating expenses accordingly;

 

●Successfully compete with other companies that are currently in, or may in the future enter, the smart eyewear industry or the markets in which we compete, and respond to developments from these competitors such as pricing changes and the introduction of new products and features, noting that most, if not all, of our competitors have stronger balance sheets and larger staffs to devote to their products;

 

●Comply with existing and new laws and regulations applicable to our business;

 

●Develop new product offerings, with services and features, including in response to new trends, competitive dynamics, or the needs of customers;

 

●Successfully identify and acquire or invest in businesses, products, or technologies that we believe could complement or expand our business;

 

●Avoid interruptions or disruptions in our supply chain from natural disasters and political uncertainty;

 

●Provide customers with a high-quality experience and customer service and support that meets their needs;

 

●Hire, integrate, and retain talented sales, customer experience, product design, and development and other personnel;

 

●Effectively manage growth of our business, personnel, and operations;

 

●Effectively manage our costs related to our business and operations; and,

 

●Enhance our reputation and the value of the Lucyd brand.

 

21

 

 

Because we have a limited history operating our business, it is difficult to evaluate our current business and future prospects, including our ability to plan for and model future growth. Our limited operating experience combined with the rapidly evolving nature of the market in which we sell our products and services, substantial uncertainty concerning how these markets may develop, and other economic factors beyond our control, reduces our ability to accurately forecast quarterly or annual revenue. Failure to manage our future growth effectively could have an adverse effect on our business, financial condition, and operating results.

 

We also expect to continue to expend substantial financial and other resources to grow our business, and we may fail to allocate our resources in a manner that results in increased net revenue growth in our business. Additionally, we may encounter unforeseen operating expenses, difficulties, complications, delays, and other unknown factors that may result in losses in future periods. If our net revenue growth does not meet our expectations in future periods, our business, financial condition, and results of operations may be harmed, and we may not achieve or sustain profitability in the future.

 

Increases in component costs, shipping costs, long lead times, supply shortages, and supply changes could disrupt our supply chain and factors such as wage rate increases and inflation can have a material adverse effect on our business, financial condition, and operating results.

 

Meeting customer demand partially depends on our ability to obtain timely and adequate delivery of components for our products and services. All of the components that go into the manufacturing of our products and services are sourced from a limited number of third-party suppliers predominantly in the U.S., and China. Our contract manufacturers purchase and provide many of these components on our behalf, including sun lenses, demo lenses, hinge and chip sets and other electronic components, and we do not have long-term arrangements with most of our component suppliers. We are therefore subject to the risk of shortages and long lead times in the supply of these components and the risk that our suppliers discontinue or modify components used in our products. In addition, the lead times associated with certain components are lengthy and may preclude rapid changes in design, quantities, and delivery schedules. Our ability to meet temporary unforeseen increases in demand has been, and may in the future be, impacted by our reliance on the availability of components from these suppliers. We may in the future experience component shortages, and the predictability of the availability of these components may be limited, which may be heightened in light of Covid-19 safety measures undertaken in China, our principal country of manufacturing. In the event of a component shortage or supply interruption from suppliers of these components, we may experience supply chain delays. Developing alternate sources of supply for these components may be time-consuming, difficult, and costly, and we may not be able to source these components on terms that are acceptable to us, or at all, which may undermine our ability to fill our orders in a timely manner. Any interruption or delay in the supply of any of these parts or components, or the inability to obtain these parts or components from alternate sources at acceptable prices and within a reasonable amount of time, would harm our ability to timely ship our products to our customers.

 

In addition, substantially all of our components are shipped directly from our contract manufacturers to our warehouse facility in Miami or to a third-party optical laboratory in the United States, where lenses are cut and mounted into frames. These laboratories process most of the glasses ordered by our customers. Once processed at the laboratories, the finished products are then sorted and shipped using third-party carriers to our customers. Our eyeglasses are also shipped directly to our third-party distribution center in the United States for shipment directly to our customers and resellers. We depend in large part on the orderly operation of this distribution process, which depends, in turn, on adherence to shipping schedules and effective management of our optical laboratory network and third-party distribution center. Increases in transportation costs (including increases in fuel costs), issues with overseas shipments, supplier-side delays, as well as reductions in the transportation capacity of carriers, labor strikes or shortages in the transportation industry, disruptions to the national and international transportation infrastructure, and unexpected delivery interruptions or delays also have the potential to derail our distribution process.

 

Moreover, volatile economic conditions may make it more likely that our suppliers and logistics providers may be unable to timely deliver supplies, or at all, and there is no guarantee that we will be able to timely locate alternative suppliers of comparable quality at an acceptable price. In addition, international supply chains may be impacted by events outside of our control, including but not limited to the COVID-19 pandemic, and limit our ability to procure timely delivery of supplies or finished goods and services. We face additional risks related to the manufacturing facility we contract with in China and suppliers in China, including port of entry risks such as longshoremen strikes, import restrictions, foreign government regulations, trade restrictions, customs, and duties.

 

22

 

 

We source components from suppliers located in China. Effective September 1, 2019, the U.S. government implemented a 15% tariff on specified products imported into the U.S. from China and effective February 14, 2020, the 15% tariff was reduced to 7.5%. In June 2020, the U.S. government granted a temporary exclusion for plastic and metal frames with a retroactive effective date of September 1, 2019, and such exclusion expired in September 2020. Given the recent change in the U.S. presidential administration, there is uncertainty whether there will be, and the resulting impacts of, any changes to U.S. government trade policy. If we are unable to mitigate the full impact of the enacted tariffs or if there is a further escalation of tariffs, costs on a significant portion of our products may increase further and our financial results may be negatively affected. While it is too early to predict how the current and future China tariffs will impact our business, our financial results may also be impacted by any resulting economic slowdown.

 

The inability to fulfill, or any delays in processing, customer orders through third party optical laboratory optical laboratory could result in the loss of customers, issuances of refunds or credits, and may also adversely affect our income and reputation. The success of our retail and e-commerce sales depends on the timely receipt of products by our customers and any repeated, intermittent or long-term disruption in, or failures of, the operations of our distribution center and/or optical laboratories could result in lower sales and profitability, a loss of loyalty to our brands, and excess inventory.

 

Furthermore, increases in compensation, wage pressure, and other expenses for our employees, may adversely affect our profitability. Increases in minimum wages and other wage and hour regulations can exacerbate this risk. These cost increases may be the result of inflationary pressures which could further reduce our sales or profitability. Increases in other operating costs, may increase our cost of products sold or selling, general, and administrative expenses. Our competitive price model and pricing pressures in the optical retail industry may inhibit our ability to reflect these increased costs in the prices of our products, in which case such increased costs could have a material adverse effect on our business, financial condition, and results of operations.

 

We currently derive all of our revenue from sales of our glasses. A decline in sales of our eyewear would negatively affect our business, financial condition, and results of operations.

 

We derive all of our revenue from the sale of one product line, our Lucyd Lyte smart eyewear. Our glasses are sold in highly competitive markets with limited barriers to entry. Introduction by competitors of comparable products at lower price points, a maturing product lifecycle, a decline in consumer spending, or other factors could result in a material decline in our revenue. Because we derive most of our revenue from the sale of our glasses, any material decline in sales of our glasses would have a material adverse impact on our business, financial condition, and operating results.

 

We face significant risks due to our dependency on foreign supply and manufacturing chains, geopolitical and economic changes, and changes in public perception about internationally sourced and manufactured products.

 

Since our component materials are sourced in China, our production may face additional risks such as, but not limited to: increased shipping costs, imposition of additional import or trade restrictions, increased custom duties and tariffs, legal or economic restrictions on our supplier and manufacturer’s ability to meet our needs, unforeseen delays in customs clearance of goods, transportation delays, issues with ports of entry, new and adverse foreign government regulations, political instability, war, natural disasters, and overall economic uncertainty. Our overseas sourcing and manufacturing could also suffer due to health-related concerns surrounding infectious diseases, such as Covid-19 safety measures in China, our primary country of supply. Public opinion about internationally sourced and manufactured products could be changed by negative press, which could have an impact on our customers’ confidence and satisfaction and could also have a negative impact on our public image and brand perception.

 

If we fail to cost-effectively retain our existing customers or to acquire new customers, our business, financial condition, and results of operations would be harmed.

 

The growth of our business is dependent upon our ability to continue to grow by cost-effectively retaining our existing customers and adding new customers. Although we believe that many customers originate from word-of-mouth and paid and non-paid referrals, we expect to continue to expend resources and run marketing campaigns to acquire additional customers, all of which could impact our overall profitability. If we are not able to continue to expand our customer base, or fail to retain customers, our net revenue will grow slower than expected or decline.

 

23

 

 

The growth of our e-commerce channel is critical to our continued customer retention and growth. Historically, consumers have been slower to adopt online shopping for glasses than e-commerce offerings in other industries such as consumer electronics and apparel. Improving upon the consumer in-store experience through an online platform is difficult due to broad consumer demands on selection, quality, convenience, and affordability. Changing traditional optical retail habits is difficult, and if consumers and retailers do not embrace smart eyewear as we expect, our business and operations could be harmed.

 

Our ability to attract new customers and increase net revenue from existing customers also depends in large part on our ability to enhance and improve our existing products and to introduce new products and services, in each case, in a timely manner. We also must be able to identify and originate styles and trends as well as to anticipate and react to changing consumer demands in a timely manner. The success of new and/or enhanced products and services depends on several factors, including their timely introduction and completion, sufficient demand, and cost-effectiveness. New products that we develop may not be well received and could negatively impact our financial performance.

 

Our number of customers may decline materially or fluctuate as a result of many factors, including, among other things:

 

●the quality, consumer appeal, price, and reliability of products and services offered by us;

 

●intense competition in the optical retail industry by better financed participants;

 

●negative publicity related to our brand or brand influencers;

 

●the impact of the COVID-19 pandemic or a future outbreak of disease or similar public health concern;

 

●customer dissatisfaction with changes we make to our products and services.

 

In addition, if we are unable to provide high-quality support to customers or help resolve issues in a timely and acceptable manner, our ability to attract new customers and retain customers could be adversely affected. If our number of customers declines or fluctuates for any of these reasons among others, our business would suffer.

 

Our profitability and cash flows may be negatively affected if we are not successful in managing our inventory balances and inventory shrinkage.

 

Efficient inventory management is a key component of our business success and profitability. To be successful, we must maintain sufficient inventory levels to meet our customers’ demands without allowing those levels to increase to such an extent that the costs to hold the goods unduly impact our financial results. We must balance the need to maintain inventory levels that are sufficient to ensure competitive lead times against the risk of inventory obsolescence because of changing customer requirements, fluctuating commodity prices, changes to our products, product transfers, or the life cycle of our products. If we fail to adequately forecast demand for any product, or fail to determine the optimal product mix for production purposes, we may face production capacity issues in processing sufficient quantities of a given product. If our buying and distribution decisions do not accurately predict customer trends or spending levels in general or if we inappropriately price products, we may have to record potential write-downs relating to the value of obsolete or excess inventory. Conversely, if we underestimate future demand for a particular product or do not respond quickly enough to replenish our best performing products, we may have a shortfall in inventory of such products, likely leading to unfulfilled orders, reduced net revenue, and customer dissatisfaction. In addition, because we source components from suppliers located in China, our inventory management may be impacted by enactment or further escalation of tariffs, import restrictions, foreign government regulations, trade restrictions, customs, and duties.

 

Maintaining adequate inventory requires significant attention and monitoring of market trends, local markets, developments with suppliers, and our distribution network, and it is not certain that we will be effective in our inventory management.

 

24

 

 

If we fail to maintain and enhance our brand, our ability to engage or expand our base of customers will be impaired, and our business, financial condition, and results of operations may suffer.

 

Maintaining and enhancing our appeal and reputation as a stylish, innovative, and coveted brand is critical to attracting and expanding our relationships with customers. The successful promotion of our brand and the market’s awareness of our products and services will depend on a number of factors, including our marketing efforts, ability to continue to develop our products and services, and ability to successfully differentiate our offerings from competitive offerings. We expect to invest substantial resources to promote and maintain our brand, but there is no guarantee that our brand development strategies will enhance the recognition of our brand or lead to increased sales. The strength of our brand will depend largely on our ability to provide stylish, technologically enhanced products and quality services at competitive prices. Brand promotion activities may not yield increased net revenue, and even if they do, the increased net revenue may not offset the expenses we incur in promoting and maintaining our brand and reputation. In order to protect our brand, we also plan to expend substantial resources to register and defend our trademarks and to prevent others from using the same or substantially similar marks. Despite these efforts, we and Lucyd Ltd. may not always be successful in protecting the trademarks we license from Lucyd Ltd. Our trademarks may be diluted, and we may suffer harm to our reputation, or other harm to our brand. If our efforts to cost-effectively promote and maintain our brand are not successful, our results of operations and our ability to attract and engage customers, partners, and employees may be adversely affected.

 

Unfavorable publicity regarding our products, customer service, or privacy and security practices could also harm our reputation and diminish confidence in, and the use of, our products and services. In addition, negative publicity related to key brands that we have partnered with may damage our reputation, even if the publicity is not directly related to us. If we fail to maintain, protect, and enhance our brand successfully or to maintain loyalty among customers, or if we incur substantial expenses in unsuccessful attempts to maintain, protect, and enhance our brand, we may fail to attract or increase the engagement of customers, and our business, financial condition, and results of operations may suffer.

 

We rely heavily on our information technology systems, as well as those of our third-party vendors, business partners, and service providers, for our business to effectively operate and to safeguard confidential information; any significant failure, inadequacy, interruption, or data security incident could adversely affect our business, financial condition, and operations.

 

We rely heavily on our in-house information technology and enterprise resource planning systems for many functions across our operations, including managing our supply chain and inventory, processing customer transactions in our stores, allocating lens processing jobs to the appropriate laboratories, our financial accounting and reporting, compensating our employees, and operating our website, mobile applications and in-store systems. Our ability to effectively manage our business and coordinate the manufacturing, sourcing, distribution, and sale of our products depends significantly on the reliability and capacity of these systems. We are critically dependent on the integrity, security, and consistent operations of these systems, which are highly reliant on the coordination of our internal business and engineering teams. We also collect, process, and store sensitive and confidential information, including our proprietary business information and that of our customers, employees, suppliers, and business partners. The secure processing, maintenance, and transmission of this information is critical to our operations.

 

Our systems may be subject to damage or interruption from power outages or damages, telecommunications problems, data corruption, software errors, network failures, acts of war or terrorist attacks, fire, flood, global pandemics, and natural disasters; our existing safety systems, data backup, access protection, user management, and information technology emergency planning may not be sufficient to prevent data loss or long-term network outages. In addition, we may have to upgrade our existing information technology systems or choose to incorporate new technology systems from time to time in order for such systems to support the increasing needs of our expanding business. Costs and potential problems and interruptions associated with the implementation of new or upgraded systems and technology or with maintenance or adequate support of existing systems could disrupt or reduce the efficiency of our operations.

 

25

 

 

Our systems and those of our third-party service providers and business partners may be vulnerable to security incidents, attacks by hackers, acts of vandalism, computer viruses, misplaced or lost data, human errors or other similar events. If unauthorized parties gain access to our networks or databases, or those of our third-party service providers or business partners, they may be able to steal, publish, delete, use inappropriately, or modify our private and sensitive third-party information including personal health information, credit card information, and personal identification information. In addition, employees may intentionally or inadvertently cause data or security incidents that result in unauthorized release of personal or confidential information. Because the techniques used to circumvent security systems can be highly sophisticated, change frequently, are often not recognized until launched against a target, and may originate from less regulated and remote areas around the world, we may be unable to proactively address all possible techniques or implement adequate preventive measures for all situations.

 

Security incidents compromising the confidentiality, integrity, and availability of this information and our systems could result from cyber-attacks, computer malware, viruses, social engineering (including spear phishing and ransomware attacks), credential stuffing, supply chain attacks, efforts by individuals or groups of hackers and sophisticated organizations, including state-sponsored organizations, errors or malfeasance of our personnel, and security vulnerabilities in the software or systems on which we rely. We anticipate that these threats will continue to grow in scope and complexity over time and such incidents have occurred in the past, and may occur in the future, resulting in unauthorized, unlawful, or inappropriate access to, inability to access, disclosure of, or loss of the sensitive, proprietary and confidential information that we handle.

 

We also rely on a number of third-party service providers to operate our critical business systems, provide us with software, and process confidential and personal information, such as the payment processors that process customer credit card payments, which expose us to security risks outside of our direct control and our ability to monitor these third-party service providers’ data security is limited. These service providers could experience a security incident that compromises the confidentiality, integrity, or availability of the systems they operate for us or the information they process on our behalf. Cybercrime and hacking techniques are constantly evolving, and we or our third-party service providers may be unable to anticipate attempted security breaches, react in a timely manner, or implement adequate preventative measures, particularly given the increasing use of hacking techniques designed to circumvent controls, avoid detection, and remove or obfuscate forensic artifacts. While we have taken measures designed to protect the security of the confidential and personal information under our control, we cannot assure you that any security measures that we or our third-party service providers have implemented will be effective against current or future security threats. Moreover, we or our third-party service providers may be more vulnerable to such attacks in remote work environments, which have increased in response to the COVID-19 pandemic.

 

A security breach may also cause us to breach our contractual obligations. Our agreements with certain customers, business partners, or other stakeholders may require us to use industry-standard or reasonable measures to safeguard personal information. We also may be subject to laws that require us to use industry-standard or reasonable security measures to safeguard personal information. A security incident could lead to claims by our customers, business partners, or other relevant stakeholders that we have failed to comply with such legal or contractual obligations. In addition, our inability to comply with data privacy obligations in our contracts or our inability to flow down such obligations to our vendors, collaborators, other contractors, or consultants may cause us to breach our contracts. As a result, we could be subject to legal action, or our customers or business partners could end their relationships with us. There can be no assurance that the limitations of liability in our contracts would be enforceable or adequate or would otherwise protect us from liabilities or damages.

 

In addition, any such access, disclosure or other loss or unauthorized use of information or data, whether actual or perceived, could result in legal claims or proceedings, regulatory investigations or actions, and other types of liability under laws that protect the privacy and security of personal information, including federal, state and foreign data protection and privacy regulations, violations of which could result in significant penalties and fines in the EU and United States. In addition, although we seek to detect and investigate all data security incidents, security breaches, and other incidents of unauthorized access to our information technology systems and data can be difficult to detect and any delay in identifying such breaches or incidents may lead to increased harm and legal exposure of the type described above.

 

26

 

 

The cost of investigating, mitigating, and responding to potential security breaches and complying with applicable breach notification obligations to individuals, regulators, partners, and others can be significant. Further, defending a suit, regardless of its merit, could be costly, divert management attention, and harm our reputation. The successful assertion of one or more large claims against us that exceed available insurance coverage, or the occurrence of changes in our insurance policies, including premium increases or the imposition of large deductible or co-insurance requirements, could adversely affect our reputation, business, financial condition, revenues, results of operations, or cash flows. Any material disruption or slowdown of our systems or those of our third-party service providers and business partners, could have a material adverse effect on our business, financial condition, and results of operations. Our risks are likely to increase as we continue to expand, grow our customer base, and process, store, and transmit increasing amounts of proprietary and sensitive data.

 

Our e-commerce and multichannel channel business faces distinct risks, and our failure to successfully manage it could have a negative impact on our profitability.

 

As an e-commerce and multichannel retailer, we encounter risks and difficulties frequently experienced by businesses with significant online and in-store sales. The successful operation of our business as well as our ability to provide a positive shopping experience that will generate orders and drive subsequent visits depends on efficient and uninterrupted operation of our e-commerce order-taking and fulfillment operations. If we are unable to allow real-time and accurate visibility to product availability when customers are ready to purchase, quickly and efficiently fulfill our customers’ orders using the fulfillment and payment methods they demand, provide a convenient and consistent experience for our customers regardless of the ultimate sales channel, or effectively manage our online sales, our ability to compete and our results of operations could be adversely affected. Risks associated with our e-commerce and multichannel business include:

 

●uncertainties associated with our websites, mobile applications and in-store virtual try-on kiosks including changes in required technology interfaces, website downtime and other technical failures, costs and technical issues as we upgrade our systems software, inadequate system capacity, computer viruses, human error, security breaches, legal claims related to our systems operations, and fulfillment;

 

●our partnership with select third-party apps, through which we sell a portion of our products, are subject to changes in their technology interfaces, website downtime and other technical failures, costs, and issues;

 

●disruptions in internet service or power outages;

 

●reliance on third parties for computer hardware and software, as well as delivery of merchandise to our customers;

 

●rapid technology changes;

 

●credit or debit card fraud and other payment processing related issues;

 

●cybersecurity and consumer privacy; and

 

●natural disasters or adverse weather conditions.

 

In addition, we must keep up to date with competitive technology trends, including the use of new or improved technology, creative user interfaces, virtual and augmented reality, and other e-commerce marketing tools such as paid search and mobile application, among others, which may increase our costs and which may not increase sales or attract customers. Our competitors, most of whom have significantly greater resources than we do, may also be able to benefit from changes in e-commerce technologies, which could harm our competitive position.

 

27

 

 

If we fail to adapt and respond effectively to rapidly changing technology, evolving industry standards and changing customer needs or requirements, our solutions may become less competitive.

 

Our success depends on our customers’ willingness to adopt and use our products, as well as our ability to adapt and enhance our products. To attract new customers and increase revenue from existing customers, we need to continue to enhance and improve our products and to meet customer needs at prices that customers are willing to pay. Such efforts will require adding new features, expanding related applications and responding to technological advancements, which will increase our research and development costs. If we are unable to develop solutions that address customers’ needs or enhance and improve our platform in a timely manner, we may not be able to increase or maintain market acceptance of our products. Further, we may make changes to our products that customers do not find useful. We may also face unexpected problems or challenges in connection with new applications or feature introductions.

 

Moreover, many competitors expend a considerably greater amount of funds on their research and development programs, and those that do not may be acquired by larger companies that would allocate greater resources to competitors’ research and development programs. If we fail to compete effectively with the research and development programs of competitors, our business could be harmed. Our ability to grow is also subject to the risk of future disruptive technologies. If new technologies emerge that are able to deliver smart eyewear products at lower prices, more efficiently, more conveniently or more securely, such technologies could adversely affect our ability to compete.

 

We depend on highly skilled personnel to grow and operate our business, and if we are unable to hire, retain, and motivate our personnel, we may not be able to grow effectively.

 

Our success and future growth depend largely upon the continued services of our management team, including our Chief Executive Officer Harrison Gross. From time to time, there may be changes in our executive management team resulting from the hiring or departure of our executives. Our executive officers are employed on an at-will basis, which means they may terminate their employment with us at any time. The loss of one or more of our executive officers, or the failure by our executive team to effectively work with our employees and lead our company, could harm our business. We do not maintain key person life insurance with respect to any member of management or other employee.

 

In addition, our future success will depend, in part, upon our continued ability to identify and hire skilled employees with the skills and technical knowledge that we require, including software design and programming, eyewear design, marketing, merchandising, operations, and other key management skills and knowledge. Such efforts will require significant time, expense, and attention as there is intense competition for such individuals.

 

Certain technological advances, greater availability of, or increased consumer preferences for, vision correction alternatives to prescription eyeglasses or contact lenses, and future drug development for the correction of vision-related problems may reduce the demand for our products and adversely impact our business and profitability.

 

Technological advances in vision care, including the development of new or improved products, as well as future drug development for the correction of vision-related problems, could significantly change how vision care may be conducted and make our existing products less attractive or even obsolete. The greater availability and acceptance, or reductions in the cost, of vision correction alternatives to prescription eyeglasses and contact lenses, such as corneal refractive surgery procedures, including radial keratotomy, photorefractive keratotomy, or PRK, and LASIK, may reduce the demand for our products, lower our sales, and thereby adversely impact our business and profitability.

 

We could be adversely affected by product liability, product recall or personal injury issues.

 

We could be adversely impacted by the supply of defective products, including the infiltration of counterfeit products into the supply chain or product mishandling issues. Product liability or personal injury claims may be asserted against us with respect to any of the products we sell or services we provide.

 

If the products that we sell, including those that we process, package, or label, are defective or otherwise result in product liability or personal injury claims against us, our business could be adversely affected and we could be subject to adverse regulatory action. If our products or services do not meet applicable governmental safety standards or our customers’ expectations regarding quality or safety, we could experience lost sales and increased costs, be exposed to legal and reputational risk, and face fines or penalties which could materially adversely affect our financial results.

 

28

 

 

Refunds, cancellations, and warranty claims could harm our business.

 

We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason and receive a full refund within the first 7 days for sales made through our website, 30 days for sales made through Amazon, and 30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns). At the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. If we experience a substantial increase in refunds, our cancellation reserve levels might not be sufficient and our business, financial condition, and results of operations could be harmed.

 

We expect a number of factors to cause our results of operations and operating cash flows to fluctuate on a quarterly and annual basis, which may make it difficult to predict our future performance.

 

Our results of operations could vary significantly from quarter to quarter and year to year because of a variety of factors, many of which are outside of our control. As a result, comparing our results of operations on a period-to-period basis may not be meaningful. In addition to other risk factors discussed in this section, factors that may contribute to the variability of our quarterly and annual results include:

 

●our ability to accurately forecast and achieve net revenues and appropriately plan our expenses;

 

●changes to financial accounting standards and the interpretation of those standards, which may affect the way we recognize and report our financial results;

 

●the effectiveness of our internal controls;

 

●the early-stage nature of our business and the need to scale our operations and,

 

●the impact of the COVID-19 pandemic on our business.

 

The impact of one or more of the foregoing and other factors may cause our results of operations to vary significantly. As such, quarter-to-quarter and year-over-year comparisons of our results of operations may not be meaningful and should not be relied upon as an indication of future performance.

 

We may require additional capital to support the growth of our business, and this capital might not be available on acceptable terms, if at all.

 

We have funded our operations since inception primarily through net proceeds from the sale of convertible loan notes common stock sales through two registered crowdfunds and our initial public offering. We cannot be certain when, or if, our operations will generate sufficient cash to fully fund our ongoing operations or the growth of our business. We intend to continue to make investments to support the development of our products and services and will require additional funds for such development. We may need additional funding for marketing expenses and to develop and expand sales resources, develop new products and improve existing products with new features or enhance our products and services with new technology, improve our operating infrastructure, or acquire complementary businesses and technologies. Accordingly, we might need or may want to engage in future equity or debt financings to secure additional funds. Additional financing may not be available on terms favorable to us, if at all. If adequate funds are not available on acceptable terms, we may be unable to invest in future growth opportunities, which could harm our business, financial condition, and results of operations. In particular, the ongoing COVID-19 pandemic has caused disruption in the credit and financial markets in the United States and worldwide, which may reduce our ability to access capital and negatively affect our liquidity in the future. If we are unable to obtain adequate financing or financing on terms satisfactory to us, our ability to develop our products and services, support our business growth, and respond to business challenges could be significantly impaired, and our business may be adversely affected.

 

29

 

 

If we incur additional debt, the debt holders would have rights senior to holders of common stock to make claims on our assets, and the terms of any additional debt could include restrictive covenants that restrict our operations, including our ability to pay dividends on our common stock. Furthermore, if we issue additional equity securities, stockholders will experience dilution, and the new equity securities could have rights senior to those of our common stock. Because our decision to issue securities in the future will depend on numerous considerations, including factors beyond our control, we cannot predict or estimate the amount, timing, or nature of any future issuances of debt or equity securities. As a result, our stockholders bear the risk of future issuances of debt or equity securities reducing the value of our common stock and diluting their interests.

 

The occurrence of any of these foregoing risks could adversely affect our business, financial condition, and results of operations and expose us to unknown risks or liabilities.

 

Eyeglasses are regulated as medical devices by the FDA, and our failure, or the failure of any third-party manufacturer or optical laboratory, to obtain and maintain the necessary agency authorizations for our products could have a material adverse effect on our business.

 

We are an FDA registered eyewear importer, and we also engage in certain manufacturing, packaging, shipping and labeling activities that subject us and our overseas manufacturing partners to oversight by the FDA under the FDCA and its implementing regulations. The FDA regulates, among other things, with respect to medical devices: design, development and manufacturing, testing, labeling, content, and language of instructions for use and storage; clinical trials; product safety; establishment registration and device listing; marketing, sales and distribution; premarket clearance, classification and approval; recordkeeping procedures; advertising and promotion; recalls and field safety corrective actions; post market surveillance, including reporting of deaths or serious injuries and malfunctions that, if they were to recur, could lead to death or serious injury; post-market approval studies; and product import and export. The regulations to which we are subject are simpler than most medical products due to the relatively low risk classification of eyewear—regularly, only our lenses are reviewed for FDA clearance. Regulatory changes could result in restrictions on our ability to carry on or expand our operations, higher than anticipated costs, or lower than anticipated sales. The FDA enforces its regulatory requirements through, among other means, periodic unannounced inspections. Failure to comply with applicable regulations could jeopardize our or our contract manufacturers’ ability to manufacture and sell our products and result in FDA enforcement actions such as: warning letters; fines; injunctions; civil penalties; termination of distribution; recalls or seizures of products; delays in the introduction of products into the market; total or partial suspension of production; refusal to grant future clearances or approvals; withdrawals or suspensions of clearances or approvals, resulting in prohibitions on sales of our products; and in the most serious cases, criminal penalties.

 

Due to the nature of Vyrb as a social media application, and our collection of customer data in the process of taking orders, we are subject to rapidly changing and increasingly stringent laws, regulations, obligations, and industry standards relating to privacy, data security, and data protection. The restrictions and costs imposed by these laws and other obligations, or our actual or perceived failure to comply with them, could subject us to liabilities that adversely affect our business, operations, and financial performance.

 

We collect, process, store, and use a wide variety of data from current and prospective customers, including personal information, such as home addresses and geolocation, and health information related to their ophthalmic prescriptions. These activities are regulated by a variety of federal, state, local, and foreign privacy, data security, and data protection laws and regulations, which have become increasingly stringent in recent years.

 

Domestic privacy and data security laws are complex and changing rapidly. Many states have enacted laws regulating the online collection, use, and disclosure of personal information and requiring that companies implement reasonable data security measures. Laws in all states and U.S. territories also require businesses to notify affected individuals, governmental entities, and/or credit reporting agencies of certain security incidents affecting personal information. These laws are not consistent, and compliance with them in the event of a widespread data breach is complex and costly.

 

30

 

 

Further, the California Consumer Privacy Act (CCPA) took effect on January 1, 2020. The CCPA gives California residents expanded rights related to their personal information, including the right to access and delete their personal information, and receive detailed information about how their personal information is used and shared. The CCPA also created restrictions on “sales” of personal information that allow California residents to opt-out of certain sharing of their personal information and may restrict the use of cookies and similar technologies for advertising purposes. Our e-commerce platform, including our websites and mobile applications, rely on these technologies and could be adversely affected by the CCPA’s restrictions. The CCPA prohibits discrimination against individuals who exercise their privacy rights, provides for civil penalties for violations, and creates a private right of action for data breaches that is expected to increase data breach litigation. Additionally, a new California ballot initiative, the California Privacy Rights Act, or CPRA, was recently passed in California. The CPRA will restrict use of certain categories of sensitive personal information that we handle; further restrict the use of cross-context behavioral advertising techniques on which our products may rely in the future; establish restrictions on the retention of personal information; expand the types of data breaches subject to the private right of action; and establish the California Privacy Protection Agency to implement and enforce the new law, as well as impose administrative fines. The majority of the CPRA’s provisions will go into effect on January 1, 2023, and additional compliance investment and potential business process changes will likely be required. Similar laws have been proposed in other states and at the federal level, reflecting a trend toward more stringent privacy legislation in the United States. Compliance with such laws could be difficult and costly to achieve and we could be subject to fines and penalties in the event of non-compliance.

 

Additionally, we are subject to certain health information privacy and security laws as a result of the health information that we receive in connection with our products and services. These laws and regulations include not be adequate to indemnify us for the full extent of our potential liabilities.

 

Finally, since the Vyrb social app allows users to create and share various types of multimedia content in a public space operated by the Company, the Company has a basic responsibility to ensure that illegal or otherwise personally harmful content is removed from the platform with speed, which if we fail to do so, could potentially result in legal action against the Company.

 

Our business could be adversely impacted by changes in the internet and mobile device accessibility of users. Companies and governmental agencies may restrict access to our products and services, our mobile applications, website, application stores, or the internet generally, which could negatively impact our operations.

 

Our business depends on customers accessing our products and services via a mobile device or a personal computer, and the internet. We may operate in jurisdictions that provide limited internet connectivity. Internet access and access to a mobile device or personal computer are frequently provided by companies with significant market power that could take actions that degrade, disrupt, or increase the cost of consumers’ ability to access our products and services. In addition, the internet infrastructure that we and our customers rely on in any particular geographic area may be unable to support the demands placed upon it and could interfere with the speed and availability of our products and services. Any such failure in internet or mobile device or computer accessibility, even for a short period of time, could adversely affect our results of operations.

 

Governmental agencies in any of the countries in which we or our customers are located could block access to or require a license for our mobile applications, website, or the internet generally for a number of reasons, including security, confidentiality, or regulatory concerns. In addition, companies may adopt policies that prohibit their employees from using our products and services. If companies or governmental entities block, limit, or otherwise restrict customers from accessing our products and services, our business could be negatively impacted, the number of customers could decline or grow more slowly, and our results of operations could be adversely affected.

 

31

 

 

We could incur significant liabilities related to, and significant costs in complying with, environmental, health, and safety laws and regulations.

 

Our operations are subject to various national, state, and local environmental, health, and safety laws and regulations that govern, among other things, the health and safety of our employees and the end-users of our products and the materials used in, and the recycling of, our products and their packaging. Non-compliance with, or liability related to, these laws and regulations, which tend to become more stringent over time, could result in substantial fines or penalties, injunctive relief, civil, or criminal sanctions, and could expose us to costs of investigation or remediation, as well as tort claims for property damage or personal injury.

 

In addition, a number of governmental authorities, both in the United States and abroad, have considered, and are expected to consider, legislation aimed at reducing the amount of plastic non-recyclable waste. Programs have included banning certain types of products, mandating certain rates of recycling and/or the use of recycled materials, imposing deposits or taxes on single-use plastic bags, paper bags, reusable bags, and packaging materials. Such legislation, as well as voluntary initiatives, aimed at reducing the level of plastic wastes could result in increased cost of packaging for our products or otherwise require us to alter our current packaging and bagging practices. Additional regulatory efforts addressing other environmental or safety concerns in the future could similarly impact our business, financial condition, and results of operations.

 

From time to time, we may be subject to legal proceedings, regulatory disputes, and governmental inquiries that could cause us to incur significant expenses, divert our management’s attention, and materially harm our business, financial condition, and operating results.

 

From time to time, we may be subject to claims, lawsuits, government investigations, and other proceedings involving products liability, competition and antitrust, intellectual property, privacy, false advertising, consumer protection, securities, tax, labor and employment, commercial disputes, and other matters that could adversely affect our business operations and financial condition. As we grow, we may see a rise in the number and significance of these disputes and inquiries. Litigation and regulatory proceedings may be protracted and expensive, and the results are difficult to predict. Certain of these matters include speculative claims for substantial or indeterminate amounts of damages and include claims for injunctive relief. Additionally, our litigation costs could be significant. Adverse outcomes with respect to litigation or any of these legal proceedings may result in significant settlement costs or judgments, penalties and fines, or require us to modify our products or services, all of which could negatively affect our revenue growth. The results of litigation, investigations, claims, and regulatory proceedings cannot be predicted with certainty, and determining reserves for pending litigation and other legal and regulatory matters requires significant judgment. There can be no assurance that our expectations will prove correct, and even if these matters are resolved in our favor or without significant cash settlements, these matters, and the time and resources necessary to litigate or resolve them, could harm our business, financial condition, and results of operations.

 

Risks Related to Intellectual Property

 

We license some of our technology from Lucyd Ltd., the majority stockholder of the Company, and our inability to maintain this license could materially affect our business, financial condition, and operating results.

 

Some of our current intellectual property is licensed from Lucyd Ltd., the majority stockholder of the Company, pursuant to a license agreement we entered into with Lucyd Ltd. on April 1, 2020 (the “License Agreement”). Pursuant to the License Agreement, we acquired an exclusive, worldwide license that is royalty-free, fully paid up, and perpetual license for the exclusive use of certain assets of Lucyd Ltd. related to Innovative Eyewear current products and trademarks. There can be no assurance that the license will not be terminated by Lucyd Ltd. and if we are unable to continue to license the technology (because of, for example, intellectual property infringement claims brought by third-parties against us or against Lucyd Ltd.) then our business, financial condition and operating results would be adversely affected. Please see “Business—Material Agreements” for a more complete description of the License Agreement.

 

32

 

 

Failure to adequately maintain and protect our intellectual property and proprietary rights could harm our brand, devalue our proprietary content, and adversely affect our ability to compete effectively.

 

Our success depends to a significant degree on Lucyd Ltd.’s ability to obtain, maintain, protect, and enforce our licensed intellectual property rights, including those in our proprietary technologies, know-how, and brand. To protect our rights to our intellectual property, we rely on a combination of patent, trademark, copyright and trade secret laws, domain name registrations, confidentiality agreements, and other contractual arrangements with our employees, affiliates, clients, strategic partners, and others. However, the protective steps we have taken and plan to take may be inadequate to deter misappropriation or other violation of or otherwise protect our intellectual property rights. We may be unable to detect the unauthorized use of, or take appropriate steps to enforce, our intellectual property rights. Effective patent, trademark, copyright, and trade secret protection may not be available to us or available in every jurisdiction in which we offer or intend to offer our services. Failure to adequately protect our intellectual property could harm our brand, devalue our proprietary technology and content, and adversely affect our ability to compete effectively. Further, even if we are successful, defending our intellectual property rights could result in the expenditure of significant financial and managerial resources, which could adversely affect our business, financial condition, and results of operations.

 

If we fail to protect our intellectual property rights adequately, our competitors may gain access to our licensed intellectual property and proprietary technology and develop and commercialize substantially identical offerings or technologies. Any patents, trademarks, copyrights, or other intellectual property rights that we have or may obtain may be challenged or circumvented by others or invalidated or held unenforceable through administrative process, including re-examination, inter partes review, interference and derivation proceedings, and equivalent proceedings in foreign jurisdictions (e.g., opposition proceedings), or litigation. There can be no assurance that our patent applications will result in issued patents and we may be unable to obtain or maintain patent protection for our technology. In addition, any patents issued from pending or future patent applications or licensed to us in the future may not provide us with claims sufficiently broad to provide meaningful competitive advantages or may be successfully challenged by third parties. There is also no guarantee that our pending trademark applications for any mark will proceed to registration; our pending applications may be opposed by a third party prior to registration; and even those trademarks that are registered could be challenged by a third party, including by way of revocation or invalidity actions. For example, we have registrations in a number of foreign countries in which we are not currently offering goods or services, and those registrations could be subject to invalidation proceedings if we cannot demonstrate use of the marks by the applicable use deadlines in those countries. In addition, because patent applications in the United States are currently maintained in secrecy for a period of time prior to issuance, and patent applications in certain other countries generally are not published until more than 18 months after they are first filed, and because publication of discoveries in scientific or patent literature often lags behind actual discoveries, we cannot be certain that we were the first creator of inventions covered by our pending patent applications or that we were the first to file patent applications on such inventions. To maintain a proprietary market position in foreign countries, we may seek to protect some of our proprietary inventions through foreign counterpart patent applications. Statutory differences in patentable subject matter may limit the protection we can obtain on some of our inventions outside of the United States. The diversity of patent laws may make our expenses associated with the development and maintenance of intellectual property in foreign jurisdictions more expensive than we anticipate. We probably will not be able to obtain the same patent protection in every market in which we may otherwise be able to potentially generate revenue. Further, the laws of some foreign countries may not be as protective of intellectual property rights as those in the United States, and mechanisms for enforcement of intellectual property rights may be inadequate. Moreover, policing unauthorized use of our technologies, trade secrets, and intellectual property may be difficult, expensive, and time-consuming. Despite our precautions, it may be possible for unauthorized third parties to copy our offerings and capabilities and use information that we regard as proprietary to create offerings that compete with ours. Third parties may apply to register our trademarks or other trademarks similar to our trademarks in jurisdictions before us, thereby creating risks relating to our ability to use and register our trademarks in those jurisdictions. In addition, there could be potential trade name or trademark ownership or infringement claims brought by owners of other rights, including registered trademarks, in our marks or marks similar to ours. Any claims of infringement, brand dilution, or consumer confusion related to our brand (including our trademarks) or any failure to renew key license agreements on acceptable terms could damage our reputation and brand identity and substantially harm our business and results of operations. The value of our intellectual property could diminish if others assert rights in or ownership of our trademarks and other intellectual property rights, or trademarks that are similar to our trademarks. We may be unable to successfully resolve these types of conflicts to our satisfaction. In some cases, litigation or other actions may be necessary to protect or enforce our trademarks and other intellectual property rights.

 

33

 

 

We generally enter into confidentiality and invention assignment agreements with our employees and consultants, as well as confidentiality agreements with other third parties, including suppliers and other partners. However, we cannot guarantee that we have entered into such agreements with each party that has or may have had access to our proprietary information, know-how, and trade secrets. Moreover, no assurance can be given that these agreements will be effective in controlling access to our proprietary information or the distribution, use, misuse, misappropriation, reverse engineering, or disclosure of our proprietary information, know-how, and trade secrets. Further, these agreements may not prevent our competitors from independently developing technologies that are substantially equivalent or superior to our offerings and capabilities. These agreements may be breached, and we may not have adequate remedies for any such breach.

 

We may be required to spend significant resources to monitor and protect our intellectual property rights. Litigation may be necessary in the future to enforce our intellectual property rights and to protect our trade secrets. Litigation brought to protect and enforce our intellectual property rights could be costly, time-consuming, and distracting to management, and could result in the impairment or loss of portions of our intellectual property rights. Further, our efforts to enforce our intellectual property rights may be met with defenses, counterclaims, and countersuits attacking the validity and enforceability of our intellectual property rights, and if such defenses, counterclaims, or countersuits are successful, we could lose valuable intellectual property rights. Further, any changes in law or interpretation of any such laws, particularly intellectual property laws, may impact our ability to protect, register, or enforce our intellectual property rights. Our inability to protect our proprietary technology against unauthorized copying or use, as well as any costly litigation or diversion of our management’s attention and resources, could delay further sales or the implementation of our offerings and capabilities, impair the functionality of our offerings and capabilities, delay introductions of new offerings, result in our substituting inferior or more costly technologies into our offerings, or injure our reputation.

 

Domain names generally are regulated by internet regulatory bodies, and the regulation of domain names is subject to change. Regulatory bodies have and may continue to establish additional top-level domains, appoint additional domain name registrars, or modify the requirements for holding domain names. We may not be able to, or it may not be cost-effective to, acquire or maintain all domain names that utilize the name “Lucyd Ltd.” or “Innovative Eyewear” in all of the countries in which we currently conduct or intend to conduct business. If we lose the ability to use a domain name, we could incur significant additional expenses to market our products within that country, including the development of new branding. This could substantially harm our business, results of operations, financial condition and prospects.

 

We may incur costs to defend against, face liability or for being vulnerable to intellectual property infringement claims brought against us by others.

 

Third parties may assert claims against us alleging that we infringe upon, misappropriate, dilute or otherwise violate their intellectual property rights, particularly as we expand our business and the number of products we offer. These risks have been amplified by the increase in third parties whose sole or primary business is to assert such claims. We may be particularly vulnerable to such claims, as companies having a substantial online presence are frequently subject to litigation based on allegations of infringement or other violations of intellectual property rights. As we gain an increasingly high public profile, the possibility of intellectual property rights claims against us grows. Our competitors and others may now and in the future have significantly larger and more mature patent portfolios than us.

 

We rely on contracts and releases for ownership of copyrighted materials and the right to use images of individuals on our webpage and marketing material, and we may be subject to claims that we did not properly obtain rights, consent, a release, or permission to use certain content or imagery. Many potential litigants have the ability to dedicate substantial resources to the assertion of their intellectual property rights. Any claim of infringement by a third party, even those without merit, could cause us to incur substantial costs defending against the claim, could distract our management from our business, could require us to cease use of such intellectual property, and could create ongoing obligations if we are subject to agreements or injunctions (stipulated or imposed) preventing us from engaging in certain acts. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, we risk compromising our confidential information during this type of litigation. Our defense of any claim, regardless of its merit, could be expensive and time consuming and could divert management resources. We cannot predict the outcome of lawsuits and cannot ensure that the results of any such actions will not have an adverse effect on our business, financial condition, or results of operations. Successful infringement claims against us could result in significant monetary liability or prevent us from selling some of our products. In addition, resolution of claims may require us to redesign or rebrand our products, license rights from third parties on potentially unfavorable terms, cease using certain brand names or other intellectual property rights altogether, make substantial payments for royalty or license fees, legal fees, settlement payments or other costs or damages, or admit liability. Such outcomes could encourage others to bring claims against us. To the extent we seek a license to continue offerings or operations found or alleged to infringe third-party intellectual property rights, such a license may be non-exclusive, and therefore our competitors may have access to the same technology licensed to us. In the event we are required to develop alternative, non-infringing technology, this could require significant time (during which we would be unable to continue to offer our affected offerings), effort and expense, and may ultimately not be successful. Any of these events could harm our business and cause our results of operations, liquidity, and financial condition to suffer.

 

34

 

 

Risks Related to Our Dependence on Third Parties

 

We face risks associated with suppliers from whom our products are sourced and are dependent on a limited number of suppliers.

 

We purchase all of the inputs for our products, including eyeglass frames, temples with electronics embedded within them, prescription lenses, sun lenses, demo lenses, hinges, packaging materials and other components, parts, and raw materials, directly or indirectly from domestic and international suppliers. For our business to be successful, our suppliers must be willing and able to provide us with inputs in substantial quantities, in compliance with regulatory requirements, at acceptable costs and on a timely basis. Our ability to obtain a sufficient selection or volume of inputs on a timely basis at competitive prices could suffer as a result of any deterioration or change in our supplier relationships or events that adversely affect our suppliers.

 

We typically do not enter into long-term contracts with our suppliers and, as such, we operate without significant contractual assurances of continued supply, pricing or access to inputs. Any of our suppliers could discontinue supplying us with desired inputs in sufficient quantities or offer us less favorable terms on future transactions for a variety of reasons. The benefits we currently experience from our suppliers’ relationships could be adversely affected if our suppliers:

 

●discontinue selling products to us;

 

●raise their prices;

 

●increase lead times for products and/or key components

 

We also source inputs directly from suppliers outside of the United States, including China. Global sourcing and foreign trade involve numerous factors and uncertainties beyond our control including increased shipping costs, the imposition of additional import or trade restrictions, including legal or economic restrictions on overseas suppliers’ ability to produce and deliver inputs, increased custom duties and tariffs, unforeseen delays in customs clearance of goods, more restrictive quotas, loss of a most favored nation trading status, currency exchange rates, transportation delays, port of entry issues and foreign government regulations, political instability, and economic uncertainties in the countries from which we or our suppliers source our products.

 

Additionally, sourcing could be impacted by current and future travel restrictions and/or the shut-down of certain businesses globally due to the COVID-19 pandemic.

 

We rely on a limited number of contract manufacturers and logistics partners for our products. A loss of any of these partners could negatively affect our business.

 

We rely on a limited number of third-party suppliers and contract manufacturers for the components that go into the manufacturing of our products. In particular, our frames are provided by only a handful of suppliers. We also assemble and fulfill prescription glasses at a single third-party optical laboratory. Our reliance on a limited number of contract manufacturers and logistics partners for our products increases our risks of being unable to deliver our products in a timely and cost-effective manner. In the event of interruption from any of our contract manufacturers or our own fulfillment capabilities, we should be able to increase capacity from other sources or develop alternate or secondary sources without incurring material additional costs or substantial delays.

 

Our business could be adversely affected if one or more of our manufacturers is impacted by a natural disaster, an epidemic such as COVID-19, or other interruption at a particular location. In particular, the ongoing COVID-19 pandemic has caused, and will likely continue to cause, interruptions in the development, manufacturing (including the sourcing of key components), and shipment of our products, which could adversely impact our revenue, gross margins, and operating results.

 

35

 

 

Additionally, we do not own or operate a warehouse or a warehouse management company or system, and we currently rely on three third-party warehouses. Because a significant percentage of our products are stored in and shipped out of third-party warehouses, we face significant risks such as, but not limited to: our operations could be disrupted and our inventory could be destroyed by earthquakes, floods, fires or other natural disasters or other events outside of our control, or the control of our third-party warehouse. Our dependence on third-party warehouses also exposes us to the risk that the warehouse may experience operational disruptions due to security or computer viruses, software and hardware failure, power interruptions and other system failures. If we encounter problems with our third-party warehouse, we may be unable to meet customer expectations, manage our inventory and fulfillment capacity, complete sales, fulfill orders in a timely fashion, and our ability to achieve objectives for operating efficiencies could be adversely affected, all of which could harm our reputation and our relationship with our customers.

 

Our projects could be hindered due to our dependence on third parties to complete many of our contracts.

 

In the current economic environment, third parties may find it difficult to obtain sufficient financing to help fund their operations. The inability to obtain financing could adversely affect a third party’s ability to provide materials, equipment or services which could have a material adverse impact on our business, financial condition, and results of operations. In addition, a failure by a third-party subcontractor, supplier or manufacturer to comply with applicable laws, regulations or client requirements could negatively impact our business and, for government clients, could result in fines, penalties, suspension or even debarment being imposed on us, which could have a material adverse impact on our business, financial condition, and results of operations.

 

We depend on search engines, social media platforms, digital application stores, content-based online advertising, and other online sources to attract consumers to and promote our website and our mobile applications, which may be affected by third-party interference beyond our control and as we grow our customer acquisition costs may rise.

 

Our success depends in part on our ability to attract consumers to our website, mobile applications, and retail partners to convert them into customers in a cost-effective manner. We depend, in large part, on search engines, social media platforms, digital application stores, content-based online advertising, and other online sources for traffic to our website, mobile applications, and select application partners.

 

With respect to search engines, we are included in search results as a result of both paid search listings, where we purchase specific search terms that result in the inclusion of our advertisement, and free search listings, which depend on algorithms used by search engines. For paid search listings, if one or more of the search engines or other online sources on which we rely for purchased listings modifies or terminates its relationship with us, our expenses could rise, we could lose consumers and traffic to our website could decrease, any of which could have a material adverse effect on our business, financial condition, and results of operations.

 

We plan to rely primarily on third-party insurance policies to insure our operations-related risks. If our insurance coverage is insufficient for the needs of our business or our insurance providers are unable to meet their obligations, we may not be able to mitigate the risks facing our business, which could adversely affect our business, financial condition, and results of operations.

 

We procure third-party insurance policies or plan to procure policies to cover various operations-related risks including employment practices liability, workers’ compensation, property and business interruptions, cybersecurity and data breaches, crime, directors’ and officers’ liability, and general business liabilities. We rely on a limited number of insurance providers, and should such providers discontinue or increase the cost of coverage, we cannot guarantee that we would be able to secure replacement coverage on reasonable terms or at all. If our insurance carriers change the terms of our policies in a manner not favorable to us, our insurance costs could increase. Further, if the insurance coverage we maintain is not adequate to cover losses that occur, or if we are required to purchase additional insurance for other aspects of our business, we could be liable for significant additional costs. Additionally, if any of our insurance providers becomes insolvent, it would be unable to pay any operations-related claims that we make.

 

36

 

 

General Risk Factors

 

Failure to establish and maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse effect on our business and stock price.

 

Since the completion of our initial public offering in August 2022, we have been required to comply with the SEC’s rules implementing Sections 302 and 404 of the Sarbanes-Oxley Act, which will require management to certify financial and other information in our quarterly and annual reports and provide an annual management report on the effectiveness of controls over financial reporting. Though we will be required to disclose changes made in our internal controls and procedures on a quarterly basis, we are not required to make our first annual assessment of our internal control over financial reporting pursuant to Section 404 until the year following our first annual report required to be filed with the SEC. As an “emerging growth company,” as defined in the JOBS Act, we may take advantage of certain temporary exemptions from various reporting requirements, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes Oxley Act (and the rules and regulations of the Securities and Exchange Commission thereunder). Once we no longer qualify as an “emerging growth company” under the JOBS Act and lose the ability to rely on the exemptions related thereto discussed above and depending on our status as per Rule 12b-2 of the Securities Exchange Act of 1934, as amended, our independent registered public accounting firm may also need to attest to the effectiveness of our internal control over financial reporting under Section 404.

 

Based on the number of personnel available to serve the Company’s accounting function, management believes we are not able to adequately segregate responsibility over financial transaction processing and reporting. Further, the Company does not have a formal internal control environment in place and operating effectively. As such, we have identified these issues as material weaknesses in our internal control over financial reporting and insufficient controls with respect to revenue recognition, and we may identify additional material weaknesses in the future that may cause us to fail to meet our reporting obligations or result in material misstatements of our financial statements. If our remediation of such material weaknesses is not effective, or if we fail to develop and maintain an effective system of internal controls and internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable laws and regulations could be materially and adversely affected and the market price of our common stock could be negatively affected, which could require additional financial and management resources.

 

Changes in tax treatment of companies engaged in e-commerce may adversely affect the commercial use of our sites and our financial results.

 

Due to the global nature of the Internet, it is possible that various states or foreign countries might attempt to impose additional or new regulation on our business or levy additional or new sales, income, or other taxes relating to our activities. Tax authorities at the international, federal, state, and local levels are currently reviewing the appropriate treatment of companies engaged in e-commerce and digital services. New or revised international, federal, state, or local tax regulations or court decisions may subject us or our customers to additional sales, income and other taxes. For example, on June 21, 2018, the U.S. Supreme Court rendered a 5-4 majority decision in South Dakota v. Wayfair Inc., 17-494 where the Court held, among other things, that a state may require an out-of-state seller with no physical presence in the state to collect and remit sales taxes on goods the seller ships to consumers in the state, overturning existing court precedent. Other new or revised taxes and, in particular, digital taxes, sales taxes, VAT, and similar taxes could increase the cost of doing business online and decrease the attractiveness of selling products over the Internet. New taxes and rulings could also create significant increases in internal costs necessary to capture data and collect and remit taxes. Any of these events could have a material adverse effect on our business, financial condition, and operating results.

 

37

 

 

An overall decline in the health of the economy and other factors impacting consumer spending, such as recessionary conditions, governmental instability, inclement weather, and natural disasters, may affect consumer purchases, which could reduce demand for our products and harm our business, financial conditions, and results of operations.

 

Our business depends on consumer demand for our products and, consequently, is sensitive to a number of factors that influence consumer confidence and spending, such as general economic conditions, consumer disposable income, energy and fuel prices, recession and fears of recession, unemployment, minimum wages, availability of consumer credit, consumer debt levels, conditions in the housing market, interest rates, tax rates and policies, inflation, consumer confidence in future economic conditions and political conditions, war and fears of war, inclement weather, natural disasters, terrorism, outbreak of viruses or widespread illness, and consumer perceptions of personal well-being and security. However, as eyewear is a necessary medical device for a large segment of the population, we believe our business is more insulated from economic forces compared to other consumer electronics.

 

We are an “emerging growth company,” and we cannot be certain if the reduced reporting and disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors.

 

We are an “emerging growth company,” as defined in the JOBS Act, and we may take advantage of certain exemptions from reporting requirements that are applicable to other public companies that are not “emerging growth companies,” including the auditor attestation requirements of Section 404, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Pursuant to Section 107 of the JOBS Act, as an emerging growth company, we have elected to use the extended transition period for complying with new or revised accounting standards until those standards would otherwise apply to private companies. As a result, our financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective dates for new or revised accounting standards that are applicable to public companies, which may make our common stock less attractive to investors. In addition, if we cease to be an emerging growth company, we will no longer be able to use the extended transition period for complying with new or revised accounting standards.

 

We will remain an emerging growth company until the earliest of: (1) the last day of the fiscal year following the fifth anniversary of our listing; (2) the last day of the first fiscal year in which our annual gross revenue is $1.07 billion or more; (3) the date on which we have, during the previous rolling three-year period, issued more than $1 billion in non-convertible debt securities; and (4) the date on which we are deemed to be a “large accelerated filer” under the rules of the SEC.

 

We cannot predict if investors will find our common stock less attractive if we choose to rely on these exemptions. For example, if we do not adopt a new or revised accounting standard, our future results of operations may not be comparable to the results of operations of certain other companies in our industry that adopted such standards. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock, and our stock price may be more volatile.

 

If our estimates or judgments relating to our critical accounting policies prove to be incorrect, our results of operations could be adversely affected.

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes appearing elsewhere in this 10-K. We base our estimates on short duration historical experience and on various other assumptions that we believe to be reasonable under the circumstances, as provided in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates.” The results of these estimates form the basis for making judgments about the carrying values of assets, liabilities, and equity, and the amount of revenue and expenses. Significant estimates and judgments involve: inventory valuation; intangible assets; income taxes; valuation of our common stock and equity awards; revenue recognition, including revenue-related reserves; shipping and handling; and the computation of earnings/loss per share. Our results of operations may be adversely affected if our assumptions change or if actual circumstances differ from those in our assumptions, which could cause our results of operations to fall below the expectations of securities analysts and investors, resulting in a decline in the market price of our common stock.

 

38

 

 

Our current insurance coverage may not be adequate, and we may not be able to obtain insurance at acceptable rates, or at all.

 

We currently have General Liability and Product Liability policies covering our business. These policies may not provide sufficient coverage in the face of significant claims or multiple claims. Claims exceeding our insurance coverage could create significant increases in internal costs. This even could have a material adverse effect on our business, financial condition, and operating results.

 

We may decide to pursue strategic licensing deals to accelerate our growth. These potential brand acquisitions may not be successful. We may not be able to successfully integrate future IP acquisitions or generate sufficient revenues from future acquisitions, which could cause our business to suffer.

 

If we license an intellectual property (IP) from a company, there can be no assurance that we will be able to profitably manage this intellectual property or successfully integrate a new business unit without substantial costs, delays or other operational or financial problems. There can be no assurance that the IP we acquire in the future will achieve anticipated revenues and earnings. Additionally:

 

●the key personnel operating the acquired IP may decide not to work with us;

 

●we may be unable to maintain uniform standards, controls, procedures and policies among acquired IPs;

 

●we may be unable to successfully implement infrastructure, logistics and systems integration;

 

●we may be held liable for legal claims (including environmental claims) arising out of activities of the acquired IP prior to our acquisitions, some of which we may not have discovered during our due diligence, and we may not have indemnification claims available to us or we may not be able to realize on any indemnification claims with respect to those legal claims;

 

●we will assume risks associated with deficiencies in the internal controls of acquired IPs;

 

●we may not be able to realize the cost savings or other financial benefits we anticipated; and

 

●our ongoing business may be disrupted or receive insufficient management attention.

 

Future acquisitions may require us to obtain additional equity or debt financing, which may not be available on attractive terms. Moreover, to the extent an acquisition transaction financed by non-equity consideration results in additional goodwill, it will reduce our tangible net worth, which might have an adverse effect on our credit and bonding capacity.

 

Risks Related to Our Common Stock

 

Our directors, executive officers and principal stockholders have substantial control over our company, which could limit your ability to influence the outcome of key transactions, including a change of control.

 

Our executive officers, directors and principal stockholders and their affiliates own 5,189,085 shares of our common stock, or approximately 67% of the outstanding shares of our common stock, based on the number of shares outstanding as of March 17, 2023. As a result, these stockholders are able to exercise a significant level of control over all matters requiring stockholder approval, including the election of directors and the approval of mergers, acquisitions or other extraordinary transactions. They may also have interests that differ from yours and may vote in a way with which you disagree and which may be adverse to your interests. This concentration of ownership may have the effect of delaying, preventing or deterring a change of control of our company, could deprive our stockholders of an opportunity to receive a premium for their common stock as part of a sale of our company and might ultimately affect the market price of our common stock.

 

39

 

 

Lucyd Ltd., our principal stockholder, beneficially owns greater than 50% of our outstanding shares of common stock, which causes us to be deemed a “controlled company” under the rules of NASDAQ.

 

Lucyd Ltd. currently controls approximately 67% of the voting power of our capital stock. As a result, Lucyd Ltd. owns more than 50% of our outstanding shares and as such, we are a “controlled company” under the rules of NASDAQ. Under these rules, a company of which more than 50% of the voting power is held by an individual, a group or another company is a “controlled company” and, as such, can elect to be exempt from certain corporate governance requirements, including requirements that:

 

●a majority of the Board of Directors consist of independent directors;

 

●the board maintain a nominations committee with prescribed duties and a written charter; and

 

●the board maintain a compensation committee with prescribed duties and a written charter and comprised solely of independent directors.

 

As a “controlled company,” we may elect to rely on some or all of these exemptions, however, we do not intend take advantage of any of these exemptions. Despite the fact we do not intend to take advantage of these exemptions, our status as a “controlled company” could make our common stock less attractive to some investors or otherwise harm our stock price.

 

Separately, although our audit committee is currently in compliance and we intend to maintain compliance with NASDAQ rules, we are permitted to phase-in our compliance with the independent audit committee requirements set forth in NASDAQ rules, as follows: (1) one independent member of the audit committee at the time of listing, (2) a majority of independent members of the audit committee within 90 days of listing, and (3) all independent members of the audit committee (i.e., at least three members) within one year of listing. During these phase-in periods, our stockholders would not have the same protections afforded to stockholders of companies who have more ‘independent’ members of its audit committee and, if, within the phase-in periods, we are not able to recruit additional directors who would qualify as independent, or otherwise comply with the NASDAQ listing requirements, we may be subject to enforcement actions by NASDAQ.

 

The market prices of our common stock has been volatile and can fluctuate substantially, which could result in substantial losses for our investors.

 

The market price of our common stock is highly volatile, and since our initial public offering in August 2022, the market price of our common stock has ranged from $0.70 to $7.00 per share. The market price of our securities could be subject to wide fluctuations in response to a variety of factors, which include:

 

●actual or anticipated fluctuations in our quarterly or annual operating results;

 

●publication of research reports by securities analysts about us or our competitors or our industry;

 

●the public’s reaction to our press releases, our other public announcements and our filings with the SEC;

 

●our failure or the failure of our competitors to meet analysts’ projections or guidance that we or our competitors may give to the market;

 

●additions and departures of key personnel;

 

●strategic decisions by us or our competitors, such as acquisitions, divestitures, spin-offs, joint ventures, strategic investments or changes in business strategy;

 

●the passage of legislation or other regulatory developments affecting us or our industry;

 

40

 

 

●speculation in the press or investment community;

 

●changes in accounting principles;

 

●terrorist acts, acts of war or periods of widespread civil unrest;

 

●natural disasters and other calamities; and

 

●changes in general market and economic conditions.

 

In addition, the stock market has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of companies. Broad market and industry factors may negatively affect the market price of our common stock and Warrants, regardless of our actual operating performance. In the past, securities class action litigation has often been initiated against companies following periods of volatility in their stock price. This type of litigation could result in substantial costs and divert our management’s attention and resources, and could also require us to make substantial payments to satisfy judgments or to settle litigation.

 

We do not intend to pay dividends for the foreseeable future.

 

We have never declared or paid any cash dividends on our capital stock, and we do not intend to pay any cash dividends in the foreseeable future. We expect to retain future earnings, if any, to fund the development and growth of our business. Any future determination to pay dividends on our capital stock will be at the discretion of our board of directors. Accordingly, you must rely on the sale of your common stock after price appreciation, which may never occur, as the only way to realize any future gain on your investment.

 

Our quarterly operating results may fluctuate significantly and could fall below the expectations of securities analysts and investors due to the introduction of technologically more advanced products, seasonality and other factors, some of which are beyond our control, resulting in a decline in our stock price.

 

Our quarterly operating results may fluctuate significantly because of several factors, including:

 

●labor availability and costs for hourly and management personnel;

 

●changes in interest rates;

 

●macroeconomic conditions, both nationally and locally;

 

●changes in consumer preferences and competitive conditions;

 

●expansion to new markets;

 

●weather conditions in the regions we operate;

 

●increases in infrastructure costs; and

 

●fluctuations in commodity prices.

 

Unanticipated fluctuations in our quarterly operating results could result in a decline in our stock price.

 

41

 

 

Our failure to meet the continued listing requirements of NASDAQ could result in a de-listing of our common stock and Warrants.

 

If we fail to satisfy the continued listing requirements of NASDAQ, such as the corporate governance requirements or the minimum closing bid price requirement, NASDAQ may take steps to de-list our common stock and Warrants. Such a de-listing would likely have a negative effect on the price of our common stock and Warrants and would impair your ability to sell or purchase our common stock and Warrants when you wish to do so. In the event of a de-listing, we would take actions to restore our compliance with NASDAQ’s listing requirements, but we can provide no assurance that any such action taken by us would allow our common stock and Warrants to become listed again, stabilize the market price or improve the liquidity of our common stock and Warrants, prevent our common stock and Warrants from dropping below the NASDAQ minimum bid price requirement or prevent future non-compliance with NASDAQ’s listing requirements.

 

If our shares are delisted from NASDAQ and become subject to the penny stock rules, it would become more difficult to trade our shares.

 

The Securities and Exchange Commission (“SEC”) has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or authorized for quotation on certain automated quotation systems, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system. If we do not obtain or retain a listing on NASDAQ and if the price of our common stock is less than $5.00, our common stock will be deemed a penny stock. The penny stock rules require a broker-dealer, before a transaction in a penny stock not otherwise exempt from those rules, to deliver a standardized risk disclosure document containing specified information. In addition, the penny stock rules require that before effecting any transaction in a penny stock not otherwise exempt from those rules, a broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive (i) the purchaser’s written acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement to transactions involving penny stocks; and (iii) a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for our common stock, and therefore stockholders may have difficulty selling their shares.

 

Item 1B. Unresolved Staff Comments.

 

None.

 

Item 2. Properties.

 

Our executive offices are located at 11900 Biscayne Blvd., Suite 630, North Miami, Florida 33181. Our executive offices are provided to us by the parent of our majority stockholder, Tekcapital. We consider our current office space adequate for our operations.

 

From June 1, 2020, through February 1, 2022, we paid Tekcapital $25,000 per fiscal quarter under a management service agreement, which included rent-free office space, utilities, advisory services and other services. This agreement was amended effective February 1, 2022 such that we are billed $35,000 per fiscal quarter and no longer receive rent-free office space. Since then, Tekcapital bills us for an allocation of rent paid by Tekcapital on our behalf, and we recognized $74,442 of expense related to rent for the year ended December 31, 2022. Our management service agreement with Tekcapital does not stipulate a specific maturity date, and can be terminated with 30 calendar days written notice by any party.

 

Item 3. Legal Proceedings.

 

We are not the subject of any material pending legal proceedings, however, may from time to time become a party to various legal proceedings arising in the ordinary course of business. Except as discussed below, we are not the subject of any pending legal proceedings.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

42

 

 

PART II

 

Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

 

Market Information

 

Our common stock and Warrants trade on the NASDAQ Capital Market under the symbols “LUCY” and “LUCYW,” respectively since August 15, 2022. Prior to that date, there was no public market for our common stock or Warrants.

 

Holders

 

As of December 30, 2022, the approximate number of holders of record of our common stock was 3,828 and the closing price of our common stock was $1.37 per share. As of December 30, 2022, the approximate number of holders of record of our Warrants was 1 and the closing price of our Warrants was $0.15 per Warrant.

 

Securities Authorized for Issuance Under Equity Compensation Plans

 

See “Item 11. Executive Compensation.”

 

Dividend Policy

 

No cash dividends have been paid on our common stock since our inception. We have no present intention to pay any cash dividends in the foreseeable future.

 

Use of Proceeds from Registered Securities

 

On August 17, 2022, we consummated our initial public offering of 980,000 units at a price to the public of $7.50 per unit, each unit consisting of one share of Common Stock and two Warrants, with each Warrant exercisable to acquire one share of common stock. The securities sold in the offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333-261616). The SEC declared the registration statement effective on August 12, 2022. Of the gross proceeds received from the initial public offering, we received approximately $6.1 million, and we paid a total of approximately $588,000 in underwriting discounts and commissions and $600,000 for other costs and expenses related to the initial public offering. No payments were made by us to directors, officers or persons owning ten percent or more of our common stock or to their associates, or to our affiliates. There has been no material change in the planned use of proceeds from our initial public offering as described in our final prospectus filed with the SEC on August 16, 2023, pursuant to Rule 424(b).

 

Recent Sales of Unregistered Securities

 

The Company did not issue any unregistered securities during the three months ended December 31, 2022.

 

Item 6. Reserved.

 

43

 

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

You should read the following discussion and analysis of our financial condition and results of operations together with the accompanying “Index to Consolidated Financial Statements” included within this Annual Report on Form 10-K. Except for historical information, the matters discussed in this Management’s Discussion and Analysis of Financial Condition and Results of Operations are forward-looking statements that involve risks and uncertainties and are based upon judgments concerning factors that are beyond our control.

 

Overview

 

We develop and sell smart eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering vision correction and protection. Our flagship product, Lucyd Lyte, enables the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands-free. Innovative Eyewear owns the exclusive rights to the Lucyd brand and the Lyte product line.

 

Our mission is to Upgrade Your Eyewear®. Our smart eyewear is a fusion of headphones with glasses, bringing vision correction and protection together with digital connectivity and clear audio, while also offering a solution for listening to music outdoors (as compared to in-ear headphones). The convenience of having a Bluetooth headset and comfortable glasses in one, especially for those who are already accustomed to all-day eyewear use, offers a lifestyle upgrade at a price similar to traditional prescription eyewear.

 

After the full launch of Lucyd Lyte in January 2021, we had strong interest and demand from customers in the U.S. and have since sold thousands of our smart eyewear. In order to meet the growing demand for our products, and in an effort to expand our reach, we have engaged over 180 unique wholesale accounts. All of our products are designed in Miami, manufactured in Asia, and currently sold through two major types of channels:

 

1.e-commerce, primarily via our website (Lucyd.co) and marketplaces such as Amazon, Bestbuy.com, and DicksSportingGoods.com; and,

 

2.a growing network of independent eyewear and sporting goods stores.

 

We apply a manufacturer suggested retail price (“MSRP”) of $199 (for our standard frames) to $229 (for our titanium frames) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels, with our wholesale pricing offering volume discounts to these prices. Please refer to discussion in the Components of Results of Operations for more details regarding our pricing structure.

 

We are working to expand these channels with national eyewear chains, big box retail stores (electronics, sporting goods, general merchandise) and specialty retail stores.

 

We view this business model as capital light, by electing not to build our own manufacturing facilities and Company-owned retail distribution, but rather contract with existing sources of production and proven consumer-facing retail distribution.

 

Impact of COVID-19 on Our Business

 

On March 11, 2020, the World Health Organization officially declared the outbreak of the COVID-19 virus a “pandemic.” This contagious disease outbreak has continued to spread across the globe and has had an impact on worldwide economic activity and financial markets. In light of the uncertain and rapidly evolving situation relating to the spread of COVID-19, we took precautionary measures intended to minimize the risk of the virus to our employees, by following the CDC guidelines. Specifically, we set up a system that enabled our employees to work remotely when it was beneficial for them or when they felt ill. Additionally, precautionary measures that have been adopted may negatively affect our ability to sell our products. This includes, for example, reducing company attendance at trade shows. Additionally, our product is manufactured in China and shipped from China on a regular basis. We have not experienced substantial delays in manufacturing or shipping due to COVID-19; however, we are exposed to such risk in the future as a potential impact of COVID-19. More generally, the outbreak of COVID-19 could adversely affect economies and financial markets globally, potentially leading to an economic downturn, which could decrease consumer spending and adversely affect demand for our products.

 

44

 

 

Key Factors Affecting Performance

 

Expansion of retail points of purchase

 

In addition to sustained growth of our e-commerce business, our future revenues are correlated positively with our placement of Lucyd glasses in optical stores, as well as sporting goods stores and other specialty stores such as cellular shops. To address this, we assembled a team with decades of experience in the eyewear industry and are offering a strong co-op marketing program and reordering incentives program. We currently offer an expansive line of 16 different styles and several accessories, with plans to continuously expand this offering over time.

 

Retail store client retention and re-orders

 

Our ability to sustain and increase revenue is correlated positively with our ability to receive re-orders from stores, either directly or through our wholesale distributors. To support our sales to retail stores directly, we offer a strong co-op marketing program that includes free and paid store display materials. As part of this strategy, we have launched the Lucyd Digital Try-on Display for our resellers to help educate their in-store customers about Lucyd Lyte and enable customers to try them on virtually. This proprietary virtual try on software and display is central to our efforts to introduce traditional retail customers to Lucyd eyewear, and we are planning further enhancements to our merchandising displays to enable more immersive experiences.

 

Investing in business growth

 

We believe that people care about what they wear on their faces, and because we understand that customers have diverse preferences about the shape, size and design of their eyewear, we aim to continuously invest in the design and development of new models in an effort to provide the consumer with a wide selection of styles, colors and finishes.

 

We are offering a strong co-op marketing program with retail stores, and intend to expand our sales, marketing and brand ambassador teams to broaden our brand awareness and online presence. We will also increase our general and administrative expenses in the foreseeable future to cover the additional costs for finance, compliance, supply chain, quality assurance and investor relations as we grow as a public company.

 

Key Performance Indicators

 

Store Count (B2B)

 

We believe that one of the key indicators for our business is the number of retail stores onboarded to sell Lucyd Lyte. We started onboarding our first retail stores in June 2021. Currently, we have over 250 retail stores selling Lucyd Lyte primarily in the United States and Canada, across 180 unique wholesale accounts. Based on the existing demand for our products, current distribution and recently consummated supply agreements, we anticipate that our products will be available in a significant number of new third-party retail locations in 2023.

 

Re-order ratio (B2B)

 

Many of the retail stores that placed initial stocking orders, either directly or through our wholesale distributors, have also placed follow-on orders in the few short months since launching our wholesale business in June 2021. As of December 31, 2022, 28.6% of stores have re-ordered our product. Smart eyewear is still a new, emerging category for our optical sales partners. As such it can be expected that their sell-through rate is slower compared to traditional eyewear, and we expect many accounts to take some time to familiarize their clientele with the product category before reordering. We believe our reorder rate is a positive signal, given the overall lack of awareness of smart eyewear among consumers. The fact that a reasonable portion of our retail partners are experiencing enough early success and sell-through with our products to drive them to reorder, is an indication that success can be had with our product for the stores willing to put in the effort to merchandise it well, and educate staff and customers about it.

 

We expect this number to gradually increase as we continue to improve our product, roll out our co-op marketing program and introduce more of our virtual try-on kiosks into retail stores, to facilitate customer education and product sell-through.

 

45

 

 

Number of online orders (B2C)

 

For our e-commerce business, we track the number of online orders as an indicator of the success of our online marketing efforts. As of December 31, 2022, we received a total of 11,988 orders from customers online. We believe that the addition of new styles, as well as further investment in brand awareness, product ambassadors, and influencer campaigns, will enable continued growth of online orders in the foreseeable future. We expect to allocate a significant portion of our advertising expenditures towards influencer marketing programs.

 

Components of Results of Operations

 

Net Revenue

 

Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, and on our own website Lucyd.co and on Amazon.

 

Our flagship product line increased in price with the launch of the version 2.0 models, from $149 to $199 on acetate models, and $179 to $229 on titanium models for non-prescription glasses across all of our online channels. In addition, we have introduced a minimum advertised price on the new models of $169 and $199, respectively, to support our retail partners with guaranteed minimum pricing.

 

When adding a prescription lens upgrade to our glasses on the Lucyd.co website, the price can increase from between $40 for a basic clear prescription lens, all the way up to $450 for the latest Transitions® progressive bifocal lens. Glasses with prescription lenses are only available through our website Lucyd.co, while our sales through Amazon and to our retail partners only include non-prescription glasses.

 

U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers. We charge applicable state sales taxes for both online channels and all other marketplaces on which sell.

 

Our wholesale pricing for eyewear sold to retail store partners and distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.

 

Cost of Goods Sold

 

Cost of goods sold includes the costs incurred to acquire materials, assemble, and sell our finished products.

 

For retail sales placed on one of our e-commerce channels, these costs include (i) product costs held at the lesser of cost and net realizable value and inclusive of inventory reserves, (ii) freight, import, and inspection costs, (iii) optical laboratory costs for RX glasses, (iv) merchant fees, (v) fees paid to third-party e-commerce platforms, and (vi) cost of shipping the product to the consumer.

 

For wholesale sales these costs include (i) product costs stated at the lesser of cost and net realizable value and inclusive of inventory reserves, (ii) freight, import, and inspection costs, and (iii) credit card fees.

 

When consumers place their orders directly on our online store, we save approximately 12-15% on marketplace fees than when consumers place their orders directly from third-party platforms like Amazon and eBay.

 

46

 

 

We expect our cost of goods sold to fluctuate as a percentage of net revenue primarily due to product mix, customer preferences and resulting demand, customer shipping costs, and management of our inventory and merchandise mix.

 

Over time we expect our total cost of goods sold on a per unit basis to decrease as a result of an increase in scale. Increase in scale is achieved as a result of increase in volumes from both business to consumer and business to business (retail store) orders. We continue to expand our products with line extensions and new models and broaden our presence in retail stores carrying our products.

 

Gross Profit and Gross Margin

 

We define gross profit as net revenues less cost of goods sold. Gross margin is gross profit expressed as a percentage of net revenues. Our gross margin may fluctuate in the future based on a number of factors, including the cost at which we can obtain, transport, and assemble our inventory, the rate at our vendor network expands, and how effective we can be at controlling costs, in any given period.

 

We anticipate our cost of goods sold, on a per unit basis, will decrease with scale, and this will likely have a positive impact on our gross margins.

 

Operating Expenses

 

Our operating expenses consist primarily of:

 

●general & administrative expenses that include primarily consulting and payroll expenses, IT & software, legal, stock compensation expense, postage and non-customer product shipping, and other administrative expense;

 

●sales and marketing expenses including cost of online and TV advertising, marketing agency fees, influencers, trade shows, and other initiatives;

 

●related party management fees for a range of back-office services provided by Tekcapital LLC and

 

●research and development expenses related to (i) development of new styles and features of our smart eyewear, (ii) development and improvement of our e-commerce website, and (iii) development of our Vyrb social media app for wearables.

 

Interest and Other Income, Net

 

Interest and other income, net, consists primarily of interest expense paid on convertible note loan due to the Parent.

 

Provision for Income Taxes

 

Provision for income taxes consists of income taxes related to foreign and domestic federal and state jurisdictions in which we conduct business, adjusted for allowable credits, deductions, and valuation allowance against deferred tax assets.

 

47

 

 

Results of Operations

 

Years Ended December 31, 2022 and 2021

 

   Year ended December 31, 
   2022       2021       2022 vs 2021     
Revenues, net   659,788   100%   690,670   100%   (30,882)  -4%
Less: Cost of Goods Sold   (716,077)  109%   (542,416)  79%   (173,661)  32%
Gross Profit   (56,289)  -9%   148,254   21%   (204,543)  -138%
                            
Operating expenses:                           
General & administrative   (2,796,669)  424%   (1,386,079)  201%   (1,410,590)  102%
Sales and marketing   (2,059,012)  312%   (1,771,012)  256%   (288,000)  16%
Research and development   (524,692)  80%   (86,261)  12%   (438,431)  508%
Related party management fee   (140,000)  21%   (109,975)  16%   (30,025)  27%
Total Operating Expenses   (5,520,373)  837%   (3,353,327)  486%   (2,167,046)  65%
                            
Other Income/(Expense):                           
Interest Expense   (105,171)  16%   (39,433)  -6%   (65,738)  0%
Total Other Income/(Expense)   (105,171)  16%   (39,433)  -6%   (65,738)  0%
                            
Net Loss   (5,681,833)  861%   (3,244,506)  470%   (2,437,327)  75%

 

Revenue

 

Our revenues for the year ended December 31, 2022, were $659,788, representing a decrease of approximately 4% as compared to revenues of $690,670 during the year ended December 31, 2021. Our revenue is generated entirely from sales of eyewear products, namely smart frames, lenses, and accessories. The decline in revenue was primarily attributable to several factors, including unfavorable channel mix as described in the following paragraph, partially offset by higher unit volumes, and favorable price impacts as we increased the MSRP of our flagship product line with the launch of the version 2.0 models in the current year. Additionally, due to the relative age of the version 1.0 models on the market, we deployed significant discounts on those models to assist in inventory turnover. Finally, we experienced an increase in the rate of customer returns due to minor product imperfections that were the result of supplier inaccuracies in manufacturing. These manufacturing imperfections have been wholly addressed with our new version 2.0 product line. In addition, we anticipate that new licensing agreements which we entered into during 2022 will help to increase our sales in 2023 and beyond.

 

For the year ended December 31, 2022, approximately 32% of sales were processed on our online store (Lucyd.co), 38% on Amazon, and 30% with reseller partners. This sales channel mix impacted our revenue for the period, due to the fact we charge an additional $35 to $275 for our prescription lenses available only on Lucyd.co. For the year ended December 31, 2022, we generated $579,214 of revenue from sales of non-prescription frames and accessories and $80,574 was generated from sales of frames with prescription lenses. All of the $252,799 in sales generated on Amazon.com during the period were for non-prescription frames and accessories as we only offer prescription lenses through our website. Of the $208,477 in online sales generated through Lucyd.co, $80,574 related to frames with prescription lenses and $127,873 of glasses sold were with non-prescription lenses. E-commerce sales are the most material portion of our sales to date. There were several notable advances in the Company’s technology products and partnerships in 2022 which speak to the potential to grow revenues well beyond the current level.

 

Key hardware improvements include the development of a new proprietary four-speaker audio temple for the Lucyd Lyte flagship line, the increase in battery life of all of our flagship to 12 hours of playback, which is longer than the vast majority of wireless audio products, and design improvements to the frames overall that were the result of hiring two new expert eyewear designers.

 

48

 

 

Key software improvements include the development of a live broadcasting feature on the Company’s proprietary Vyrb mobile app, the ability to import any form of audio content into Vyrb to support the migration of existing audio content creators to the platform, and the introduction of the Company’s Digital Try-on Display into dozens of retail stores, to offer an immersive product experience for in-store shoppers at our partner locations.

 

The Company believes that Nautica Powered by Lucyd line launching in 2023, made possible by the exclusive agreement with Authentic Brands Group for the Nautica brand, represents significant revenue potential in the coming year. The Company intends to partner with Nautica-branded sales channels, and expects to be able to increase our presence in other retail channels via the Nautica brand, a household name in dozens of countries.

 

For the year ended December 31, 2021, approximately 41% of sales were processed on our online store (Lucyd.co), 39% on Amazon and 20% with retail store partners. This sales channel mix impacted our revenue for the period, due to the fact we charge additional $35 to $275 for our prescription lenses available only on Lucyd.co. For the year ended December 31, 2021, we generated $530,885 of revenue from sales of nonprescription frames and $159,815 was generated from sales of frames with prescription lenses. All of the $266,733 in sales generated on Amazon.com during the period were for non-prescription frames as we only offer prescription lenses through our website. Of the $282,364 in online sales generated through Lucyd.co, $159,785 related to frames with prescription lenses and $122,579 of glasses sold were with non-prescription lenses. Lucyd.co sales are the most material portion of our sales to date, aided by higher price compared to retail store pricing as well as additional revenue recorded due to sales of prescription lenses.

 

We expect that the online portion of our sales will gradually decrease on a percentage basis but remain an important component of our total sales as we onboard more retail stores. We pursued growth in retail store segment in the year ended 2021 and during 2022, growing our retail store presence to over 250 stores as of December 31, 2022.

 

Cost of goods sold

 

Our total cost of goods sold increased to $716,077 for the year ended December 31, 2022, as compared to $542,416 for the year ended December 31, 2021. This increase was primarily driven by the combination of (i) a $78,288 write-off of inventory as a result of our physical inventory count procedures performed in December 2022 and (ii) damaged inventory received from one of our suppliers in 2022, which resulted in write-offs of $69,532 of inventory. Subsequently, we have engaged new suppliers for our product sourcing. The Company faced a supply chain challenge in 2022, and received two shipments of glasses that included a few thousand defective units. Once the high rate of defects became apparent, the Company immediately undertook a second 100% inspection of all inventory, and discovered the extent of the issue. The Company then worked to pull any problematic units from standing inventory, and also offered immediate replacement to any customers experiencing issues with any units from these batches. As a result of these problems, the Company severed the relationship with that supplier and conducted a detailed research investigation in China to identify better potential manufacturers of our products, and settled on two new suppliers.

 

Although the Company was reimbursed for a portion of these units from the old supplier, in some cases the units were not discovered to be defective until many months after receipt from the manufacturer and were not able to be compensated.

 

Early customer feedback on the Lyte 2.0 products and feedback from our independent inspection team, indicates that our products from our new suppliers have improved reliability and build quality compared to the original Lyte product, therefore the Company expects significantly less damaged inventory in the future.

 

In regards to the Company’s overall cost of goods, they have remained relatively constant with an increase of only $4-5 per unit compared to the previous supplier - however the improved components and aesthetics allowed the company to adjust the retail MSRP of our products upward by $50, which compensates well for this increase. Our wholesale prices adjusted $10 upward to compensate for this increase.

 

49

 

 

A positive development in COGs is a significant decrease in air shipping costs in the latter half of 2022 ($6.50 per unit at the height of the pandemic to $3.50 per unit in Q4 2022), with the company able to ship goods at approximately just over half the price per unit by air compared to 2021 and H1 2022, and with a new sea route available through our local 3PL partner at approximately $1.50/unit.

 

Smart eyewear is a highly specialized product that has the combined specifications and component requirements of a wireless Bluetooth headset and optical eyewear in one, meaning it is expensive to manufacture in small quantities of a few thousand at a time. As demand and awareness for smart eyewear continues to grow, the Company expects that its per unit cost will decrease as its order volumes increase.

 

Key components of cost of goods sold for the year ended December 31, 2022 included, but were not limited to, the cost of frames of $478,020, cost of prescription lenses incurred with our third-party vendor of $104,217, affiliate referral fees, sales commission expense, and e-commerce platform fees of $128,340, and quality assurance costs related to our products sold of $5,500. Out of our total cost of goods sold for the year ended December 31, 2022, $113,024 related to orders with prescription lenses, while $639,294 pertained to non-prescription orders.

 

For the year ended December 31, 2022, approximately 32% of sales were processed on our online store (Lucyd.co), 38% on Amazon, and 30% with reseller partners. This sales channel mix impacted our cost of goods sold, as the cost of prescription lenses attributable to our Lucyd.co sales increased our cost of goods sold through Lucyd.co while not impacting cost of goods sold for sales realized through Amazon or retail store partners. As we continue to grow our business, we expect that our cost of goods sold per unit will decrease as we realize economies of scale.

 

Key components of cost of goods sold for the year ended December 31, 2021 included, but were not limited to, the cost of frames of $303,909, cost of prescription lenses incurred with our third-party vendor of $144,957, affiliate referral fees, sales commission expense, e-commerce platform fees of $89,950, and quality assurance costs related to our products sold of $3,600. In Q4 2022, the company standardized all custom lens profit margins at 35%, except one variant, the basic Single Vision clear prescription lens, which is sold at a 17.5% margin to enable the company to advertise an competitive $40 basic prescription upgrade price.

 

A number of factors in 2022 caused our overall lens lab vendor costs to be higher than revenue from lenses sold:

 

●Primarily, a large number of prescription units are provided annually as promotional items to influencers, investors, online and traditional media, and other press outlets for the purpose of gaining various forms of brand awareness, investor interest and site traffic for the company.

 

●The lens lab charges the Company $3,000 annually for the storage of frames in their facility.

 

●Improperly cut prescriptions, and pairs lost in transit, both infrequent occurrences, are typically replaced for free to enhance customer retention and customer lifetime value.

 

●When a frame does not properly fit a customer, sometimes a new lens set is provided for free in a different frame that will fit the customer properly.

 

●Warranty replacements sometimes require a new lens set to be made at no cost to the consumer.

 

●Our 7-day return policy provides customers comfort when trying our products, but sometimes causes a prescription pair to be returned (custom lenses are refunded in store credit, which may be used to purchase an additional lens set). With active customer care, we are able to keep our return rate low on Lucyd.co (our only prescription channel).

 

●In conclusion, prescription lenses can often be expensive, running to the hundreds of dollars per set for specialty and bifocal lenses, so a seemingly low number of free prescription pairs can cause a large deficit. However, prescription fitted smart eyewear is a USP of the Company and an incredibly useful tool for attracting positive media coverage. As we continue to scale up the volume of our ecommerce business, we fully expect the standardized lens profit margin to bring more revenue than overall lens costs in the future.

 

50

 

 

Out of our total cost of goods sold for the year ended December 31, 2021, $211,620 related to orders with prescription lenses, while $330,796 pertained to non-prescription orders. For the year ended December 31, 2021, approximately 41% of sales were processed on our online store (Lucyd.co), 39% on Amazon and 20% from retail store partners.

 

Over time, we expect third-party retail stores to become our primary sales channel as we onboard additional stores. Consequently, we expect sales of prescription lens, offered through our website to decrease, as our third-party retail partners outfit our Lyte frames with more prescriptions. As a result, over time we expect prescription lens costs to gradually decrease as a percentage of our overall cost of goods sold.

 

We anticipate growth in both wholesale and e-commerce channel sales in 2023, and we also expect corresponding growth in total cost of goods sold, primarily from additional product related costs.

 

Gross (deficit) profit

 

Our gross profit decreased to negative $56,289 for the year ended December 31, 2022, as compared to positive $148,254 for the year ended December 31, 2021. This decrease was primarily driven by the aforementioned inventory write-offs during the current year totaling $147,820.

 

We expect gross profit for the fiscal year ending December 31, 2023, to improve, primarily due to economies of scale from large, anticipated orders. As we expect retail stores to become our primary sales channel as we on board new stores, we also expect our overall gross margin to be better than that of the wholesale channel, since no e-commerce platform fees or prescription lens costs apply in wholesale channels.

 

Operating expenses

 

Our operating expenses increased by 65% to $5,520,373 for the year ended December 31, 2022, as compared to $3,353,327 for the year ended December 31, 2021. This increase was primarily due to the expansion of our business following the launch of Lucyd Lyte in January 2021 and included, but was not limited to, the following:

 

General and administrative expenses

 

Our general and administrative expenses increased by 102% to $2,796,669 for the year ended December 31, 2022, as compared to $1,386,079 for the year ended December 31, 2021. This increase was primarily attributable to (i) an increase of approximately $436,000 in employee-related costs, resulting from increases in our staffing and new employment agreements entered into with executives, (ii) increased costs associated with being a publicly-traded company, including directors’ remuneration, legal and insurance expense, and public and investor relations, which altogether resulted in an increase in expense of approximately $416,000, (iii) bad debt expense in the current year of approximately $116,000, and (iv) an increase in consulting fees of approximately $103,000 as a result of our growth and increased used of consultants.

 

Sales and marketing expenses

 

Our sales and marketing expenses increased by 16% to $2,059,012 for the year ended December 31, 2022, as compared to $1,771,012 for the year ended December 31, 2021. The increase was primarily due to our multi-prong sales and marketing strategy, growing continuously over the past two years after the launch of our main product in January 2021.

 

We anticipate these costs to further increase as we continue to invest in and build our brand, expand the number of e-commerce platforms we sell our products on, invest in retail store co-op marketing programs to help educate our in-store customers about Lucyd Lytes, and increase our brand’s physical presence and role in the eyewear industry.

 

51

 

 

Related party management fee

 

Our related party management fee was $140,000 for the year ended December 31, 2022, as compared with $109,975 for the year ended December 31, 2021. This increase was due to increased scope of assistance received under the agreement, corresponding to continuous scale-up of Company’s operations after launch of its flagship product in the first quarter of 2021. The management fees are related to the management services agreement between us and an affiliate of our Parent.

 

Research and development costs

 

Our research and development costs increased by 508% to $524,692 for the year ended December 31, 2022, as compared with $86,261 for the year ended December 31, 2021. The increase was primarily due to stock-based compensation totaling $263,612 in addition to the increased cost of new frame development as the Company continued to expand its product line. Eyewear R&D includes the purchase and testing of new components, the compensation of staff involved primarily in frame design and the creation of new eyewear molds. Software R&D includes the portion of the work hours spent by the CEO and CTO on new software development on the Vyrb app and our glasses, and external coding teams we have engaged to write the programming for our software, and enhance our software user experiences with code updates. Other software costs such as the Apple Developer program are nominal fees only.

 

Liquidity and Capital Resources

 

Cash Flow Data:

 

   Year ended   Year ended 
   December 31,   December 31, 
   2022   2021 
Net cash flows from operating activities  $(3,224,418)  $(1,214,160)
Net cash flows from investing activities   (219,951)   (118,454)
Net cash flows from financing activities   6,955,751    1,385,318 
Net Change in Cash  $3,511,382   $52,704 

 

Initial Public Offering

 

On August 17, 2022, the Company closed on its initial public offering of 980,000 units, consisting of 980,000 shares of its common stock and 1,960,000 warrants to purchase 1,960,000 shares of common stock, at a combined offering price of $7.50 per unit in exchange for gross proceeds of approximately $7.35 million, before deducting underwriting discounts and offering expenses. Each share of common stock was sold together with two warrants, each warrant to purchase one share of common stock at an exercise price of $7.50 per share. In addition, the Company granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or warrants to purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which the underwriter exercised its option to purchase additional warrants to purchase 294,000 shares of common stock.

 

After deducting underwriting discounts and offering expenses, net proceeds received by the Company amounted to $6,189,734. We intend to use proceeds from this offering primarily on (i) sales and marketing, (ii) expanding our inventory, (iii) updating and developing our in-store displays, (iv) developing new smart eyewear styles and sizes, as well as further development and commercialization of the Vyrb app, and (v) working capital and other general corporate purposes.

 

We expect that operating losses could continue in the foreseeable future as we continue to invest in the expansion and development of our business. We believe our existing cash and cash equivalents, proceeds from the aforementioned offering, proceeds received from investors’ exercises of warrants, funds available under our existing credit facility, and cash flows from operating activities will be sufficient to fund our operations for at least the next twelve months. In February 2023, investors exercised warrants to purchase an aggregate of 408,600 shares of our common stock, at an adjusted exercise price of $3.75 per share, resulting in cash proceeds to us of $1,532,250.

 

52

 

 

However, our future capital requirements will depend on many factors, including, but not limited to, growth in the number of retail store customers, the needs of our e-commerce business and retail distribution network, expansion of our product and software offerings, and the timing of investments in technology and personnel to support the overall growth of our business. To the extent that current and anticipated future sources of liquidity are insufficient to fund our future business activities and requirements, we may be required to seek additional equity or debt financing. The sale of additional equity would result in additional dilution to our stockholders. The incurrence of debt financing would result in debt service obligations and the instruments governing such debt could provide for operating and financing covenants that would restrict our operations. There can be no assurances that we will be able to raise additional capital. In the event that additional financing is required from outside sources, we may not be able to negotiate terms acceptable to us or at all. The COVID-19 pandemic along with other geopolitical and macroeconomic factors has caused disruption in the global financial markets, which could reduce our ability to access capital and negatively affect our liquidity in the future. If we are unable to raise additional capital when required, or if we cannot expand our operations or otherwise capitalize on our business opportunities because we lack sufficient capital, our business, results of operations, financial condition, and cash flows would be adversely affected.

 

Off-Balance Sheet Arrangements

 

As of December 31, 2022, we did not have any off-balance sheet arrangements.

 

Critical Accounting Policies and Significant Developments and Estimates

 

Management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with GAAP. The preparation of our financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, as well as the reported revenue generated and expenses incurred during the reporting periods, as well as related disclosures. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and the amount of revenue and expenses that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions, and any such differences may be material. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management’s judgments and estimates.

 

We believe that our application of accounting policies, and the estimates inherently required therein, are reasonable. We periodically re-evaluate these accounting policies and estimates and make adjustments when facts and circumstances dictate a change. Historically, we have found our application of accounting policies to be appropriate, and actual results have not differed materially from those determined using necessary estimates.

 

Inventory

 

Our inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. No provisions were determined as needed as of December 31, 2022 and 2021.

 

As of December 31, 2022 and 2021, we recorded an inventory prepayment in the amount of $197,750 and $64,715, respectively, related to down payment on eyewear purchased from the manufacturer, prior to shipment of the product that occurred after December 31, 2022 and 2021, respectively.

 

53

 

 

Intangible Assets

 

Intangible assets relate to:

 

●Internally-developed and licensed utility and design patents. We amortize these assets over the estimated useful life of the patents.

 

●Capitalized software costs incurred due to development of the Vyrb app. We amortize these assets over the estimated useful life of the software application.

 

We review our intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.

 

Income Taxes

 

We are taxed as a C corporation. We comply with Financial Accounting Standards Board (FASB) ASC 740 for accounting for uncertainty in income taxes recognized in a company’s financial statements, which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. FASB ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, and disclosure. Based on our evaluation, we have concluded that there are no significant uncertain tax positions requiring recognition in our financial statements. We believe that our income tax positions would be sustained on audit and do not anticipate any adjustments that would result in a material change to the Company’s financial position.

 

We have incurred taxable losses since inception but are current in our tax filing obligations. We are not presently subject to any income tax audit in any taxing jurisdiction.

 

Stock-Based Compensation

 

We account for stock-based compensation to employees and directors in accordance with FASB ASC Topic 718, which requires that compensation expense be recognized in the financial statements for stock-based awards based on the grant date fair value. For stock option awards, the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility. The expected term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).

 

The share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies. The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.

 

The fair value of common stock used in the option pricing model for stock-based awards granted in 2021 was determined using the most recent price paid by independent investors through a Regulation Crowdfunding (“CF”) securities offering undertaken by the Company. For the majority of time during which stock option awards were granted by the Company in 2021, we had been raising funds from investors under Regulation CF campaigns, with a significant number of transactions from both accredited and non-accredited investors. Specifically:

 

●from June 2020 to April 2021, we were conducting a REG CF offering of our shares of common stock at a price of $1 per share, and we utilized this $1 per share price to issue and value our stock-based awards during such period, and

 

●from May 2021 to September 2021, we were conducting a second REG CF offering of our shares of common stock at a price of $3.56 per share, and we utilized this $3.56 per share price to issue and value our stock-based awards during such period.

 

54

 

 

The pre-money valuation determining price per share was agreed upon each time with the crowdfunding platform, who has a great deal of experience in setting the proper pre-money valuations for companies that list on their platforms. The determination was made using our business progress.

 

Revenue Recognition

 

Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, and on our own website Lucyd.co and on Amazon.

 

To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract, determine those that are performance obligations, and assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In instances where the collectability of contractual consideration is not probable at the time of sale, the revenue is deferred on our balance sheet as a contract liability, and the associated cost of goods sold is deferred on our balance sheet as a contract asset; subsequently, we recognize such revenue and cost of goods sold as payments are received.

 

All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.

 

For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.

 

For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation which is delivery of our eyewear products to the retail store and also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to the retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.

 

For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order and after collectability of substantially all of the contract consideration is probable. Our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale distributor orders, no e-commerce fees are applicable.

 

The Company’s sales to both retail partners and through our e-commerce channels do not contain any variable consideration.

 

55

 

 

We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason within the first:

 

  ● 7 days for sales made through our website (Lucyd.co)

 

  ● 30 days for sales made through Amazon

 

  ● 30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns)

 

For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we review all individual returns received in the month following the balance sheet date pertaining to orders processed prior to the balance sheet date in order to determine whether an allowance for sales returns is necessary. The Company recorded an allowance for sales returns of $24,897 and $22,266 as of December 31, 2022 and 2021, respectively.

 

Shipping and Handling

 

Costs incurred for shipping and handling are included in cost of goods sold at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.

 

Earnings/loss per share

 

We present earnings and loss per share data by calculating the quotient of earnings/(loss) divided by the weighted average number of common shares outstanding during the period as required by ASC 260-10-50. As of December 31, 2022 and December 31, 2021, all shares underlying the related party convertible debt and common stock options were excluded from the earnings per share calculation, due to their anti-dilutive effect.

 

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

 

Not required for a smaller reporting company.

 

Item 8. Financial Statements and Supplementary Data.

 

See accompanying “Index to Consolidated Financial Statements.”

 

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.

 

None.

 

Item 9A. Controls and Procedures.

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15 and 15d-15 of the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of the end of fiscal year 2022.

 

56

 

 

Management’s Report on Internal Control Over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Our management, including the principal executive officer and principal financial officer, does not expect that our internal controls over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and operated, cannot provide full assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles.

 

Under the supervision and with the participation of our management, including the principal executive officer and principal financial officer, we conducted an evaluation as to the effectiveness of our internal control over financial reporting as of December 31, 2022. In making this assessment, our management used the criteria for effective internal control set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the 2013 Internal Control – Integrated Framework. Based on this assessment, our management concluded that our internal control over financial reporting was not effective as of December 31, 2022.

 

This Annual Report on Form 10-K does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s independent registered public accounting firm pursuant to a permanent exemption of the Commission that permits the Company to provide only management’s report in this Annual Report on Form 10-K. Accordingly, our management’s assessment of the effectiveness of our internal control over financial reporting as of December 31, 2022 has not been audited by our auditors, Cherry Bekaert LLP.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting during the fourth quarter of fiscal year 2022 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

Item 9B. Other Information.

 

None.

 

57

 

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance.

 

The following table sets forth certain information regarding our board of directors, our executive officers, and some of our key employees.

 

Name   Age   Position
Harrison R. Gross   30   Chief Executive Officer and Director
Konrad Dabrowski   40   Chief Financial Officer
David Eric Cohen   50   Chief Technology Officer
Frank Rescigna   62   Director
Kristen Mclaughlin   50   Director
Louis Castro   64   Director
Olivia C. Bartlett   64   Director

 

Harrison Gross is one of the founders of Innovative Eyewear and has served as our Chief Executive Officer and as a director since August 2019, where he guides the company’s product and brand development. Prior to his employment at Innovative Eyewear, from August 2017 to August 2019, Mr. Gross served in various positions, including chief executive officer and media & UX lead, of Lucyd Ltd., our largest stockholder and the licensor of our technology which is also a smart eyewear development company where he developed the Lucyd brand identity and oversaw general operations and product development. Additionally, from November 2015 to August 2021, Mr. Gross served as the Digital Media Manager of Tekcapital PLC (“Tekcapital”) (LON: TEK), a university intellectual property investment firm that is the parent company of Tekcapital Europe Limited, and Lucyd Ltd, the holding company for Tekcapital’s shares in Innovative Eyewear, where he created, developed and marketed for the company’s licensed properties. Prior to that, from October 2013 to September 2014, Mr. Gross worked as a credit analyst for a Verizon, Inc. contractor, where he managed credit systems and provided support to Verizon agents. Mr. Gross is a graduate of Columbia University with a BA in Writing and received a BA in Jewish Studies from the Jewish Theological Seminary. Mr. Gross is well qualified to serve as a director due to his substantial knowledge of our product and his experience in marketing, product and app development.

 

Konrad Dabrowski has served as our Chief Financial Officer on a part-time basis since August 2019. Between June 2017 and July 2020, Mr. Dabrowski has served as the group controller, and starting on July 2020 the chief financial officer of Tekcapital PLC (“Tekcapital”), where he co-manages the group’s investment strategy and oversees financial reporting for all of its portfolio companies. Prior to his employment at Tekcapital, from March 2016 to June 2017, Mr. Dabrowski was a Global Accounting Manager for Restaurant Brands International (NYSE:QSR), a multinational fast food holding company, where he oversaw accounting and tax projects for Burger King within the Europe Middle East and Africa (EMEA) market. Prior to his employment at Restaurant Brands International, Mr. Dabrowski was an Audit Manager at Deloitte, where he managed end-to-end accounting audits for a portfolio of public and private corporate clients. Mr. Dabrowski has a Master’s in Finance and Banking from the Warsaw School of Economics and is a Certified Public Accountant.

 

David Eric Cohen is one of the founders of Innovative Eyewear and has served as our Chief Technology Officer since September 2019. Prior to his employment at Innovative Eyewear, from August 2017 to August 2019, Mr. Cohen served as the chief technology officer of Lucyd Ltd., a smart eyewear development company, where he led the company’s technological advancements and digital ad campaigns. Also, prior to his employment at Innovative Eyewear, from September 2009 to October 2019, Mr. Cohen served as President of Emaze Design Agency, a digital design agency, where he led the development of web and applications for e-commerce, web performance monitoring, website design and mobile applications. Prior to his employment at Emaze Design Agency, Mr. Cohen was lead Business Intelligence Specialist at Jewish General Hospital where he assisted with the data solutions and business processes and requirements. He received a BS in Computer Science from the Academy of Bordeaux and an MS in Advanced Technician & Information Systems Management from Hadassah University.

 

58

 

 

Frank Rescigna has served as a director since August 2021. Mr. Rescigna has more than 25 years of brand building and sales experience in the eyewear industry. Prior to his directorship at Innovative Eyewear, from October 2019 to May 2021, Mr. Rescigna was the Director of Global Sales at House of Wu, a global wholesale luxury bridal and evening dress distributor, where he led the company’s sales strategy throughout the world. Prior to his employment at House of Wu, from September 2018 to September 2019, Mr. Rescigna was the President of Teka Eyewear, a boutique global wholesale luxury eyewear distributor specializing in exotic materials, where he managed all aspects of its sales organization and operations. Prior to his employment at Teka Eyewear, from March 2015 to August 2018, Mr. Rescigna was the Senior Vice President of Global Sales at Wiley X, a multi-brand global eyewear company that designs and distributes sunglasses, where he managed the company’s sales activities at the corporate and sales level. Prior to his employment at Wiley X, from February 2011 to February 2015, Mr. Rescigna was the President of Jewelry & Global Brand Licensing for Guess Inc. (NYSE: GES), a global fashion/lifestyle company with varying business models, distribution models and products, where he assisted the company with the expansion of its brand and new brands/products. Prior to his employment at Guess, from February 2004 to January 2011, Mr. Rescigna was the President of Viva International Group, a large eyewear company that designs, manufactures and distributes core and luxury global brands, where he led the company’s expansion and integration with its parent company Highmark Vision Holding Company. He received a degree in Opticianry from Middlesex College. Mr. Rescigna is well qualified to serve as a director due his substantial brand and sales experience and his experience in the eyewear industry.

 

Kristen Mclaughlin has served as one of our directors since August 2021. Ms. Mclaughlin has 20 years’ experience launching, managing and developing products in the eyewear, accessories, cosmetics and skincare industries. From March 2019 to April 2020, Ms. Mclaughlin served as the Global Marketing Director at DePasquale Companies, a skincare, hair care and cosmetics manufacturer, where she led the global marketing strategy and new product development. Prior to her employment at DePasquale Companies, from March 2000 to January 2019, Ms. Mclaughlin was employed at Silhouette International, an eyewear manufacturer, where she served as the Director of Marketing: Eyewear Manufacturer, Regional Sales Manager, and Brand Manager: Daniel Swarovski Crystal Eyewear. While at Silhouette International, Ms. Mclaughlin led the company’s brand portfolio in the U.S. and its brand direction, product development and campaign content. She has a BS and MBA from Ramapo College of New Jersey. Ms. Mclaughlin is well qualified to serve as a director due to her substantial experience in the eyewear industry and her experience in brand and product development.

 

Louis Castro has served as one of our directors since August 2021. Mr. Castro is an experienced public company director and chartered accountant. Mr. Castro is currently on the board of directors of the following public companies (1) Tekcapital where he has been a director since December 2019, (2) Orosur Mining Inc. (TSE:OMI), a company exploring for minerals in South America, where he has been chairman of the board since April 2020, (3) Stanley Gibbons Group plc (LON:SGI), a company that specializes in the retailing of collectable stamps and similar products, where he has been a director since June 2016, (4) Tomco Energy plc (LON:TOM), an oil exploration and technology company, where he has been a director since April 2021, (5) Predator Oil & Gas Holdings plc (LON:PRD), an oil and gas exploration company, where he has been a director since July 2020, and (6) Veteran Capital Corp. (TSX-V:VCC), a capital pool company, where he has been a director since January 2021. From September 2012 to June 2016, Mr. Castro was a director and, from September 2014 to June 2016 served as the Chief Financial Officer, of Eland Oil & Gas plc, a Nigerian focused upstream oil and natural gas exploration and production company, where he was responsible for the company’s finance, legal and corporate finance activities. Prior to his employment at Eland, from May 2011 to May 2014, Mr. Castro served as Head of Capital Markets and then as Chief Executive Officer of Northland Capital Partners, an investment bank, where he was responsible for the investment banks day-to-day activities. He is a fellow of the Institute of Chartered Accountants of England & Wales, has a double degree in Engineering Production and Economics from Birmingham University and attended the Postgraduate Advanced Course in Production Management and Methods at Cambridge University. Mr. Castro is well qualified to serve as a director due to his substantial experience as a director of public companies and his distinction as chartered accountant.

 

59

 

 

Olivia C. Bartlett has served as one of our directors since August 2021. Ms. Bartlett has been in the eyewear industry for over 40 years holding various roles including optician, optical manager, marketing manager and operations management. Since September 2015, Ms. Bartlett has been the Chief Operating Officer of Todd Rogers Eyewear, a specialty eyewear company, where she manages the day-to-day operations of the company. Prior to her time at Todd Rogers Eyewear, from March 2010 to May 2015, Ms. Bartlett was the sales representative for eyewear sales in the northeast of Massachusetts for Safilo USA, a specialty eyewear company. Additionally, from September 2013 to May 2018, Ms. Bartlett was an Adjunct Professor at Benjamin Franklin Institute of Technology in Boston, Massachusetts. Since February 2020 Ms. Bartlett has been the President of the Opticians Association of America, a national organization representing the professional, business, educational, legislative and regulatory interests of opticianry. Prior to that, Ms. Bartlett was a director for ten years for the Opticians Association of Massachusetts. Ms. Bartlett has received a number of awards through her time in the industry, including but not limited to, the 2020 Eyecare Business Game Changer Award and the 2020 and 2018 Vision Monday Most Influential Woman Executive. Ms. Bartlett received her Massachusetts Opticians license in 1987 and is ABO certified. Ms. Bartlett received her BA in Political Science from Clark University. Ms. Bartlett is well qualified to serve as a director due to her substantial experience in the optical industry.

 

Number and Terms of Office of Officers and Directors

 

Our board of directors consists of five members. Our directors are appointed for one-year terms to hold office until the next annual general meeting of our stockholders or until removed from office in accordance with our second amended and restated bylaws.

 

Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices set forth in our second amended and restated bylaws, as it deems appropriate.

 

Director Independence and Committees of the Board of Directors

 

Director Independence

 

Of our directors, we have determined that Frank Rescigna, Mr. Louis Castro and Mss. Kristen Mclaughlin and Olivia Bartlett are “independent” directors under NASDAQ listing standards, while Harrison Gross is not independent under such standards. We have also determined that each of the three members of the Audit Committee is “independent” for purposes of Section 10A(m)(3) of the Exchange Act and the rules promulgated thereunder and under the NASDAQ listing standards. Further, the Board has determined that each of the two members of both the Compensation Committee and the Nominating and Corporate Governance Committee is “independent” under NASDAQ listing standards.

 

Board Committees

 

We have three standing committees of the Board: the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee. Each of the board committees act pursuant to a separate written charter adopted by our board of directors, each of which is available on our website at www.lucyd.co. Our board of directors may at any time or from time to time appoint certain other committees in its sole discretion as it deems necessary or appropriate to carry out its functions.

 

Audit Committee

 

The Audit Committee consists of Mr. Louis Castro (Chair) and Mss. Kristen Mclaughlin and Olivia Bartlett. The Board has determined that all of the members of the Audit Committee are “independent,” as defined by NASDAQ listing standards and by applicable SEC rules. In addition, the Board has determined that Mr. Castro is an audit committee financial expert, as that term is defined by the SEC rules, by virtue of having the following attributes through relevant experience: (i) an understanding of generally accepted accounting principles and financial statements; (ii) the ability to assess the general application of such principles in connection with the accounting for estimates, accruals, and reserves; (iii) experience preparing, auditing, analyzing, or evaluating financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by the Company’s financial statements, or experience actively supervising one or more persons engaged in such activities; (iv) an understanding of internal controls and procedures for financial reporting; and (v) an understanding of audit committee functions.

 

60

 

 

The function of the Audit Committee relates to oversight of the auditors, the auditing, accounting, and financial reporting processes, and the review of the Company’s financial reports and information. In addition, the functions of the Audit Committee will include, among other things, recommending to the Board the engagement or discharge of independent auditors, discussing with the auditors their review of the Company’s quarterly results and the results of their audit, and reviewing the Company’s internal accounting controls.

 

Compensation Committee

 

The Compensation Committee consists of Ms. Kristen Mclaughlin (Chair) and Mr. Louis Castro. The Board has determined that all of the members of the Compensation Committee are “independent,” as defined by NASDAQ listing standards. The responsibility of the Compensation Committee is to review and approve the compensation and other terms of employment of our President and Chief Executive Officer and our other executive officers, including all of the executive officers named in the Summary Compensation Table under the heading “Executive Compensation” below (the “named executive officers”). Among its other duties, the Compensation Committee oversees all significant aspects of the Company’s compensation plans and benefit programs. The Compensation Committee annually reviews and approves corporate goals and objectives for the President and Chief Executive Officer’s compensation and evaluates the Chief Executive Officer’s performance in light of those goals and objectives. The Compensation Committee also recommends to the Board the compensation and benefits for members of the Board. The Compensation Committee has also been appointed by the Board to administer our 2021 Equity Incentive Plan. The Compensation Committee does not delegate any of its authority to other persons.

 

Nominating and Corporate Governance Committee

 

The Nominating and Corporate Governance Committee consists of Mss. Olivia Bartlett (Chair) and Kristen Mclaughlin and Mr. Harrison Gross. The majority of committee members are independent under applicable NASDAQ rules and regulations. The Nominating and Corporate Governance Committee is responsible for, among other things, considering potential board members, making recommendations to the full board as to nominees for election to the board, assessing the effectiveness of the board and implementing our corporate governance guidelines.

 

Section 16(a) Beneficial Ownership Reporting Compliance

 

Section 16(a) of the Exchange Act requires that our directors and executive officers and persons who beneficially own more than 10% of our common stock (referred to herein as the “reporting persons”) file with the SEC various reports as to their ownership of and activities relating to our common stock. Such reporting persons are required by the SEC regulations to furnish us with copies of all Section 16(a) reports they file.

 

Based solely upon a review of copies of Section 16(a) reports and representations received by us from reporting persons, and without conducting any independent investigation of our own, in fiscal year 2022, all Forms 3, 4 and 5 were timely filed with the SEC by such reporting persons.

 

Code of Ethics

 

We have adopted a formal code of ethics that applies to our directors and principal executives and financial officers or persons performing similar functions. A copy of our Code of Ethical Conduct can be found on our website under “Investors” at www.lucyd.co.

 

61

 

 

Item 11. Executive Compensation.

 

The following table sets forth the aggregate compensation paid to our named executive officers for the fiscal years ended December 31, 2022 and 2021. Individuals we refer to as our “named executive officers” include our Chief Executive Officer, our Chief Financial Officer and our Chief Technology Officer.

 

Summary Compensation Table

 

Name and Principal Position  Year  Salary(1)
($)		   Bonus
($)		   Option
Awards ($)		   Non-Equity
Incentive Plan
Compensation
($)		   Nonqualified
Deferred
Compensation
Earnings
($)		   All Other
Compensation
($)		   Total
($)		 
Harrison Gross,  2022   114,758    -    -    -    -    -    114,758 
Chief Executive Officer  2021   69,584    -    1,781,980(2)    -    -    -    1,851,564 
                                       
Konrad Dabrowski,  2022   105,500    -    -    -    -    -    105,500 
Chief Financial Officer  2021   21,885    -    158,388    -    -    -    180,273 
                                       
David Eric Cohen,  2022   70,270    -    -    -    -    -    70,270 
Chief Technology Officer  2021   38,401    -    158,382    -    -    -    158,382 

 

 
(1)Salary amounts shown for Mr. Cohen include $34,500 and $38,401 paid in 2022 and 2021, respectively, to Mr. Cohen as an independent consultant, prior to his hire as an employee on October 1, 2022.
(2)Consists of 700,000 options to purchase common stock of the Company issued to Mr. Gross for services rendered to the Company for the fiscal year ended December 31, 2021.

 

Employment Arrangements with our Executive Officers

 

Harrison Gross

 

On August 11, 2021, we entered into an employment agreement with Harrison Gross to serve in the capacity of the Chief Executive Officer of the Company. We agreed to pay Mr. Gross an annual base salary of $85,800 for the remainder of 2021, and we also agreed that from the initial public offering date in August 2022, we increased his base salary to $150,000 per year. Pursuant to the terms of the employment agreement, our Board may exercise its sole discretion to grant Mr. Gross an annual bonus, the amount of which bonus shall be determined in the sole discretion of our Board. Additionally, in 2021, we granted Mr. Gross an option to purchase 100,000 shares of our common stock.

 

The employment agreement has an initial term of three years, and will terminate on the third anniversary of the effective date unless Mr. Gross and the Company agree otherwise in writing. If we terminate the employment agreement for any reason other than for cause (as such is defined in the agreement) or Mr. Gross terminates his employment for good reason (as such is defined in the agreement): (1) Mr. Gross shall be entitled to payment of his base salary for the balance of the agreement’s term; (2) if Mr. Gross elects to continue group health insurance benefits, we shall reimburse Mr. Gross for any COBRA premiums he pays for the duration of COBRA’s coverage; and, (3) we shall provide Mr. Gross with payment of all accrued amounts (as defined in the agreement).

 

Konrad Dabrowski

 

On August 11, 2021, we entered into an employment agreement with Konrad Dabrowski to serve as the Chief Financial Officer of the Company on a part-time basis, which agreement became effective on September 1, 2021. Mr. Dabrowski devotes 50% of his business time to our Company. We agreed to pay Mr. Dabrowski an annual base salary of $100,000. Pursuant to the terms of the employment agreement, we may exercise our discretion to grant Mr. Dabrowski an annual bonus, the amount of which bonus shall be determined in the sole discretion of the Company. Additionally, in 2021, we granted Mr. Dabrowski an option to purchase 60,000 shares of our common stock.

 

62

 

 

Following the effective date, the employment agreement shall continue, unless terminated by Mr. Dabrowski or the Company. Mr. Dabrowski’s employment is at-will, which may be terminated by the Company or by Mr. Dabrowski at any time and for any reason. Pursuant to the terms of the employment agreement, a sixty days’ written notice of termination or resignation is required. If Mr. Dabrowski notifies us of his resignation, or if we terminate Mr. Dabrowski’s employment agreement, the Company reserves the right to determine, in its sole discretion, whether Mr. Dabrowski will be required to actively work during the sixty-day notice period; however, Mr. Dabrowski will be entitled to receive his base salary for the duration of the sixty day notice period. The Company has the right to terminate Mr. Dabrowski’s employment agreement for cause (as defined in the agreement), which termination shall be effective immediately.

 

David Eric Cohen

 

David Cohen was an independent consultant for the company from inception until October 1, 2022, when we offered him a full-time letter of employment. He accepted and has been the full-time Chief Technology since then. The company pays him $140,000 annually to serve in this role. Pursuant to the terms of the employment agreement, we may exercise our discretion to grant Mr. Cohen an annual bonus, the amount of which bonus shall be determined in the sole discretion of the Company.

 

Following the effective date, the employment agreement shall continue, unless terminated by Mr. Cohen or the Company. Mr. Cohen’s employment is at-will, which may be terminated by the Company or by Mr. Cohen at any time and for any reason. Pursuant to the terms of the employment agreement, a sixty days’ written notice of termination or resignation is required. If Mr. Cohen notifies us of his resignation, or if we terminate Mr. Cohen’s employment agreement, the Company reserves the right to determine, in its sole discretion, whether Mr. Cohen will be required to actively work during the sixty-day notice period; however, Mr. Cohen will be entitled to receive his base salary for the duration of the sixty day notice period. The Company has the right to terminate Mr. Cohen’s employment agreement for cause (as defined in the agreement), which termination shall be effective immediately.

 

Additionally, in 2021, we granted Mr. Cohen an option to purchase 60,000 shares of our common stock.

 

Compensation of Directors

 

The following table sets forth all compensation paid to our Board members during the year ended December 31, 2022:

 

Name  Fees
Earned or
Paid in Cash
($)		   Stock
Awards
($)		   Option
Awards
($)		   Non-Equity
Incentive Plan Compensation
($)		   Change in
Pension Value
and Nonqualified Deferred
Compensation
Earnings
($)		   All Other Compensation
($)		   Total
($)		 
Frank Rescigna   1,875    -    -    -    -    -    1,875 
Kristen Mclaughlin   7,500    -    -    -    -    -    7,500 
Louis Castro   11,250    -    -    -    -    -    11,250 
Olivia C. Bartlett   3,750    -    -    -    -    -    3,750 

 

63

 

 

Outstanding Equity Awards

 

The following table sets forth outstanding equity awards to our named executive officers as of December 31, 2022.

 

   Option awards  Stock awards 
Name  Number of
securities
underlying
unexercised
options
(#)
exercisable		   Number of
securities
underlying
unexercised
options
(#)
unexercisable		   Equity
incentive
plan
awards:
Number of
securities
underlying
unexercised
unearned
options
(#)		   Option
exercise
price
($)		   Option
expiration
date		  Number
of shares
or units
of stock
that
have not
vested
(#)		   Market
value of
shares
of units
of stock
that
have not
vested
($)		   Equity
incentive
plan
awards:
Number of
unearned
shares,
units or
other
rights that
have not
vested
(#)		   Equity
incentive
plan awards:
Market or
payout value
of unearned
shares, units
or other
rights that
have not
vested
($)		 
Harrison Gross   250,000    125,000    -   $1.00   04/01/2024   -    -    -    - 
Harrison Gross   200,000    400,000    -   $3.56   05/05/2025   -    -    -    - 
Harrison Gross   44,432    55,568    -   $3.56   11/11/2024   -    -    -    - 
Konrad Dabrowski   26,656    33,344    -   $3.56   11/11/2024   -    -    -    - 
David Eric Cohen   26,656    33,344    -   $3.56   12/01/2024   -    -    -    - 

 

Our 2021 Equity Incentive Plan was adopted by the Board and approved by our shareholders on July 1, 2021, under which:

 

(i)Harrison Gross was issued stock options on August 11, 2021, to purchase 100,000 shares of our common stock;

 

(ii)Konrad Dabrowski was issued stock options on August 11, 2021, to purchase 60,000 shares of our common stock;

 

(iii)David Eric Cohen was issued stock options on September 1, 2021, to purchase 60,000 shares of our common stock;

 

(iv)Frank Rescigna was issued stock options on July 29, 2021, to purchase 25,000 shares of our common stock;

 

(v)Kristen Mclaughlin was issued stock options on August 20, 2021, to purchase 25,000 shares of our common stock;

 

(vi)Louis Castro was issued stock options on July 21, 2021, to purchase 20,000 shares of our common stock;

 

(vii)Louis Castro was also issued stock options on July 29, 2021, to purchase an additional 25,000 shares of our common stock; and

 

(viii)Olivia Bartlett was issued stock options on July 29, 2021, to purchase 25,000 shares of our common stock.

 

All of these stock options issued under our 2021 Equity Incentive Plan are subject to time-based vesting, except for Mr. Castro’s July 21, 2021 option grant that vests upon an acquisition or flotation at a valuation greater than or equal to four times (400%) the most recent published annual Company valuation (2020: $2.7 million).

 

64

 

 

Additionally, the following awards were granted by the Company prior to the approval of the 2021 Equity Incentive Plan:

 

(i)Mr. Gross was issued stock options on May 5, 2021 to purchase 600,000 shares of our common stock, which are subject to time-based vesting; and

 

(ii)Mr. Rescigna was issued stock options on May 1, 2021, to purchase 100,000 shares of our common stock, which vest upon successful completion of an $8 million sales quota.

 

Option Exercises and Stock Vested

 

There were no options exercised by our executive officers during the years ended December 31, 2022 or 2021.

 

Employee Benefit Plans

 

We currently do not provide retirement, health, or welfare benefits to any of our employees.

 

Non-qualified Deferred Compensation

 

None of our employees participate in or have account balances in non-qualified defined contribution plans or other non-qualified deferred compensation plans maintained by us. Our Compensation Committee may elect to provide our officers and other employees with non-qualified defined contribution or other non-qualified compensation benefits in the future if it determines that doing so is in the Company’s best interest.

 

2021 Equity Incentive Plan

 

General

 

Our 2021 Equity Incentive Plan was adopted by the Board and approved by our shareholders on July 1, 2021. The general purposes of the 2021 Equity Incentive Plan are to (i) enable the Company and its subsidiaries to attract and retain the types of employees, consultants, and directors who will contribute to the Company’s long-range success; (ii) provide incentives that align the interests of employees, consultants, and directors with those of our shareholders; and (iii) promote the success of the Company’s business.

 

Description of the 2021 Equity Incentive Plan

 

The following description of the principal terms of the 2021 Equity Incentive Plan is a summary and is qualified in its entirety by the full text of the 2021 Equity Incentive Plan.

 

Administration. The 2021 Equity Incentive Plan is administered by a committee appointed by our Board, or in the Board’s discretion, by the Board (as applicable, the “Incentive Plan Administrator”). Subject to the terms of the 2021 Equity Incentive Plan, the Incentive Plan Administrator has the authority to (a) determine the eligible individuals who are to receive awards, (b) determine the terms and conditions of each award, including exercise price, vesting or performance criteria, performance period, and terms of the award, (c) determine whether vesting and performance criteria have been achieved, (d) accelerate the vesting or exercisability of, payment for or lapse of restrictions on, or otherwise modify or amend awards, (e) construe and interpret the 2021 Equity Incentive Plan, including the ability to reconcile any inconsistency in, correct any defect in and/or supply any omission in the plan and award agreement; any instrument or agreement, (f) promulgate, amend, and rescind rules and regulations relating to the administration of the 2021 Equity Incentive Plan, and (g) exercise discretion to make any and all other determinations which it determines to be necessary or advisable for the administration of the 2021 Equity Incentive Plan and awards granted thereunder. The Incentive Plan Administrator may also delegate its authority to a subcommittee or to one or more officers of the Company, subject to terms and conditions determined by the Incentive Plan Administrator. All decisions made by the Incentive Plan Administrator are final and binding on the Company and the participants.

 

65

 

 

Types of Awards. The 2021 Equity Incentive Plan provides for the grant of stock options, which may be incentive stock options (“ISOs”) or nonqualified stock options (“NSOs”), stock appreciation rights (“SARs”), restricted stock, restricted stock units (“RSUs”), performance share awards, and other cash-based or equity-based awards, or collectively, awards.

 

Share Reserve. A total equal to 20% of our issued and outstanding common stock shall be available for the grant of awards under the 2021 Equity Incentive Plan.

 

If options, stock appreciation rights, restricted stock units or any other awards are forfeited, cancelled or expire before being exercised or settled in full, the shares subject to such awards will again be available for issuance under the 2021 Equity Incentive Plan. If restricted stock or shares issued upon exercise of an option are reacquired by the Company pursuant to a forfeiture provision, repurchase right or for any other reason, then such shares will again be available for issuance under the 2021 Equity Incentive Plan. Notwithstanding the foregoing, shares applied to pay the exercise price of an option or satisfy withholding taxes related to any award will not become available for issuance under the 2021 Equity Incentive Plan.

 

Shares issued under the 2021 Equity Incentive Plan may be authorized but unissued shares or treasury shares. As of December 31, 2022, awards covering 2,332,500 shares of Common Stock were issued, of which 1,685,000 option awards were granted by the Company prior to the approval of the Plan and 647,500 option awards were granted subject to the 2021 Equity Incentive Plan.

 

Incentive Stock Option Limit. No more than 25,000,000 shares of Common Stock may be issued under the 2021 Equity Incentive Plan upon the exercise of ISOs.

 

Eligibility. Employees (including officers), non-employee directors and consultants who render services to the Company or a parent or subsidiary thereof (whether now existing or subsequently established) are eligible to receive awards under the 2021 Equity Incentive Plan. ISOs may only be granted to employees of the Company or a parent or subsidiary thereof (whether now existing or subsequently established).

 

Stock Options. A stock option is the right to purchase a certain number of shares of stock at a fixed exercise price which, pursuant to the 2021 Equity Incentive Plan, may not be less than 100% of the fair market value of Common Stock on the date of grant. Subject to limited exceptions, an option may have a term of up to 10 years and will generally expire sooner if the optionholder’s service terminates. Options will vest at the rate determined by the Incentive Plan Administrator. An optionholder may pay the exercise price of an option in cash, or, with the Incentive Plan Administrator’s consent, with shares of stock the optionholder already owns, with proceeds from an immediate sale of the option shares, through a net exercise procedure or by any other method permitted by applicable law.

 

Tax Limitations on Incentive Stock Options. The aggregate fair market value, determined at the time of grant, of the Common Stock with respect to ISOs that are exercisable for the first time by an optionholder during any calendar year under all of the Company’s stock plans may not exceed $100,000. Options or portions thereof that exceed such limit will generally be treated as NSOs. No ISO may be granted to any person who, at the time of the grant, owns or is deemed to own stock possessing more than 10% of the Company’s total combined voting power or that of any of the Company’s affiliates unless (a) the option exercise price is at least 110% of the fair market value of Common Stock on the date of grant and (b) the term of the ISO does not exceed five years from the date of grant.

 

Stock Appreciation Rights. A stock appreciation right provides the recipient with the right to the appreciation in a specified number of shares of stock. The Incentive Plan Administrator determines the exercise price of stock appreciation rights granted under the 2021 Equity Incentive Plan, which may not be less than 100% of the fair market value of Common Stock on the date of grant. A stock appreciation right may have a term of up to 10 years and will generally expire sooner if the recipient’s service terminates. SARs will vest at the rate determined by the Incentive Plan Administrator. Upon exercise of a SAR, the recipient will receive an amount in cash, stock, or a combination of stock and cash determined by the Incentive Plan Administrator, equal to the excess of the fair market value of the shares being exercised over their exercise price.

 

66

 

 

Restricted Stock Awards. Shares of restricted stock may be issued under the 2021 Equity Incentive Plan and may be subject to vesting, as determined by the Incentive Plan Administrator. Recipients of restricted stock generally have all of the rights of a shareholder with respect to those shares, including voting rights and dividends, except as provided in the award agreement.

 

Restricted Stock Units. A restricted stock unit is a right to receive a share, at no cost to the recipient, upon satisfaction of certain conditions, including vesting conditions, established by the Incentive Plan Administrator. RSUs vest at the rate determined by the Incentive Plan Administrator and any unvested RSUs will generally be forfeited upon termination of the recipient’s service. Settlement of restricted stock units may be made in the form of cash, stock or a combination of cash and stock, as provided in the award agreement and as determined by the Incentive Plan Administrator. Recipients of restricted stock units generally will have no voting or dividend rights prior to the time the vesting conditions are satisfied, and the award is settled.

 

Performance Share Award. A performance share award is a right to receive a share or share units based upon the Company’s performance during a specified performance period, as determined by the Incentive Plan Administrator. The Incentive Plan Administrator has the discretion to determine: (i) the number of shares or stock-denominated units subject to a Performance Share Award granted to any recipient; (ii) the performance period applicable to any award; (iii) the conditions that must be satisfied for a recipient to earn an award; and (iv) the other terms, conditions and restrictions of the award.

 

Cash Awards and Other Equity-Based Awards. The Incentive Plan Administrator may grant cash awards and other awards based in whole or in part by reference to Common Stock, either alone or in tandem with other awards. The Incentive Plan Administrator will determine the terms and conditions of any such awards.

 

Changes to Capital Structure. In the event of certain changes in capitalization, including a stock split, reverse stock split, stock dividend, or an extraordinary corporate transaction such as any recapitalization, reorganization, merger, consolidation, combination, or exchange, proportionate adjustments will be made in the number and kind of shares available for issuance under the 2021 Equity Incentive Plan, the limit on the number of shares that may be issued under the 2021 Equity Incentive Plan as ISOs, the number and kind of shares subject to each outstanding award and/or the exercise price of each outstanding award.

 

Change in Control. If the Company is party to certain change in control transactions, each outstanding award will be treated as the Incentive Plan Administrator determines, which may include the continuation, assumption or substitution of an outstanding award, the cancellation of an outstanding award after an opportunity to exercise or the cancellation of an outstanding award in exchange for a payment equal to the value of the shares subject to such award less any applicable exercise price.

 

Transferability of Awards. Unless the Incentive Plan Administrator determines otherwise, an award generally will not be transferable other than by beneficiary designation, a will or the laws of descent and distribution. The Incentive Plan Administrator may permit transfer of an award in a manner consistent with applicable law.

 

Amendment and Termination. The Board may amend or terminate the 2021 Equity Incentive Plan at any time. Any such amendment or termination will not affect outstanding awards. If not sooner terminated, the 2021 Equity Incentive Plan will automatically terminate 10 years after its adoption by the Board. Shareholder approval is not required for any amendment of the 2021 Equity Incentive Plan, unless required by applicable law, government regulation or exchange listing standards.

 

67

 

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

 

Based solely upon information made available to us, the following table sets forth information as of March 17, 2023, regarding the beneficial ownership of our common stock:

 

●each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock;

 

●each of our named executive officers and directors; and

 

●all our executive officers and directors as a group.

 

The address of each holder listed in the following table, except as otherwise indicated, is 11900 Biscayne Blvd., Suite 630, North Miami, Florida, 33181.

 

Percentage ownership shown in the following table is based on 7,715,757 shares of our common stock outstanding.

 

Name of Beneficial Owner  Shares of
Common Stock
Beneficially
Owned(1)		   Percent of
Common Stock
Beneficially
Owned		 
Named Executive Officers and Directors           
Harrison Gross(2)   800,817    9.40%
Konrad Dabrowski(3)   64,986    * %
David Eric Cohen(4)   54,986    * %
Frank Rescigna(5)   25,000    * %
Kristen McLaughlin(6)   25,000    * %
Louis Castro(7)   45,000    * %
Olivia Bartlett(8)   25,000    * %
All directors and executive officers as a group
(7 persons)		   1,040,789    11.89 %
5% Stockholders           
Lucyd Ltd.(9)   5,189,085    67.25 %

 

 
*Less than 1%.
(1)We have determined beneficial ownership in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended, which is generally determined by voting power and/or dispositive power with respect to securities. Unless otherwise noted, the shares of common stock listed above are owned as of the date of this 10-K, and are owned of record by each individual named as beneficial owner and such individual has sole voting and dispositive power with respect to the shares of common stock owned by each of them.
(2)Includes 800,817 shares of common stock issuable upon exercise of stock options held by Mr. Gross exercisable within 60 days of the date of this 10-K.
(3)Includes 64,986 shares of common stock issuable upon exercise of stock options held by Mr. Dabrowski exercisable within 60 days of the date of this 10-K.
(4)Includes 54,986 shares of common stock issuable upon exercise of stock options held by Mr. Cohen exercisable within 60 days of the date of this 10-K.
(5)Includes 25,000 shares of common stock issuable upon exercise of stock options held by Mr. Rescigna exercisable within 60 days of the date of this 10-K.
(6)Includes 25,000 shares of common stock issuable upon exercise of stock options held by Ms. McLaughlin exercisable within 60 days of the date of this 10-K.
(7)Includes 45,000 shares of common stock issuable upon exercise of stock options held by Mr. Castro exercisable within 60 days of the date of this 10-K.
(8)Includes 25,000 shares of common stock issuable upon exercise of stock options held by Ms. Bartlett exercisable within 60 days of the date of this 10-K.
(9)Tekcapital plc, a public company listed on the London Stock Exchange, owns all issued and outstanding securities of Tekcapital Europe Ltd., which owns all issued and outstanding securities of Lucyd Ltd. As such, Tekcapital plc may be deemed to beneficially own the shares held by Lucyd Ltd. by virtue of their control over Lucyd Ltd. Tekcapital plc disclaims beneficial ownership of the shares held by Lucyd Ltd. Mr. Clifford Gross, the Chief Executive Officer of Tekcapital plc, is the father of Mr. Harrison Gross, our Chief Executive Officer.

 

68

 

 

Item 13. Certain Relationships and Related Transactions, and Director Independence.

 

On occasion we may engage in certain related party transactions. All prior related party transactions were approved by our board of directors and a majority of our issued and outstanding shares of capital stock. Upon the consummation of offering, our policy is that all related party transactions will be reviewed and approved by the Audit Committee of our Board of Directors prior to our entering into any related party transactions.

 

License Agreement

 

On April 1, 2020, we entered into an exclusive, worldwide license agreement with Lucyd Ltd., the majority stockholder of the Company, for the use of the Lucyd brand, and the associated intellectual property and assets (the “License Agreement”). The License Agreement is royalty-free, fully paid up, and perpetual license for the exclusive use of certain assets of Lucyd Ltd. related to Innovative Eyewear current products and trademarks. As compensation for entrance into the License Agreement, we issued Lucyd Ltd. 3,750,000 shares of our common stock. On October 5, 2021, the parties to the License Agreement executed an Addendum, to the exclusive license agreement, which clarified that Innovative Eyewear shall commercialize, continue with any on-going intellectual property prosecutions and pay all maintenance or other patent fees (the “Addendum”). For all new intellectual property, Innovative Eyewear will own control it and be responsible for all prosecution and maintenance costs. The Addendum also confirms that Innovative Eyewear issued Lucyd Ltd. 3,750,000 shares of its common stock as consideration for the license. Please see “Business — Material Agreements” for a more complete description of the License Agreement and Addendum.

 

Management Service Agreement

 

On June 1, 2020, we entered into a management service agreement with Tekcapital Europe Ltd., an affiliate of our majority stockholder, Lucyd Ltd., whose Chief Executive Officer is the father of our Chief Executive Officer, pursuant to which we agreed to pay Tekcapital Europe Ltd. $25,000 per fiscal quarter for rent-free office space, utilities, advisory services and any other services in accordance with Tekcapital Europe Ltd.’s areas of expertise. The management agreement provided for a perpetual term, with the right of either party to terminate for any reason with 30 days’ notice. Effective February 1, 2022, the original management service agreement was amended to have us billed at $35,000 quarterly for advisory and other services, and in addition, Tekcapital Europe Ltd. began to bill us for an allocation of rent paid by Tekcapital Europe Ltd. on our behalf.

 

During the years ended December 31, 2022 and 2021, we incurred $140,000 and $100,000, respectively, under our management services agreement with Tekcapital Europe Ltd., and we also recognized $74,442 of rent expense for the year ended December 31, 2022.

 

Convertible Note Financing

 

On December 1, 2020, we issued a convertible note for an aggregate principal amount of up to $2,000,000 to Lucyd Ltd., the majority stockholder of the Company (the “Note”).

 

On June 1, 2021, we completed the partial conversion of an aggregate of $778,500 of the outstanding balance on the Note, at $1.00 per share, into an aggregate of 778,500 shares of common stock. On September 5, 2021, we completed the partial conversion of an aggregate of $500,002 of the outstanding balance on the Note, at $3.56 per share, into an aggregate of 140,449 shares of common stock.

 

On November 1, 2021, we executed an amended and restated Note, increasing the amount of available financing from $2,000,000 to $3,000,000. On November 16, 2021, we completed the partial conversion of an aggregate of $901,271 of the outstanding balance of the Note, at $3.56 per share, into an aggregate of 253,166 shares of common stock. As of December 31, 2021, $289,029 remained outstanding on the Note.

 

69

 

 

On August 15, 2022, in connection with our initial public offering, we completed the partial conversion of an aggregate of $2,002,280 of the outstanding balance of the Note, at $7.50 per share, into an aggregate of 266,970 shares of common stock. As of December 31, 2022, approximately $61,356 remains outstanding on the Note.

 

The Note has an interest rate of 10.0% per annum, is unsecured, matures on December 1, 2023 and provides for conversion, at the election of Lucyd Ltd., into our common stock upon the earlier of (i) the Company consummating an equity financing pursuant to which it raises an aggregate amount of not less than $750,000, (ii) the Company entering into a transaction pursuant to which the Company sells not less than 10% of the Company’s shares, excluding any and all convertible notes which are convertible into shares, (iii) the Company lists its shares on a national securities exchange or (iv) the holder determines to convert the Note. The Note can be converted by the Holder using the price of either (i) the per share purchase price paid for by investors under the terms of recent equity financing, (ii) the closing price of the Company’s trading shares on the relevant public exchange for the day immediately preceding the date of conversion of the Note or (iii) the valuation of the last equity investment. The principal amount and accrued but unpaid interest under each note will automatically convert into shares of our common stock at the stated conversion price per share.

 

Intercompany Loan and Debt Transfer Agreements

 

On June 1, 2021, we entered into an intercompany loan and debt transfer agreement, whereby Lucyd Ltd, Tekcapital plc, Tekcapital Europe Ltd or Tekcapital LLC incurred a debt on behalf of the Company in the amount of $387,328. Pursuant to the terms of the agreement, there is no interest payable on the amount of the debt outstanding, unless we agree otherwise with Lucyd Ltd. The debt, along with any accrued interest and other amounts that may be due in connection with the debt, is repayable by the Company upon demand from Lucyd Ltd, at any time, unless we agree otherwise with Lucyd Ltd. The Company may prepay the whole or any part of the debt at any time unless we agree otherwise.

 

On September 5, 2021, we entered into an intercompany loan and debt transfer agreement, whereby Lucyd Ltd, Tekcapital plc, Tekcapital Europe Ltd or Tekcapital LLC incurred a debt on behalf of the Company in the amount of $500,002. Pursuant to the terms of the agreement, there is no interest payable on the amount of the debt outstanding, unless we agree otherwise with Lucyd Ltd. The debt, along with any accrued interest and other amounts that may be due in connection with the debt, is repayable by the Company upon demand from Lucyd Ltd, at any time, unless we agree otherwise with Lucyd Ltd. The Company may prepay the whole or any part of the debt at any time unless we agree otherwise.

 

See “Item 11. Executive Compensation” regarding the employment agreements with Harrison Gross and Konrad Dabrowski.

 

Statement of Policy

 

All future transactions between us and our officers, directors or five percent stockholders, and respective affiliates will be on terms no less favorable than could be obtained from unaffiliated third parties and will be approved by a majority of our independent directors who do not have an interest in the transactions and who had access, at our expense, to our legal counsel or independent legal counsel.

 

To the best of our knowledge, during the past three fiscal years, other than as set forth above, there were no material transactions, or series of similar transactions, or any currently proposed transactions, or series of similar transactions, to which we were or are to be a party, in which the amount involved exceeds the lesser of $120,000 or one percent of the average of our total assets at year-end for the last two completed financial years, and in which any director or executive officer, or any security holder who is known by us to own of record or beneficially more than 5% of any class of our common stock, or any member of the immediate family of any of the foregoing persons, has an interest (other than compensation to our officers and directors in the ordinary course of business).

 

70

 

 

Item 14. Principal Accounting Fees and Services.

 

Audit Fees

 

The aggregate fees billed for professional services rendered by our Independent Registered Public Accounting Firm, Cherry Bekaert LLP (PCAOB ID 00677), for the audit of our annual financial statements, review of our consolidated financial statements included in our quarterly reports, and other fees that are normally provided by the accounting firm in connection with statutory and regulatory filings or engagements for the years ended December 31, 2022 and December 31, 2021 were approximately $88,800 and $69,300, respectively.

 

Audit-Related Fees

 

There were approximately $58,700 and $13,800 of fees billed by our Independent Registered Public Accounting Firm for audit-related services for the fiscal years ended December 31, 2022 and 2021 respectively, which included consent and comfort letter procedures related to our Form S-1filings, initial public offering, and due diligence procedures.

 

Tax Fees

 

There were no fees billed for professional services rendered by our Independent Registered Public Accounting Firm for tax compliance, tax advice, and tax planning for the fiscal years ended December 31, 2022 and 2021.

 

All Other Fees

 

There were no fees billed for non-audit services by our Independent Registered Public Accounting Firm for the fiscal years ended December 31, 2022 and 2021.

 

Audit Committee Determination

 

The Audit Committee considered and determined that the services performed are compatible with maintaining the independence of the independent registered public accounting firm.

 

Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Auditor

 

The Audit Committee is responsible for pre-approving all audit and permitted non-audit services to be performed for us by our Independent Registered Public Accounting Firm as outlined in its Audit Committee charter. Prior to engagement of the Independent Registered Public Accounting Firm for each year’s audit, management or the Independent Registered Public Accounting Firm submits to the Audit Committee for approval an aggregate request of services expected to be rendered during the year, which the Audit Committee pre-approves. During the year, circumstances may arise when it may become necessary to engage the Independent Registered Public Accounting Firm for additional services not contemplated in the original pre-approval. In those circumstances, the Audit Committee requires specific pre-approval before engaging the Independent Registered Public Accounting Firm. The engagements of our Independent Registered Public Accounting Firm were approved by the Company’s Audit Committee.

 

71

 

 

PART IV

 

Item 15. Exhibits, Financial Statement Schedules.

 

(a)(1)(2) Financial Statement Schedules

 

See accompanying “Index to Consolidated Financial Statements.”

 

(b) Exhibits

 

Exhibit No.   Description
1.1*   Underwriting Agreement by and among Innovative Eyewear, Inc. and Maxim Group LLC, as representative of the several underwriters, dated August 14, 2022, (Incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K (File No. 001-41392) filed with the Securities and Exchange Commission August 18, 2022)
3.1*   Amended and restated Articles of Incorporation of Innovative Eyewear, Inc., (Incorporated by reference to Exhibit 3.1 to the Amended Registration Statement filed on Form S-1/A 1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
3.2*   Form of Second Amended and Restated Articles of Incorporation of Innovative Eyewear, Inc., (Incorporated by reference to Exhibit 3.1 to the Amended Registration Statement filed on Form S-1/A 1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
3.3*   Amended and Restated Bylaws of innovative Eyewear, Inc., (Incorporated by reference to Exhibit 3.1 to the Amended Registration Statement filed on Form S-1/A 1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
3.4*   Form of Amended and Restated Bylaws of Innovative Eyewear, Inc., (Incorporated by reference to Exhibit 3.1 to the Amended Registration Statement filed on Form S-1/A 1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
4.1*   Form of Representative’s Warrant Agreement (Incorporated by reference to Exhibit 4.1 to the Amended Registration Statement filed on Form S-1/A 2 (File No. 333-261616) filed with the Securities Exchange Commission January 20, 2022)
4.2*   Representative’s Warrant issued to Maxim Group LLC., dated August 17, 2022, (Incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K (File No. 001-41392) filed with the Securities and Exchange Commission August 18, 2022)
4.3*   Form of Common Stock Purchase Warrant, (Incorporated by reference to Exhibit 4.2 to the Amended Registration Statement filed on Form S-1/A 2 (File No. 333-261616) filed with the Securities Exchange Commission January 20, 2022)
10.1*   License Agreement between Innovative Eyewear, Inc. and Lucyd Ltd., dated April 1, 2020, (Incorporated by reference to Exhibit 10.1 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
10.2*   Addendum to License Agreement between Innovative Eyewear, Inc. and Lucyd Ltd., dated December 7, 2021, (Incorporated by reference to Exhibit 10.2 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
10.3   Management Agreement between Innovative Eyewear, Inc. and Tekcapital Europe Ltd., dated June 1, 2020, (Incorporated by reference to Exhibit 10.3 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
10.4*   Convertible Note issued to Lucyd, Ltd., dated December 1, 2020, (Incorporated by reference to Exhibit 10.4 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
10.5*   Amended and Restated Convertible Note issued to Lucyd Ltd., dated November 1, 2021, (Incorporated by reference to Exhibit 10.13 to the Amended Registration Statement filed on Form S-1/A 4 (File No. 333-261616) filed with the Securities and Exchange Commission on March 23, 2022)

 

72

 

 

10.6*   Intercompany Loan and Debt transfer Agreement by and among Innovative Eyewear, Inc., Lucyd Ltd., Tekcapital pk, Tekcapital Europe Ltd. And Tekcapital LLC, dated June 1, 2021, (Incorporated by reference to Exhibit 10.5 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
10.7*   Employment Agreement by and between Innovative Eyewear, Inc. and Harrison Gross, dated August 11, 2021, (Incorporated by reference to Exhibit 10.6 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
10.8*   Employment Agreement by and between Innovative Eyewear, Inc. and Konrad Dabrowski, dated August 11, 2021, (Incorporated by reference to Exhibit 10.7 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
10.9*   Innovative Eyewear, Inc., 2021 Equity Incentive Plan, (Incorporated by reference to Exhibit 10.10 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
10.10*   Sales Representation Agreement by and between Innovative Eyewear, Inc. and D. Landstrom Associates, Inc., dated March 4, 2021, (Incorporated by reference to Exhibit 10.11 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
14.1*   Form of Code of Ethics of innovative Eyewear, Inc. (Incorporated by reference to Exhibit 14.1 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
19   Insider trading policy
23.1   Consent of Cherry Bekeart LLP, Independent Registered Public Accounting Firm
31.1   Certification of Principle Executive Officer Pursuant to Securities Exchange Act Rules 13A-14(A)and 15D-14(A)
31.2   Certification of Principle Financial Officer Pursuant to Securities Exchange Act Rules 13A-14(A)and 15D-14(A)
32.1   Certification of Principle Executive Officer Pursuant to 18 U.S.C. Section 1350
32.2   Certification of Principle Financial Officer Pursuant to 18 U.S.C. Section 1350
101.ins   XBRL Instance Document
101.sch   XBRL Taxonomy Extension Schema Document
101.cal   XBRL Taxonomy Calculation Linkbase Document
101.def   XBRL Taxonomy Definition Linkbase Document
101.lab   XBRL Taxonomy Label Linkbase Document
101.pre   XRL Taxonomy Presentation Linkbase Document

 

 
*Previously filed

 

Item 16. Form 10-K Summary.

 

The Company has elected not to include a summary pursuant to this Item 16.

 

73

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Innovative Eyewear, Inc.
     
  By: /s/ Harrison Gross
    Harrison Gross
March 24, 2023   Chief Executive Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.

 

  By: /s/ Harrison Gross
    Harrison Gross
    Chief Executive Officer and Director
March 24, 2023   (Principal Executive Officer)
     
  By: /s/ Konrad Dabrowski
    Konrad Dabrowski
    Chief Financial Officer
March 24, 2023   (Principal Financial and Accounting Officer)
     
  By: /s/ Kristen McLaughlin
    Kristen McLaughlin
March 24, 2023   Director
     
  By: /s/ Louis Castro
    Louis Castro
March 24, 2023   Director
     
  By: /s/ Olivia C. Bartlett
    Olivia C. Bartlett
March 24, 2023   Director

 

74

 

 

Report of Independent Registered Public Accounting Firm

 

To the Board of Directors and Stockholders

Innovative Eyewear, Inc.

Miami, Florida

 

Opinion on the Financial Statements

 

We have audited the accompanying balance sheets of Innovative Eyewear, Inc. (the “Company”) as of December 31, 2022 and 2021, and the related statements of operations, changes in stockholders’ equity, and cash flows for the years then ended and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable

basis for our opinion.

 

Emphasis of Matter

 

As more fully described in Note 3 to the financial statements, the Company has incurred historical net losses and sustained substantial cash losses. Our opinion is not modified with respect to this matter.

 

We have served as the Company’s auditor since 2021.

 

/s/ Cherry Bekaert LLP

 

Tampa, Florida

March 24, 2023

 

F-1

 

 

INNOVATIVE EYEWEAR, INC.

BALANCE SHEETS

December 31, 2022 and 2021

 

           
   2022   2021 
TOTAL ASSETS          
Current Assets          
Cash and cash equivalents  $3,591,109   $79,727 
Accounts receivable, net of allowance of $92,646 and $0, respectively   110,258    43,394 
Prepaid expenses   210,673    68,381 
Deferred offering costs   -    111,149 
Inventory prepayment   197,750    64,715 
Inventory   94,701    275,501 
Other current assets   36,240    1,460 
Total Current Assets   4,240,731    644,327 
           
Non-Current Assets          
Patent costs, net   137,557    87,306 
Capitalized software costs   110,073    72,400 
Property and equipment, net   119,744    20,284 
Other non-current assets   81,779    - 
TOTAL ASSETS  $4,689,884   $824,317 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Liabilities          
Current Liabilities          
Accounts payable and accrued expenses  $275,660   $167,050 
Deferred revenue   30,000    - 
Due to Parent and Affiliates   232,989    160,722 
Related party convertible debt   61,356    289,029 
Total Current Liabilities   600,005    616,801 
           
Non-Current Liabilities          
Deferred revenue   65,450    - 
TOTAL LIABILITIES   665,455    616,801 
           
Commitments and contingencies   -    - 
           
Stockholders’ Equity          
Common stock (par value $0.00001, 50,000,000 shares authorized, and 7,307,157 and 6,060,187 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively)   73    60 
Additional paid-in capital   14,330,343    4,842,836 
Stock subscription receivable   -    (11,226)
Accumulated deficit   (10,305,987)   (4,624,154)
TOTAL STOCKHOLDERS’ EQUITY   4,024,429    207,516 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $4,689,884   $824,317 

 

See accompanying Notes to the Financial Statements.

 

F-2

 

 

INNOVATIVE EYEWEAR, INC.

STATEMENTS OF OPERATIONS

For the years ended December 31, 2022 and 2021

 

           
   Year Ended
December 31,		 
   2022   2021 
Revenues, net  $659,788   $690,670 
Less: Cost of Goods Sold   (716,077)   (542,416)
Gross (Deficit) Profit   (56,289)   148,254 
           
Operating Expenses:          
General and administrative   (2,796,669)   (1,386,079)
Sales and marketing   (2,059,012)   (1,771,012)
Research and development   (524,692)   (86,261)
Related party management fee   (140,000)   (109,975)
Total Operating Expenses   (5,520,373)   (3,353,327)
           
Interest Expense   (105,171)   (39,433)
           
Net Loss  $(5,681,833)  $(3,244,506)
           
Weighted average number of shares outstanding   6,528,959    5,245,622 
Loss per share, basic and diluted  $(0.87)  $(0.62)

 

See accompanying Notes to the Financial Statements.

 

F-3

 

 

INNOVATIVE EYEWEAR, INC.

STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

For the years ended December 31, 2022 and 2021

 

                               
   Common Stock   Additional
Paid In		   Stock
Subscription		   Accumulated   Total
Stockholders’		 
   # Shares   Amount   Capital   Receivable   Deficit   Equity 
Balances, January 1, 2022   6,060,187   $60   $4,842,836  $(11,226)  $(4,624,154)  $207,516 
                               
Collection of stock subscription receivable   -    -         6,684    -    6,684 
Write-off of uncollectible stock subscription receivable   -    -    (4,542)   4,542    -    - 
Shares issued for conversion of related party convertible note   266,970    3    2,002,277    -    -    2,002,280 
Initial public offering (see Note 8)   980,000    10    6,015,908    -    -    6,015,918 
Stock based compensation   -    -    1,473,864    -    -    1,473,864 
Net loss   -    -    -    -    (5,681,833)   (5,681,833)
Balances, December 31, 2022   7,307,157   $73   $14,330,343   $-   $(10,305,987)  $4,024,429 
                               
Balances, January 1, 2021   4,131,469   $41   $845,417   $(20,647)  $(1,379,648)  $(554,837)
                               
Shares issued for conversion of related party convertible note   1,172,115    12    2,179,760    -    -    2,179,772 
Issuance of shares, net of offering costs of $351,411   756,603    7    482,724    (44,763)   -    437,968 
Collection of stock subscription receivable   -    -    -    54,184    -    54,184 
Stock based compensation   -    -    1,334,935    -    -    1,334,935 
Net loss   -    -    -    -    (3,244,506)   (3,244,506)
Balances, December 31, 2021   6,060,187   $60   $4,842,836   $(11,226)  $(4,624,154)  $207,516 

 

See accompanying Notes to the Financial Statements.

 

F-4

 

 

INNOVATIVE EYEWEAR, INC.

STATEMENTS OF CASH FLOWS

For the years ended December 31, 2022 and 2021

 

           
   2022   2021 
Operating Activities          
Net Loss  $(5,681,833)  $(3,244,506)
Adjustments to reconcile net loss to net cash used in operating activities:          
Amortization   10,466    7,179 
Depreciation   22,101    498 
Non cash interest expense   105,171    1,251 
Stock based compensation expense   1,473,864    1,334,935 
Expenses paid by parent and affiliates   960,362    867,618 
Provision for doubtful accounts   116,230    - 
           
Changes in operating assets and liabilities:          
Accounts receivable   (183,094)   (43,394)
Accounts payable and accrued expenses   67,951    157,536 
Prepaid expenses   (142,292)   (43,381)
Inventory   47,765    (250,436)
Other current assets   1,460    (1,460)
Contract assets and liabilities   (22,569)   - 
Net cash flows from operating activities   (3,224,418)   (1,214,160)
           
Investing Activities          
Patent costs   (60,717)   (25,272)
Purchases of property and equipment   (121,561)   (20,782)
Capitalized software expenditures   (37,673)   (72,400)
Net cash flows from investing activities   (219,951)   (118,454)
           
Financing Activities          
Proceeds from initial public offering (see Note 8)   6,127,067    - 
Proceeds from issuance of shares, net of offering costs   -    492,152 
Payment of deferred offering cost   -    (111,149)
Collection of stock subscription receivable   6,684    - 
Proceeds from related party convertible debt   1,475,000    1,061,500 
Repayment of related party convertible debt   (653,000)   (57,185)
Net cash flows from financing activities   6,955,751    1,385,318 
           
Net Change In Cash   3,511,382    52,704 
Cash at Beginning of Year  $79,727   $27,023 
Cash at End of Year  $3,591,109   $79,727 
           
Significant Non-Cash Transaction          
Expenses paid for by Parent reported as increase in Due to Parent and Affiliates and related party convertible debt   960,362    867,618 
Write-off of uncollectible stock subscription receivable   (4,542)   - 
Issuance of shares from conversion of related party convertible debt   2,002,280    2,179,772 

 

See accompanying Notes to the Financial Statements.

 

F-5

 

 

INNOVATIVE EYEWEAR, INC.

NOTES TO THE FINANCIAL STATEMENTS

December 31, 2022 and 2021

 

NOTE 1 – GENERAL INFORMATION

 

Innovative Eyewear, Inc. (the “Company,” “us,” “we,” or “our”) is a corporation organized under the laws of the State of Florida that develops and sells cutting-edge eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The Company was founded by Lucyd Ltd. (the “Parent” or “Lucyd”), a portfolio company of Tekcapital Plc through Tekcapital Europe, Ltd. (collectively, the “Parent and Affiliates”), which owned approximately 71% of our issued and outstanding shares of common stock as of December 31, 2022. Innovative Eyewear licensed the exclusive rights to the Lucyd® brand from Lucyd Ltd., which includes the exclusive use of all of Lucyd’s intellectual property, including our main product, Lucyd Lyte® glasses.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and in accordance with the accounting rules under Regulation S-X, as promulgated by the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statements for the years presented have been included. The results of operations for the years ended December 31, 2022 and 2021 are not necessarily indicative of the results to be expected for future periods.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant economic disruptions and uncertainties associated with the ongoing economic environment, including potential supply chain constraints.

 

Receivables and Credit Policy

 

Trade receivables from customers are uncollateralized customer obligations due under normal trade terms. For direct-to-consumer sales, payment is required before product is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice. The Company, by policy, routinely assesses the financial strength of its customers. To comply with industry standards, we offer “net 30” payments on wholesale orders of $1,500 or more. For wholesale orders, to acquire an order on net 30 terms, the customer is provided a credit check application as well as a credit card authorization form. The authorization form explicitly states when and for much we will bill the customer via credit card.

 

Accounts receivable are reported net of the allowance for doubtful accounts. The allowance for doubtful accounts is based on the Company’s evaluation of each customer’s payment history, account aging, and financial position. The Company recognized bad debt expense of $116,230 for the year ended December 31, 2022, and no bad debt expense for the year ended December 31, 2021.

 

F-6

 

 

Capitalized Software

 

The Company incurred software development costs related to development of the Vyrb app. The Company capitalized these costs in accordance with ASC 985-20, “Software – Costs of Software to be Sold, Leased, or Marketed,” considering it is the Company’s intention to market and sell the software externally. Planning, designing, coding, and testing occurred necessary to meet Vyrb’s design specifications. As such, all coding, development, and testing costs incurred subsequent to establishing technical feasibility were capitalized. We have launched a beta version of the Vyrb application in December 2021 that demonstrates the functionality of the software. We expect an estimated useful life of five years for this product.

 

Inventory

 

Our inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. No provisions were determined as needed as of December 31, 2022 and 2021.

 

As of December 31, 2022 and 2021, the Company recorded an inventory prepayment in the amount of $197,750 and $64,715, respectively, related to down payment on eyewear purchased from the manufacturer, prior to shipment of the product that occurred after December 31, 2022 and 2021, respectively.

 

Intangible Assets

 

Intangible assets relate to patent costs received in conjunction with the initial capitalization of the Company and internally developed utility and design patents. The Company amortizes these assets over the estimated useful life of the patents. The Company reviews its intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.

 

Property and Equipment

 

Property and equipment are depreciated using the straight-line method over the estimated useful lives or lease terms if shorter. Depreciation expense for the years ended December 31, 2022 and 2021 was approximately $22,100 and $500, respectively. For income tax purposes, accelerated depreciation methods are generally used. Repair and maintenance costs are expensed as incurred.

 

             
   As of
December 31,		   Estimated Useful Lives
Property & Equipment  2022   2021   (in Years)
Mobile Kiosk Display  $63,395   $18,120   3 years
Computer Equipment   44,901    2,662   3 Years
Office Equipment   17,273    -   3 Years
Internal-Use Software   16,775    -   3 to 5 Years
Property and equipment, gross   142,343    20,782    
Less: Accumulated depreciation   (22,599)   (498)   
Property and equipment, net  $119,744   $20,284    

 

F-7

 

 

Income Taxes

 

The Company accounts for income taxes under an asset and liability approach that recognizes deferred tax assets and liabilities based on the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.

 

The Company follows a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return. Any interest and penalties accrued related to uncertain tax positions are recorded in tax expense.

 

The Company assesses the realizability of its net deferred tax assets on an annual basis. If, after considering all relevant positive and negative evidence, it is more likely than not that some portion or all of the net deferred tax assets will not be realized, the Company will reduce the net deferred tax assets by a valuation allowance. The realization of net deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of net operating loss carryforwards.

 

Fair Value of Financial Instruments

 

For certain of the Company’s financial instruments, including cash, accounts receivable, accounts payable, and cash advances provided by the Parent and Affiliates, the carrying amounts approximate fair value due to the short-term maturities of these instruments. The carrying value of the convertible note approximates fair value because the interest rate approximates market rates.

 

Concentrations of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and accounts receivable. The Company limits its credit risk with respect to cash by maintaining cash balances with high quality financial institutions. At times, the Company’s cash balances may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are considered minimal due to collection history.

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation to employees and directors in accordance with FASB ASC Topic 718, which requires that compensation expense be recognized in the financial statements for stock-based awards based on the grant date fair value. For stock option awards, the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility. The expected term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).

 

The share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies. The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.

 

The fair value of common stock used in the option pricing model for stock-based awards granted in 2021 was determined using the most recent price paid by independent investors through a Regulation Crowdfunding (“CF”) securities offering undertaken by the Company. For the majority of time during which stock option awards were granted by the Company in 2021, the Company had been raising funds from investors under Regulation CF campaigns, with a significant number of transactions from both accredited and non-accredited investors.

 

Revenue Recognition

 

Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.

 

F-8

 

 

To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract and determine those that are performance obligations, and also assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In instances where the collectibility of contractual consideration is not probable at the time of sale, the revenue is deferred on our balance sheet as a contract liability, and the associated cost of goods sold is deferred on our balance sheet as a contract asset; subsequently, we recognize such revenue and cost of goods sold as payments are received.

 

All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.

 

For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.

 

For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation, which is delivery of the Company’s eyewear products to the retail store and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to the retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.

 

For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order and after collectibility of substantially all of the contract consideration is probable. Our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale distributor orders, no e-commerce fees are applicable.

 

The Company’s sales do not contain any variable consideration.

 

We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason within the first:

 

  ● 7 days for sales made through our website (Lucyd.co)

 

  ● 30 days for sales made through Amazon

 

  ● 30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns)

 

For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we review all individual returns received in the month following the balance sheet date pertaining to orders processed prior to the balance sheet date in order to determine whether an allowance for sales returns is necessary. The Company recorded an allowance for sales returns of $24,897 and $22,266 as of December 31, 2022 and 2021, respectively.

 

F-9

 

 

Shipping and Handling

 

Costs incurred for shipping and handling are included in cost of revenue at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.

 

Recent Accounting Pronouncements

 

In February 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, “Leases (Topic 842),” that requires organizations that lease assets, referred to as “lessees,” to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases with lease terms of more than 12 months. ASU 2016-02 also requires disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases and will include qualitative and quantitative requirements. The Company adopted ASU 2016-02 as of January 1, 2021. The Company’s management determined that the adoption of this guidance had no material impact on the Company’s financial statements due to the lack of long-term leasing arrangements.

 

In May 2018, the FASB issued ASU 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic 470-20), and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contract’s in Entity’s Own Equity.” The guidance in ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the previous guidance related to debt with conversion and other options that required entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. In addition, the amendments revised the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification. The amendments in ASU 2020-06 further revised the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. The Company adopted ASU 2020-06 as of January 1, 2021. The Company’s management determined that the adoption of this guidance had no material impact on the Company’s financial statements due to the lack of beneficial conversion features contained within the Company’s debt.

 

Subsequent Events

 

In connection with the preparation of these financial statements, the Company has evaluated subsequent events through March 24, 2023, which is the date the financial statements were available to be issued.

 

NOTE 3 – GOING CONCERN

 

The Company has a limited operating history. The Company’s business and operations are sensitive to general business and economic conditions in the United States. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverse conditions may include recession, downturn, or otherwise, changes in regulations or restrictions in imports, competition, or changes in consumer taste including the economic impacts from the COVID-19 pandemic. These adverse conditions could affect the Company’s financial condition and the results of its operations.

 

The Company meets its day to day working capital requirements through monies raised through sales of eyewear and issuances of equity, including past crowdfunding transactions, and more recently an initial public offering completed in August 2022. The Company also has issued a convertible note held by its parent company. The Company’s forecasts and projections indicate that the Company expects to have sufficient cash reserves and future income to operate within the level of its current facilities. The Company anticipates that its available liquidity will be sufficient to fund operations through at least the end of March 2024.

 

F-10

 

 

NOTE 4 – INCOME TAX PROVISION

 

The following is a reconciliation of tax computed at the statutory federal rate to the income tax benefit in the statements of operations:

 

          
   2022   2021 
Income tax benefit at the statutory federal rate  $1,193,185   $681,346 
State income tax benefits, net of federal benefit   35,149    110,647 
Change in valuation allowance   (1,228,334)   (791,993)
Total  $-    - 

 

The components of the Company’s deferred tax assets are as follows:

 

          
   2022   2021 
Deferred tax assets:          
Stock-based compensation  $610,530   $359,032 
Other – net   122,133    6,757 
Net operating losses – federal   1,346,823    534,771 
Net operating losses – state   81,911    110,647 
 Deferred tax assets Gross   2,161,397    1,011,207 
Less Valuation Allowance   (2,161,397)   (1,011,207)
Net deferred tax assets  $-   $- 

 

Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities. Deferred tax assets or liabilities at the end of each period are determined using the tax rate expected to be in effect when taxes are actually paid or recovered.

 

A valuation allowance is established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. A review of all available positive and negative evidence needs to be considered, including a company’s current and past performance, the market environment in which the company operates, length of carryback and carryforward periods, and existing contracts that will result in future profits. After reviewing all the evidence, the Company has recorded a full valuation allowance against its deferred tax assets.

 

At December 31, 2022, the Company had federal net operating loss carryforwards of $6,413,441 and state net operating loss carryforwards of $3,653,332, both of which do not expire.

 

The Company files Federal and Florida tax returns. The years that remain subject to examination are the years ended December 31, 2020, 2021, and 2022. As of December 31, 2022 and 2021, the Company does not believe that is has any liabilities for uncertain tax positions.

 

NOTE 5 – INTANGIBLE ASSETS

 

          
   December 31,   December 31, 
Finite-lived intangible assets  2022   2021 
Patent Costs  $156,196   $95,480 
Intangible assets, gross   156,196    95,480 
           
Less: Accumulated amortization   (18,639)   (8,174)
Intangible assets, net  $137,557   $87,306 

 

Amortization expense totalled approximately $10,500 and $7,200 for the years ended December 31, 2022 and 2021, respectively. Future amortization is expected to approximate $11,500 per year.

 

F-11

 

 

NOTE 6 – RELATED PARTY TRANSACTIONS

 

Convertible Note and Due to Parent and Affiliates

 

During the years ended December 31, 2022 and 2021, the Company had the availability of, but not the contractual right to, intercompany financing from the Parent and Affiliates in the form of either cash advances or borrowings under a convertible note (as discussed below). The convertible notes balances were $61,356 and $289,029 as of December 31, 2022 and 2021, respectively.

 

On December 1, 2020, the Company issued a convertible note to its Parent and Affiliates for up to $2,000,000 that bears interest at 10% per annum, which includes the option to convert the debt into the Company’s common stock at market price. The note can be converted into shares of common stock of the Company upon occurrence of certain conversion events, as defined.

 

On June 1, 2021, the Company converted related party borrowings totalling $778,500 into 778,500 shares of common stock at $1.00 each.

 

On September 5, 2021, the Company converted related party borrowings totalling $500,002 into 140,449 shares of common stock at $3.56 each.

 

On November 1, 2021, the Company amended and restated its December 1, 2020, convertible note agreement with Parent and Affiliates, increasing the amount of available financing from $2,000,000 to $3,000,000.

 

On November 16, 2021, the Company converted related party borrowings totalling $901,271 into 253,166 shares of common stock at $3.56 per share.

 

On August 15, 2022, in connection with the Company’s initial public offering (see Note 8), the Company converted related party borrowings totalling $2,002,280 into 266,970 shares of common stock at $7.50 per share.

 

Management Service Agreement

 

In 2020, the Company entered into a management services agreement with a related party (related through common ownership), for which the Company was billed $25,000 quarterly. Effective February 1, 2022, the original management services agreement was amended to have the Company billed at $35,000 quarterly. While the agreement does not stipulate a specific maturity date, it can be terminated with 30 calendar days written notice by any party.

 

The related party provides the following services:

 

  ● Support and advice to the Company in accordance with their area of expertise;

 

  ● Research, technical review, legal review, recruitment, software development, marketing, public relations, and advertisement; and

 

  ● Advice, assistance, and consultation services to support the Company or in relation to any other related matter.

 

During the years ended December 31, 2022 and 2021, the Company incurred $140,000 and $100,000, respectively, under its management services agreement with Tekcapital Europe Ltd.

 

Rent of Office Space

 

Prior to the February 1, 2022 amendment of the aforementioned management services agreement, the Company was provided with rent-free office space by the Parent and Affiliates. Effective February 1, 2022, Tekcapital began to bill the Company for an allocation of rent paid by Tekcapital on the Company’s behalf. The Company recognized $74,442 of expense related to this arrangement for the year ended December 31, 2022.

 

F-12

 

 

NOTE 7 – COMMITMENTS AND CONTINGENCIES

 

Legal Matters

 

We are not the subject of any material pending legal proceedings, however, may from time to time become a party to various legal proceedings arising in the ordinary course of business.

 

Leases

 

Our executive offices are located at 11900 Biscayne Blvd., Suite 630 Miami, Florida 33181. Our executive offices are provided to us by the parent of our majority stockholder, Tekcapital (see Note 6). We consider our current office space adequate for our current operations.

 

License Agreements

 

During the year ended December 31, 2022, the Company entered into license agreements which grant the Company the right to sell certain branded smart eyewear. These agreements require the Company to pay royalties based on a percentage of net retail and wholesale sales, and also require guaranteed minimum royalty payments. The agreements have base terms of 10 years but are cancellable at the option of the Company during the fifth year.

 

The aggregate future minimum payments due under these license agreements are as follows:

 

     
2023  $36,750 
2024   161,210 
2025   356,000 
2026   654,000 
2027   930,000 
Thereafter (through 2032)   7,200,000 
Total  $9,337,960 

 

Other Commitments

 

See related party management services agreement discussed in Note 6.

 

F-13

 

 

NOTE 8 – STOCKHOLDERS’ EQUITY

 

Pursuant to a corporate resolution on July 1, 2021, the Company has authority to issue up to 15,000,000 shares of preferred stock and 50,000,000 shares of common stock. There were no shares of preferred stock issued or outstanding as of December 31, 2022 and 2021.

 

Initial Public Offering

 

On August 17, 2022, the Company closed on its initial public offering of 980,000 units consisting of 980,000 shares of its common stock and 1,960,000 warrants to purchase 1,960,000 shares of common stock at a combined offering price of $7.50 per unit in exchange for gross proceeds of approximately $7.35 million, before deducting underwriting discounts and offering expenses. Each share of common stock was sold together with two warrants. Each warrant is exercisable to purchase one share of common stock at an initial exercise price of $7.50 per share, subject to certain adjustments as set forth in the warrant agreement. In addition, the Company granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or warrants to purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which the Underwriter exercised its option to purchase additional warrants to purchase 294,000 shares of common stock concurrently with the closing.

 

The shares of common stock and warrants began trading on The Nasdaq Capital Market on August 15, 2022, under the symbols “LUCY” and “LUCYW,” respectively.

 

Also, pursuant to the terms of the underwriting agreement for the offering, the Company issued by the Underwriter certain other warrants to purchase up to 58,800 shares of the Company’s common stock at an exercise price of $8.228 per share.

 

The net proceeds received by the Company amounted to $6,189,734.

 

As of December 31, 2022, none of the aforementioned warrants had been exercised.

 

F-14

 

 

NOTE 9 – STOCK BASED COMPENSATION

 

On July 1, 2021, an Equity Incentive Plan was approved, allowing for total of 20% of our issued and outstanding common stock immediately after the consummation of the initial public offering, less the number of outstanding option grants, or 1,124,043, of total issued shares to be available for the grant of awards under the Plan. 1,685,000 option awards were granted by the Company prior to the approval of the Plan, while 647,500 option awards were granted subject to the Plan.

 

During the year ended December 31, 2021, the Company, granted 1,687,500 option awards, of which 1,347,500 vest rateably over time and 340,000 vest based on certain performance conditions. There were no option awards granted during the year ended December 31, 2022.

 

The fair value of options granted is calculated using the Black-Scholes-Merton option pricing model. The underlying assumptions used in the option pricing model for stock option awards granted in 2021 were as follows:

 

    
Attribute    
Share price at date of grant  $1.00 - $5.00 
Options life in years  2 - 3 
Risk free rate  0.16% - 0.44% 
Expected volatility  121% - 151% 
Expected dividend yield  0 
Grant date fair value of options  $0.71 - $3.46 

 

The weighted average grant date fair value of options outstanding as of December 31, 2022 and 2021 was $1.84.

 

Details of the number of share options and the weighted average exercise price outstanding as of and during the years ended December 31, 2022 and 2021 are as follows:

 

           
    Av. Exercise     
    price per share   Options 
    $   (Number) 
As at January 1, 2021    1.00    645,000 
Granted    3.23    1,687,500 
Exercised    -    - 
Forfeited    -    - 
As at December 31, 2021    2.61    2,332,500 
Exercisable as at December 31, 2021    1.87    395,269 
            
As at January 1, 2022    2.61    2,332,500 
Granted    -    - 
Exercised    -    - 
Forfeited    -    - 
As at December 31, 2022    2.61    2,332,500 
Exercisable as at December 31, 2022    2.18    1,198,577 

 

As of December 31, 2022, the weighted average remaining contractual life of options was 1.68 years for outstanding options, and 1.79 years for exercisable options.

 

As of December 31, 2022, unrecognized stock option expense of $1,409,958 remains to be recognized over next 1.41 years.

 

F-15

 

 

NOTE 10 – EARNINGS PER SHARE

 

The Company calculates earnings/(loss) per share data by calculating the quotient of earnings/(loss) divided by the weighted average number of common shares outstanding during the respective period as required by ASC 260-10-50. Due to the net losses for the years ended December 31, 2022 and 2021, all shares underlying the related party convertible debt, common stock warrants, and common stock options were excluded from the earnings per share calculation due to their anti-dilutive effect.

 

Calculation of net earnings per common share — basic and diluted:

 

          
   For the
year ended		 
   December 31,
2022		   December 31,
2021		 
Basic and diluted:          
Net loss   (5,681,833)   (3,244,506)
Weighted-average number of common shares   6,528,959    5,245,622 
Basic and diluted net loss per common share  $(0.87)  $(0.62)

 

NOTE 11 – SUBSEQUENT EVENTS

 

In February 2023, holders of the Company’s warrants (see Note 8) exercised warrants to purchase an aggregate of 408,600 shares of the Company’s common stock, at an adjusted exercise price of $3.75 per share, resulting in cash proceeds to the Company of $1,532,250.

 

F-16

 EX-19 2 innovativeeye_ex19.htm EXHIBIT 19

 

Exhibit 19

 

Innovative Eyewear Inc.

 

Insider Trading Policy

 

and Guidelines with Respect to Certain Transactions in Company Securities

 

APPLICABILITY OF POLICY

 

This Policy applies to all transactions in the Company’s securities, including shares of common stock, options, warrants to purchase common stock and rights to receive common stock and any other securities the Company may issue from time to time, such as preferred stock and convertible notes, as well as to derivative securities relating to the Company’s stock, whether or not issued by the Company, such as exchange-traded options. It applies to all officers and directors of the Company, all other employees of the Company and its subsidiaries, all secretaries and assistants supporting such directors, officers, and employees, and consultants or contractors to the Company or its subsidiaries who have or may have access to Material Nonpublic Information (as defined below) regarding the Company and members of the immediate family or household of any such person. This group of people is sometimes referred to in this Policy as “Insiders.” This Policy also applies to any person who receives Material Nonpublic Information from any Insider.

 

Any person who possesses Material Nonpublic Information regarding the Company is an Insider for so long as such information is not publicly known.

 

DEFINITION OF MATERIAL NONPUBLIC INFORMATION

 

It is not possible to define all categories of material information. However, information should be regarded as material if there is a reasonable likelihood that it would be considered important to an investor in making an investment decision regarding the purchase or sale of the Company’s securities. Material Nonpublic Information is information that has not been previously disclosed to the general public and is otherwise not available to the general public.

 

While it may be difficult to determine whether particular information is material, there are various categories of information that are particularly sensitive and, as a general rule, should always be considered material. In addition, material information may be positive or negative. Examples of such information may include:

 

●Financial results;

 

●Entry into a material agreement or discussions regarding entry into a material agreement;

 

●Projections of future earnings or losses;

 

●Joint ventures/commercial partnerships with third parties;

 

●News of the disposition of material assets;

 

●New product or project announcements of a significant nature;

 

●Information regarding regulatory review of Company products;

 

1

 

 

●Intellectual property and other proprietary information;

 

●Major contract awards, cancellations or write-offs;

 

●Research milestones and related payments or royalties;

 

●Impending bankruptcy or financial liquidity problems;

 

●Gain or loss of a substantial customer or supplier or manufacturer;

 

●Significant pricing changes;

 

●Stock splits;

 

●New equity or debt offerings;

 

●Significant litigation exposure due to actual or threatened litigation;

 

●Changes in senior management or the Board of Directors of the Company;

 

●Capital investment plans; and

 

●Any delays in delivery or manufacturing of products.

 

STATEMENT OF POLICY

 

General Policy

 

It is the policy of the Company to prohibit the unauthorized disclosure of any nonpublic information acquired in the workplace and the misuse of Material Nonpublic Information in securities trading related to the Company or any other company.

 

Specific Policies

 

1. Trading on Material Nonpublic Information. With certain exceptions, no Insider shall engage in any transaction involving a purchase or sale of the Company’s or any other company’s securities, including any offer to purchase or offer to sell, during any period commencing with the date that he or she possesses Material Nonpublic Information concerning the Company, and ending at the close of business on the second Trading Day following the date of public disclosure of that information, or at such time as such nonpublic information is no longer material. However, see Section 2 under “Permitted Trading Period” below for a full discussion of trading pursuant to a pre-established plan or by delegation.

 

As used herein, the term “Trading Day” shall mean a day on which national stock exchanges are open for trading.

 

2. Tipping. No Insider shall disclose (“tip”) Material Nonpublic Information to any other person (including family members) where such information may be used by such person to his or her profit by trading in the securities of companies to which such information relates, nor shall such Insider or related person make recommendations or express opinions on the basis of Material Nonpublic Information as to trading in the Company’s securities.

 

2

 

 

Regulation FD (Fair Disclosure) is an issuer disclosure rule implemented by the SEC that addresses selective disclosure of Material Nonpublic Information. The regulation provides that when the Company, or person acting on its behalf, discloses material nonpublic information to certain enumerated persons (in general, securities market professionals and holders of the Company’s securities who may well trade on the basis of the information), it must make public disclosure of that information. The timing of the required public disclosure depends on whether the selective disclosure was intentional or unintentional; for an intentional selective disclosure, the Company must make public disclosures simultaneously; for a non-intentional disclosure the Company must make public disclosure promptly. Under the regulation, the required public disclosure may be made by filing or furnishing a Form 8-K, or by another method or combination of methods that is reasonably designed to effect broad, non-exclusionary distribution of the information to the public.

 

It is the policy of the Company that all public communications of the Company (including, without limitation, communications with the press, other public statements, statements made via the Internet or social media outlets, or communications with any regulatory authority) be handled only through the Company’s Chief Executive Officer (the “CEO”), an authorized designee of the CEO or the Company’s public or investor relations firm. Please refer all press, analyst or similar requests for information to the CEO and do not respond to any inquiries without prior authorization from the CEO. If the CEO is unavailable, the Company’s Chief Financial Officer (or the authorized designee of such officer) will fill this role.

 

3. Confidentiality of Nonpublic Information. Nonpublic information relating to the Company is the property of the Company and the unauthorized disclosure of such information (including, without limitation, via email or by posting on Internet message boards, blogs, or social media) is strictly forbidden.

 

4. Duty to Report Inappropriate and Irregular Conduct. All employees, and particularly managers and/or supervisors, have a responsibility for maintaining financial integrity within the Company, consistent with generally accepted accounting principles and both federal and state securities laws. Any employee who becomes aware of any incidents involving financial or accounting manipulation or irregularities, whether by witnessing the incident or being told of it, must report it to their immediate supervisor and to any member of the Company’s Audit Committee. In certain instances, employees are allowed to participate in federal or state proceedings. For a more complete understanding of this issue, employees should consult their employee manual and or seek the advice of counsel. Our general Corporate and Securities Counsel is Ellenoff Grossman & Schole LLP, attention: Justin Grossman, at (212)370-1300, email: jgrossman@egsllp.com.

 

3

 

 

POTENTIAL CRIMINAL AND CIVIL LIABILITY

AND/OR DISCIPLINARY ACTION

 

1. Liability for Insider Trading. Insiders may be subject to penalties of up to $5,000,000 and up to ten (10) years in jail for engaging in transactions in the Company’s securities at a time when they possess Material Nonpublic Information regarding the Company. In addition, the SEC has the authority to seek a civil monetary penalty of up to three times the amount of profit gained or loss avoided by illegal insider trading. “Profit gained” or “loss avoided” generally means the difference between the purchase or sale price of the Company’s stock and its value as measured by the trading price of the stock a reasonable period after public dissemination of the nonpublic information.

 

2. Liability for Tipping. Insiders may also be liable for improper transactions by any person (commonly referred to as a “tippee”) to whom they have disclosed Material Nonpublic Information regarding the Company or to whom they have made recommendations or expressed opinions on the basis of such information as to trading in the Company’s securities. The SEC has imposed large penalties even when the disclosing person did not profit from the trading. The SEC, the stock exchanges and the Financial Industry Regulatory Authority, Inc. use sophisticated electronic surveillance techniques to monitor trading and uncover insider trading.

 

3. Possible Disciplinary Actions. Individuals subject to the Policy who violate this Policy shall also be subject to disciplinary action by the Company, which may include suspension, forfeiture of perquisites, ineligibility for future participation in the Company’s equity incentive plans and/or termination of employment.

 

PERMITTED TRADING PERIOD

 

1. Black-Out Period and Trading Window.

 

To ensure compliance with this Policy and applicable federal and state securities laws, the Company requires that all officers, directors, employees, members of the immediate family or household of any such person and others who are subject to this Policy refrain from conducting any transactions involving the purchase or sale of the Company’s securities, other than during the period in any fiscal quarter commencing at the close of business on the second Trading Day following the date of public disclosure of the financial results for the prior fiscal quarter or year and ending on the twenty-fifth day of the third month of the fiscal quarter (the “Trading Window”). If such public disclosure occurs on a Trading Day before the markets close, then such date of disclosure shall be considered the first Trading Day following such public disclosure.

 

Notwithstanding the foregoing, persons subject to this Policy may submit a request to the Company to purchase or sell the Company’s securities outside the Trading Window on the basis that they do not possess any Material Nonpublic Information. The Compliance Officer shall review all such requests and may grant such requests on a case-by-case basis if he or she determines that the person making such request does not possess any Material Nonpublic Information at that time.

 

It is the Company’s policy that the period when the Trading Window is “closed” is a particularly sensitive period of time for transactions in the Company’s securities from the perspective of compliance with applicable securities laws. This is because Insiders, as any quarter progresses, are increasingly likely to possess Material Nonpublic Information about the expected financial results for the quarter. The purpose of the Trading Window is to avoid any unlawful or improper transactions or the appearance of any such transactions.

 

4

 

 

It should be noted that even during the Trading Window any person possessing Material Nonpublic Information concerning the Company shall not engage in any transactions in the Company’s (or any other company’s, as applicable) securities until such information has been known publicly for at least two Trading Days. The Company has adopted the policy of delaying trading for “at least two Trading Days” because the securities laws require that the public be informed effectively of previously undisclosed material information before Insiders trade in the Company’s securities. Public disclosure may occur through a widely disseminated press release or through filings, such as Forms 10-Q and/or 8-K, with the SEC. Furthermore, in order for the public to be effectively informed, the public must be given time to evaluate the information disclosed by the Company. Although the amount of time necessary for the public to evaluate the information may vary depending on the complexity of the information, generally two Trading Days is a sufficient period of time.

 

From time to time, the Company may also require that Insiders suspend trading because of developments known to the Company and not yet disclosed to the public. In such event, such persons may not engage in any transaction involving the purchase or sale of the Company’s securities during such period and may not disclose to others the fact of such suspension of trading.

 

Although the Company may from time to time require during a Trading Window that Insiders and others suspend trading because of developments known to the Company and not yet disclosed to the public, each person is individually responsible at all times for compliance with the prohibitions against insider trading. Trading in the Company’s securities during the Trading Window should not be considered a “safe harbor,” and all directors, officers and other persons should use good judgment at all times.

 

Notwithstanding these general rules, Insiders may trade outside of the Trading Window provided that such trades are made pursuant to a pre-established plan or by delegation; these alternatives are discussed in the next section.

 

2.  Trading According to a Pre-established Plan or by Delegation.

 

Trading which is not “on the basis of” material non-public information may not give rise to insider trading liability. The SEC has adopted Rule 10b5-1 under which insider trading liability can be avoided if Insiders follow very specific procedures. In general, such procedures involve trading according to pre-established instructions, plans or programs (a “10b5-1 Plan”).

 

10b5-1 Plans must:

 

(a) Be documented by a contract, written plan, or formal instruction which provides that the trade take place in the future. For example, an Insider can contract to sell his or her shares on a specific date, or simply delegate such decisions to an investment manager, 401(k) plan administrator or similar third party. This documentation must be provided to the Company’s Insider Trading Compliance Officer or legal counsel;

 

5

 

 

(b) Include in its documentation the specific amount, price and timing of the trade, or the formula for determining the amount, price and timing. For example, the Insider can buy or sell shares in a specific amount and on a specific date each month, or according to a pre-established percentage (of the Insider’s salary, for example) each time that the share price falls or rises to pre-established levels. In the case where trading decisions have been delegated, the specific amount, price and timing need not be provided;

 

(c) Be implemented at a time when the Insider does not possess material non-public information. As a practical matter, this means that the Insider may set up a 10b5-1 Plan, or delegate trading discretion, only during a “Trading Window” (discussed in Section 1, above); and,

 

(d) Remain beyond the scope of the Insider’s influence after implementation. In general, the Insider must allow the 10b5-1 Plan to be executed without changes to the accompanying instructions, and the Insider cannot later execute a hedge transaction that modifies the effect of the 10b5-1 Plan. An Insider wishing to change the amount, price or timing of a 10b5-1 Plan can do so only during a “Trading Window” (discussed in Section 1, above). Termination of a 10b5-1 Plan may be undertaken at any time, provided that the termination must be approved in advance by the Company’s Insider Trading Compliance Officer in order to ensure that the Insider is not in possession of Material Nonpublic Information. If the Insider has delegated decision-making authority to a third party, the Insider cannot subsequently influence the third party in any way and such third party must not possess material non-public information at the time of any of the trades.

 

Prior to implementing a pre-established plan for trading, all officers and directors must receive the approval for such plan from the Company’s Insider Trading Compliance Officer or legal counsel.

 

3. Pre-Clearance of Trades.

 

Even during a Trading Window, all Insiders must comply with the Company’s “pre-clearance” process prior to trading in the Company’s securities, implementing a pre-established plan for trading, or delegating decision-making authority over the Insider’s trades. To do so, each Insider must contact the Company’s Insider Trading Compliance Officer or legal counsel prior to initiating any of these actions. The Company may also find it necessary, from time to time, to require compliance with the pre-clearance process from others who may be in possession of Material Nonpublic Information.

 

6

 

 

4. Individual Responsibility.

 

Every person subject to this Policy has the individual responsibility to comply with this Policy against insider trading, regardless of whether the Company has established a Trading Window applicable to that Insider or any other Insiders of the Company. Each individual, and not necessarily the Company, is responsible for his or her own actions and will be individually responsible for the consequences of their actions. Therefore, appropriate judgment, diligence and caution should be exercised in connection with any trade in the Company’s securities. An Insider may, from time to time, have to forego a proposed transaction in the Company’s securities even if he or she planned to make the transaction before learning of the Material Nonpublic Information and even though the Insider believes he or she may suffer an economic loss or forego anticipated profit by waiting.

 

5. Exceptions to the Policy.

 

Any exceptions to this Policy may only be made by advance written approval of each of: (i) the Company’s Chief Executive Officer, (ii) the Insider Trading Compliance Officer and (iii) the Chairman of the Audit Committee of the Board. Any such exceptions shall be immediately reported to the remaining members of the Board.

 

APPLICABILITY OF POLICY TO MATERIAL NONPUBLIC INFORMATION

REGARDING OTHER COMPANIES

 

This Policy and the guidelines described herein also apply to Material Nonpublic Information relating to other companies, including the Company’s customers, vendors or suppliers (“business partners”), when that information is obtained in the course of employment with, or other services performed on behalf of the Company. Civil and criminal penalties, as well as termination of employment, may result from trading on Material Nonpublic Information regarding the Company’s business partners. All Insiders should treat Material Nonpublic Information about the Company’s business partners with the same care as is required with respect to information relating directly to the Company.

 

PROHIBITION AGAINST BUYING AND SELLING

COMPANY COMMON STOCK WITHIN A SIX-MONTH PERIOD

Directors, Officers and 10% Stockholders

 

Purchases and sales (or sales and purchases) of Company common stock occurring within any six-month period in which a mathematical profit is realized result in illegal “short-swing profits.” The prohibition against short-swing profits is found in Section 16 of the Exchange Act. Section 16 was drafted as a rather arbitrary prohibition against profitable “insider trading” in a company’s securities within any six-month period regardless of the presence or absence of material nonpublic information that may affect the market price of those securities. Each executive officer, director and 10% stockholder of the Company is subject to the prohibition against short-swing profits under Section 16. Such persons are required to file Forms 3, 4 and 5 reports reporting his or her initial ownership of the Company’s common stock and any subsequent changes in such ownership. The Sarbanes-Oxley Act of 2002 requires executive officers and directors who must report transactions on a Form 4 to do so by the end of the second business day following the transaction date. Profit realized, for the purposes of Section 16, is calculated generally to provide maximum recovery by the Company. The measure of damages is the profit computed from any purchase and sale or any sale and purchase within the short-swing (i.e., six-month) period, without regard to any setoffs for losses, any first-in or first-out rules, or the identity of the shares of common stock. This approach sometimes has been called the “lowest price in, highest price out” rule.

 

7

 

 

In order to avoid trading activity that could inadvertently trigger a short-swing profit, it is the Company’s policy that no executive officer, director and 10% shareholder of the Company who has a 10b5-1 Plan in place may engage in voluntary purchases or sales of Company securities outside of and while such 10b5-1 Plan remains in place.

 

INQUIRIES

 

Please direct your questions as to any of the matters discussed in this Policy to the Company’s Insider Trading Compliance Officer or legal counsel.

 

8

 

 

 

 

 

 EX-23.1 3 innovativeeye_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

CONSENT OF REGISTERED INDEPENDENT PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statement of Innovative Eyewear, Inc. (the “Company”) on Form S-8 (File No. 333-267677) and Form S-1 (File No. 333-261616), of our report dated March 23, 2023 with respect to our audit of the financial statements of the Company as of December 31, 2022 and 2021, and for each of the years then ended, which report is included in this Annual Report on Form 10-K of the Company for the year ended December 31, 2022.

 

/s/ Cherry Bekaert LLP

 

 

Tampa, Florida

March 23, 2023

 

 

 EX-31.1 4 innovativeeye_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Harrison Gross, Chief Executive Officer of Innovative Eyewear, Inc., certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Innovative Eyewear, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 24, 2023 /s/ Harrison Gross
  Harrison Gross
  Chief Executive Officer

 

 

 EX-31.2 5 innovativeeye_ex31-2.htm EXHIBIT 31.2

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Konrad Dabrowski, Chief Financial Officer of Innovative Eyewear, Inc., certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Innovative Eyewear, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 24, 2023 /s/ Konrad Dabrowski
  Konrad Dabrowski
  Chief Financial Officer

 

 

 EX-32.1 6 innovativeeye_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, Harrison Gross, Chief Executive Officer of Innovative Eyewear, Inc. (the “Company”), hereby certifies that:

 

1. The Company’s Form 10-K Annual Report for the fiscal year ended December 31, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
   
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 24, 2023 /s/ Harrison Gross
  Harrison Gross
  Chief Executive Officer

 

 

 EX-32.2 7 innovativeeye_ex32-2.htm EXHIBIT 32.2

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, Konrad Dabrowski, Chief Financial Officer of Innovative Eyewear, Inc. (the “Company”), hereby certifies that:

 

1. The Company’s Form 10-K Annual Report for the fiscal year ended December 31, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
   
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 24, 2023 /s/ Konrad Dabrowski
  Konrad Dabrowski
  Chief Financial Officer

 

 

 EX-101.CAL 8 lucy-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 lucy-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 10 lucy-20221231_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, $0.00001 par value Warrants to purchase Common Stock Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Stock Subscription Receivable [Member] Retained Earnings [Member] Long-Lived Tangible Asset [Axis] Mobile Kiosk Display [Member] Computer Equipment [Member] Office Equipment [Member] Internal Use Software [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Finite-Lived Intangible Assets by Major Class [Axis] Patents [Member] Related Party [Axis] Parent And Affiliates [Member] Sale of Stock [Axis] IPO [Member] Lucyd [Member] Tekcapital Europe Ltd [Member] Maxim [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Auditor Name Auditor Location Auditor Firm ID Statement of Financial Position [Abstract] TOTAL ASSETS Current Assets Cash and cash equivalents Accounts receivable, net of allowance of $92,646 and $0, respectively Prepaid expenses Deferred offering costs Inventory prepayment Inventory Other current assets Total Current Assets Non-Current Assets Patent costs, net Capitalized software costs Property and equipment, net Other non-current assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities Current Liabilities Accounts payable and accrued expenses Deferred revenue Due to Parent and Affiliates Related party convertible debt Total Current Liabilities Non-Current Liabilities Deferred revenue TOTAL LIABILITIES Commitments and contingencies Stockholders’ Equity Common stock (par value $0.00001, 50,000,000 shares authorized, and 7,307,157 and 6,060,187 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively) Additional paid-in capital Stock subscription receivable Accumulated deficit TOTAL STOCKHOLDERS’ EQUITY TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Allowance Common stock, par value (in Dollars per share) Common stock, shares authorized Common stock, shares issued Common stock, shares Outstanding Income Statement [Abstract] Revenues, net Less: Cost of Goods Sold Gross (Deficit) Profit Operating Expenses: General and administrative Sales and marketing Research and development Related party management fee Total Operating Expenses Interest Expense Net Loss Weighted average number of shares outstanding Loss per share, basic and diluted Beginning balance, value Beginnig balance, shares Collection of stock subscription receivable Write-off of uncollectible stock subscription receivable Shares issued for conversion of related party convertible note Shares issued for conversion of related party convertible note, shares Issuance of shares, net of offering costs of $351,411 Issuance of shares, net of offering costs of $28,230, Shares Initial public offering (see Note 8) Initial public offering (see Note 10), shares Stock based compensation Net loss Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Operating Activities Net Loss Adjustments to reconcile net loss to net cash used in operating activities: Amortization Depreciation Non cash interest expense Stock based compensation expense Expenses paid by parent and affiliates Provision for doubtful accounts Changes in operating assets and liabilities: Accounts receivable Accounts payable and accrued expenses Prepaid expenses Inventory Other current assets Contract assets and liabilities Net cash flows from operating activities Investing Activities Patent costs Purchases of property and equipment Capitalized software expenditures Net cash flows from investing activities Financing Activities Proceeds from initial public offering (see Note 8) Proceeds from issuance of shares, net of offering costs Payment of deferred offering cost Collection of stock subscription receivable Proceeds from related party convertible debt Repayment of related party convertible debt Net cash flows from financing activities Net Change In Cash Cash at Beginning of Year Cash at End of Year Significant Non-Cash Transaction Expenses paid for by Parent reported as increase in Due to Parent and Affiliates and related party convertible debt Write-off of uncollectible stock subscription receivable Organization, Consolidation and Presentation of Financial Statements [Abstract] GENERAL INFORMATION Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES GOING CONCERN Income Tax Disclosure [Abstract] INCOME TAX PROVISION Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Equity [Abstract] STOCKHOLDERS’ EQUITY STOCK BASED COMPENSATION Earnings Per Share [Abstract] EARNINGS PER SHARE Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Use of Estimates Receivables and Credit Policy Capitalized Software Inventory Intangible Assets Property and Equipment Income Taxes Fair Value of Financial Instruments Concentrations of Credit Risk Stock-Based Compensation Revenue Recognition Shipping and Handling Recent Accounting Pronouncements Subsequent Events Schedule of estimated useful lives of property and equipment Schedule of reconciliation of federal statutory tax rate Schedule of deferred tax assets Schedule of intangible assets Schedule of future minimum payments due Schedule fair value of options granted Schedule of number of share options and the weighted average exercise price outstanding Calculation of net earnings per common share - basic and diluted Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, gross Property, Plant and Equipment, Useful Life Less: Accumulated depreciation Bad debt expenses Depreciation expense Allowance for sales returns Income tax benefit at the statutory federal rate State income tax benefits, net of federal benefit Change in valuation allowance Total Deferred tax assets: Stock-based compensation Other – net Net operating losses – federal Net operating losses – state  Deferred tax assets Gross Less Valuation Allowance Net deferred tax assets Federal net operating loss carryforwards State net operating loss carryforwards Liabilities for uncertain tax positions Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Intangible assets, gross Less: Accumulated amortization Intangible assets, net Amortization expense Future amortization Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Convertible notes balances Convertible debt issued Interest rate Conversion of stock, amount Number of shares converted Conversion Price Management fee Rent expenses 2023 2024 2025 2026 2027 Thereafter (through 2032) Total Base term Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary, Sale of Stock [Line Items] Preferred stock , shares authorized Preferred stock , shares issued Preferred stock, shares Outstanding Issauance of common stock Number of warrants purchased Share Price Proceeds from offering Underwriters description Exercise price Share price at date of grant Options life in years Risk free rate Expected volatility Expected dividend yield Grant date fair value of options Av. Exercise price per share, Option Outstanding at beginnig Option Outstanding at beginnig Av. Exercise price per share, Option Granted Option Granted Av. Exercise price per share, Option Exercised Option Exercised Av. Exercise price per share, Option Forfeited Option Forfeited Av. Exercise price per share, Option Outstanding at ending Option Outstanding at ending Av. Exercise price per share, Option Exercisable Option Exercisable Available for the grant Stock granted Weighted average grant date fair value of options outstanding Weighted average remaining contractual life of options outstanding Weighted average remaining contractual life of options exercisable Unrecognized stock compensation expense Unrecognized stock compensation expense, term Basic and diluted: Net loss Weighted-average number of common shares Basic and diluted net loss per common share Subsequent Event [Table] Subsequent Event [Line Items] Number of warrant exercised Cash proceeds Assets, Current Assets Liabilities, Current Deferred Revenue, Noncurrent Liabilities [Default Label] Stockholders' Equity Note, Subscriptions Receivable Stockholders' Equity Attributable to Parent Liabilities and Equity Cost of Revenue Gross Profit General and Administrative Expense Selling and Marketing Expense Research and Development Expense Operating Expenses Interest Expense Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Prepaid Expense Increase (Decrease) in Inventories Increase (Decrease) in Other Current Assets ContractAssetsAndLiabilities Net Cash Provided by (Used in) Operating Activities PaymentToAcquirePatentCosts Payments to Acquire Property, Plant, and Equipment Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities PaymentOfDeferredOfferingCost CollectionOfStockSubscriptionReceivable Repayments of Convertible Debt Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents WriteoffOfUncollectibleStockSubscriptionReceivables Inventory, Policy [Policy Text Block] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Income Tax Expense (Benefit) Deferred Tax Assets, Valuation Allowance Lessee, Operating Lease, Liability, to be Paid Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number EX-101.PRE 11 lucy-20221231_pre.xml XBRL PRESENTATION FILE EX-101.SCH 12 lucy-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - GENERAL INFORMATION link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - INCOME TAX PROVISION link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - STOCK BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - INCOME TAX PROVISION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - STOCK BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - INCOME TAX PROVISION (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - INCOME TAX PROVISION (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - INCOME TAX PROVISION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - STOCK BASED COMPENSATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - STOCK BASED COMPENSATION (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - STOCK BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink GRAPHIC 13 img_001.jpg GRAPHIC begin 644 img_001.jpg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htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2022
Mar. 17, 2023
Jun. 30, 2022
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --12-31    
Entity File Number 001-41392    
Entity Registrant Name INNOVATIVE EYEWEAR, INC.    
Entity Central Index Key 0001808377    
Entity Tax Identification Number 84-2794274    
Entity Incorporation, State or Country Code FL    
Entity Address, Address Line One 11900 Biscayne Blvd.    
Entity Address, Address Line Two Suite 630    
Entity Address, City or Town North Miami    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 33181    
City Area Code (954)    
Local Phone Number 826-0329    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 0
Entity Common Stock, Shares Outstanding   7,715,757  
Documents Incorporated by Reference [Text Block] NONE    
ICFR Auditor Attestation Flag false    
Auditor Name Cherry Bekaert LLP    
Auditor Location Tampa, Florida    
Auditor Firm ID 677    
Common Stock, $0.00001 par value      
Title of 12(b) Security Common Stock, $0.00001 par value    
Trading Symbol LUCY    
Security Exchange Name NASDAQ    
Warrants to purchase Common Stock      
Title of 12(b) Security Warrants to purchase Common Stock    
Trading Symbol LUCYW    
Security Exchange Name NASDAQ    
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.1
BALANCE SHEETS - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 3,591,109 $ 79,727
Accounts receivable, net of allowance of $92,646 and $0, respectively 110,258 43,394
Prepaid expenses 210,673 68,381
Deferred offering costs 111,149
Inventory prepayment 197,750 64,715
Inventory 94,701 275,501
Other current assets 36,240 1,460
Total Current Assets 4,240,731 644,327
Non-Current Assets    
Patent costs, net 137,557 87,306
Capitalized software costs 110,073 72,400
Property and equipment, net 119,744 20,284
Other non-current assets 81,779
TOTAL ASSETS 4,689,884 824,317
Current Liabilities    
Accounts payable and accrued expenses 275,660 167,050
Deferred revenue 30,000
Due to Parent and Affiliates 232,989 160,722
Related party convertible debt 61,356 289,029
Total Current Liabilities 600,005 616,801
Non-Current Liabilities    
Deferred revenue 65,450
TOTAL LIABILITIES 665,455 616,801
Commitments and contingencies
Stockholders’ Equity    
Common stock (par value $0.00001, 50,000,000 shares authorized, and 7,307,157 and 6,060,187 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively) 73 60
Additional paid-in capital 14,330,343 4,842,836
Stock subscription receivable (11,226)
Accumulated deficit (10,305,987) (4,624,154)
TOTAL STOCKHOLDERS’ EQUITY 4,024,429 207,516
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 4,689,884 $ 824,317
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.23.1
BALANCE SHEETS (Parenthetical) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Allowance $ 92,646 $ 0
Common stock, par value (in Dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized 50,000,000 50,000,000
Common stock, shares issued 7,307,157 6,060,187
Common stock, shares Outstanding 7,307,157 6,060,187
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.1
STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Revenues, net $ 659,788 $ 690,670
Less: Cost of Goods Sold (716,077) (542,416)
Gross (Deficit) Profit (56,289) 148,254
Operating Expenses:    
General and administrative (2,796,669) (1,386,079)
Sales and marketing (2,059,012) (1,771,012)
Research and development (524,692) (86,261)
Related party management fee (140,000) (109,975)
Total Operating Expenses (5,520,373) (3,353,327)
Interest Expense (105,171) (39,433)
Net Loss $ (5,681,833) $ (3,244,506)
Weighted average number of shares outstanding 6,528,959 5,245,622
Loss per share, basic and diluted $ (0.87) $ (0.62)
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.1
STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Stock Subscription Receivable [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 41 $ 845,417 $ (20,647) $ (1,379,648) $ (554,837)
Beginnig balance, shares at Dec. 31, 2020 4,131,469        
Collection of stock subscription receivable 54,184 54,184
Shares issued for conversion of related party convertible note $ 12 2,179,760 2,179,772
Shares issued for conversion of related party convertible note, shares 1,172,115        
Issuance of shares, net of offering costs of $351,411 $ 7 482,724 (44,763) 437,968
Issuance of shares, net of offering costs of $28,230, Shares 756,603        
Stock based compensation 1,334,935 1,334,935
Net loss (3,244,506) (3,244,506)
Ending balance, value at Dec. 31, 2021 $ 60 4,842,836 (11,226) (4,624,154) 207,516
Ending balance, shares at Dec. 31, 2021 6,060,187        
Collection of stock subscription receivable   6,684 6,684
Write-off of uncollectible stock subscription receivable (4,542) 4,542
Shares issued for conversion of related party convertible note $ 3 2,002,277 2,002,280
Shares issued for conversion of related party convertible note, shares 266,970        
Initial public offering (see Note 8) $ 10 6,015,908 6,015,918
Initial public offering (see Note 10), shares 980,000        
Stock based compensation 1,473,864 1,473,864
Net loss (5,681,833) (5,681,833)
Ending balance, value at Dec. 31, 2022 $ 73 $ 14,330,343 $ (10,305,987) $ 4,024,429
Ending balance, shares at Dec. 31, 2022 7,307,157        
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.1
STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating Activities    
Net Loss $ (5,681,833) $ (3,244,506)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization 10,466 7,179
Depreciation 22,101 498
Non cash interest expense 105,171 1,251
Stock based compensation expense 1,473,864 1,334,935
Expenses paid by parent and affiliates 960,362 867,618
Provision for doubtful accounts 116,230 (0)
Changes in operating assets and liabilities:    
Accounts receivable (183,094) (43,394)
Accounts payable and accrued expenses 67,951 157,536
Prepaid expenses (142,292) (43,381)
Inventory 47,765 (250,436)
Other current assets 1,460 (1,460)
Contract assets and liabilities (22,569)
Net cash flows from operating activities (3,224,418) (1,214,160)
Investing Activities    
Patent costs (60,717) (25,272)
Purchases of property and equipment (121,561) (20,782)
Capitalized software expenditures (37,673) (72,400)
Net cash flows from investing activities (219,951) (118,454)
Financing Activities    
Proceeds from initial public offering (see Note 8) 6,127,067
Proceeds from issuance of shares, net of offering costs 492,152
Payment of deferred offering cost (111,149)
Collection of stock subscription receivable 6,684
Proceeds from related party convertible debt 1,475,000 1,061,500
Repayment of related party convertible debt (653,000) (57,185)
Net cash flows from financing activities 6,955,751 1,385,318
Net Change In Cash 3,511,382 52,704
Cash at Beginning of Year 79,727 27,023
Cash at End of Year 3,591,109 79,727
Significant Non-Cash Transaction    
Expenses paid for by Parent reported as increase in Due to Parent and Affiliates and related party convertible debt 960,362 867,618
Write-off of uncollectible stock subscription receivable $ (4,542)
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
GENERAL INFORMATION
 12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GENERAL INFORMATION

NOTE 1 – GENERAL INFORMATION

 

Innovative Eyewear, Inc. (the “Company,” “us,” “we,” or “our”) is a corporation organized under the laws of the State of Florida that develops and sells cutting-edge eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The Company was founded by Lucyd Ltd. (the “Parent” or “Lucyd”), a portfolio company of Tekcapital Plc through Tekcapital Europe, Ltd. (collectively, the “Parent and Affiliates”), which owned approximately 71% of our issued and outstanding shares of common stock as of December 31, 2022. Innovative Eyewear licensed the exclusive rights to the Lucyd® brand from Lucyd Ltd., which includes the exclusive use of all of Lucyd’s intellectual property, including our main product, Lucyd Lyte® glasses.

 
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and in accordance with the accounting rules under Regulation S-X, as promulgated by the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statements for the years presented have been included. The results of operations for the years ended December 31, 2022 and 2021 are not necessarily indicative of the results to be expected for future periods.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant economic disruptions and uncertainties associated with the ongoing economic environment, including potential supply chain constraints.

 

Receivables and Credit Policy

 

Trade receivables from customers are uncollateralized customer obligations due under normal trade terms. For direct-to-consumer sales, payment is required before product is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice. The Company, by policy, routinely assesses the financial strength of its customers. To comply with industry standards, we offer “net 30” payments on wholesale orders of $1,500 or more. For wholesale orders, to acquire an order on net 30 terms, the customer is provided a credit check application as well as a credit card authorization form. The authorization form explicitly states when and for much we will bill the customer via credit card.

 

Accounts receivable are reported net of the allowance for doubtful accounts. The allowance for doubtful accounts is based on the Company’s evaluation of each customer’s payment history, account aging, and financial position. The Company recognized bad debt expense of $116,230 for the year ended December 31, 2022, and no bad debt expense for the year ended December 31, 2021.

 

Capitalized Software

 

The Company incurred software development costs related to development of the Vyrb app. The Company capitalized these costs in accordance with ASC 985-20, “Software – Costs of Software to be Sold, Leased, or Marketed,” considering it is the Company’s intention to market and sell the software externally. Planning, designing, coding, and testing occurred necessary to meet Vyrb’s design specifications. As such, all coding, development, and testing costs incurred subsequent to establishing technical feasibility were capitalized. We have launched a beta version of the Vyrb application in December 2021 that demonstrates the functionality of the software. We expect an estimated useful life of five years for this product.

 

Inventory

 

Our inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. No provisions were determined as needed as of December 31, 2022 and 2021.

 

As of December 31, 2022 and 2021, the Company recorded an inventory prepayment in the amount of $197,750 and $64,715, respectively, related to down payment on eyewear purchased from the manufacturer, prior to shipment of the product that occurred after December 31, 2022 and 2021, respectively.

 

Intangible Assets

 

Intangible assets relate to patent costs received in conjunction with the initial capitalization of the Company and internally developed utility and design patents. The Company amortizes these assets over the estimated useful life of the patents. The Company reviews its intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.

 

Property and Equipment

 

Property and equipment are depreciated using the straight-line method over the estimated useful lives or lease terms if shorter. Depreciation expense for the years ended December 31, 2022 and 2021 was approximately $22,100 and $500, respectively. For income tax purposes, accelerated depreciation methods are generally used. Repair and maintenance costs are expensed as incurred.

 

             
   As of
December 31,		   Estimated Useful Lives
Property & Equipment  2022   2021   (in Years)
Mobile Kiosk Display  $63,395   $18,120   3 years
Computer Equipment   44,901    2,662   3 Years
Office Equipment   17,273    -   3 Years
Internal-Use Software   16,775    -   3 to 5 Years
Property and equipment, gross   142,343    20,782    
Less: Accumulated depreciation   (22,599)   (498)   
Property and equipment, net  $119,744   $20,284    

 

Income Taxes

 

The Company accounts for income taxes under an asset and liability approach that recognizes deferred tax assets and liabilities based on the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.

 

The Company follows a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return. Any interest and penalties accrued related to uncertain tax positions are recorded in tax expense.

 

The Company assesses the realizability of its net deferred tax assets on an annual basis. If, after considering all relevant positive and negative evidence, it is more likely than not that some portion or all of the net deferred tax assets will not be realized, the Company will reduce the net deferred tax assets by a valuation allowance. The realization of net deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of net operating loss carryforwards.

 

Fair Value of Financial Instruments

 

For certain of the Company’s financial instruments, including cash, accounts receivable, accounts payable, and cash advances provided by the Parent and Affiliates, the carrying amounts approximate fair value due to the short-term maturities of these instruments. The carrying value of the convertible note approximates fair value because the interest rate approximates market rates.

 

Concentrations of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and accounts receivable. The Company limits its credit risk with respect to cash by maintaining cash balances with high quality financial institutions. At times, the Company’s cash balances may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are considered minimal due to collection history.

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation to employees and directors in accordance with FASB ASC Topic 718, which requires that compensation expense be recognized in the financial statements for stock-based awards based on the grant date fair value. For stock option awards, the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility. The expected term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).

 

The share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies. The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.

 

The fair value of common stock used in the option pricing model for stock-based awards granted in 2021 was determined using the most recent price paid by independent investors through a Regulation Crowdfunding (“CF”) securities offering undertaken by the Company. For the majority of time during which stock option awards were granted by the Company in 2021, the Company had been raising funds from investors under Regulation CF campaigns, with a significant number of transactions from both accredited and non-accredited investors.

 

Revenue Recognition

 

Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.

 

To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract and determine those that are performance obligations, and also assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In instances where the collectibility of contractual consideration is not probable at the time of sale, the revenue is deferred on our balance sheet as a contract liability, and the associated cost of goods sold is deferred on our balance sheet as a contract asset; subsequently, we recognize such revenue and cost of goods sold as payments are received.

 

All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.

 

For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.

 

For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation, which is delivery of the Company’s eyewear products to the retail store and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to the retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.

 

For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order and after collectibility of substantially all of the contract consideration is probable. Our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale distributor orders, no e-commerce fees are applicable.

 

The Company’s sales do not contain any variable consideration.

 

We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason within the first:

 

  ● 7 days for sales made through our website (Lucyd.co)

 

  ● 30 days for sales made through Amazon

 

  ● 30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns)

 

For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we review all individual returns received in the month following the balance sheet date pertaining to orders processed prior to the balance sheet date in order to determine whether an allowance for sales returns is necessary. The Company recorded an allowance for sales returns of $24,897 and $22,266 as of December 31, 2022 and 2021, respectively.

 

Shipping and Handling

 

Costs incurred for shipping and handling are included in cost of revenue at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.

 

Recent Accounting Pronouncements

 

In February 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, “Leases (Topic 842),” that requires organizations that lease assets, referred to as “lessees,” to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases with lease terms of more than 12 months. ASU 2016-02 also requires disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases and will include qualitative and quantitative requirements. The Company adopted ASU 2016-02 as of January 1, 2021. The Company’s management determined that the adoption of this guidance had no material impact on the Company’s financial statements due to the lack of long-term leasing arrangements.

 

In May 2018, the FASB issued ASU 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic 470-20), and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contract’s in Entity’s Own Equity.” The guidance in ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the previous guidance related to debt with conversion and other options that required entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. In addition, the amendments revised the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification. The amendments in ASU 2020-06 further revised the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. The Company adopted ASU 2020-06 as of January 1, 2021. The Company’s management determined that the adoption of this guidance had no material impact on the Company’s financial statements due to the lack of beneficial conversion features contained within the Company’s debt.

 

Subsequent Events

 

In connection with the preparation of these financial statements, the Company has evaluated subsequent events through March 24, 2023, which is the date the financial statements were available to be issued.

 
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.23.1
GOING CONCERN
 12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN

NOTE 3 – GOING CONCERN

 

The Company has a limited operating history. The Company’s business and operations are sensitive to general business and economic conditions in the United States. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverse conditions may include recession, downturn, or otherwise, changes in regulations or restrictions in imports, competition, or changes in consumer taste including the economic impacts from the COVID-19 pandemic. These adverse conditions could affect the Company’s financial condition and the results of its operations.

 

The Company meets its day to day working capital requirements through monies raised through sales of eyewear and issuances of equity, including past crowdfunding transactions, and more recently an initial public offering completed in August 2022. The Company also has issued a convertible note held by its parent company. The Company’s forecasts and projections indicate that the Company expects to have sufficient cash reserves and future income to operate within the level of its current facilities. The Company anticipates that its available liquidity will be sufficient to fund operations through at least the end of March 2024.

 
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAX PROVISION
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
INCOME TAX PROVISION

NOTE 4 – INCOME TAX PROVISION

 

The following is a reconciliation of tax computed at the statutory federal rate to the income tax benefit in the statements of operations:

 

          
   2022   2021 
Income tax benefit at the statutory federal rate  $1,193,185   $681,346 
State income tax benefits, net of federal benefit   35,149    110,647 
Change in valuation allowance   (1,228,334)   (791,993)
Total  $-    - 

 

The components of the Company’s deferred tax assets are as follows:

 

          
   2022   2021 
Deferred tax assets:          
Stock-based compensation  $610,530   $359,032 
Other – net   122,133    6,757 
Net operating losses – federal   1,346,823    534,771 
Net operating losses – state   81,911    110,647 
 Deferred tax assets Gross   2,161,397    1,011,207 
Less Valuation Allowance   (2,161,397)   (1,011,207)
Net deferred tax assets  $-   $- 

 

Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities. Deferred tax assets or liabilities at the end of each period are determined using the tax rate expected to be in effect when taxes are actually paid or recovered.

 

A valuation allowance is established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. A review of all available positive and negative evidence needs to be considered, including a company’s current and past performance, the market environment in which the company operates, length of carryback and carryforward periods, and existing contracts that will result in future profits. After reviewing all the evidence, the Company has recorded a full valuation allowance against its deferred tax assets.

 

At December 31, 2022, the Company had federal net operating loss carryforwards of $6,413,441 and state net operating loss carryforwards of $3,653,332, both of which do not expire.

 

The Company files Federal and Florida tax returns. The years that remain subject to examination are the years ended December 31, 2020, 2021, and 2022. As of December 31, 2022 and 2021, the Company does not believe that is has any liabilities for uncertain tax positions.

 
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS

NOTE 5 – INTANGIBLE ASSETS

 

          
   December 31,   December 31, 
Finite-lived intangible assets  2022   2021 
Patent Costs  $156,196   $95,480 
Intangible assets, gross   156,196    95,480 
           
Less: Accumulated amortization   (18,639)   (8,174)
Intangible assets, net  $137,557   $87,306 

 

Amortization expense totalled approximately $10,500 and $7,200 for the years ended December 31, 2022 and 2021, respectively. Future amortization is expected to approximate $11,500 per year.

 
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS
 12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 6 – RELATED PARTY TRANSACTIONS

 

Convertible Note and Due to Parent and Affiliates

 

During the years ended December 31, 2022 and 2021, the Company had the availability of, but not the contractual right to, intercompany financing from the Parent and Affiliates in the form of either cash advances or borrowings under a convertible note (as discussed below). The convertible notes balances were $61,356 and $289,029 as of December 31, 2022 and 2021, respectively.

 

On December 1, 2020, the Company issued a convertible note to its Parent and Affiliates for up to $2,000,000 that bears interest at 10% per annum, which includes the option to convert the debt into the Company’s common stock at market price. The note can be converted into shares of common stock of the Company upon occurrence of certain conversion events, as defined.

 

On June 1, 2021, the Company converted related party borrowings totalling $778,500 into 778,500 shares of common stock at $1.00 each.

 

On September 5, 2021, the Company converted related party borrowings totalling $500,002 into 140,449 shares of common stock at $3.56 each.

 

On November 1, 2021, the Company amended and restated its December 1, 2020, convertible note agreement with Parent and Affiliates, increasing the amount of available financing from $2,000,000 to $3,000,000.

 

On November 16, 2021, the Company converted related party borrowings totalling $901,271 into 253,166 shares of common stock at $3.56 per share.

 

On August 15, 2022, in connection with the Company’s initial public offering (see Note 8), the Company converted related party borrowings totalling $2,002,280 into 266,970 shares of common stock at $7.50 per share.

 

Management Service Agreement

 

In 2020, the Company entered into a management services agreement with a related party (related through common ownership), for which the Company was billed $25,000 quarterly. Effective February 1, 2022, the original management services agreement was amended to have the Company billed at $35,000 quarterly. While the agreement does not stipulate a specific maturity date, it can be terminated with 30 calendar days written notice by any party.

 

The related party provides the following services:

 

  ● Support and advice to the Company in accordance with their area of expertise;

 

  ● Research, technical review, legal review, recruitment, software development, marketing, public relations, and advertisement; and

 

  ● Advice, assistance, and consultation services to support the Company or in relation to any other related matter.

 

During the years ended December 31, 2022 and 2021, the Company incurred $140,000 and $100,000, respectively, under its management services agreement with Tekcapital Europe Ltd.

 

Rent of Office Space

 

Prior to the February 1, 2022 amendment of the aforementioned management services agreement, the Company was provided with rent-free office space by the Parent and Affiliates. Effective February 1, 2022, Tekcapital began to bill the Company for an allocation of rent paid by Tekcapital on the Company’s behalf. The Company recognized $74,442 of expense related to this arrangement for the year ended December 31, 2022.

 
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 7 – COMMITMENTS AND CONTINGENCIES

 

Legal Matters

 

We are not the subject of any material pending legal proceedings, however, may from time to time become a party to various legal proceedings arising in the ordinary course of business.

 

Leases

 

Our executive offices are located at 11900 Biscayne Blvd., Suite 630 Miami, Florida 33181. Our executive offices are provided to us by the parent of our majority stockholder, Tekcapital (see Note 6). We consider our current office space adequate for our current operations.

 

License Agreements

 

During the year ended December 31, 2022, the Company entered into license agreements which grant the Company the right to sell certain branded smart eyewear. These agreements require the Company to pay royalties based on a percentage of net retail and wholesale sales, and also require guaranteed minimum royalty payments. The agreements have base terms of 10 years but are cancellable at the option of the Company during the fifth year.

 

The aggregate future minimum payments due under these license agreements are as follows:

 

     
2023  $36,750 
2024   161,210 
2025   356,000 
2026   654,000 
2027   930,000 
Thereafter (through 2032)   7,200,000 
Total  $9,337,960 

 

Other Commitments

 

See related party management services agreement discussed in Note 6.

 
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 8 – STOCKHOLDERS’ EQUITY

 

Pursuant to a corporate resolution on July 1, 2021, the Company has authority to issue up to 15,000,000 shares of preferred stock and 50,000,000 shares of common stock. There were no shares of preferred stock issued or outstanding as of December 31, 2022 and 2021.

 

Initial Public Offering

 

On August 17, 2022, the Company closed on its initial public offering of 980,000 units consisting of 980,000 shares of its common stock and 1,960,000 warrants to purchase 1,960,000 shares of common stock at a combined offering price of $7.50 per unit in exchange for gross proceeds of approximately $7.35 million, before deducting underwriting discounts and offering expenses. Each share of common stock was sold together with two warrants. Each warrant is exercisable to purchase one share of common stock at an initial exercise price of $7.50 per share, subject to certain adjustments as set forth in the warrant agreement. In addition, the Company granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or warrants to purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which the Underwriter exercised its option to purchase additional warrants to purchase 294,000 shares of common stock concurrently with the closing.

 

The shares of common stock and warrants began trading on The Nasdaq Capital Market on August 15, 2022, under the symbols “LUCY” and “LUCYW,” respectively.

 

Also, pursuant to the terms of the underwriting agreement for the offering, the Company issued by the Underwriter certain other warrants to purchase up to 58,800 shares of the Company’s common stock at an exercise price of $8.228 per share.

 

The net proceeds received by the Company amounted to $6,189,734.

 

As of December 31, 2022, none of the aforementioned warrants had been exercised.

 
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK BASED COMPENSATION
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
STOCK BASED COMPENSATION

NOTE 9 – STOCK BASED COMPENSATION

 

On July 1, 2021, an Equity Incentive Plan was approved, allowing for total of 20% of our issued and outstanding common stock immediately after the consummation of the initial public offering, less the number of outstanding option grants, or 1,124,043, of total issued shares to be available for the grant of awards under the Plan. 1,685,000 option awards were granted by the Company prior to the approval of the Plan, while 647,500 option awards were granted subject to the Plan.

 

During the year ended December 31, 2021, the Company, granted 1,687,500 option awards, of which 1,347,500 vest rateably over time and 340,000 vest based on certain performance conditions. There were no option awards granted during the year ended December 31, 2022.

 

The fair value of options granted is calculated using the Black-Scholes-Merton option pricing model. The underlying assumptions used in the option pricing model for stock option awards granted in 2021 were as follows:

 

    
Attribute    
Share price at date of grant  $1.00 - $5.00 
Options life in years  2 - 3 
Risk free rate  0.16% - 0.44% 
Expected volatility  121% - 151% 
Expected dividend yield  0 
Grant date fair value of options  $0.71 - $3.46 

 

The weighted average grant date fair value of options outstanding as of December 31, 2022 and 2021 was $1.84.

 

Details of the number of share options and the weighted average exercise price outstanding as of and during the years ended December 31, 2022 and 2021 are as follows:

 

           
    Av. Exercise     
    price per share   Options 
    $   (Number) 
As at January 1, 2021    1.00    645,000 
Granted    3.23    1,687,500 
Exercised    -    - 
Forfeited    -    - 
As at December 31, 2021    2.61    2,332,500 
Exercisable as at December 31, 2021    1.87    395,269 
            
As at January 1, 2022    2.61    2,332,500 
Granted    -    - 
Exercised    -    - 
Forfeited    -    - 
As at December 31, 2022    2.61    2,332,500 
Exercisable as at December 31, 2022    2.18    1,198,577 

 

As of December 31, 2022, the weighted average remaining contractual life of options was 1.68 years for outstanding options, and 1.79 years for exercisable options.

 

As of December 31, 2022, unrecognized stock option expense of $1,409,958 remains to be recognized over next 1.41 years.

 
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS PER SHARE
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
EARNINGS PER SHARE

NOTE 10 – EARNINGS PER SHARE

 

The Company calculates earnings/(loss) per share data by calculating the quotient of earnings/(loss) divided by the weighted average number of common shares outstanding during the respective period as required by ASC 260-10-50. Due to the net losses for the years ended December 31, 2022 and 2021, all shares underlying the related party convertible debt, common stock warrants, and common stock options were excluded from the earnings per share calculation due to their anti-dilutive effect.

 

Calculation of net earnings per common share — basic and diluted:

 

          
   For the
year ended		 
   December 31,
2022		   December 31,
2021		 
Basic and diluted:          
Net loss   (5,681,833)   (3,244,506)
Weighted-average number of common shares   6,528,959    5,245,622 
Basic and diluted net loss per common share  $(0.87)  $(0.62)

 
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS
 12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 11 – SUBSEQUENT EVENTS

 

In February 2023, holders of the Company’s warrants (see Note 8) exercised warrants to purchase an aggregate of 408,600 shares of the Company’s common stock, at an adjusted exercise price of $3.75 per share, resulting in cash proceeds to the Company of $1,532,250.
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and in accordance with the accounting rules under Regulation S-X, as promulgated by the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statements for the years presented have been included. The results of operations for the years ended December 31, 2022 and 2021 are not necessarily indicative of the results to be expected for future periods.

 
Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant economic disruptions and uncertainties associated with the ongoing economic environment, including potential supply chain constraints.

 
Receivables and Credit Policy

Receivables and Credit Policy

 

Trade receivables from customers are uncollateralized customer obligations due under normal trade terms. For direct-to-consumer sales, payment is required before product is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice. The Company, by policy, routinely assesses the financial strength of its customers. To comply with industry standards, we offer “net 30” payments on wholesale orders of $1,500 or more. For wholesale orders, to acquire an order on net 30 terms, the customer is provided a credit check application as well as a credit card authorization form. The authorization form explicitly states when and for much we will bill the customer via credit card.

 

Accounts receivable are reported net of the allowance for doubtful accounts. The allowance for doubtful accounts is based on the Company’s evaluation of each customer’s payment history, account aging, and financial position. The Company recognized bad debt expense of $116,230 for the year ended December 31, 2022, and no bad debt expense for the year ended December 31, 2021.

 
Capitalized Software

Capitalized Software

 

The Company incurred software development costs related to development of the Vyrb app. The Company capitalized these costs in accordance with ASC 985-20, “Software – Costs of Software to be Sold, Leased, or Marketed,” considering it is the Company’s intention to market and sell the software externally. Planning, designing, coding, and testing occurred necessary to meet Vyrb’s design specifications. As such, all coding, development, and testing costs incurred subsequent to establishing technical feasibility were capitalized. We have launched a beta version of the Vyrb application in December 2021 that demonstrates the functionality of the software. We expect an estimated useful life of five years for this product.

 
Inventory

Inventory

 

Our inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. No provisions were determined as needed as of December 31, 2022 and 2021.

 

As of December 31, 2022 and 2021, the Company recorded an inventory prepayment in the amount of $197,750 and $64,715, respectively, related to down payment on eyewear purchased from the manufacturer, prior to shipment of the product that occurred after December 31, 2022 and 2021, respectively.

 
Intangible Assets

Intangible Assets

 

Intangible assets relate to patent costs received in conjunction with the initial capitalization of the Company and internally developed utility and design patents. The Company amortizes these assets over the estimated useful life of the patents. The Company reviews its intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.

 
Property and Equipment

Property and Equipment

 

Property and equipment are depreciated using the straight-line method over the estimated useful lives or lease terms if shorter. Depreciation expense for the years ended December 31, 2022 and 2021 was approximately $22,100 and $500, respectively. For income tax purposes, accelerated depreciation methods are generally used. Repair and maintenance costs are expensed as incurred.

 

             
   As of
December 31,		   Estimated Useful Lives
Property & Equipment  2022   2021   (in Years)
Mobile Kiosk Display  $63,395   $18,120   3 years
Computer Equipment   44,901    2,662   3 Years
Office Equipment   17,273    -   3 Years
Internal-Use Software   16,775    -   3 to 5 Years
Property and equipment, gross   142,343    20,782    
Less: Accumulated depreciation   (22,599)   (498)   
Property and equipment, net  $119,744   $20,284    

 
Income Taxes

Income Taxes

 

The Company accounts for income taxes under an asset and liability approach that recognizes deferred tax assets and liabilities based on the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.

 

The Company follows a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return. Any interest and penalties accrued related to uncertain tax positions are recorded in tax expense.

 

The Company assesses the realizability of its net deferred tax assets on an annual basis. If, after considering all relevant positive and negative evidence, it is more likely than not that some portion or all of the net deferred tax assets will not be realized, the Company will reduce the net deferred tax assets by a valuation allowance. The realization of net deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of net operating loss carryforwards.

 
Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

For certain of the Company’s financial instruments, including cash, accounts receivable, accounts payable, and cash advances provided by the Parent and Affiliates, the carrying amounts approximate fair value due to the short-term maturities of these instruments. The carrying value of the convertible note approximates fair value because the interest rate approximates market rates.

 
Concentrations of Credit Risk

Concentrations of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and accounts receivable. The Company limits its credit risk with respect to cash by maintaining cash balances with high quality financial institutions. At times, the Company’s cash balances may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are considered minimal due to collection history.

 
Stock-Based Compensation

Stock-Based Compensation

 

The Company accounts for stock-based compensation to employees and directors in accordance with FASB ASC Topic 718, which requires that compensation expense be recognized in the financial statements for stock-based awards based on the grant date fair value. For stock option awards, the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility. The expected term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).

 

The share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies. The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.

 

The fair value of common stock used in the option pricing model for stock-based awards granted in 2021 was determined using the most recent price paid by independent investors through a Regulation Crowdfunding (“CF”) securities offering undertaken by the Company. For the majority of time during which stock option awards were granted by the Company in 2021, the Company had been raising funds from investors under Regulation CF campaigns, with a significant number of transactions from both accredited and non-accredited investors.

 
Revenue Recognition

Revenue Recognition

 

Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.

 

To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract and determine those that are performance obligations, and also assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In instances where the collectibility of contractual consideration is not probable at the time of sale, the revenue is deferred on our balance sheet as a contract liability, and the associated cost of goods sold is deferred on our balance sheet as a contract asset; subsequently, we recognize such revenue and cost of goods sold as payments are received.

 

All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.

 

For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.

 

For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation, which is delivery of the Company’s eyewear products to the retail store and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to the retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.

 

For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order and after collectibility of substantially all of the contract consideration is probable. Our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale distributor orders, no e-commerce fees are applicable.

 

The Company’s sales do not contain any variable consideration.

 

We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason within the first:

 

  ● 7 days for sales made through our website (Lucyd.co)

 

  ● 30 days for sales made through Amazon

 

  ● 30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns)

 

For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we review all individual returns received in the month following the balance sheet date pertaining to orders processed prior to the balance sheet date in order to determine whether an allowance for sales returns is necessary. The Company recorded an allowance for sales returns of $24,897 and $22,266 as of December 31, 2022 and 2021, respectively.

 
Shipping and Handling

Shipping and Handling

 

Costs incurred for shipping and handling are included in cost of revenue at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.

 
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

In February 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, “Leases (Topic 842),” that requires organizations that lease assets, referred to as “lessees,” to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases with lease terms of more than 12 months. ASU 2016-02 also requires disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases and will include qualitative and quantitative requirements. The Company adopted ASU 2016-02 as of January 1, 2021. The Company’s management determined that the adoption of this guidance had no material impact on the Company’s financial statements due to the lack of long-term leasing arrangements.

 

In May 2018, the FASB issued ASU 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic 470-20), and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contract’s in Entity’s Own Equity.” The guidance in ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the previous guidance related to debt with conversion and other options that required entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. In addition, the amendments revised the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification. The amendments in ASU 2020-06 further revised the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. The Company adopted ASU 2020-06 as of January 1, 2021. The Company’s management determined that the adoption of this guidance had no material impact on the Company’s financial statements due to the lack of beneficial conversion features contained within the Company’s debt.

 
Subsequent Events

Subsequent Events

 

In connection with the preparation of these financial statements, the Company has evaluated subsequent events through March 24, 2023, which is the date the financial statements were available to be issued.

 
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of estimated useful lives of property and equipment
             
   As of
December 31,		   Estimated Useful Lives
Property & Equipment  2022   2021   (in Years)
Mobile Kiosk Display  $63,395   $18,120   3 years
Computer Equipment   44,901    2,662   3 Years
Office Equipment   17,273    -   3 Years
Internal-Use Software   16,775    -   3 to 5 Years
Property and equipment, gross   142,343    20,782    
Less: Accumulated depreciation   (22,599)   (498)   
Property and equipment, net  $119,744   $20,284    
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAX PROVISION (Tables)
 12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of reconciliation of federal statutory tax rate
          
   2022   2021 
Income tax benefit at the statutory federal rate  $1,193,185   $681,346 
State income tax benefits, net of federal benefit   35,149    110,647 
Change in valuation allowance   (1,228,334)   (791,993)
Total  $-    - 
Schedule of deferred tax assets
          
   2022   2021 
Deferred tax assets:          
Stock-based compensation  $610,530   $359,032 
Other – net   122,133    6,757 
Net operating losses – federal   1,346,823    534,771 
Net operating losses – state   81,911    110,647 
 Deferred tax assets Gross   2,161,397    1,011,207 
Less Valuation Allowance   (2,161,397)   (1,011,207)
Net deferred tax assets  $-   $- 
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of intangible assets
          
   December 31,   December 31, 
Finite-lived intangible assets  2022   2021 
Patent Costs  $156,196   $95,480 
Intangible assets, gross   156,196    95,480 
           
Less: Accumulated amortization   (18,639)   (8,174)
Intangible assets, net  $137,557   $87,306 
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES (Tables)
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Schedule of future minimum payments due
     
2023  $36,750 
2024   161,210 
2025   356,000 
2026   654,000 
2027   930,000 
Thereafter (through 2032)   7,200,000 
Total  $9,337,960 
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK BASED COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule fair value of options granted
    
Attribute    
Share price at date of grant  $1.00 - $5.00 
Options life in years  2 - 3 
Risk free rate  0.16% - 0.44% 
Expected volatility  121% - 151% 
Expected dividend yield  0 
Grant date fair value of options  $0.71 - $3.46 
Schedule of number of share options and the weighted average exercise price outstanding
           
    Av. Exercise     
    price per share   Options 
    $   (Number) 
As at January 1, 2021    1.00    645,000 
Granted    3.23    1,687,500 
Exercised    -    - 
Forfeited    -    - 
As at December 31, 2021    2.61    2,332,500 
Exercisable as at December 31, 2021    1.87    395,269 
            
As at January 1, 2022    2.61    2,332,500 
Granted    -    - 
Exercised    -    - 
Forfeited    -    - 
As at December 31, 2022    2.61    2,332,500 
Exercisable as at December 31, 2022    2.18    1,198,577 
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS PER SHARE (Tables)
 12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Calculation of net earnings per common share - basic and diluted
          
   For the
year ended		 
   December 31,
2022		   December 31,
2021		 
Basic and diluted:          
Net loss   (5,681,833)   (3,244,506)
Weighted-average number of common shares   6,528,959    5,245,622 
Basic and diluted net loss per common share  $(0.87)  $(0.62)
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 142,343 $ 20,782
Less: Accumulated depreciation (22,599) (498)
Property and equipment, net 119,744 20,284
Mobile Kiosk Display [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 63,395 18,120
Property, Plant and Equipment, Useful Life 3 years  
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 44,901 2,662
Property, Plant and Equipment, Useful Life 3 years  
Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 17,273
Property, Plant and Equipment, Useful Life 3 years  
Internal Use Software [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 16,775
Internal Use Software [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 3 years  
Internal Use Software [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 5 years  
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Accounting Policies [Abstract]    
Bad debt expenses $ 116,230 $ (0)
Inventory prepayment 197,750 64,715
Depreciation expense 22,100 500
Allowance for sales returns $ 24,897 $ 22,266
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAX PROVISION (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Income tax benefit at the statutory federal rate $ 1,193,185 $ 681,346
State income tax benefits, net of federal benefit 35,149 110,647
Change in valuation allowance 1,228,334 791,993
Total
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAX PROVISION (Details 1) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets:    
Stock-based compensation $ 610,530 $ 359,032
Other – net 122,133 6,757
Net operating losses – federal 1,346,823 534,771
Net operating losses – state 81,911 110,647
 Deferred tax assets Gross 2,161,397 1,011,207
Less Valuation Allowance (2,161,397) (1,011,207)
Net deferred tax assets
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAX PROVISION (Details Narrative) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Federal net operating loss carryforwards $ 6,413,441  
State net operating loss carryforwards 3,653,332  
Liabilities for uncertain tax positions $ 0 $ 0
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross $ 156,196 $ 95,480
Less: Accumulated amortization (18,639) (8,174)
Intangible assets, net 137,557 87,306
Patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross $ 156,196 $ 95,480
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization expense $ 10,500 $ 7,200
Future amortization $ 11,500  
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Sep. 05, 2022
Aug. 15, 2022
Jun. 01, 2022
Nov. 01, 2021
Dec. 01, 2020
Nov. 16, 2022
Dec. 31, 2022
Dec. 31, 2021
Related Party Transaction [Line Items]                
Convertible notes balances             $ 61,356 $ 289,029
Convertible debt issued             1,475,000 1,061,500
Conversion of stock, amount $ 500,002   $ 778,500     $ 901,271    
Number of shares converted 140,449   778,500     253,166    
Conversion Price $ 3.56   $ 1.00     $ 3.56    
Management fee             140,000 109,975
Parent And Affiliates [Member]                
Related Party Transaction [Line Items]                
Convertible debt issued       $ 3,000,000 $ 2,000,000      
Interest rate         10.00%      
Lucyd [Member] | IPO [Member]                
Related Party Transaction [Line Items]                
Conversion of stock, amount   $ 2,002,280            
Number of shares converted   266,970            
Conversion Price   $ 7.50            
Tekcapital Europe Ltd [Member]                
Related Party Transaction [Line Items]                
Management fee             140,000 $ 100,000
Rent expenses             $ 74,442  
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES (Details)
Dec. 31, 2022
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
2023 $ 36,750
2024 161,210
2025 356,000
2026 654,000
2027 930,000
Thereafter (through 2032) 7,200,000
Total $ 9,337,960
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES (Details Narrative)
 12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Base term 10 years
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Aug. 15, 2022
Aug. 17, 2022
Dec. 31, 2022
Dec. 31, 2021
Subsidiary, Sale of Stock [Line Items]        
Preferred stock , shares authorized     15,000,000 15,000,000
Common stock, shares authorized     50,000,000 50,000,000
Preferred stock , shares issued     0 0
Preferred stock, shares Outstanding     0 0
Proceeds from offering     $ 6,127,067
Common Stock [Member]        
Subsidiary, Sale of Stock [Line Items]        
Issauance of common stock   980,000    
IPO [Member]        
Subsidiary, Sale of Stock [Line Items]        
Issauance of common stock   980,000    
Number of warrants purchased   1,960,000    
Share Price   $ 7.50    
Proceeds from offering $ 6,189,734 $ 7,350,000    
Underwriters description   Company granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or warrants to purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which the Underwriter exercised its option to purchase additional warrants to purchase 294,000 shares of common stock concurrently with the closing.    
IPO [Member] | Maxim [Member]        
Subsidiary, Sale of Stock [Line Items]        
Number of warrants purchased 58,800      
Exercise price $ 8.228      
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK BASED COMPENSATION (Details) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Expected dividend yield 0.00%  
Grant date fair value of options   $ 1.84
Minimum [Member]    
Share price at date of grant $ 1.00  
Options life in years 2 years  
Risk free rate 0.16%  
Expected volatility 121.00%  
Grant date fair value of options $ 0.71  
Maximum [Member]    
Share price at date of grant $ 5.00  
Options life in years 3 years  
Risk free rate 0.44%  
Expected volatility 151.00%  
Grant date fair value of options $ 3.46  
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK BASED COMPENSATION (Details 1) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Av. Exercise price per share, Option Outstanding at beginnig $ 2.61 $ 1.00
Option Outstanding at beginnig 2,332,500 645,000
Av. Exercise price per share, Option Granted $ 3.23
Option Granted 1,687,500
Av. Exercise price per share, Option Exercised
Option Exercised
Av. Exercise price per share, Option Forfeited
Option Forfeited
Av. Exercise price per share, Option Outstanding at ending $ 2.61 $ 2.61
Option Outstanding at ending 2,332,500 2,332,500
Av. Exercise price per share, Option Exercisable $ 2.18 $ 1.87
Option Exercisable 1,198,577 395,269
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.23.1
STOCK BASED COMPENSATION (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Available for the grant 1,124,043  
Stock granted 0 1,687,500
Weighted average grant date fair value of options outstanding   $ 1.84
Weighted average remaining contractual life of options outstanding 1 year 8 months 4 days  
Weighted average remaining contractual life of options exercisable 1 year 9 months 14 days  
Unrecognized stock compensation expense $ 1,409,958  
Unrecognized stock compensation expense, term 1 year 4 months 28 days  
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.23.1
EARNINGS PER SHARE (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Basic and diluted:    
Net loss $ (5,681,833) $ (3,244,506)
Weighted-average number of common shares 6,528,959 5,245,622
Basic and diluted net loss per common share $ (0.87) $ (0.62)
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member]
 1 Months Ended
Feb. 28, 2023
USD ($)
$ / shares
shares
Subsequent Event [Line Items]  
Number of warrant exercised | shares 408,600
Exercise price | $ / shares $ 3.75
Cash proceeds | $ $ 1,532,250
XML 54 innovativeeye_10k_htm.xml IDEA: XBRL DOCUMENT 0001808377 2022-01-01 2022-12-31 0001808377 LUCY:CommonStock0.00001ParValueMember 2022-01-01 2022-12-31 0001808377 LUCY:WarrantsToPurchaseCommonStockMember 2022-01-01 2022-12-31 0001808377 2022-06-30 0001808377 2023-03-17 0001808377 2022-12-31 0001808377 2021-12-31 0001808377 2021-01-01 2021-12-31 0001808377 us-gaap:CommonStockMember 2021-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2021-12-31 0001808377 us-gaap:RetainedEarningsMember 2021-12-31 0001808377 us-gaap:CommonStockMember 2020-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2020-12-31 0001808377 us-gaap:RetainedEarningsMember 2020-12-31 0001808377 2020-12-31 0001808377 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2022-01-01 2022-12-31 0001808377 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001808377 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2021-01-01 2021-12-31 0001808377 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001808377 us-gaap:CommonStockMember 2022-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2022-12-31 0001808377 us-gaap:RetainedEarningsMember 2022-12-31 0001808377 LUCY:MobileKioskDisplayMember 2022-12-31 0001808377 LUCY:MobileKioskDisplayMember 2021-12-31 0001808377 LUCY:MobileKioskDisplayMember 2022-01-01 2022-12-31 0001808377 us-gaap:ComputerEquipmentMember 2022-12-31 0001808377 us-gaap:ComputerEquipmentMember 2021-12-31 0001808377 us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0001808377 us-gaap:OfficeEquipmentMember 2022-12-31 0001808377 us-gaap:OfficeEquipmentMember 2021-12-31 0001808377 us-gaap:OfficeEquipmentMember 2022-01-01 2022-12-31 0001808377 LUCY:InternalUseSoftwareMember 2022-12-31 0001808377 LUCY:InternalUseSoftwareMember 2021-12-31 0001808377 srt:MinimumMember LUCY:InternalUseSoftwareMember 2022-01-01 2022-12-31 0001808377 srt:MaximumMember LUCY:InternalUseSoftwareMember 2022-01-01 2022-12-31 0001808377 us-gaap:PatentsMember 2022-12-31 0001808377 us-gaap:PatentsMember 2021-12-31 0001808377 LUCY:ParentAndAffiliatesMember 2020-11-29 2020-12-01 0001808377 2022-05-30 2022-06-01 0001808377 2022-06-01 0001808377 2022-09-01 2022-09-05 0001808377 2022-09-05 0001808377 LUCY:ParentAndAffiliatesMember 2021-10-29 2021-11-01 0001808377 2022-11-01 2022-11-16 0001808377 2022-11-16 0001808377 LUCY:LucydMember us-gaap:IPOMember 2022-08-01 2022-08-15 0001808377 LUCY:LucydMember us-gaap:IPOMember 2022-08-15 0001808377 LUCY:TekcapitalEuropeLtdMember 2022-01-01 2022-12-31 0001808377 LUCY:TekcapitalEuropeLtdMember 2021-01-01 2021-12-31 0001808377 us-gaap:IPOMember 2022-08-01 2022-08-17 0001808377 us-gaap:CommonStockMember 2022-08-01 2022-08-17 0001808377 us-gaap:IPOMember 2022-08-17 0001808377 LUCY:MaximMember us-gaap:IPOMember 2022-08-01 2022-08-15 0001808377 LUCY:MaximMember us-gaap:IPOMember 2022-08-15 0001808377 us-gaap:IPOMember 2022-08-01 2022-08-15 0001808377 srt:MinimumMember 2022-12-31 0001808377 srt:MaximumMember 2022-12-31 0001808377 srt:MinimumMember 2022-01-01 2022-12-31 0001808377 srt:MaximumMember 2022-01-01 2022-12-31 0001808377 us-gaap:SubsequentEventMember 2023-02-01 2023-02-28 0001808377 us-gaap:SubsequentEventMember 2023-02-28 iso4217:USD shares iso4217:USD shares pure 0001808377 false 2022 FY 10-K true 2022-12-31 --12-31 false 001-41392 INNOVATIVE EYEWEAR, INC. FL 84-2794274 11900 Biscayne Blvd. Suite 630 North Miami FL 33181 (954) 826-0329 Common Stock, $0.00001 par value LUCY NASDAQ Warrants to purchase Common Stock LUCYW NASDAQ No No No Yes Yes Non-accelerated Filer true true false false false 0 7715757 NONE Cherry Bekaert LLP Tampa, Florida 677 3591109 79727 92646 0 110258 43394 210673 68381 111149 197750 64715 94701 275501 36240 1460 4240731 644327 137557 87306 110073 72400 119744 20284 81779 4689884 824317 275660 167050 30000 232989 160722 61356 289029 600005 616801 65450 665455 616801 0.00001 0.00001 50000000 50000000 7307157 7307157 6060187 6060187 73 60 14330343 4842836 11226 -10305987 -4624154 4024429 207516 4689884 824317 659788 690670 716077 542416 -56289 148254 2796669 1386079 2059012 1771012 524692 86261 140000 109975 5520373 3353327 105171 39433 -5681833 -3244506 6528959 5245622 -0.87 -0.62 6060187 60 4842836 -11226 -4624154 207516 6684 6684 -4542 4542 266970 3 2002277 2002280 980000 10 6015908 6015918 1473864 1473864 -5681833 -5681833 7307157 73 14330343 -10305987 4024429 4131469 41 845417 -20647 -1379648 -554837 1172115 12 2179760 2179772 756603 7 482724 -44763 437968 54184 54184 1334935 1334935 -3244506 -3244506 6060187 60 4842836 -11226 -4624154 207516 -5681833 -3244506 10466 7179 22101 498 105171 1251 1473864 1334935 960362 867618 116230 -0 183094 43394 67951 157536 142292 43381 -47765 250436 -1460 1460 22569 -3224418 -1214160 60717 25272 121561 20782 37673 72400 -219951 -118454 6127067 492152 111149 6684 1475000 1061500 653000 57185 6955751 1385318 3511382 52704 79727 27023 3591109 79727 960362 867618 -4542 <p id="xdx_80B_eus-gaap--NatureOfOperations_z3GxVlqEeT88" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_826_zpPy4FpIYY7i">GENERAL INFORMATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Innovative Eyewear, Inc. (the “Company,” “us,” “we,” or “our”) is a corporation organized under the laws of the State of Florida that develops and sells cutting-edge eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The Company was founded by Lucyd Ltd. (the “Parent” or “Lucyd”), a portfolio company of Tekcapital Plc through Tekcapital Europe, Ltd. (collectively, the “Parent and Affiliates”), which owned approximately 71% of our issued and outstanding shares of common stock as of December 31, 2022. Innovative Eyewear licensed the exclusive rights to the Lucyd<sup>®</sup> brand from Lucyd Ltd., which includes the exclusive use of all of Lucyd’s intellectual property, including our main product, Lucyd Lyte<sup>®</sup> glasses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_zi2o7jQSsUAi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – <span id="xdx_82F_zR2XGMWAEi33">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zwm8JgWhMPHk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86A_zWL4QZwNXKRh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basis of Presentation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and in accordance with the accounting rules under Regulation S-X, as promulgated by the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statements for the years presented have been included. The results of operations for the years ended December 31, 2022 and 2021 are not necessarily indicative of the results to be expected for future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--UseOfEstimates_zQqeUvf2Mwbb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_869_zuu18hnQD8Rl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant economic disruptions and uncertainties associated with the ongoing economic environment, including potential supply chain constraints.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ReceivablesPolicyTextBlock_zfLSH9RX6My8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86B_zE4ql3jJVfUh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Receivables and Credit Policy</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade receivables from customers are uncollateralized customer obligations due under normal trade terms. For direct-to-consumer sales, payment is required before product is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice. The Company, by policy, routinely assesses the financial strength of its customers. To comply with industry standards, we offer “net 30” payments on wholesale orders of $1,500 or more. For wholesale orders, to acquire an order on net 30 terms, the customer is provided a credit check application as well as a credit card authorization form. The authorization form explicitly states when and for much we will bill the customer via credit card.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable are reported net of the allowance for doubtful accounts. The allowance for doubtful accounts is based on the Company’s evaluation of each customer’s payment history, account aging, and financial position. The Company recognized bad debt expense of $<span id="xdx_901_eus-gaap--ProvisionForDoubtfulAccounts_c20220101__20221231_pp0p0">116,230</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the year ended December 31, 2022, and <span id="xdx_90F_eus-gaap--ProvisionForDoubtfulAccounts_pp0p0_do_c20210101__20211231_zpgMpJmU3dT1" title="Bad debt expenses">no</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">bad debt expense for the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_ecustom--CapitalizedSoftwarePolicyTextBlock_z3CtPVJzQ5Uj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_862_zjIEjWUHRVX7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Capitalized Software</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company incurred software development costs related to development of the Vyrb app. The Company capitalized these costs in accordance with ASC 985-20, “Software – Costs of Software to be Sold, Leased, or Marketed,” considering it is the Company’s intention to market and sell the software externally. Planning, designing, coding, and testing occurred necessary to meet Vyrb’s design specifications. As such, all coding, development, and testing costs incurred subsequent to establishing technical feasibility were capitalized. We have launched a beta version of the Vyrb application in December 2021 that demonstrates the functionality of the software. We expect an estimated useful life of five years for this product.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_zxaYNtxbIkih" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_865_zltwrszxebo1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Inventory</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. No provisions were determined as needed as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 and 2021, the Company recorded an inventory prepayment in the amount of $<span id="xdx_901_ecustom--InventoryPrepayment_iI_pp0p0_c20221231_zBdG0BBYYr45" title="Inventory prepayment">197,750 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90A_ecustom--InventoryPrepayment_c20211231_pp0p0">64,715</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, related to down payment on eyewear purchased from the manufacturer, prior to shipment of the product that occurred after December 31, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zuOZsj3RqSxi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86F_zScLAweHGS7i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Intangible Assets</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets relate to patent costs received in conjunction with the initial capitalization of the Company and internally developed utility and design patents. The Company amortizes these assets over the estimated useful life of the patents. The Company reviews its intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zjZg3qmCz7ua" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_863_zQqlukUZaYnb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Property and Equipment</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are depreciated using the straight-line method over the estimated useful lives or lease terms if shorter. Depreciation expense for the years ended December 31, 2022 and 2021 was approximately $<span id="xdx_90E_eus-gaap--Depreciation_pp0p0_c20220101__20221231_zCCXBH8qUm62" title="Depreciation expense">22,100 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_902_eus-gaap--Depreciation_c20210101__20211231_pp0p0">500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively. For income tax purposes, accelerated depreciation methods are generally used. Repair and maintenance costs are expensed as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock_zIthwJYpq7c9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BF_zSRgxCeM4TK8" style="display: none; font-size: 10pt">Schedule of estimated useful lives of property and equipment</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">As of<br/> December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 10pt">Estimated Useful Lives</span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">Property &amp; Equipment</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">(in Years)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 53%; text-align: left"><span style="font-size: 10pt">Mobile Kiosk Display</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_pp0p0" style="width: 9%; text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">63,395</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_pp0p0" style="width: 9%; text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">18,120</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 22%; text-align: center"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_zD4oJi0fJZng" style="font-size: 10pt">3 </span><span style="font-size: 10pt">years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Computer Equipment</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">44,901</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">2,662</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zPFLyiWmpfLf" style="font-size: 10pt">3 </span><span style="font-size: 10pt">Years</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Office Equipment</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">17,273</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0474">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zLsQNNgzAcFf" style="font-size: 10pt">3 </span><span style="font-size: 10pt">Years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Internal-Use Software</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">16,775</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0479">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember__srt--RangeAxis__srt--MinimumMember_zwEQd78rNt8c" style="font-size: 10pt">3 </span><span style="font-size: 10pt">to <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember__srt--RangeAxis__srt--MaximumMember_zwe790KP3ak8">5 </span></span><span style="font-size: 10pt">Years</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 10pt">Property and equipment, gross</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20221231_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">142,343</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">20,782</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Less: Accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_ze4JfhQ0yZkc" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation"><span style="font-size: 10pt">(22,599</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zQwA0MdcZwhj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation"><span style="font-size: 10pt">(498</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Property and equipment, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"><span style="font-size: 10pt">119,744</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"><span style="font-size: 10pt">20,284</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="text-align: center; padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_ziIep3DfhQH9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86E_zJhCxxqCL3ze" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Income Taxes</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income taxes under an asset and liability approach that recognizes deferred tax assets and liabilities based on the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return. Any interest and penalties accrued related to uncertain tax positions are recorded in tax expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assesses the realizability of its net deferred tax assets on an annual basis. If, after considering all relevant positive and negative evidence, it is more likely than not that some portion or all of the net deferred tax assets will not be realized, the Company will reduce the net deferred tax assets by a valuation allowance. The realization of net deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of net operating loss carryforwards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zRI3SHfp7Ssh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_861_zV09djXDSVK6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair Value of Financial Instruments</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For certain of the Company’s financial instruments, including cash, accounts receivable, accounts payable, and cash advances provided by the Parent and Affiliates, the carrying amounts approximate fair value due to the short-term maturities of these instruments. The carrying value of the convertible note approximates fair value because the interest rate approximates market rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zl3QU4HMsXN1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_860_zNrYKjMesJUf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Concentrations of Credit Risk</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and accounts receivable. The Company limits its credit risk with respect to cash by maintaining cash balances with high quality financial institutions. At times, the Company’s cash balances may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are considered minimal due to collection history.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zGLNPWE19Ig4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86F_zYKdTGUoWQqe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock-Based Compensation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation to employees and directors in accordance with FASB ASC Topic 718, which requires that compensation expense be recognized in the financial statements for stock-based awards based on the grant date fair value. For stock option awards, the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility. The expected term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies. The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of common stock used in the option pricing model for stock-based awards granted in 2021 was determined using the most recent price paid by independent investors through a Regulation Crowdfunding (“CF”) securities offering undertaken by the Company. For the majority of time during which stock option awards were granted by the Company in 2021, the Company had been raising funds from investors under Regulation CF campaigns, with a significant number of transactions from both accredited and non-accredited investors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--RevenueRecognitionPolicyTextBlock_z4eqRh3i4LJk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86E_zl2oaP6dmwOl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue Recognition</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract and determine those that are performance obligations, and also assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In instances where the collectibility of contractual consideration is not probable at the time of sale, the revenue is deferred on our balance sheet as a contract liability, and the associated cost of goods sold is deferred on our balance sheet as a contract asset; subsequently, we recognize such revenue and cost of goods sold as payments are received.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation, which is delivery of the Company’s eyewear products to the retail store and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to the retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order and after collectibility of substantially all of the contract consideration is probable. Our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale distributor orders, no e-commerce fees are applicable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s sales do not contain any variable consideration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason within the first:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7 days for sales made through our website (Lucyd.co)</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 days for sales made through Amazon</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we review all individual returns received in the month following the balance sheet date pertaining to orders processed prior to the balance sheet date in order to determine whether an allowance for sales returns is necessary. The Company recorded an allowance for sales returns of $<span id="xdx_90B_ecustom--AllowanceForSalesReturns_iI_pp0p0_c20221231_zgo39JmTGIDk" title="Allowance for sales returns">24,897 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_908_ecustom--AllowanceForSalesReturns_c20211231_pp0p0">22,266 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_ecustom--ShippingAndHandlingsPolicyTextBlock_zntLqWf3SFv6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_862_zqqDYKFhEJE7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shipping and Handling</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs incurred for shipping and handling are included in cost of revenue at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zORFFlopKckc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86E_zsb1mk6AG5Ck" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recent Accounting Pronouncements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, “Leases (Topic 842),” that requires organizations that lease assets, referred to as “lessees,” to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases with lease terms of more than 12 months. ASU 2016-02 also requires disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases and will include qualitative and quantitative requirements. The Company adopted ASU 2016-02 as of January 1, 2021. The Company’s management determined that the adoption of this guidance had no material impact on the Company’s financial statements due to the lack of long-term leasing arrangements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2018, the FASB issued ASU 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic 470-20), and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contract’s in Entity’s Own Equity.” The guidance in ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the previous guidance related to debt with conversion and other options that required entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. In addition, the amendments revised the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification. The amendments in ASU 2020-06 further revised the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. The Company adopted ASU 2020-06 as of January 1, 2021. The Company’s management determined that the adoption of this guidance had no material impact on the Company’s financial statements due to the lack of beneficial conversion features contained within the Company’s debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zNFGRirLzzbl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86B_zonrQgAICQal" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subsequent Events</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the preparation of these financial statements, the Company has evaluated subsequent events through March 24, 2023, which is the date the financial statements were available to be issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zwm8JgWhMPHk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86A_zWL4QZwNXKRh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basis of Presentation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and in accordance with the accounting rules under Regulation S-X, as promulgated by the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statements for the years presented have been included. The results of operations for the years ended December 31, 2022 and 2021 are not necessarily indicative of the results to be expected for future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--UseOfEstimates_zQqeUvf2Mwbb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_869_zuu18hnQD8Rl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant economic disruptions and uncertainties associated with the ongoing economic environment, including potential supply chain constraints.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--ReceivablesPolicyTextBlock_zfLSH9RX6My8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86B_zE4ql3jJVfUh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Receivables and Credit Policy</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade receivables from customers are uncollateralized customer obligations due under normal trade terms. For direct-to-consumer sales, payment is required before product is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice. The Company, by policy, routinely assesses the financial strength of its customers. To comply with industry standards, we offer “net 30” payments on wholesale orders of $1,500 or more. For wholesale orders, to acquire an order on net 30 terms, the customer is provided a credit check application as well as a credit card authorization form. The authorization form explicitly states when and for much we will bill the customer via credit card.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable are reported net of the allowance for doubtful accounts. The allowance for doubtful accounts is based on the Company’s evaluation of each customer’s payment history, account aging, and financial position. The Company recognized bad debt expense of $<span id="xdx_901_eus-gaap--ProvisionForDoubtfulAccounts_c20220101__20221231_pp0p0">116,230</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the year ended December 31, 2022, and <span id="xdx_90F_eus-gaap--ProvisionForDoubtfulAccounts_pp0p0_do_c20210101__20211231_zpgMpJmU3dT1" title="Bad debt expenses">no</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">bad debt expense for the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 116230 0 <p id="xdx_843_ecustom--CapitalizedSoftwarePolicyTextBlock_z3CtPVJzQ5Uj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_862_zjIEjWUHRVX7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Capitalized Software</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company incurred software development costs related to development of the Vyrb app. The Company capitalized these costs in accordance with ASC 985-20, “Software – Costs of Software to be Sold, Leased, or Marketed,” considering it is the Company’s intention to market and sell the software externally. Planning, designing, coding, and testing occurred necessary to meet Vyrb’s design specifications. As such, all coding, development, and testing costs incurred subsequent to establishing technical feasibility were capitalized. We have launched a beta version of the Vyrb application in December 2021 that demonstrates the functionality of the software. We expect an estimated useful life of five years for this product.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_zxaYNtxbIkih" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_865_zltwrszxebo1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Inventory</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. No provisions were determined as needed as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 and 2021, the Company recorded an inventory prepayment in the amount of $<span id="xdx_901_ecustom--InventoryPrepayment_iI_pp0p0_c20221231_zBdG0BBYYr45" title="Inventory prepayment">197,750 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90A_ecustom--InventoryPrepayment_c20211231_pp0p0">64,715</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, related to down payment on eyewear purchased from the manufacturer, prior to shipment of the product that occurred after December 31, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 197750 64715 <p id="xdx_84A_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zuOZsj3RqSxi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86F_zScLAweHGS7i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Intangible Assets</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets relate to patent costs received in conjunction with the initial capitalization of the Company and internally developed utility and design patents. The Company amortizes these assets over the estimated useful life of the patents. The Company reviews its intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zjZg3qmCz7ua" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_863_zQqlukUZaYnb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Property and Equipment</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are depreciated using the straight-line method over the estimated useful lives or lease terms if shorter. Depreciation expense for the years ended December 31, 2022 and 2021 was approximately $<span id="xdx_90E_eus-gaap--Depreciation_pp0p0_c20220101__20221231_zCCXBH8qUm62" title="Depreciation expense">22,100 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_902_eus-gaap--Depreciation_c20210101__20211231_pp0p0">500</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively. For income tax purposes, accelerated depreciation methods are generally used. Repair and maintenance costs are expensed as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock_zIthwJYpq7c9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BF_zSRgxCeM4TK8" style="display: none; font-size: 10pt">Schedule of estimated useful lives of property and equipment</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">As of<br/> December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 10pt">Estimated Useful Lives</span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">Property &amp; Equipment</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">(in Years)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 53%; text-align: left"><span style="font-size: 10pt">Mobile Kiosk Display</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_pp0p0" style="width: 9%; text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">63,395</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_pp0p0" style="width: 9%; text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">18,120</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 22%; text-align: center"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_zD4oJi0fJZng" style="font-size: 10pt">3 </span><span style="font-size: 10pt">years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Computer Equipment</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">44,901</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">2,662</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zPFLyiWmpfLf" style="font-size: 10pt">3 </span><span style="font-size: 10pt">Years</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Office Equipment</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">17,273</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0474">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zLsQNNgzAcFf" style="font-size: 10pt">3 </span><span style="font-size: 10pt">Years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Internal-Use Software</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">16,775</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0479">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember__srt--RangeAxis__srt--MinimumMember_zwEQd78rNt8c" style="font-size: 10pt">3 </span><span style="font-size: 10pt">to <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember__srt--RangeAxis__srt--MaximumMember_zwe790KP3ak8">5 </span></span><span style="font-size: 10pt">Years</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 10pt">Property and equipment, gross</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20221231_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">142,343</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">20,782</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Less: Accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_ze4JfhQ0yZkc" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation"><span style="font-size: 10pt">(22,599</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zQwA0MdcZwhj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation"><span style="font-size: 10pt">(498</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Property and equipment, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"><span style="font-size: 10pt">119,744</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"><span style="font-size: 10pt">20,284</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="text-align: center; padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> 22100 500 <table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock_zIthwJYpq7c9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BF_zSRgxCeM4TK8" style="display: none; font-size: 10pt">Schedule of estimated useful lives of property and equipment</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">As of<br/> December 31,</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-size: 10pt">Estimated Useful Lives</span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">Property &amp; Equipment</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">(in Years)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 53%; text-align: left"><span style="font-size: 10pt">Mobile Kiosk Display</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_pp0p0" style="width: 9%; text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">63,395</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_pp0p0" style="width: 9%; text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">18,120</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 22%; text-align: center"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_zD4oJi0fJZng" style="font-size: 10pt">3 </span><span style="font-size: 10pt">years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Computer Equipment</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">44,901</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">2,662</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zPFLyiWmpfLf" style="font-size: 10pt">3 </span><span style="font-size: 10pt">Years</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Office Equipment</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">17,273</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0474">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zLsQNNgzAcFf" style="font-size: 10pt">3 </span><span style="font-size: 10pt">Years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Internal-Use Software</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">16,775</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0479">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember__srt--RangeAxis__srt--MinimumMember_zwEQd78rNt8c" style="font-size: 10pt">3 </span><span style="font-size: 10pt">to <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember__srt--RangeAxis__srt--MaximumMember_zwe790KP3ak8">5 </span></span><span style="font-size: 10pt">Years</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 10pt">Property and equipment, gross</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20221231_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">142,343</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" style="text-align: right" title="Property and equipment, gross"><span style="font-size: 10pt">20,782</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Less: Accumulated depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_ze4JfhQ0yZkc" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation"><span style="font-size: 10pt">(22,599</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zQwA0MdcZwhj" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation"><span style="font-size: 10pt">(498</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Property and equipment, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"><span style="font-size: 10pt">119,744</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"><span style="font-size: 10pt">20,284</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="text-align: center; padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td></tr> </table> 63395 18120 P3Y 44901 2662 P3Y 17273 P3Y 16775 P3Y P5Y 142343 20782 22599 498 119744 20284 <p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_ziIep3DfhQH9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86E_zJhCxxqCL3ze" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Income Taxes</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for income taxes under an asset and liability approach that recognizes deferred tax assets and liabilities based on the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return. Any interest and penalties accrued related to uncertain tax positions are recorded in tax expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assesses the realizability of its net deferred tax assets on an annual basis. If, after considering all relevant positive and negative evidence, it is more likely than not that some portion or all of the net deferred tax assets will not be realized, the Company will reduce the net deferred tax assets by a valuation allowance. The realization of net deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of net operating loss carryforwards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zRI3SHfp7Ssh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_861_zV09djXDSVK6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair Value of Financial Instruments</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For certain of the Company’s financial instruments, including cash, accounts receivable, accounts payable, and cash advances provided by the Parent and Affiliates, the carrying amounts approximate fair value due to the short-term maturities of these instruments. The carrying value of the convertible note approximates fair value because the interest rate approximates market rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zl3QU4HMsXN1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_860_zNrYKjMesJUf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Concentrations of Credit Risk</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and accounts receivable. The Company limits its credit risk with respect to cash by maintaining cash balances with high quality financial institutions. At times, the Company’s cash balances may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are considered minimal due to collection history.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zGLNPWE19Ig4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86F_zYKdTGUoWQqe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock-Based Compensation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation to employees and directors in accordance with FASB ASC Topic 718, which requires that compensation expense be recognized in the financial statements for stock-based awards based on the grant date fair value. For stock option awards, the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility. The expected term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies. The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of common stock used in the option pricing model for stock-based awards granted in 2021 was determined using the most recent price paid by independent investors through a Regulation Crowdfunding (“CF”) securities offering undertaken by the Company. For the majority of time during which stock option awards were granted by the Company in 2021, the Company had been raising funds from investors under Regulation CF campaigns, with a significant number of transactions from both accredited and non-accredited investors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--RevenueRecognitionPolicyTextBlock_z4eqRh3i4LJk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86E_zl2oaP6dmwOl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenue Recognition</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract and determine those that are performance obligations, and also assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In instances where the collectibility of contractual consideration is not probable at the time of sale, the revenue is deferred on our balance sheet as a contract liability, and the associated cost of goods sold is deferred on our balance sheet as a contract asset; subsequently, we recognize such revenue and cost of goods sold as payments are received.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation, which is delivery of the Company’s eyewear products to the retail store and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to the retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order and after collectibility of substantially all of the contract consideration is probable. Our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale distributor orders, no e-commerce fees are applicable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s sales do not contain any variable consideration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason within the first:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7 days for sales made through our website (Lucyd.co)</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 days for sales made through Amazon</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we review all individual returns received in the month following the balance sheet date pertaining to orders processed prior to the balance sheet date in order to determine whether an allowance for sales returns is necessary. The Company recorded an allowance for sales returns of $<span id="xdx_90B_ecustom--AllowanceForSalesReturns_iI_pp0p0_c20221231_zgo39JmTGIDk" title="Allowance for sales returns">24,897 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_908_ecustom--AllowanceForSalesReturns_c20211231_pp0p0">22,266 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 24897 22266 <p id="xdx_846_ecustom--ShippingAndHandlingsPolicyTextBlock_zntLqWf3SFv6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_862_zqqDYKFhEJE7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shipping and Handling</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs incurred for shipping and handling are included in cost of revenue at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zORFFlopKckc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86E_zsb1mk6AG5Ck" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recent Accounting Pronouncements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, “Leases (Topic 842),” that requires organizations that lease assets, referred to as “lessees,” to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases with lease terms of more than 12 months. ASU 2016-02 also requires disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases and will include qualitative and quantitative requirements. The Company adopted ASU 2016-02 as of January 1, 2021. The Company’s management determined that the adoption of this guidance had no material impact on the Company’s financial statements due to the lack of long-term leasing arrangements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2018, the FASB issued ASU 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic 470-20), and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contract’s in Entity’s Own Equity.” The guidance in ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the previous guidance related to debt with conversion and other options that required entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. In addition, the amendments revised the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification. The amendments in ASU 2020-06 further revised the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. The Company adopted ASU 2020-06 as of January 1, 2021. The Company’s management determined that the adoption of this guidance had no material impact on the Company’s financial statements due to the lack of beneficial conversion features contained within the Company’s debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zNFGRirLzzbl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_86B_zonrQgAICQal" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subsequent Events</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the preparation of these financial statements, the Company has evaluated subsequent events through March 24, 2023, which is the date the financial statements were available to be issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_805_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zlGy5zFMa8z5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_82E_zCdZdraTVUJ6">GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has a limited operating history. The Company’s business and operations are sensitive to general business and economic conditions in the United States. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverse conditions may include recession, downturn, or otherwise, changes in regulations or restrictions in imports, competition, or changes in consumer taste including the economic impacts from the COVID-19 pandemic. These adverse conditions could affect the Company’s financial condition and the results of its operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company meets its day to day working capital requirements through monies raised through sales of eyewear and issuances of equity, including past crowdfunding transactions, and more recently an initial public offering completed in August 2022. The Company also has issued a convertible note held by its parent company. The Company’s forecasts and projections indicate that the Company expects to have sufficient cash reserves and future income to operate within the level of its current facilities. The Company anticipates that its available liquidity will be sufficient to fund operations through at least the end of March 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> <p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_zDBlYfdQCzPk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_82E_zzaALJEkojx5">INCOME TAX PROVISION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a reconciliation of tax computed at the statutory federal rate to the income tax benefit in the statements of operations:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zqldTTuzZU2k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX PROVISION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B5_znrop0fHrgn3" style="display: none; font-size: 10pt">Schedule of reconciliation of federal statutory tax rate</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_49E_20220101__20221231_zZrmXnaDb3we" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_493_20210101__20211231_z0z3nwfrhLwi" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzvMf_z2M8B0Zdquka" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-size: 10pt">Income tax benefit at the statutory federal rate</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">1,193,185</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">681,346</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzvMf_zcQMmfpVwM63" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">State income tax benefits, net of federal benefit</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">35,149</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">110,647</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pp0p0_maITEBzvMf_zq1h4MDD23Il" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Change in valuation allowance</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">(1,228,334</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">(791,993</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzvMf_zIEkNdLQXrDc" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0533">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0534">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_zIy9ZcN7zuCc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The components of the Company’s deferred tax assets are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zPu99QPm3iQa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX PROVISION (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8BE_zpR11MzQTlBi" style="display: none; font-size: 10pt">Schedule of deferred tax assets</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_49F_20221231_zqhcOrgb9BI7" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_49F_20211231_zM2RKDUjY6ia" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGrossAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Deferred tax assets:</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left"><span style="font-size: 10pt">Stock-based compensation</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">610,530</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">359,032</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 10pt">Other – net</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">122,133</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">6,757</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 10pt">Net operating losses – federal</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">1,346,823</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">534,771</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Net operating losses – state</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">81,911</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">110,647</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsGross_i01I_pp0p0_zGqyvTwJvDg3" style="vertical-align: bottom; background-color: White"> <td style="display: none; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt"> Deferred tax assets Gross</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,161,397</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">1,011,207</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di_zVHu22z2rnKg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Less Valuation Allowance</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">(2,161,397</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">(1,011,207</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Net deferred tax assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0559">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0560">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_zKiE5nxscPh4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities. Deferred tax assets or liabilities at the end of each period are determined using the tax rate expected to be in effect when taxes are actually paid or recovered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A valuation allowance is established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. A review of all available positive and negative evidence needs to be considered, including a company’s current and past performance, the market environment in which the company operates, length of carryback and carryforward periods, and existing contracts that will result in future profits. After reviewing all the evidence, the Company has recorded a full valuation allowance against its deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, the Company had federal net operating loss carryforwards of $<span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20221231_zs3QfKNIvRR5" title="Federal net operating loss carryforwards">6,413,441 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and state net operating loss carryforwards of $<span id="xdx_90F_ecustom--StateNetOperatingLossCarryforwards_iI_pp0p0_c20221231_zGKsyCggUvR" title="State net operating loss carryforwards">3,653,332</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, both of which do not expire.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company files Federal and Florida tax returns. The years that remain subject to examination are the years ended December 31, 2020, 2021, and 2022. As of December 31, 2022 and 2021, the Company does <span id="xdx_906_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_pp0p0_do_c20221231_zLt2BqH9RXo2" title="Liabilities for uncertain tax positions"><span id="xdx_908_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_pp0p0_do_c20211231_zF6VPLXyfv8h" title="Liabilities for uncertain tax positions">no</span></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">t believe that is has any liabilities for uncertain tax positions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zqldTTuzZU2k" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX PROVISION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B5_znrop0fHrgn3" style="display: none; font-size: 10pt">Schedule of reconciliation of federal statutory tax rate</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_49E_20220101__20221231_zZrmXnaDb3we" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_493_20210101__20211231_z0z3nwfrhLwi" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzvMf_z2M8B0Zdquka" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-size: 10pt">Income tax benefit at the statutory federal rate</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">1,193,185</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">681,346</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzvMf_zcQMmfpVwM63" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">State income tax benefits, net of federal benefit</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">35,149</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">110,647</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pp0p0_maITEBzvMf_zq1h4MDD23Il" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Change in valuation allowance</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">(1,228,334</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">(791,993</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr> <tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzvMf_zIEkNdLQXrDc" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0533">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0534">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> 1193185 681346 35149 110647 -1228334 -791993 <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zPu99QPm3iQa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX PROVISION (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8BE_zpR11MzQTlBi" style="display: none; font-size: 10pt">Schedule of deferred tax assets</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_49F_20221231_zqhcOrgb9BI7" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_49F_20211231_zM2RKDUjY6ia" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGrossAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Deferred tax assets:</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left"><span style="font-size: 10pt">Stock-based compensation</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">610,530</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">359,032</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 10pt">Other – net</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">122,133</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">6,757</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 10pt">Net operating losses – federal</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">1,346,823</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">534,771</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Net operating losses – state</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">81,911</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">110,647</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsGross_i01I_pp0p0_zGqyvTwJvDg3" style="vertical-align: bottom; background-color: White"> <td style="display: none; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt"> Deferred tax assets Gross</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">2,161,397</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">1,011,207</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di_zVHu22z2rnKg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Less Valuation Allowance</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">(2,161,397</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">(1,011,207</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Net deferred tax assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0559">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0560">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> 610530 359032 122133 6757 1346823 534771 81911 110647 2161397 1011207 2161397 1011207 6413441 3653332 0 0 <p id="xdx_803_eus-gaap--IntangibleAssetsDisclosureTextBlock_zZtDPkhQ9k1d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_82F_zyQB1C6xRLn9">INTANGIBLE ASSETS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zi3F954v1Lr8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B0_zfLoGpZI37Z6" style="display: none; font-size: 10pt">Schedule of intangible assets</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">December 31,</span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">December 31,</span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">Finite-lived intangible assets</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Patent Costs</span></td><td style="width: 1%; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Intangible assets, gross"><span style="font-size: 10pt">156,196</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Intangible assets, gross"><span style="font-size: 10pt">95,480</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 10pt">Intangible assets, gross</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231_pp0p0" style="text-align: right" title="Intangible assets, gross"><span style="font-size: 10pt">156,196</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231_pp0p0" style="text-align: right" title="Intangible assets, gross"><span style="font-size: 10pt">95,480</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Less: Accumulated amortization</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font-size: 10pt">(18,639</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font-size: 10pt">(8,174</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Intangible assets, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net"><span style="font-size: 10pt">137,557</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net"><span style="font-size: 10pt">87,306</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization expense totalled approximately $<span id="xdx_90C_eus-gaap--AdjustmentForAmortization_pp0p0_c20220101__20221231_zjwDFfVv59za" title="Amortization expense">10,500</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90D_eus-gaap--AdjustmentForAmortization_c20210101__20211231_pp0p0">7,200 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the years ended December 31, 2022 and 2021, respectively. Future amortization is expected to approximate $<span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20221231_zP5T1JFDC4u8" title="Future amortization">11,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_883_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zi3F954v1Lr8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8B0_zfLoGpZI37Z6" style="display: none; font-size: 10pt">Schedule of intangible assets</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">December 31,</span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">December 31,</span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">Finite-lived intangible assets</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Patent Costs</span></td><td style="width: 1%; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Intangible assets, gross"><span style="font-size: 10pt">156,196</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Intangible assets, gross"><span style="font-size: 10pt">95,480</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span style="font-size: 10pt">Intangible assets, gross</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231_pp0p0" style="text-align: right" title="Intangible assets, gross"><span style="font-size: 10pt">156,196</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20211231_pp0p0" style="text-align: right" title="Intangible assets, gross"><span style="font-size: 10pt">95,480</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt"><span style="font-size: 10pt">Less: Accumulated amortization</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font-size: 10pt">(18,639</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20211231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font-size: 10pt">(8,174</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Intangible assets, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net"><span style="font-size: 10pt">137,557</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net"><span style="font-size: 10pt">87,306</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> 156196 95480 156196 95480 -18639 -8174 137557 87306 10500 7200 11500 <p id="xdx_807_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zRhozELhGXp3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – <span id="xdx_82D_zXA5Zt8q7HKb">RELATED PARTY TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Convertible Note and Due to Parent and Affiliates</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2022 and 2021, the Company had the availability of, but not the contractual right to, intercompany financing from the Parent and Affiliates in the form of either cash advances or borrowings under a convertible note (as discussed below). The convertible notes balances were $<span id="xdx_905_eus-gaap--ConvertibleDebtCurrent_iI_pp0p0_c20221231_zvYOsaQ8qxQe" title="Convertible notes balances">61,356</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90A_eus-gaap--ConvertibleDebtCurrent_c20211231_pp0p0">289,029</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2022 and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 1, 2020, the Company issued a convertible note to its Parent and Affiliates for up to $<span id="xdx_904_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20201129__20201201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ParentAndAffiliatesMember_z8GwEMLF4g6c" title="Convertible debt issued">2,000,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that bears interest at <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20201129__20201201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ParentAndAffiliatesMember_zHJBdj60gbMj" title="Interest rate">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum, which includes the option to convert the debt into the Company’s common stock at market price. The note can be converted into shares of common stock of the Company upon occurrence of certain conversion events, as defined.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 1, 2021, the Company converted related party borrowings totalling $<span id="xdx_902_eus-gaap--ConversionOfStockAmountConverted1_pp0p0_c20220530__20220601_zPv9Nt4bZY6j" title="Conversion of stock, amount">778,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">into <span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20220530__20220601_zRoa3HnUBpwe" title="Number of shares converted">778,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at $<span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20220601_zKXCA4vsgzU6" title="Conversion Price">1.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 5, 2021, the Company converted related party borrowings totalling $<span id="xdx_908_eus-gaap--ConversionOfStockAmountConverted1_c20220901__20220905_pp0p0">500,002 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">into <span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_c20220901__20220905_pdd">140,449 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at $<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20220905_pdd">3.56 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 1, 2021, the Company amended and restated its December 1, 2020, convertible note agreement with Parent and Affiliates, increasing the amount of available financing from $2,000,000 to $<span id="xdx_90D_eus-gaap--ProceedsFromConvertibleDebt_c20211029__20211101__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ParentAndAffiliatesMember_pp0p0">3,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 16, 2021, the Company converted related party borrowings totalling $<span id="xdx_903_eus-gaap--ConversionOfStockAmountConverted1_c20221101__20221116_pp0p0">901,271 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">into <span id="xdx_906_eus-gaap--ConversionOfStockSharesConverted1_c20221101__20221116_pdd">253,166 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at $<span id="xdx_90A_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20221116_pdd">3.56 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 15, 2022, in connection with the Company’s initial public offering (see Note 8), the Company converted related party borrowings totalling $<span id="xdx_902_eus-gaap--ConversionOfStockAmountConverted1_c20220801__20220815__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LucydMember_pp0p0">2,002,280 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">into <span id="xdx_907_eus-gaap--ConversionOfStockSharesConverted1_c20220801__20220815__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LucydMember_pdd">266,970 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock at $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20220815__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LucydMember_pdd">7.50 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Management Service Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2020, the Company entered into a management services agreement with a related party (related through common ownership), for which the Company was billed $25,000 quarterly. Effective February 1, 2022, the original management services agreement was amended to have the Company billed at $35,000 quarterly. While the agreement does not stipulate a specific maturity date, it can be terminated with 30 calendar days written notice by any party.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The related party provides the following services:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Support and advice to the Company in accordance with their area of expertise; </span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research, technical review, legal review, recruitment, software development, marketing, public relations, and advertisement; and</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advice, assistance, and consultation services to support the Company or in relation to any other related matter.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2022 and 2021, the Company incurred $<span id="xdx_908_eus-gaap--ManagementFeeExpense_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TekcapitalEuropeLtdMember_zdShuqLPoafa" title="Management fee">140,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_908_eus-gaap--ManagementFeeExpense_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TekcapitalEuropeLtdMember_pp0p0">100,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively, under its management services agreement with Tekcapital Europe Ltd.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rent of Office Space</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to the February 1, 2022 amendment of the aforementioned management services agreement, the Company was provided with rent-free office space by the Parent and Affiliates. Effective February 1, 2022, Tekcapital began to bill the Company for an allocation of rent paid by Tekcapital on the Company’s behalf. The Company recognized $<span id="xdx_908_ecustom--RentExpenses_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TekcapitalEuropeLtdMember_zPcFivpzjGP9" title="Rent expenses">74,442 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of expense related to this arrangement for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 61356 289029 2000000 0.10 778500 778500 1.00 500002 140449 3.56 3000000 901271 253166 3.56 2002280 266970 7.50 140000 100000 74442 <p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zTDDWe14qjY1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_829_z18MWTtdfqbd">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Legal Matters</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are not the subject of any material pending legal proceedings, however, may from time to time become a party to various legal proceedings arising in the ordinary course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Leases</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our executive offices are located at 11900 Biscayne Blvd., Suite 630 Miami, Florida 33181. Our executive offices are provided to us by the parent of our majority stockholder, Tekcapital (see Note 6). We consider our current office space adequate for our current operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>License Agreements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company entered into license agreements which grant the Company the right to sell certain branded smart eyewear. These agreements require the Company to pay royalties based on a percentage of net retail and wholesale sales, and also require guaranteed minimum royalty payments. The agreements have base terms of <span id="xdx_90B_ecustom--BaseTerm_dtY_c20220101__20221231_zobbvozonjnd" title="Base term">10 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years but are cancellable at the option of the Company during the fifth year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate future minimum payments due under these license agreements are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zLJdAY0UPCl5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B5_z644s8z6tHd2" style="display: none; font-size: 10pt">Schedule of future minimum payments due</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_496_20221231_zBlQVORrDsj2" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzG61_zqNfx5gApJg7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left"><span style="font-size: 10pt">2023</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">36,750</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzG61_z7urCdKuzFv" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">2024</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">161,210</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzG61_zxkpkfY0PFO1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">2025</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">356,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPzG61_zmhOEQ47Sys8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">2026</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">654,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_maLOLLPzG61_zxztghaqEe7j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">2027</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">930,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzG61_zGbERvPYpuPa" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter (through 2032)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">7,200,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzG61_zaqLXcpLNwnl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">9,337,960</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other Commitments</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See related party management services agreement discussed in Note 6.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P10Y <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zLJdAY0UPCl5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B5_z644s8z6tHd2" style="display: none; font-size: 10pt">Schedule of future minimum payments due</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_496_20221231_zBlQVORrDsj2" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzG61_zqNfx5gApJg7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left"><span style="font-size: 10pt">2023</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt">$</span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">36,750</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzG61_z7urCdKuzFv" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">2024</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">161,210</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPzG61_zxkpkfY0PFO1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">2025</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">356,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPzG61_zmhOEQ47Sys8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-size: 10pt">2026</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">654,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_maLOLLPzG61_zxztghaqEe7j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">2027</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt">930,000</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPzG61_zGbERvPYpuPa" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter (through 2032)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">7,200,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzG61_zaqLXcpLNwnl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">9,337,960</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> 36750 161210 356000 654000 930000 7200000 9337960 <p id="xdx_808_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zC3h5VnXa7h1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span id="xdx_825_zv8zNmPA8AWh">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to a corporate resolution on July 1, 2021, the Company has authority to issue up to <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_c20221231_pdd" title="Preferred stock , shares authorized"><span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231_zEzZHxLKMdk8" title="Preferred stock , shares authorized">15,000,000</span></span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of preferred stock and <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_c20221231_zdN5HguUzVs6" title="Common stock, shares authorized"><span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_c20211231_zNvWrrozUAJ3" title="Common stock, shares authorized">50,000,000</span></span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock. There were <span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zdGrL4YN9DLf" title="Preferred stock , shares issued"><span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_do_c20211231_z4HWCe0Wfovk" title="Preferred stock , shares issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zJ6c6TypmAy6" title="Preferred stock, shares Outstanding"><span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20211231_z00FuednF3pd" title="Preferred stock, shares Outstanding">no</span></span></span></span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of preferred stock issued or outstanding as of December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial Public Offering</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 17, 2022, the Company closed on its initial public offering of <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220801__20220817__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zyaAW1obCub1" title="Issauance of common stock">980,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units consisting of <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220801__20220817__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd">980,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock and <span id="xdx_901_ecustom--NumberOfWarrantsPurchased_c20220801__20220817__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDVoovuMnNJ1" title="Number of warrants purchased">1,960,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants to purchase 1,960,000 shares of common stock at a combined offering price of $<span id="xdx_908_eus-gaap--SharePrice_iI_c20220817__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zGZpGxcRm1v7" title="Share Price">7.50 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per unit in exchange for gross proceeds of approximately $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0n3_dm_c20220801__20220817__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z0uIFGvt1FSh" title="Proceeds from offering">7.35 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, before deducting underwriting discounts and offering expenses. Each share of common stock was sold together with two warrants. Each warrant is exercisable to purchase one share of common stock at an initial exercise price of $7.50 per share, subject to certain adjustments as set forth in the warrant agreement. In addition, the <span id="xdx_909_ecustom--UnderwritersDescription_c20220801__20220817__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zEplEo2nXpJl" title="Underwriters description">Company granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or warrants to purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which the Underwriter exercised its option to purchase additional warrants to purchase 294,000 shares of common stock concurrently with the closing.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The shares of common stock and warrants began trading on The Nasdaq Capital Market on August 15, 2022, under the symbols “LUCY” and “LUCYW,” respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also, pursuant to the terms of the underwriting agreement for the offering, the Company issued by the Underwriter certain other warrants to purchase up to <span id="xdx_90F_ecustom--NumberOfWarrantsPurchased_c20220801__20220815__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MaximMember_pdd">58,800 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company’s common stock at an exercise price of $<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220815__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MaximMember_zH52K5uosja5" title="Exercise price">8.228 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The net proceeds received by the Company amounted to $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20220801__20220815__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zv8z4ehJqIF8">6,189,734</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, none of the aforementioned warrants had been exercised.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 15000000 15000000 50000000 50000000 0 0 0 0 980000 980000 1960000 7.50 7350000 Company granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or warrants to purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which the Underwriter exercised its option to purchase additional warrants to purchase 294,000 shares of common stock concurrently with the closing. 58800 8.228 6189734 <p id="xdx_802_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zTWocNKtvERk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 – <span id="xdx_821_zmjcFEVTVw25">STOCK BASED COMPENSATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 1, 2021, an Equity Incentive Plan was approved, allowing for total of 20% of our issued and outstanding common stock immediately after the consummation of the initial public offering, less the number of outstanding option grants, or <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20221231_zXxGlwsGJ109" title="Available for the grant">1,124,043</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, of total issued shares to be available for the grant of awards under the Plan. 1,685,000 option awards were granted by the Company prior to the approval of the Plan, while 647,500 option awards were granted subject to the Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company, granted <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231_zxshrbTFYT64" title="Stock granted">1,687,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">option awards, of which 1,347,500 vest rateably over time and 340,000 vest based on certain performance conditions. There were <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_do_c20220101__20221231_z9hi3P9tleii">no</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">option awards granted during the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of options granted is calculated using the Black-Scholes-Merton option pricing model. The underlying assumptions used in the option pricing model for stock option awards granted in 2021 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_zPxK6bF5wtC1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B8_zoQhwokB2Twi" style="display: none; font-size: 10pt">Schedule fair value of options granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">Attribute</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Share price at date of grant</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-size: 10pt">$<span id="xdx_90E_eus-gaap--SharePrice_iI_c20221231__srt--RangeAxis__srt--MinimumMember_zHI20lZzkvi2" title="Share price at date of grant">1.00 </span></span><span style="font-size: 10pt">- $<span id="xdx_90A_eus-gaap--SharePrice_c20221231__srt--RangeAxis__srt--MaximumMember_pdd">5.00</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Options life in years</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z6yQPggzURD5" style="font-size: 10pt" title="Options life in years">2 </span><span style="font-size: 10pt">- <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zvprNwppfGLd">3</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Risk free rate</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zyd4ZXq99RBi" style="font-size: 10pt" title="Risk free rate">0.16</span><span style="font-size: 10pt">% - <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zEskC4yUmAt6">0.44</span></span><span style="font-size: 10pt">%</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Expected volatility</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z2pAE0SuAOeh" style="font-size: 10pt" title="Expected volatility">121</span><span style="font-size: 10pt">% - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zkyIW2oE7JEd">151</span></span><span style="font-size: 10pt">%</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 86%; text-align: left"><span style="font-size: 10pt">Expected dividend yield</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 12%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20220101__20221231_z1KdkStTDE1i" style="font-size: 10pt" title="Expected dividend yield">0</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Grant date fair value of options</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-size: 10pt">$<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zuQZAt9410Oa" title="Grant date fair value of options">0.71 </span></span><span style="font-size: 10pt">- $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_pdd">3.46</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zeNltZGIT0bk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted average grant date fair value of options outstanding as of December 31, 2022 and 2021 was $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_zJgtmbA7Llnf" title="Weighted average grant date fair value of options outstanding">1.84</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Details of the number of share options and the weighted average exercise price outstanding as of and during the years ended December 31, 2022 and 2021 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_ziDXv7Dnf83c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B5_zPZrSKQFbuu6" style="display: none; font-size: 10pt">Schedule of number of share options and the weighted average exercise price outstanding</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">Av. Exercise</span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">price per share</span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">Options</span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td><td><span style="font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: center"><span style="font-size: 10pt"><b>$</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"><b> </b></span></td><td style="font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>(Number)</b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 75%; text-align: left"><span style="font-size: 10pt">As at January 1, 2021</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zG2f2YZpOExb" style="width: 9%; text-align: right" title="Av. Exercise price per share, Option Outstanding at beginnig"><span style="font-size: 10pt">1.00</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zOzojxyz5pB" style="width: 9%; text-align: right" title="Option Outstanding at beginnig"><span style="font-size: 10pt">645,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Granted</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="text-align: right" title="Av. Exercise price per share, Option Granted"><span style="font-size: 10pt">3.23</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_pdd" style="text-align: right" title="Option Granted"><span style="font-size: 10pt">1,687,500</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Exercised</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="text-align: right" title="Av. Exercise price per share, Option Exercised"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0720">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20211231_pdd" style="text-align: right" title="Option Exercised"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0722">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Forfeited</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Av. Exercise price per share, Option Forfeited"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Option Forfeited"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0726">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">As at December 31, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zWfz0pOtZQMc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Av. Exercise price per share, Option Outstanding at ending"><span style="font-size: 10pt">2.61</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_z7piQtgqaq9l" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Option Outstanding at ending"><span style="font-size: 10pt">2,332,500</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">Exercisable as at December 31, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231_pdd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Av. Exercise price per share, Option Exercisable"><span style="font-size: 10pt">1.87</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231_pdd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Option Exercisable"><span style="font-size: 10pt">395,269</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">As at January 1, 2022</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zOJQL8ycSW51" style="text-align: right" title="Av. Exercise price per share, Option Outstanding at beginnig"><span style="font-size: 10pt">2.61</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zjbaznyMQ8og" style="text-align: right" title="Option Outstanding at beginnig"><span style="font-size: 10pt">2,332,500</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Granted</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="text-align: right" title="Av. Exercise price per share, Option Granted"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0740">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20221231_pdd" style="text-align: right" title="Option Granted"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Exercised</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="text-align: right" title="Av. Exercise price per share, Option Exercised"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0744">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20221231_pdd" style="text-align: right" title="Option Exercised"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Forfeited</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Av. Exercise price per share, Option Forfeited"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0748">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Option Forfeited"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0750">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">As at December 31, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_zvsSOU69B374" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Av. Exercise price per share, Option Outstanding at ending"><span style="font-size: 10pt">2.61</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231_zm7cz4SnL9gh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Option Outstanding at ending"><span style="font-size: 10pt">2,332,500</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">Exercisable as at December 31, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231_pdd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Av. Exercise price per share, Option Exercisable"><span style="font-size: 10pt">2.18</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231_zk3Z3YluMge7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Option Exercisable"><span style="font-size: 10pt">1,198,577</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A8_zVCbHRWYV5m1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the weighted average remaining contractual life of options was <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_z5GTVNZ68Hq7" title="Weighted average remaining contractual life of options outstanding">1.68 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years for outstanding options, and <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20221231_zWryM6TNIR0b" title="Weighted average remaining contractual life of options exercisable">1.79 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years for exercisable options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, unrecognized stock option expense of $<span id="xdx_90F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_pp0p0_c20221231_zPngu838AwM3" title="Unrecognized stock compensation expense">1,409,958 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">remains to be recognized over next <span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20220101__20221231_zRRup4xvfnoa" title="Unrecognized stock compensation expense, term">1.41 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1124043 1687500 0 <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_zPxK6bF5wtC1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B8_zoQhwokB2Twi" style="display: none; font-size: 10pt">Schedule fair value of options granted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">Attribute</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="text-align: center"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Share price at date of grant</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-size: 10pt">$<span id="xdx_90E_eus-gaap--SharePrice_iI_c20221231__srt--RangeAxis__srt--MinimumMember_zHI20lZzkvi2" title="Share price at date of grant">1.00 </span></span><span style="font-size: 10pt">- $<span id="xdx_90A_eus-gaap--SharePrice_c20221231__srt--RangeAxis__srt--MaximumMember_pdd">5.00</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Options life in years</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z6yQPggzURD5" style="font-size: 10pt" title="Options life in years">2 </span><span style="font-size: 10pt">- <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zvprNwppfGLd">3</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Risk free rate</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: right"><span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zyd4ZXq99RBi" style="font-size: 10pt" title="Risk free rate">0.16</span><span style="font-size: 10pt">% - <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zEskC4yUmAt6">0.44</span></span><span style="font-size: 10pt">%</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Expected volatility</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_z2pAE0SuAOeh" style="font-size: 10pt" title="Expected volatility">121</span><span style="font-size: 10pt">% - <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zkyIW2oE7JEd">151</span></span><span style="font-size: 10pt">%</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 86%; text-align: left"><span style="font-size: 10pt">Expected dividend yield</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 12%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20220101__20221231_z1KdkStTDE1i" style="font-size: 10pt" title="Expected dividend yield">0</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Grant date fair value of options</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-size: 10pt">$<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zuQZAt9410Oa" title="Grant date fair value of options">0.71 </span></span><span style="font-size: 10pt">- $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_pdd">3.46</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> 1.00 5.00 P2Y P3Y 0.0016 0.0044 1.21 1.51 0 0.71 3.46 1.84 <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_ziDXv7Dnf83c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8B5_zPZrSKQFbuu6" style="display: none; font-size: 10pt">Schedule of number of share options and the weighted average exercise price outstanding</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">Av. Exercise</span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">price per share</span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="font-weight: bold; text-align: center"><span style="font-size: 10pt">Options</span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt"><b> </b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td><td><span style="font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: center"><span style="font-size: 10pt"><b>$</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"><b> </b></span></td><td style="font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>(Number)</b></span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"><b> </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 75%; text-align: left"><span style="font-size: 10pt">As at January 1, 2021</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zG2f2YZpOExb" style="width: 9%; text-align: right" title="Av. Exercise price per share, Option Outstanding at beginnig"><span style="font-size: 10pt">1.00</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zOzojxyz5pB" style="width: 9%; text-align: right" title="Option Outstanding at beginnig"><span style="font-size: 10pt">645,000</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Granted</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="text-align: right" title="Av. Exercise price per share, Option Granted"><span style="font-size: 10pt">3.23</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20210101__20211231_pdd" style="text-align: right" title="Option Granted"><span style="font-size: 10pt">1,687,500</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Exercised</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="text-align: right" title="Av. Exercise price per share, Option Exercised"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0720">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210101__20211231_pdd" style="text-align: right" title="Option Exercised"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0722">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Forfeited</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20210101__20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Av. Exercise price per share, Option Forfeited"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20210101__20211231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Option Forfeited"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0726">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">As at December 31, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zWfz0pOtZQMc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Av. Exercise price per share, Option Outstanding at ending"><span style="font-size: 10pt">2.61</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_z7piQtgqaq9l" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Option Outstanding at ending"><span style="font-size: 10pt">2,332,500</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">Exercisable as at December 31, 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231_pdd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Av. Exercise price per share, Option Exercisable"><span style="font-size: 10pt">1.87</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231_pdd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Option Exercisable"><span style="font-size: 10pt">395,269</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">As at January 1, 2022</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zOJQL8ycSW51" style="text-align: right" title="Av. Exercise price per share, Option Outstanding at beginnig"><span style="font-size: 10pt">2.61</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zjbaznyMQ8og" style="text-align: right" title="Option Outstanding at beginnig"><span style="font-size: 10pt">2,332,500</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Granted</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="text-align: right" title="Av. Exercise price per share, Option Granted"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0740">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20221231_pdd" style="text-align: right" title="Option Granted"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0742">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Exercised</span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="text-align: right" title="Av. Exercise price per share, Option Exercised"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0744">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20221231_pdd" style="text-align: right" title="Option Exercised"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-size: 10pt">Forfeited</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Av. Exercise price per share, Option Forfeited"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0748">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Option Forfeited"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0750">-</span></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">As at December 31, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_zvsSOU69B374" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Av. Exercise price per share, Option Outstanding at ending"><span style="font-size: 10pt">2.61</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231_zm7cz4SnL9gh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Option Outstanding at ending"><span style="font-size: 10pt">2,332,500</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">Exercisable as at December 31, 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231_pdd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Av. Exercise price per share, Option Exercisable"><span style="font-size: 10pt">2.18</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231_zk3Z3YluMge7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Option Exercisable"><span style="font-size: 10pt">1,198,577</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font-size: 10pt"> </span></td></tr> </table> 1.00 645000 3.23 1687500 2.61 2332500 1.87 395269 2.61 2332500 2.61 2332500 2.18 1198577 P1Y8M4D P1Y9M14D 1409958 P1Y4M28D <p id="xdx_807_eus-gaap--EarningsPerShareTextBlock_zZq8ZTr6eeBh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 – <span id="xdx_827_zTaI8hV3iwSe">EARNINGS PER SHARE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company calculates earnings/(loss) per share data by calculating the quotient of earnings/(loss) divided by the weighted average number of common shares outstanding during the respective period as required by ASC 260-10-50. Due to the net losses for the years ended December 31, 2022 and 2021, all shares underlying the related party convertible debt, common stock warrants, and common stock options were excluded from the earnings per share calculation due to their anti-dilutive effect.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculation of net earnings per common share — basic and diluted:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zYx2eYLu0n8f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS PER SHARE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BB_zK2VpMpOIk5a" style="display: none; font-size: 10pt">Calculation of net earnings per common share - basic and diluted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_490_20220101_20221231" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_49F_20210101_20211231" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">For the<br/> year ended</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">December 31, <br/> 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">December 31, <br/> 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">Basic and diluted:</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-size: 10pt">Net loss</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">(5,681,833</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">(3,244,506</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">)</span></td></tr> <tr id="xdx_40B_ecustom--WeightedaverageNumberOfCommonShares_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt"><span style="font-size: 10pt">Weighted-average number of common shares</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">6,528,959</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">5,245,622</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--BasicAndDilutedNetIncomeLossPerCommonShare_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Basic and diluted net loss per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">(0.87</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">(0.62</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zYx2eYLu0n8f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS PER SHARE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span id="xdx_8BB_zK2VpMpOIk5a" style="display: none; font-size: 10pt">Calculation of net earnings per common share - basic and diluted</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_490_20220101_20221231" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td id="xdx_49F_20210101_20211231" style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">For the<br/> year ended</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: center"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">December 31, <br/> 2022</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt">December 31, <br/> 2021</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left"><span style="font-size: 10pt">Basic and diluted:</span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td><td><span style="font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left"><span style="font-size: 10pt">Net loss</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">(5,681,833</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">)</span></td><td style="width: 1%"><span style="font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-size: 10pt"> </span></td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">(3,244,506</span></td><td style="width: 1%; text-align: left"><span style="font-size: 10pt">)</span></td></tr> <tr id="xdx_40B_ecustom--WeightedaverageNumberOfCommonShares_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt"><span style="font-size: 10pt">Weighted-average number of common shares</span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">6,528,959</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt">5,245,622</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_ecustom--BasicAndDilutedNetIncomeLossPerCommonShare_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Basic and diluted net loss per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">(0.87</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-size: 10pt">(0.62</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-size: 10pt">)</span></td></tr> </table> -5681833 -3244506 6528959 5245622 -0.87 -0.62 <p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_zbWw3QJCkfC2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 – <span id="xdx_82C_zrFPpubVRfCh">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2023, holders of the Company’s warrants (see Note 8) exercised warrants to purchase an aggregate of <span id="xdx_90A_ecustom--NumberOfWarrantExercised_c20230201__20230228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zfWITgPcTZ48" title="Number of warrant exercised">408,600 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company’s common stock, at an adjusted exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zFleCsOxjwxd" title="Exercise price">3.75 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, resulting in cash proceeds to the Company of $<span id="xdx_904_eus-gaap--ProceedsFromWarrantExercises_pp0p0_c20230201__20230228__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zgTJqXPwZE41" title="Cash proceeds">1,532,250</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> 408600 3.75 1532250 EXCEL 55 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 57 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 58 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 68 226 1 false 19 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://lucyd.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - BALANCE SHEETS Sheet http://lucyd.com/role/BalanceSheets BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - BALANCE SHEETS (Parenthetical) Sheet http://lucyd.com/role/BalanceSheetsParenthetical BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - STATEMENTS OF OPERATIONS Sheet http://lucyd.com/role/StatementsOfOperations STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00000005 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://lucyd.com/role/StatementsOfChangesInStockholdersEquity STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 00000006 - Statement - STATEMENTS OF CASH FLOWS Sheet http://lucyd.com/role/StatementsOfCashFlows STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 00000007 - Disclosure - GENERAL INFORMATION Sheet http://lucyd.com/role/GeneralInformation GENERAL INFORMATION Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://lucyd.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - GOING CONCERN Sheet http://lucyd.com/role/GoingConcern GOING CONCERN Notes 9 false false R10.htm 00000010 - Disclosure - INCOME TAX PROVISION Sheet http://lucyd.com/role/IncomeTaxProvision INCOME TAX PROVISION Notes 10 false false R11.htm 00000011 - Disclosure - INTANGIBLE ASSETS Sheet http://lucyd.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 11 false false R12.htm 00000012 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://lucyd.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 12 false false R13.htm 00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://lucyd.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 13 false false R14.htm 00000014 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://lucyd.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 14 false false R15.htm 00000015 - Disclosure - STOCK BASED COMPENSATION Sheet http://lucyd.com/role/StockBasedCompensation STOCK BASED COMPENSATION Notes 15 false false R16.htm 00000016 - Disclosure - EARNINGS PER SHARE Sheet http://lucyd.com/role/EarningsPerShare EARNINGS PER SHARE Notes 16 false false R17.htm 00000017 - Disclosure - SUBSEQUENT EVENTS Sheet http://lucyd.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 17 false false R18.htm 00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 18 false false R19.htm 00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://lucyd.com/role/SummaryOfSignificantAccountingPolicies 19 false false R20.htm 00000020 - Disclosure - INCOME TAX PROVISION (Tables) Sheet http://lucyd.com/role/IncomeTaxProvisionTables INCOME TAX PROVISION (Tables) Tables http://lucyd.com/role/IncomeTaxProvision 20 false false R21.htm 00000021 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://lucyd.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://lucyd.com/role/IntangibleAssets 21 false false R22.htm 00000022 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://lucyd.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://lucyd.com/role/CommitmentsAndContingencies 22 false false R23.htm 00000023 - Disclosure - STOCK BASED COMPENSATION (Tables) Sheet http://lucyd.com/role/StockBasedCompensationTables STOCK BASED COMPENSATION (Tables) Tables http://lucyd.com/role/StockBasedCompensation 23 false false R24.htm 00000024 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://lucyd.com/role/EarningsPerShareTables EARNINGS PER SHARE (Tables) Tables http://lucyd.com/role/EarningsPerShare 24 false false R25.htm 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesTables 25 false false R26.htm 00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesTables 26 false false R27.htm 00000027 - Disclosure - INCOME TAX PROVISION (Details) Sheet http://lucyd.com/role/IncomeTaxProvisionDetails INCOME TAX PROVISION (Details) Details http://lucyd.com/role/IncomeTaxProvisionTables 27 false false R28.htm 00000028 - Disclosure - INCOME TAX PROVISION (Details 1) Sheet http://lucyd.com/role/IncomeTaxProvisionDetails1 INCOME TAX PROVISION (Details 1) Details http://lucyd.com/role/IncomeTaxProvisionTables 28 false false R29.htm 00000029 - Disclosure - INCOME TAX PROVISION (Details Narrative) Sheet http://lucyd.com/role/IncomeTaxProvisionDetailsNarrative INCOME TAX PROVISION (Details Narrative) Details http://lucyd.com/role/IncomeTaxProvisionTables 29 false false R30.htm 00000030 - Disclosure - INTANGIBLE ASSETS (Details) Sheet http://lucyd.com/role/IntangibleAssetsDetails INTANGIBLE ASSETS (Details) Details http://lucyd.com/role/IntangibleAssetsTables 30 false false R31.htm 00000031 - Disclosure - INTANGIBLE ASSETS (Details Narrative) Sheet http://lucyd.com/role/IntangibleAssetsDetailsNarrative INTANGIBLE ASSETS (Details Narrative) Details http://lucyd.com/role/IntangibleAssetsTables 31 false false R32.htm 00000032 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://lucyd.com/role/RelatedPartyTransactions 32 false false R33.htm 00000033 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://lucyd.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://lucyd.com/role/CommitmentsAndContingenciesTables 33 false false R34.htm 00000034 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://lucyd.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://lucyd.com/role/CommitmentsAndContingenciesTables 34 false false R35.htm 00000035 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://lucyd.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://lucyd.com/role/StockholdersEquity 35 false false R36.htm 00000036 - Disclosure - STOCK BASED COMPENSATION (Details) Sheet http://lucyd.com/role/StockBasedCompensationDetails STOCK BASED COMPENSATION (Details) Details http://lucyd.com/role/StockBasedCompensationTables 36 false false R37.htm 00000037 - Disclosure - STOCK BASED COMPENSATION (Details 1) Sheet http://lucyd.com/role/StockBasedCompensationDetails1 STOCK BASED COMPENSATION (Details 1) Details http://lucyd.com/role/StockBasedCompensationTables 37 false false R38.htm 00000038 - Disclosure - STOCK BASED COMPENSATION (Details Narrative) Sheet http://lucyd.com/role/StockBasedCompensationDetailsNarrative STOCK BASED COMPENSATION (Details Narrative) Details http://lucyd.com/role/StockBasedCompensationTables 38 false false R39.htm 00000039 - Disclosure - EARNINGS PER SHARE (Details) Sheet http://lucyd.com/role/EarningsPerShareDetails EARNINGS PER SHARE (Details) Details http://lucyd.com/role/EarningsPerShareTables 39 false false R40.htm 00000040 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://lucyd.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://lucyd.com/role/SubsequentEvents 40 false false All Reports Book All Reports innovativeeye_10k.htm innovativeeye_ex19.htm innovativeeye_ex23-1.htm innovativeeye_ex31-1.htm innovativeeye_ex31-2.htm innovativeeye_ex32-1.htm innovativeeye_ex32-2.htm lucy-20221231.xsd lucy-20221231_cal.xml lucy-20221231_def.xml lucy-20221231_lab.xml lucy-20221231_pre.xml img_001.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 60 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "innovativeeye_10k.htm": { "axisCustom": 0, "axisStandard": 8, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 353, "http://xbrl.sec.gov/dei/2022": 43 }, "contextCount": 68, "dts": { "calculationLink": { "local": [ "lucy-20221231_cal.xml" ] }, "definitionLink": { "local": [ "lucy-20221231_def.xml" ] }, "inline": { "local": [ "innovativeeye_10k.htm" ] }, "labelLink": { "local": [ "lucy-20221231_lab.xml" ] }, "presentationLink": { "local": [ "lucy-20221231_pre.xml" ] }, "schema": { "local": [ "lucy-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 327, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 39, "http://lucyd.com/20221231": 18, "http://xbrl.sec.gov/dei/2022": 4, "total": 61 }, "keyCustom": 29, "keyStandard": 197, "memberCustom": 9, "memberStandard": 10, "nsprefix": "LUCY", "nsuri": "http://lucyd.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://lucyd.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - INCOME TAX PROVISION", "menuCat": "Notes", "order": "10", "role": "http://lucyd.com/role/IncomeTaxProvision", "shortName": "INCOME TAX PROVISION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - INTANGIBLE ASSETS", "menuCat": "Notes", "order": "11", "role": "http://lucyd.com/role/IntangibleAssets", "shortName": "INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "12", "role": "http://lucyd.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "13", "role": "http://lucyd.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "menuCat": "Notes", "order": "14", "role": "http://lucyd.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - STOCK BASED COMPENSATION", "menuCat": "Notes", "order": "15", "role": "http://lucyd.com/role/StockBasedCompensation", "shortName": "STOCK BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - EARNINGS PER SHARE", "menuCat": "Notes", "order": "16", "role": "http://lucyd.com/role/EarningsPerShare", "shortName": "EARNINGS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "17", "role": "http://lucyd.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "18", "role": "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "LUCY:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "19", "role": "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "LUCY:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://lucyd.com/role/BalanceSheets", "shortName": "BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - INCOME TAX PROVISION (Tables)", "menuCat": "Tables", "order": "20", "role": "http://lucyd.com/role/IncomeTaxProvisionTables", "shortName": "INCOME TAX PROVISION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - INTANGIBLE ASSETS (Tables)", "menuCat": "Tables", "order": "21", "role": "http://lucyd.com/role/IntangibleAssetsTables", "shortName": "INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "menuCat": "Tables", "order": "22", "role": "http://lucyd.com/role/CommitmentsAndContingenciesTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - STOCK BASED COMPENSATION (Tables)", "menuCat": "Tables", "order": "23", "role": "http://lucyd.com/role/StockBasedCompensationTables", "shortName": "STOCK BASED COMPENSATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - EARNINGS PER SHARE (Tables)", "menuCat": "Tables", "order": "24", "role": "http://lucyd.com/role/EarningsPerShareTables", "shortName": "EARNINGS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "LUCY:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "menuCat": "Details", "order": "25", "role": "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "LUCY:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProvisionForDoubtfulAccounts", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "26", "role": "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - INCOME TAX PROVISION (Details)", "menuCat": "Details", "order": "27", "role": "http://lucyd.com/role/IncomeTaxProvisionDetails", "shortName": "INCOME TAX PROVISION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - INCOME TAX PROVISION (Details 1)", "menuCat": "Details", "order": "28", "role": "http://lucyd.com/role/IncomeTaxProvisionDetails1", "shortName": "INCOME TAX PROVISION (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - INCOME TAX PROVISION (Details Narrative)", "menuCat": "Details", "order": "29", "role": "http://lucyd.com/role/IncomeTaxProvisionDetailsNarrative", "shortName": "INCOME TAX PROVISION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://lucyd.com/role/BalanceSheetsParenthetical", "shortName": "BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - INTANGIBLE ASSETS (Details)", "menuCat": "Details", "order": "30", "role": "http://lucyd.com/role/IntangibleAssetsDetails", "shortName": "INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AdjustmentForAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - INTANGIBLE ASSETS (Details Narrative)", "menuCat": "Details", "order": "31", "role": "http://lucyd.com/role/IntangibleAssetsDetailsNarrative", "shortName": "INTANGIBLE ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AdjustmentForAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConvertibleDebtCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "menuCat": "Details", "order": "32", "role": "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-09-012022-09-05", "decimals": "0", "lang": null, "name": "us-gaap:ConversionOfStockAmountConverted1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)", "menuCat": "Details", "order": "33", "role": "http://lucyd.com/role/CommitmentsAndContingenciesDetails", "shortName": "COMMITMENTS AND CONTINGENCIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "LUCY:BaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "menuCat": "Details", "order": "34", "role": "http://lucyd.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "LUCY:BaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "menuCat": "Details", "order": "35", "role": "http://lucyd.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - STOCK BASED COMPENSATION (Details)", "menuCat": "Details", "order": "36", "role": "http://lucyd.com/role/StockBasedCompensationDetails", "shortName": "STOCK BASED COMPENSATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - STOCK BASED COMPENSATION (Details 1)", "menuCat": "Details", "order": "37", "role": "http://lucyd.com/role/StockBasedCompensationDetails1", "shortName": "STOCK BASED COMPENSATION (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - STOCK BASED COMPENSATION (Details Narrative)", "menuCat": "Details", "order": "38", "role": "http://lucyd.com/role/StockBasedCompensationDetailsNarrative", "shortName": "STOCK BASED COMPENSATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - EARNINGS PER SHARE (Details)", "menuCat": "Details", "order": "39", "role": "http://lucyd.com/role/EarningsPerShareDetails", "shortName": "EARNINGS PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "lang": null, "name": "LUCY:WeightedaverageNumberOfCommonShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://lucyd.com/role/StatementsOfOperations", "shortName": "STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2023-02-012023-02-28_us-gaap_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "LUCY:NumberOfWarrantExercised", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "menuCat": "Details", "order": "40", "role": "http://lucyd.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2023-02-012023-02-28_us-gaap_SubsequentEventMember", "decimals": "INF", "first": true, "lang": null, "name": "LUCY:NumberOfWarrantExercised", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "menuCat": "Statements", "order": "5", "role": "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity", "shortName": "STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "6", "role": "http://lucyd.com/role/StatementsOfCashFlows", "shortName": "STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - GENERAL INFORMATION", "menuCat": "Notes", "order": "7", "role": "http://lucyd.com/role/GeneralInformation", "shortName": "GENERAL INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "8", "role": "http://lucyd.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - GOING CONCERN", "menuCat": "Notes", "order": "9", "role": "http://lucyd.com/role/GoingConcern", "shortName": "GOING CONCERN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "innovativeeye_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 19, "tag": { "LUCY_AllowanceForSalesReturns": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Allowance for sales returns" } } }, "localname": "AllowanceForSalesReturns", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "LUCY_BaseTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Base term" } } }, "localname": "BaseTerm", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "LUCY_BasicAndDilutedNetIncomeLossPerCommonShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted net loss per common share" } } }, "localname": "BasicAndDilutedNetIncomeLossPerCommonShare", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/EarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "LUCY_CapitalizedSoftwarePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Capitalized Software" } } }, "localname": "CapitalizedSoftwarePolicyTextBlock", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "LUCY_CollectionOfStockSubscriptionReceivable": { "auth_ref": [], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "CollectionOfStockSubscriptionReceivable", "verboseLabel": "Collection of stock subscription receivable" } } }, "localname": "CollectionOfStockSubscriptionReceivable", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "LUCY_CollectionOfStockSubscriptionsReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Collection of stock subscription receivable" } } }, "localname": "CollectionOfStockSubscriptionsReceivable", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "LUCY_CommonStock0.00001ParValueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, $0.00001 par value" } } }, "localname": "CommonStock0.00001ParValueMember", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "domainItemType" }, "LUCY_ContractAssetsAndLiabilities": { "auth_ref": [], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "ContractAssetsAndLiabilities", "negatedLabel": "Contract assets and liabilities" } } }, "localname": "ContractAssetsAndLiabilities", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "LUCY_DueToParentAndAffiliates": { "auth_ref": [], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Due to Parent and Affiliates" } } }, "localname": "DueToParentAndAffiliates", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "LUCY_EarningsPerSharesBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loss per share, basic and diluted" } } }, "localname": "EarningsPerSharesBasicAndDiluted", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "LUCY_ExpensesPaidByParentAndAffiliates": { "auth_ref": [], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Expenses paid by parent and affiliates" } } }, "localname": "ExpensesPaidByParentAndAffiliates", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "LUCY_ExpensesPaidForByParentReportedAsIncreaseInDueToParentAndAffiliatesAndRelatedPartyConvertibleDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Expenses paid for by Parent reported as increase in Due to Parent and Affiliates and related party convertible debt" } } }, "localname": "ExpensesPaidForByParentReportedAsIncreaseInDueToParentAndAffiliatesAndRelatedPartyConvertibleDebt", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "LUCY_InitialPublicOfferingSeeNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Initial public offering (see Note 8)" } } }, "localname": "InitialPublicOfferingSeeNote", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "LUCY_InitialPublicOfferingShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Initial public offering (see Note 10), shares" } } }, "localname": "InitialPublicOfferingShares", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "LUCY_InternalUseSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Internal Use Software [Member]" } } }, "localname": "InternalUseSoftwareMember", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "LUCY_InventoryPrepayment": { "auth_ref": [], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Inventory prepayment" } } }, "localname": "InventoryPrepayment", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/BalanceSheets", "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "LUCY_LucydMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lucyd [Member]" } } }, "localname": "LucydMember", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "LUCY_MaximMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Maxim [Member]" } } }, "localname": "MaximMember", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "LUCY_MobileKioskDisplayMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mobile Kiosk Display [Member]" } } }, "localname": "MobileKioskDisplayMember", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "LUCY_NumberOfWarrantExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of warrant exercised" } } }, "localname": "NumberOfWarrantExercised", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "LUCY_NumberOfWarrantsPurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of warrants purchased" } } }, "localname": "NumberOfWarrantsPurchased", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "LUCY_ParentAndAffiliatesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Parent And Affiliates [Member]" } } }, "localname": "ParentAndAffiliatesMember", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "LUCY_PaymentOfDeferredOfferingCost": { "auth_ref": [], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "PaymentOfDeferredOfferingCost", "negatedLabel": "Payment of deferred offering cost" } } }, "localname": "PaymentOfDeferredOfferingCost", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "LUCY_PaymentToAcquirePatentCosts": { "auth_ref": [], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "PaymentToAcquirePatentCosts", "negatedLabel": "Patent costs" } } }, "localname": "PaymentToAcquirePatentCosts", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "LUCY_RentExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Rent expenses" } } }, "localname": "RentExpenses", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "LUCY_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of estimated useful lives of property and equipment" } } }, "localname": "ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "LUCY_SharesIssuedForConversionOfRelatedPartyConvertibleNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares issued for conversion of related party convertible note" } } }, "localname": "SharesIssuedForConversionOfRelatedPartyConvertibleNote", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "LUCY_SharesIssuedForConversionOfRelatedPartyConvertibleNoteShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares issued for conversion of related party convertible note, shares" } } }, "localname": "SharesIssuedForConversionOfRelatedPartyConvertibleNoteShares", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "LUCY_ShippingAndHandlingsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shipping and Handling" } } }, "localname": "ShippingAndHandlingsPolicyTextBlock", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "LUCY_StateNetOperatingLossCarryforwards": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "State net operating loss carryforwards" } } }, "localname": "StateNetOperatingLossCarryforwards", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "LUCY_StockSubscriptionReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Subscription Receivable [Member]" } } }, "localname": "StockSubscriptionReceivableMember", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "LUCY_TekcapitalEuropeLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Tekcapital Europe Ltd [Member]" } } }, "localname": "TekcapitalEuropeLtdMember", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "LUCY_UnderwritersDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Underwriters description" } } }, "localname": "UnderwritersDescription", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "LUCY_WarrantsToPurchaseCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants to purchase Common Stock" } } }, "localname": "WarrantsToPurchaseCommonStockMember", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "domainItemType" }, "LUCY_WeightedAverageNumberOfSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstanding", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "LUCY_WeightedaverageNumberOfCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted-average number of common shares" } } }, "localname": "WeightedaverageNumberOfCommonShares", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "LUCY_WriteoffOfUncollectibleStockSubscriptionReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Write-off of uncollectible stock subscription receivable" } } }, "localname": "WriteoffOfUncollectibleStockSubscriptionReceivable", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "LUCY_WriteoffOfUncollectibleStockSubscriptionReceivables": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "WriteoffOfUncollectibleStockSubscriptionReceivables", "verboseLabel": "Write-off of uncollectible stock subscription receivable" } } }, "localname": "WriteoffOfUncollectibleStockSubscriptionReceivables", "nsuri": "http://lucyd.com/20221231", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r359", "r361", "r362" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r359", "r361", "r362" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r359", "r361", "r362" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r359", "r361", "r362" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r360" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r348" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r364" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r359", "r361", "r362" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r361" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_MaximumMember": { "auth_ref": [ "r195", "r196", "r197", "r198", "r228", "r297", "r320", "r329", "r330", "r342", "r343", "r347", "r391", "r403", "r404", "r405", "r406", "r407", "r408" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails", "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r195", "r196", "r197", "r198", "r228", "r297", "r320", "r329", "r330", "r342", "r343", "r347", "r391", "r403", "r404", "r405", "r406", "r407", "r408" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails", "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r195", "r196", "r197", "r198", "r226", "r228", "r238", "r239", "r240", "r296", "r297", "r320", "r329", "r330", "r342", "r343", "r347", "r387", "r391", "r404", "r405", "r406", "r407", "r408" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails", "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r195", "r196", "r197", "r198", "r226", "r228", "r238", "r239", "r240", "r296", "r297", "r320", "r329", "r330", "r342", "r343", "r347", "r387", "r391", "r404", "r405", "r406", "r407", "r408" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails", "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r9" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r174", "r175" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net of allowance of $92,646 and $0, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r47", "r96" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r4", "r346" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r242", "r243", "r244", "r376", "r377", "r378", "r397" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r27", "r43" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization expense" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r60", "r61", "r229" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Stock based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r103", "r176", "r179", "r180", "r182" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r27", "r39", "r43" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r76", "r82", "r99", "r122", "r162", "r165", "r169", "r177", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r267", "r271", "r276", "r346", "r389", "r390", "r401" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "TOTAL ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r91", "r108", "r122", "r177", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r267", "r271", "r276", "r346", "r389", "r390", "r401" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-Current Assets" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalizedComputerSoftwareNet": { "auth_ref": [ "r331" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.", "label": "Capitalized software costs" } } }, "localname": "CapitalizedComputerSoftwareNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r29", "r94", "r333" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r24", "r29", "r33" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash at End of Year", "periodStartLabel": "Cash at Beginning of Year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r24", "r71" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net Change In Cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Non-Cash Transaction" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r100", "r101", "r102", "r122", "r137", "r138", "r140", "r141", "r148", "r149", "r177", "r199", "r201", "r202", "r203", "r206", "r207", "r210", "r211", "r213", "r217", "r223", "r276", "r332", "r368", "r374", "r379" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative", "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r14", "r78", "r86" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r49", "r193", "r194", "r326", "r388" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r376", "r377", "r397" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheetsParenthetical", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r3", "r52" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r3", "r346" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock (par value $0.00001, 50,000,000 shares authorized, and 7,307,157 and 6,060,187 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively)" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Stock-Based Compensation" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r81", "r153" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentrations of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConversionOfStockAmountConverted1": { "auth_ref": [ "r30", "r31", "r32" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of stock, amount" } } }, "localname": "ConversionOfStockAmountConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r30", "r31", "r32" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Number of shares converted" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleDebtCurrent": { "auth_ref": [ "r1" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Related party convertible debt", "verboseLabel": "Convertible notes balances" } } }, "localname": "ConvertibleDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets", "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r18", "r122", "r177", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r276", "r389" ], "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "negatedLabel": "Less: Cost of Goods Sold" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r50", "r208" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Conversion Price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r13", "r72", "r209" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DeferredOfferingCosts": { "auth_ref": [ "r386" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.", "label": "Deferred offering costs" } } }, "localname": "DeferredOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r369" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueNoncurrent": { "auth_ref": [ "r370" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Deferred Revenue, Noncurrent", "verboseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r252" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred tax assets Gross" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGrossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred tax assets:" } } }, "localname": "DeferredTaxAssetsGrossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r395" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": { "auth_ref": [ "r66", "r396" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.", "label": "Net operating losses \u2013 state" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": { "auth_ref": [ "r66", "r396" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.", "label": "Net operating losses \u2013 federal" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r66", "r396" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Other \u2013 net" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r66", "r396" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Stock-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r253" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Less Valuation Allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r27", "r45" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r27", "r160" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r142", "r143", "r144", "r145" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "EARNINGS PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r241" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Unrecognized stock compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r241" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Unrecognized stock compensation expense, term" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r52", "r89", "r112", "r113", "r114", "r125", "r126", "r127", "r129", "r134", "r136", "r147", "r178", "r225", "r242", "r243", "r244", "r257", "r258", "r274", "r277", "r278", "r279", "r280", "r281", "r282", "r286", "r321", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r69", "r70" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r97", "r190" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Less: Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Future amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r188", "r189", "r190", "r191", "r303", "r304" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r42", "r304" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangible assets, gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r40", "r41" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r42", "r303" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedPatentsGross": { "auth_ref": [ "r42" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.", "label": "Patent costs, net" } } }, "localname": "FiniteLivedPatentsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r19" ], "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "negatedLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r17", "r122", "r162", "r164", "r168", "r170", "r177", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r276", "r341", "r389" ], "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross (Deficit) Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r123", "r249", "r250", "r255", "r259", "r261", "r263", "r264", "r265" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAX PROVISION" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvision" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r124", "r135", "r136", "r161", "r247", "r260", "r262", "r319" ], "calculation": { "http://lucyd.com/role/IncomeTaxProvisionDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "totalLabel": "Total" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r111", "r245", "r246", "r250", "r251", "r254", "r256" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r394" ], "calculation": { "http://lucyd.com/role/IncomeTaxProvisionDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "negatedLabel": "Change in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r248" ], "calculation": { "http://lucyd.com/role/IncomeTaxProvisionDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Income tax benefit at the statutory federal rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r394" ], "calculation": { "http://lucyd.com/role/IncomeTaxProvisionDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "State income tax benefits, net of federal benefit" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r26" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r26" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r26" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "auth_ref": [ "r373" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current assets classified as other.", "label": "Increase (Decrease) in Other Current Assets", "negatedLabel": "Other current assets" } } }, "localname": "IncreaseDecreaseInOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r26" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "INTANGIBLE ASSETS" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r41", "r299", "r300", "r301", "r303", "r336" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible Assets" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r73", "r80", "r115", "r159", "r284" ], "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest Expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r105", "r334", "r346" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r93", "r104", "r146", "r183", "r184", "r185", "r298", "r337" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Schedule of future minimum payments due" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r285" ], "calculation": { "http://lucyd.com/role/CommitmentsAndContingenciesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r285" ], "calculation": { "http://lucyd.com/role/CommitmentsAndContingenciesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter (through 2032)" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r285" ], "calculation": { "http://lucyd.com/role/CommitmentsAndContingenciesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r285" ], "calculation": { "http://lucyd.com/role/CommitmentsAndContingenciesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r285" ], "calculation": { "http://lucyd.com/role/CommitmentsAndContingenciesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r285" ], "calculation": { "http://lucyd.com/role/CommitmentsAndContingenciesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r285" ], "calculation": { "http://lucyd.com/role/CommitmentsAndContingenciesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r10", "r122", "r177", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r268", "r271", "r272", "r276", "r340", "r389", "r401", "r402" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities [Default Label]", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r8", "r77", "r84", "r346", "r375", "r385", "r398" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r12", "r92", "r122", "r177", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r268", "r271", "r272", "r276", "r346", "r389", "r401", "r402" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-Current Liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUncertainTaxPositionsCurrent": { "auth_ref": [ "r11" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for uncertainty in income taxes classified as current.", "label": "Liabilities for uncertain tax positions" } } }, "localname": "LiabilityForUncertainTaxPositionsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ManagementFeeExpense": { "auth_ref": [ "r74" ], "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).", "label": "Management fee", "negatedLabel": "Related party management fee" } } }, "localname": "ManagementFeeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r150", "r156" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "GENERAL INFORMATION" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/GeneralInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r119" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r119" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r24", "r25", "r28" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r16", "r28", "r79", "r87", "r90", "r109", "r110", "r114", "r122", "r128", "r130", "r131", "r132", "r133", "r135", "r136", "r139", "r162", "r164", "r168", "r170", "r177", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r275", "r276", "r341", "r389" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "verboseLabel": "Net Loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows", "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "negatedTotalLabel": "Total Operating Expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r65" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Federal net operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r107", "r346" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r98" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other non-current assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashExpense": { "auth_ref": [ "r28" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.", "label": "Non cash interest expense" } } }, "localname": "OtherNoncashExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r20" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Capitalized software expenditures" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r20" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock , shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r2", "r210" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock , shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r106", "r186", "r187", "r335" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r22" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from related party convertible debt", "verboseLabel": "Convertible debt issued" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r21" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from initial public offering (see Note 8)", "verboseLabel": "Proceeds from offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r21" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from issuance of shares, net of offering costs" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r372" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Cash proceeds" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r90", "r109", "r110", "r118", "r122", "r128", "r135", "r136", "r162", "r164", "r168", "r170", "r177", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r266", "r269", "r270", "r275", "r276", "r317", "r341", "r344", "r345", "r371", "r389" ], "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Net Loss", "verboseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/EarningsPerShareDetails", "http://lucyd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r46", "r95" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r48", "r85", "r318", "r346" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets", "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r48", "r327", "r328" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r117", "r181" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision for doubtful accounts", "verboseLabel": "Bad debt expenses" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows", "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r381", "r382", "r383", "r384" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Receivables and Credit Policy" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r227", "r289", "r290" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r227", "r289", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r400" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r287", "r288", "r290", "r291", "r292" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfConvertibleDebt": { "auth_ref": [ "r23" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Repayments of Convertible Debt", "negatedLabel": "Repayment of related party convertible debt" } } }, "localname": "RepaymentsOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r63", "r88", "r409" ], "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "negatedLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r5", "r53", "r83", "r324", "r325", "r346" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r89", "r125", "r126", "r127", "r129", "r134", "r136", "r178", "r242", "r243", "r244", "r257", "r258", "r274", "r321", "r323" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r338", "r339" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r116", "r122", "r157", "r158", "r163", "r166", "r167", "r171", "r172", "r173", "r177", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r276", "r317", "r389" ], "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues, net" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Issauance of common stock" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of deferred tax assets" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Calculation of net earnings per common share - basic and diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of reconciliation of federal statutory tax rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r40", "r41", "r303" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r40", "r41" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of intangible assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r74", "r75" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "negatedLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r26" ], "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r238" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk free rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Available for the grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r232" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Option Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r232" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Av. Exercise price per share, Option Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r392" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Av. Exercise price per share, Option Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Option Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Option Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Stock granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Grant date fair value of options", "verboseLabel": "Weighted average grant date fair value of options outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails", "http://lucyd.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.", "label": "Schedule fair value of options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r230", "r231" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Option Outstanding at ending", "periodStartLabel": "Option Outstanding at beginnig" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r230", "r231" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Av. Exercise price per share, Option Outstanding at ending", "periodStartLabel": "Av. Exercise price per share, Option Outstanding at beginnig" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Schedule of number of share options and the weighted average exercise price outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r234" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Av. Exercise price per share, Option Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r233" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Av. Exercise price per share, Option Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1" ], "xbrltype": "perShareItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "verboseLabel": "Share price at date of grant" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r237" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Options life in years" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual life of options exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual life of options outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [ "r54", "r62" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).", "label": "STOCK BASED COMPENSATION" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginnig balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r34", "r120" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r100", "r101", "r102", "r122", "r137", "r138", "r140", "r141", "r148", "r149", "r177", "r199", "r201", "r202", "r203", "r206", "r207", "r210", "r211", "r213", "r217", "r223", "r276", "r332", "r368", "r374", "r379" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r15", "r52", "r89", "r112", "r113", "r114", "r125", "r126", "r127", "r129", "r134", "r136", "r147", "r178", "r225", "r242", "r243", "r244", "r257", "r258", "r274", "r277", "r278", "r279", "r280", "r281", "r282", "r286", "r321", "r322", "r323" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/Cover", "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity", "http://lucyd.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r125", "r126", "r127", "r147", "r302" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/Cover", "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity", "http://lucyd.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Issuance of shares, net of offering costs of $28,230, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r2", "r3", "r52", "r53", "r234" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Option Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Issuance of shares, net of offering costs of $351,411" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r3", "r6", "r7", "r38", "r346", "r375", "r385", "r398" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "TOTAL STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets", "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r54", "r121", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r225", "r273" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteSubscriptionsReceivable": { "auth_ref": [ "r2", "r3", "r6", "r51" ], "calculation": { "http://lucyd.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Note received instead of cash as contribution to equity. The transaction may be a sale of capital stock or a contribution to paid-in capital.", "label": "Stockholders' Equity Note, Subscriptions Receivable", "negatedLabel": "Stock subscription receivable" } } }, "localname": "StockholdersEquityNoteSubscriptionsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r283", "r294" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r283", "r294" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r283", "r294" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r283", "r294" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reporting subsequent events.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r293", "r295" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "GOING CONCERN" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r35", "r36", "r37", "r151", "r152", "r154", "r155" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r34": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r348": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r349": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r351": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r352": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r353": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r354": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r355": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r356": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r357": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r358": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r359": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r361": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r362": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r363": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r364": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r365": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r366": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r367": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.A)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r388": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 61 0001829126-23-002253-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001829126-23-002253-xbrl.zip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�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�<7MY M1A30P_W2%8(GJ](]:?VF$VB;7?("@#=M.*JV&0^4J-#N#B-U!^6X[6'_3+89 MYZ^$SC)4*>(1(KN1.LI"9DX46 <\O;[X771[^"X65<86KSY ($)[G$R3,*&U M;.E5ZAG<,R5:DP)'B:;Q2#J/\9I[4YOVCQ-;BSL %:W\V] M+U"C.2:R(OB$A2KCV@#VT&D $K(G']B3QUBHD7M7 1@$:2 ^"NT1+)%-J3NU M;Y"X*#+K[B2/HVEV993FE;,]**4=OV-1]0X55JNS$,E<'#]QW(6VDUE5E%(% MU:EU*<% SKZ)'R]CD@2N+HG%(TF $&MI"IYU>@SW@FDY^^3H*=RJ^,2@/:50 MM5!E;'V8N02I^?5C?O7"&B"L>2@H<525C#MLE #W^K2MC]//V5W1?1$D )"D>)>5H ^AB\OU M& IK#(;60Z"L&*F$!6AX%N!PSSP1^;H5Q'8Y@-A"$-OI &)[D'+\\(=-GL/? M636*EI*0JMJ-Y$*\&ER(+0[[1^9^OPY5M>2T+ZFQ;ARENV9): >5E8W.6$.H M6V+J3R]-,E]KV>_NN*X)CED_H, _/(PO+RZB$);@;1]Y6,=RM7:X"Z;;J()- M P78+LU3:Z1\SNS?2'9V,P*Q.PY]+L$E(R8YZT,ZM!,R[&GU&.5$M[?I?%>$ M$H#;.M.ZF1RP/59V=WYWCH!RI+$5V(V=K%G(C$EO)+G."0B:!:F+*,&.6(=C MWC QAH38=C, OBJ:=>0U7*]#*F#;QQ::R?XJ0*KAD-HRP"T L$ENM0E;K=2V M.4.'0 VZ>)TRP45Q'!5>2$/I*JLX #2CUV1\JB6GW-V1SUP[%'OFQ+X+B6_P M ;2$[0LM&04<,#ZT$,3:0F_,8\?BM?B_>$(<3%WCR]')=@ M=&:W>T?Z EUC$^]GAR27S@X!!!$(] M-NRCVXNXE\_A^25#8)A$!+$H2Q^B6)D^\I"[$X)P":LUG'PZRP4=8)EQ;2D] MT!H:"'YJ/U2Q9 +D#O.AG%WJT"\OXTZOYEA K!X@NA[=$R;+-D%;*H,23GVT M$H$,69^WF2%DF1LH9/3 QM]C8" KFE& M*U0NB$FU3K J]B_9^@@ C[))B7,#-]^/_JKO(J4+P<-W=W)!]S"NJ4!2U"4X M.]F5-=UM.5,#1+1>+=I<>'K+W@W!CU'8\\8VW]W1>1_VQ9:)/Z;W'B0SR M^?Y5KB(&H__C[9NW"B 8,UG3HJR;9&JT!F:2H&E1A/)ZTJ(KME48H.5$2.K, MR2MG*)C4G6L^"KW*F%H_$+/='96S?5#W6U%27)PS=+):1H>;T>!]#D9EDOE, M'7V/][/1'W3=6B*'GIFKN9&OYV5 M"UH2'LZZDI". /P:+WB+H;"],H%9YH8GQ4K\!3KFY63U,<2.&P#8/9:\-W(Z MCD 6O';N"7H/QR+' SJDBN""8+,0MMJPM;9I:FV0DLFNT#2B$,=V$QQ!9E J M'YQ1[:I%-NC,8DMYP,9+PK!,,EQREJ=_HS5?UJQLQEN2E78X[IZ]KD2NQ.S* M%X *P8Y VHL#H=V/ON\;BYL(N$?\MC:U7Y1A1(^W'>/"_1T?W=(_4HGE<$XM M9$5,K1J])0$=P@?;&[:;?BW5E2ZTND.E5@"'%7T$S%L:-K=U16*QJ\F-?5,+ M[=Z#DH'TJ9%Z//QA<^K"*GFQ@ 2.5!86);J6V/#\EDI/:->=[>;GV0L/A^%O M9@8$,Y(VR&%:5=+C6(G="P/+@U[P/V)77"$];*LNM>\&<[]>F:(!MJ:2?H3T M_.<9/8Q,+J' R^9P=6WJ0!QA;LE0-W(M76RC5F0%HJD8;N=K 7[]?UTT:W?G M>7;UPD)&&E;]= _ZB \!+H3D<\1C*8,9#K,-X%ZEF:^/N,G0,AKADZK%**X_5B/\7EMY/S'/WIDP.&*^2[96JM2E(KH-/'1Z,("'0O#0V0 >^MQ; M_[%J+ ^R%$BDV":!90\@8PX><(9$,#P9I@TX08U@/AI'AN&K;-35MR?E/'L? M>Q!DI^39=>;D>B"IGPFN]1Z_/^7FKL6E-4J]3>O)P_&TKF'3%[9[H MH@!:S^3[9:.UMFO"Q0R;)$\HM&J$8I,1XL;#>A,5#_PR3&)D-&8RX+ECW]I' M$;B-DO$,0*5T_1[A#21$I7 G#EBZD@FIIY>2=ZYR#KYP_WX>QL1>1#9T];O' M(W$9=%!!'51KT=/XZ*2'M0X6_>N+-R"7RI KL T?\4VW$G ='-/.(K+1H"35#93JHHFT2@/@JX7Z;+NX[ M=Q5/ZXY>/J#X.(TCRQ@HE\!/)!-/RA9]L9KG=.<\:2CYPU&TQ:-((:VPIG]0 M9I3A_-ER1K6T:^#):6!-9K03O8]43H96FS<^?>C==]-"7)Z=7_J5V&H#/R5C MNE\;O_^3S&D%KN-N"IDF@SW"/ECNN*86R8I+..W/XNCU;Q\R"DO<&),9.$6% M-=?R<]4XW3>1;M'RC-A"BASZ.8AC:/FFQBCNV7S4DQOW3TIW<9]VW\)!@WQ9 M&H03;/??+D&YFR=]LZZ1-70UI8+K?_MG6*C58:XC'39>23KW?N/PA5UU+*UG M(NX\$P<;6BA"F.M[V,7#+GZJNUAIK^_9Z0O_32/E(&>GZFWEG&Q_^]-,K;+UAGPW[[,GNL]J@'^#]#\R0[=<= MF9:MOBD9SM+#""Q%W,+A:Q(I;-94&W,,W6\@CG2)X2SAXQC)(D0M83HO0%"Y M6A8/;PEN<+]QZ-W_N:I&$0/IT>XVS1+ +5@!89386D/+\(<4TDB#4H$WX(<8:+>VN-O>P,Z29E[0BK+1HM]0VC/LM.T- M>VT99)-IA97;9()H\%\$9SMP78[UGZZ@ 8[I.$\=C[K4R?RKK;(ZS<:.]]6G M%CB M.3%2()"\YW* )P-9N!6_>#C@%T/\XOF 7WR0VR(\"W=V#<:U'ZBL,>U08I.1.0KWN,W M!#Q$/WQE58$/#O1&1GA),IHNC'+O8/\0 8MO(WVQO=Q,&H0QUCZV.N@0>BE< M55SOYZL;G.C],2_BD@M+,/0\[?S:OP/-!5;JSU\=7GYUX^%TZ ^GC7OWG2=? MLGV4[=&C!F]YPA]1 MG-]RNF9:E6V1[G'[MV^B:CIZ?G1P$A\=G\='IZ[5_?/+ONLKMK\\K9L_[1TQJ:J]DS[%=N,H^MZ#[O3U1])WO\^RQO0HN=[#X).8E3^9 MNOXF>J4@F) :Y0\>,+<=F7>5P_O%9?'!^?JN]WO_5!;OM? M?N 8-Q3!HUJ?TY.C^.3P[,&OS_F7N3R'Y\?QV=G=+-0/6Y[[*_P[WN0ZU7]\ M=$>;]C,< G

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end